{
  "5713394af9287de436000001": {
    "query": "Which is the underlying mechanism for exon skipping used to treat Duchenne muscular dystrophy?",
    "type": "summary",
    "ideal_answer": [
      "Antisense-mediated exon skipping therapy is a promising therapeutic approach that uses short DNA-like molecules called antisense oligonucleotides (AOs) to skip over/splice out the mutated part of the gene to produce a shortened but functional dystrophin protein. Many Duchenne Muscular Dystrophy patients need exon skipping of multiple exons in order to restore the reading frame, depending on how many base pairs the mutated exon(s) and adjacent exons have.",
      "Antisense-mediated exon skipping therapy is a promising therapeutic approach that uses short DNA-like molecules called antisense oligonucleotides (AOs) to skip over/splice out the mutated part of the gene to produce a shortened but functional dystrophin protein ",
      "Antisense-mediated exon skipping therapy is a promising therapeutic approach that uses short DNA-like molecules called antisense oligonucleotides (AOs) to skip over/splice out the mutated part of the gene to produce a shortened but functional dystrophin protein",
      "Antisense oligonucleotides (AONs) that bind to complementary sequences of the dystrophin pre-mRNA to induce skipping of the targeted exon by modulating pre-mRNA splicing are promising therapeutic agents for DMD. In addition, multiple exon skipping could be used to select deletions that optimize the functionality of the truncated dystrophin protein. Theoretically, multiple exon skipping could be used to treat approximately 90%, 80%, and 98% of DMD patients with deletion, duplication, and nonsense mutations, respectively. One major challenge has been its limited applicability."
    ],
    "ground_truth_ids": [
      "19140108",
      "22086232",
      "23521559",
      "20150322",
      "24380394",
      "17612397"
    ],
    "retrieved_ids": [
      "24380394",
      "30171554",
      "17612397",
      "19140108",
      "20150322",
      "22086232",
      "22968481",
      "23521559",
      "7557061",
      "31546754"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24380394",
        "score": 0.7194156646728516,
        "title": "Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24380394"
      },
      {
        "pubmed_id": "30171554",
        "score": 0.697716236114502,
        "title": "In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30171554"
      },
      {
        "pubmed_id": "17612397",
        "score": 0.6873046159744263,
        "title": "Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17612397"
      },
      {
        "pubmed_id": "19140108",
        "score": 0.6768410205841064,
        "title": "In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19140108"
      },
      {
        "pubmed_id": "20150322",
        "score": 0.6365670561790466,
        "title": "RNA-targeted splice-correction therapy for neuromuscular disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20150322"
      },
      {
        "pubmed_id": "22086232",
        "score": 0.6353046298027039,
        "title": "Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22086232"
      },
      {
        "pubmed_id": "22968481",
        "score": 0.6272941827774048,
        "title": "Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22968481"
      },
      {
        "pubmed_id": "23521559",
        "score": 0.6151017546653748,
        "title": "Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23521559"
      },
      {
        "pubmed_id": "7557061",
        "score": 0.5916852951049805,
        "title": "[Relations between delayed diagnosis and forms of onset in Duchenne muscular dystrophy].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7557061"
      },
      {
        "pubmed_id": "31546754",
        "score": 0.568392813205719,
        "title": "miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31546754"
      }
    ],
    "query_time": 1.0521938800811768,
    "metrics": {
      "precision": 0.6,
      "recall": 1.0,
      "f1_score": 0.7499999999999999,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "54e22ee4ae9738404b000013": {
    "query": "Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.",
    "type": "summary",
    "ideal_answer": [
      "LINX Reflux Management System is a sphincter augmentation device designed to prevent gastroesophageal reflux due to abnormal opening of the lower esophageal sphincter (LES) by augmenting the sphincter barrier. It is implanted via laparoscopic procedure that does not alter gastric anatomy and is easily reversible."
    ],
    "ground_truth_ids": [
      "23155537",
      "22538694",
      "24117632",
      "21037442",
      "25062898",
      "24778041",
      "19951799",
      "25000345",
      "25012804",
      "23814607",
      "23237251",
      "25264655"
    ],
    "retrieved_ids": [
      "25062898",
      "23814607",
      "23237251",
      "22538694",
      "25264655",
      "25000345",
      "24778041",
      "24117632",
      "25012804",
      "23155537"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25062898",
        "score": 0.7865391969680786,
        "title": "Is the LINX reflux management system an effective treatment for gastro-oesophageal reflux disease?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25062898"
      },
      {
        "pubmed_id": "23814607",
        "score": 0.7580617070198059,
        "title": "LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23814607"
      },
      {
        "pubmed_id": "23237251",
        "score": 0.7566564679145813,
        "title": "LINX(™) Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23237251"
      },
      {
        "pubmed_id": "22538694",
        "score": 0.6963282227516174,
        "title": "The LINX® reflux management system: confirmed safety and efficacy now at 4 years.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22538694"
      },
      {
        "pubmed_id": "25264655",
        "score": 0.6372886300086975,
        "title": "Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25264655"
      },
      {
        "pubmed_id": "25000345",
        "score": 0.5981509685516357,
        "title": "Nonmedical therapeutic strategies for nonerosive reflux disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25000345"
      },
      {
        "pubmed_id": "24778041",
        "score": 0.5538294315338135,
        "title": "Modern GERD treatment: feasibility of minimally invasive esophageal sphincter augmentation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24778041"
      },
      {
        "pubmed_id": "24117632",
        "score": 0.5283408761024475,
        "title": "Outcomes of esophageal surgery, especially of the lower esophageal sphincter.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24117632"
      },
      {
        "pubmed_id": "25012804",
        "score": 0.5251936912536621,
        "title": "A comparative trial of laparoscopic magnetic sphincter augmentation and Nissen fundoplication.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25012804"
      },
      {
        "pubmed_id": "23155537",
        "score": 0.5191720724105835,
        "title": "[Treatment of gastroesophageal reflux disease: comments from thoracic surgeon].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23155537"
      }
    ],
    "query_time": 0.03573799133300781,
    "metrics": {
      "precision": 1.0,
      "recall": 0.8333333333333334,
      "f1_score": 0.9090909090909091,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 12
    }
  },
  "5a74e6eb0384be9551000009": {
    "query": "What is Morgellons disease?",
    "type": "summary",
    "ideal_answer": [
      "It is a skin condition in which individuals have skin lesions that contain some kind of fibers. Patients often complain of bugs crawling under their skin. The disease is of unknown origin and may be psychosomatic, however recent evidence indicates it could be transmitted by a tick."
    ],
    "ground_truth_ids": [
      "21749875",
      "27269255",
      "16489838",
      "28665169",
      "21437061",
      "27789971",
      "25879673",
      "21390982",
      "29052453",
      "28392653",
      "28299553",
      "21110523",
      "23326202",
      "25192328",
      "24671866"
    ],
    "retrieved_ids": [
      "16489838",
      "21749875",
      "28299553",
      "25192328",
      "28392653",
      "24671866",
      "27789971",
      "28665169",
      "23326202",
      "21437061"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "16489838",
        "score": 0.7702345252037048,
        "title": "The mystery of Morgellons disease: infection or delusion?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16489838"
      },
      {
        "pubmed_id": "21749875",
        "score": 0.743438184261322,
        "title": "An oral ulceration associated with Morgellons disease: a case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21749875"
      },
      {
        "pubmed_id": "28299553",
        "score": 0.7353903651237488,
        "title": "History of Morgellons disease: the same name for different psychodermatologic diseases?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28299553"
      },
      {
        "pubmed_id": "25192328",
        "score": 0.6861388683319092,
        "title": "Morgellons Disease Presenting As an Eyelid Lesion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25192328"
      },
      {
        "pubmed_id": "28392653",
        "score": 0.66759192943573,
        "title": "Morgellons Disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28392653"
      },
      {
        "pubmed_id": "24671866",
        "score": 0.6247812509536743,
        "title": "Information, consent and treatment of patients with Morgellons disease: an ethical perspective.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24671866"
      },
      {
        "pubmed_id": "27789971",
        "score": 0.6214721202850342,
        "title": "Morgellons disease: a filamentous borrelial dermatitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27789971"
      },
      {
        "pubmed_id": "28665169",
        "score": 0.5907577276229858,
        "title": "Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28665169"
      },
      {
        "pubmed_id": "23326202",
        "score": 0.5890673398971558,
        "title": "Characterization and evolution of dermal filaments from patients with Morgellons disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23326202"
      },
      {
        "pubmed_id": "21437061",
        "score": 0.5871533155441284,
        "title": "Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21437061"
      }
    ],
    "query_time": 0.9560282230377197,
    "metrics": {
      "precision": 1.0,
      "recall": 0.6666666666666666,
      "f1_score": 0.8,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "58dff3f06fddd3e83e000007": {
    "query": "What is the Genome 10K Project?",
    "type": "summary",
    "ideal_answer": [
      "The Genome 10K Project was established in 2009 by a consortium of biologists and genome scientists determined to facilitate the sequencing and analysis of the complete genomes of 10,000 vertebrate species."
    ],
    "ground_truth_ids": [
      "25689317",
      "22897955"
    ],
    "retrieved_ids": [
      "25689317",
      "11261244",
      "22897955",
      "26952518",
      "10418432",
      "12046269",
      "30546257",
      "27087232",
      "24903420",
      "26921234"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25689317",
        "score": 0.6780693531036377,
        "title": "The Genome 10K Project: a way forward.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25689317"
      },
      {
        "pubmed_id": "11261244",
        "score": 0.6115229725837708,
        "title": "[The human genome project in the year 2000].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11261244"
      },
      {
        "pubmed_id": "22897955",
        "score": 0.6038821339607239,
        "title": "The fishes of Genome 10K.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22897955"
      },
      {
        "pubmed_id": "26952518",
        "score": 0.5809286236763,
        "title": "A decade of human genome project conclusion: Scientific diffusion about our genome knowledge.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26952518"
      },
      {
        "pubmed_id": "10418432",
        "score": 0.5633647441864014,
        "title": "Implications for nursing of the Human Genome Project.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10418432"
      },
      {
        "pubmed_id": "12046269",
        "score": 0.5597676038742065,
        "title": "The human genome project: exploring its progress and successes and the ethical, legal, and social implications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12046269"
      },
      {
        "pubmed_id": "30546257",
        "score": 0.5314888954162598,
        "title": "Genomic Interventions in Medicine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30546257"
      },
      {
        "pubmed_id": "27087232",
        "score": 0.455453485250473,
        "title": "[Precision medicine: new opportunities and challenges for molecular epidemiology].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27087232"
      },
      {
        "pubmed_id": "24903420",
        "score": 0.4511262774467468,
        "title": "Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24903420"
      },
      {
        "pubmed_id": "26921234",
        "score": 0.4319547116756439,
        "title": "HPG pore: an efficient and scalable framework for nanopore sequencing data.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26921234"
      }
    ],
    "query_time": 0.007521867752075195,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "587f90fa8ce3255b64000002": {
    "query": "What is DENdb?",
    "type": "summary",
    "ideal_answer": [
      "DENdb is a centralized on-line repository of predicted enhancers derived from multiple human cell-lines. DENdb integrates enhancers predicted by five different methods generating an enriched catalogue of putative enhancers for each of the analysed cell-lines. DENdb provides information about the overlap of enhancers with DNase I hypersensitive regions, ChIP-seq regions of a number of transcription factors and transcription factor binding motifs, means to explore enhancer interactions with DNA using several chromatin interaction assays and enhancer neighbouring genes. DENdb is designed as a relational database that facilitates fast and efficient searching, browsing and visualization of information."
    ],
    "ground_truth_ids": [
      "26342387"
    ],
    "retrieved_ids": [
      "26342387",
      "12733175",
      "19815002",
      "10418432",
      "20049400",
      "29509874",
      "23037556",
      "23629963",
      "16381962",
      "21692107"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "26342387",
        "score": 0.33433496952056885,
        "title": "DENdb: database of integrated human enhancers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26342387"
      },
      {
        "pubmed_id": "12733175",
        "score": 0.2572387754917145,
        "title": "Septooptic dysplasia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12733175"
      },
      {
        "pubmed_id": "19815002",
        "score": 0.2313237488269806,
        "title": "Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19815002"
      },
      {
        "pubmed_id": "10418432",
        "score": 0.22999207675457,
        "title": "Implications for nursing of the Human Genome Project.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10418432"
      },
      {
        "pubmed_id": "20049400",
        "score": 0.2268168330192566,
        "title": "[Optic nerve hypoplasia and septo-optic dysplasia].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20049400"
      },
      {
        "pubmed_id": "29509874",
        "score": 0.2196834534406662,
        "title": "CarbonylDB: a curated data-resource of protein carbonylation sites.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29509874"
      },
      {
        "pubmed_id": "23037556",
        "score": 0.21196264028549194,
        "title": "Surgical treatment for secondary dystonia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23037556"
      },
      {
        "pubmed_id": "23629963",
        "score": 0.2100665271282196,
        "title": "Stress granules as crucibles of ALS pathogenesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23629963"
      },
      {
        "pubmed_id": "16381962",
        "score": 0.20567384362220764,
        "title": "GOBASE--a database of organelle and bacterial genome information.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16381962"
      },
      {
        "pubmed_id": "21692107",
        "score": 0.19946788251399994,
        "title": "Pre-operative evaluations for DBS in dystonia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21692107"
      }
    ],
    "query_time": 0.8106050491333008,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "55033064e9bde69634000036": {
    "query": "What is  the clinical value of naltrexone in Parkinson's disease patients?",
    "type": "summary",
    "ideal_answer": [
      "Naltrexone does not improve clinical features, including motor function, in Parkinson's disease patients. Naltrexone was shown to be effective for treatment of pathological gambling in Parkinson's disease patients."
    ],
    "ground_truth_ids": [
      "152622",
      "11254789",
      "22426027",
      "7969211",
      "23634190",
      "25037206"
    ],
    "retrieved_ids": [
      "25037206",
      "7969211",
      "11254789",
      "22426027",
      "9399217",
      "15853578",
      "152622",
      "23483627",
      "16004599",
      "15298067"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25037206",
        "score": 0.7001921534538269,
        "title": "Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25037206"
      },
      {
        "pubmed_id": "7969211",
        "score": 0.6852921843528748,
        "title": "Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7969211"
      },
      {
        "pubmed_id": "11254789",
        "score": 0.6787261962890625,
        "title": "High dose naltrexone for dyskinesias induced by levodopa.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11254789"
      },
      {
        "pubmed_id": "22426027",
        "score": 0.5930739045143127,
        "title": "Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22426027"
      },
      {
        "pubmed_id": "9399217",
        "score": 0.5558450222015381,
        "title": "Tolcapone added to levodopa in stable parkinsonian patients: a double-blind placebo-controlled study. Tolcapone in Parkinson's Disease Study Group II (TIPS II).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9399217"
      },
      {
        "pubmed_id": "15853578",
        "score": 0.5416153073310852,
        "title": "Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15853578"
      },
      {
        "pubmed_id": "152622",
        "score": 0.5386213660240173,
        "title": "Effect of an opiate antagonist on movement disorders.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/152622"
      },
      {
        "pubmed_id": "23483627",
        "score": 0.5343852043151855,
        "title": "Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23483627"
      },
      {
        "pubmed_id": "16004599",
        "score": 0.509233832359314,
        "title": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16004599"
      },
      {
        "pubmed_id": "15298067",
        "score": 0.5058874487876892,
        "title": "Drugs in development for Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15298067"
      }
    ],
    "query_time": 0.034394025802612305,
    "metrics": {
      "precision": 0.5,
      "recall": 0.8333333333333334,
      "f1_score": 0.625,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "56c9f9d95795f9a73e00001e": {
    "query": "Which are the main features of CREST and other ALS-linked proteins?",
    "type": "summary",
    "ideal_answer": [
      "CREST and certain other ALS-linked proteins share several features implicated in ALS pathogenesis, namely the ability to aggregate, be recruited to stress granules and alter paraspeckle integrity.",
      "Similar to several proteins implicated in ALS, CREST contains a prion-like domain and was reported to be a component of paraspeckles. Like several other ALS-associated proteins, CREST is recruited to induced stress granules. Our data indicate that CREST and certain other ALS-linked proteins share several features implicated in ALS pathogenesis, namely the ability to aggregate, be recruited to stress granules and alter paraspeckle integrity.",
      "Like several other ALS-associated proteins, CREST is recruited to induced stress granules. "
    ],
    "ground_truth_ids": [
      "13129802",
      "25173930",
      "24360741",
      "16808883",
      "24115583",
      "24355598",
      "24920614",
      "25888396"
    ],
    "retrieved_ids": [
      "25888396",
      "24360741",
      "23629963",
      "21844169",
      "34603008",
      "22065782",
      "22170630",
      "22563080",
      "22454397",
      "19815002"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25888396",
        "score": 0.6152733564376831,
        "title": "Calcium-responsive transactivator (CREST) protein shares a set of structural and functional traits with other proteins associated with amyotrophic lateral sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25888396"
      },
      {
        "pubmed_id": "24360741",
        "score": 0.5138270258903503,
        "title": "Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24360741"
      },
      {
        "pubmed_id": "23629963",
        "score": 0.5107734203338623,
        "title": "Stress granules as crucibles of ALS pathogenesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23629963"
      },
      {
        "pubmed_id": "21844169",
        "score": 0.5023893117904663,
        "title": "Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21844169"
      },
      {
        "pubmed_id": "34603008",
        "score": 0.48346349596977234,
        "title": "Motor Neuron Diseases and Neuroprotective Peptides: A Closer Look to Neurons.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34603008"
      },
      {
        "pubmed_id": "22065782",
        "score": 0.4685974419116974,
        "title": "A yeast functional screen predicts new candidate ALS disease genes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22065782"
      },
      {
        "pubmed_id": "22170630",
        "score": 0.4620167016983032,
        "title": "Adult craniofacial stem cells: sources and relation to the neural crest.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22170630"
      },
      {
        "pubmed_id": "22563080",
        "score": 0.4595393240451813,
        "title": "Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22563080"
      },
      {
        "pubmed_id": "22454397",
        "score": 0.44616782665252686,
        "title": "Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22454397"
      },
      {
        "pubmed_id": "19815002",
        "score": 0.44230151176452637,
        "title": "Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19815002"
      }
    ],
    "query_time": 0.09062910079956055,
    "metrics": {
      "precision": 0.2,
      "recall": 0.25,
      "f1_score": 0.22222222222222224,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "623648723a8413c6530000af": {
    "query": "What is IDD in relation to organ transplantation?",
    "type": "summary",
    "ideal_answer": [
      "Imminent death donation (IDD) has been proposed as a separate category of organ donation: distinct from living donation and donation after cardiac death",
      "Imminent death donation (IDD) is a proposal to procure organs from patients prior to the withdrawal of life support, which is anticipated to lead to death",
      "Imminent death donation (IDD) is described as living organ donation prior to a planned withdrawal of life-sustaining care in an imminently dying patient."
    ],
    "ground_truth_ids": [
      "28027062",
      "32633023",
      "28030433"
    ],
    "retrieved_ids": [
      "28030433",
      "28027062",
      "32065475",
      "32633023",
      "29336578",
      "21839145",
      "29625577",
      "31029610",
      "10037079",
      "11375792"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28030433",
        "score": 0.5752335786819458,
        "title": "The case against imminent death donation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28030433"
      },
      {
        "pubmed_id": "28027062",
        "score": 0.5740168690681458,
        "title": "Organ donation and imminent death: pro position.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28027062"
      },
      {
        "pubmed_id": "32065475",
        "score": 0.46498385071754456,
        "title": "Heart transplantation from donation after circulatory death donors: Present and future.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32065475"
      },
      {
        "pubmed_id": "32633023",
        "score": 0.42290446162223816,
        "title": "Survey of public attitudes towards imminent death donation in the United States.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32633023"
      },
      {
        "pubmed_id": "29336578",
        "score": 0.38803035020828247,
        "title": "[Intestinal transplantation in Czech Republic].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29336578"
      },
      {
        "pubmed_id": "21839145",
        "score": 0.35418373346328735,
        "title": "Induction of pluripotent stem cells from autopsy donor-derived somatic cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21839145"
      },
      {
        "pubmed_id": "29625577",
        "score": 0.3528504967689514,
        "title": "Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29625577"
      },
      {
        "pubmed_id": "31029610",
        "score": 0.34565505385398865,
        "title": "Therapeutic apheresis in neurological, nephrological and gastrointestinal diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31029610"
      },
      {
        "pubmed_id": "10037079",
        "score": 0.34374579787254333,
        "title": "Pendred's syndrome: identification of the genetic defect a century after its recognition.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10037079"
      },
      {
        "pubmed_id": "11375792",
        "score": 0.33711567521095276,
        "title": "Clinical and molecular analysis of three Mexican families with Pendred's syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11375792"
      }
    ],
    "query_time": 0.8216428756713867,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "56c1f00fef6e394741000040": {
    "query": "Describe July Effect.",
    "type": "summary",
    "ideal_answer": [
      "The July effect is the hypothetical increase in morbidity and mortality thought to be associated with the influx of new (or newly promoted) trainees during the first portion of the academic year (in July)."
    ],
    "ground_truth_ids": [
      "20145785",
      "24152859",
      "23737378",
      "20512532",
      "24578770",
      "25374038",
      "25633735",
      "25542761",
      "24384663",
      "25860519",
      "24059450"
    ],
    "retrieved_ids": [
      "20512532",
      "24578770",
      "24384663",
      "25374038",
      "24152859",
      "23737378",
      "24059450",
      "20145785",
      "34535192",
      "25542761"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "20512532",
        "score": 0.3923700451850891,
        "title": "A July spike in fatal medication errors: a possible effect of new medical residents.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20512532"
      },
      {
        "pubmed_id": "24578770",
        "score": 0.37519118189811707,
        "title": "The July Effect: is emergency department length of stay greater at the beginning of the hospital academic year?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24578770"
      },
      {
        "pubmed_id": "24384663",
        "score": 0.3443370759487152,
        "title": "\"July effect\" in elective spine surgery: analysis of the American College of Surgeons National Surgical Quality Improvement Program database.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24384663"
      },
      {
        "pubmed_id": "25374038",
        "score": 0.3108060359954834,
        "title": "Seasonal variation in family member perceptions of physician competence in the intensive care unit: findings from one academic medical center.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25374038"
      },
      {
        "pubmed_id": "24152859",
        "score": 0.3060813248157501,
        "title": "Mortality among high-risk patients with acute myocardial infarction admitted to U.S. teaching-intensive hospitals in July: a retrospective observational study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24152859"
      },
      {
        "pubmed_id": "23737378",
        "score": 0.30284491181373596,
        "title": "Is there a \"July effect\" for head and neck cancer surgery?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23737378"
      },
      {
        "pubmed_id": "24059450",
        "score": 0.2684289813041687,
        "title": "The impact of academic calendar cycle on coronary artery bypass outcomes: a comparison of teaching and non-teaching hospitals.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24059450"
      },
      {
        "pubmed_id": "20145785",
        "score": 0.2676889896392822,
        "title": "Hip fracture outcome: is there a \"July effect\"?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20145785"
      },
      {
        "pubmed_id": "34535192",
        "score": 0.2614533305168152,
        "title": "The incubation period of COVID-19: a global meta-analysis of 53 studies and a Chinese observation study of 11 545 patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34535192"
      },
      {
        "pubmed_id": "25542761",
        "score": 0.25907671451568604,
        "title": "Academic year-end changeover and stroke outcomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25542761"
      }
    ],
    "query_time": 0.8014969825744629,
    "metrics": {
      "precision": 0.9,
      "recall": 0.8181818181818182,
      "f1_score": 0.8571428571428572,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 11
    }
  },
  "6414c3f3690f196b51000005": {
    "query": "What is the definition of dermatillomania?",
    "type": "summary",
    "ideal_answer": [
      "Dermatillomania is a condition that leads to repetitive picking of their skin ending up in skin and soft tissue damage. It is a chronic, recurrent, and treatment resistant neuropsychiatric disorder with an underestimated prevalence that has a concerning negative impact on an individual's health and quality of life."
    ],
    "ground_truth_ids": [
      "33654612",
      "21323095",
      "33808008"
    ],
    "retrieved_ids": [
      "21323095",
      "33654612",
      "33808008",
      "28299553",
      "27789971",
      "23326202",
      "29052453",
      "27779083",
      "28665169",
      "21110523"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "21323095",
        "score": 0.6832295656204224,
        "title": "Pathologic grooming behavior: facial dermatillomania.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21323095"
      },
      {
        "pubmed_id": "33654612",
        "score": 0.6396861672401428,
        "title": "Dermatillomania: A Case Report and Literature Review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33654612"
      },
      {
        "pubmed_id": "33808008",
        "score": 0.6331668496131897,
        "title": "Dermatillomania: Strategies for Developing Protective Biomaterials/Cloth.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33808008"
      },
      {
        "pubmed_id": "28299553",
        "score": 0.5507786273956299,
        "title": "History of Morgellons disease: the same name for different psychodermatologic diseases?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28299553"
      },
      {
        "pubmed_id": "27789971",
        "score": 0.5112416744232178,
        "title": "Morgellons disease: a filamentous borrelial dermatitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27789971"
      },
      {
        "pubmed_id": "23326202",
        "score": 0.5064308047294617,
        "title": "Characterization and evolution of dermal filaments from patients with Morgellons disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23326202"
      },
      {
        "pubmed_id": "29052453",
        "score": 0.5037102699279785,
        "title": "Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29052453"
      },
      {
        "pubmed_id": "27779083",
        "score": 0.5033037662506104,
        "title": "Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27779083"
      },
      {
        "pubmed_id": "28665169",
        "score": 0.5013533234596252,
        "title": "Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28665169"
      },
      {
        "pubmed_id": "21110523",
        "score": 0.4987102448940277,
        "title": "Morgellons disease and delusions of parasitosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21110523"
      }
    ],
    "query_time": 0.3145742416381836,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "5e48339fd14c9f295d00000e": {
    "query": "What is the aim of iodine prophylaxis?",
    "type": "summary",
    "ideal_answer": [
      "Due to high volatility and environmental mobility, radioactive isotopes of iodine pose a serious risk in the acute phases of a nuclear accident. The critical organ for iodine is the thyroid. A number of studies dealing with thyroid protection from exposure to radioiodine have shown that radioiodine uptake by the thyroid can be effectively blocked by administration of stable iodine, usually in the form of potassium iodide (KI) pills."
    ],
    "ground_truth_ids": [
      "27655110",
      "10566200",
      "17205086"
    ],
    "retrieved_ids": [
      "10566200",
      "17205086",
      "27655110",
      "29290671",
      "11899395",
      "24338165",
      "16972673",
      "27487107",
      "34486707",
      "21142259"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "10566200",
        "score": 0.5609592795372009,
        "title": "Iodine prophylaxis and nuclear accidents.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10566200"
      },
      {
        "pubmed_id": "17205086",
        "score": 0.5602255463600159,
        "title": "[Iodine prophylaxis following nuclear accidents].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17205086"
      },
      {
        "pubmed_id": "27655110",
        "score": 0.4875280261039734,
        "title": "The effects of iodine blocking on thyroid cancer, hypothyroidism and benign thyroid nodules following nuclear accidents: a systematic review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27655110"
      },
      {
        "pubmed_id": "29290671",
        "score": 0.3777218461036682,
        "title": "Pharmaceutical Approval Update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29290671"
      },
      {
        "pubmed_id": "11899395",
        "score": 0.3655340075492859,
        "title": "Thalidomide: when everything old is new again.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11899395"
      },
      {
        "pubmed_id": "24338165",
        "score": 0.3414326310157776,
        "title": "Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): a review of its use in the management of HIV-1 infection in adults.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24338165"
      },
      {
        "pubmed_id": "16972673",
        "score": 0.33884042501449585,
        "title": "[SERM].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16972673"
      },
      {
        "pubmed_id": "27487107",
        "score": 0.32111990451812744,
        "title": "Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27487107"
      },
      {
        "pubmed_id": "34486707",
        "score": 0.3192540407180786,
        "title": "NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34486707"
      },
      {
        "pubmed_id": "21142259",
        "score": 0.3161964416503906,
        "title": "Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21142259"
      }
    ],
    "query_time": 0.8227047920227051,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "554403395beec11c10000001": {
    "query": "Which is the primary distinction between the Reverse Warburg effect and the conventional Warburg effect?",
    "type": "summary",
    "ideal_answer": [
      "The conventional \"Warburg effect\" reffers to  the metabolic shift of cancer cells towards aerobic glycolysis, due to mitochondrial dysfunction. The \"reverse Warburg effect\" or \"parasitic\" energy-transfer, is a model of \"two-compartment tumor metabolism\". In this model, cancer cells secrete hydrogen peroxide (H2O2), initiating oxidative stress and aerobic glycolysis in the tumor stroma. The cancer-associated fibroblasts of the stroma are glycolytic and lack detectable mitochondria. These glycolytic stromal cells produce mitochondrial fuels (L-lactate, ketone bodies and chemical building blocks, such as amino acids -glutamine-, and nucleotides) that are then transferred to oxidative epithelial cancer cells. Lactate and ketones drive cancer cell  oxidative mitochondrial metabolism (OXPHOS), and building blocks sustain the anabolic needs of rapidly proliferating cancer cells. Therefore, according to the \"reverse Warburg effect\", stromal catabolism fuels anabolic tumor growth via energy transfer. Thus, in \"reverse Warburg effect\" the cancer-associated fibroblasts of the stroma undergo aerobic glycolysis, rather than epithelial cancer cells themselves, as proposed by the conventional \"Warburg effect\"."
    ],
    "ground_truth_ids": [
      "19923890",
      "22236875",
      "25197670",
      "20495363",
      "22313602",
      "21300172",
      "21778829",
      "22395432",
      "20562527",
      "23388463",
      "20818174",
      "23844381",
      "21558814",
      "23443971",
      "21521946"
    ],
    "retrieved_ids": [
      "21300172",
      "25197670",
      "36636028",
      "22592723",
      "26949713",
      "19923890",
      "6453959",
      "36239611",
      "26589718",
      "33035373"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "21300172",
        "score": 0.27946507930755615,
        "title": "Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21300172"
      },
      {
        "pubmed_id": "25197670",
        "score": 0.23791128396987915,
        "title": "Autophagy, Warburg, and Warburg reverse effects in human cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25197670"
      },
      {
        "pubmed_id": "36636028",
        "score": 0.21550291776657104,
        "title": "Bayesian modelling strategies for borrowing of information in randomised basket trials.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36636028"
      },
      {
        "pubmed_id": "22592723",
        "score": 0.20887596905231476,
        "title": "Interventions for female pattern hair loss.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22592723"
      },
      {
        "pubmed_id": "26949713",
        "score": 0.18926432728767395,
        "title": "Erratum: Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26949713"
      },
      {
        "pubmed_id": "19923890",
        "score": 0.18714864552021027,
        "title": "The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19923890"
      },
      {
        "pubmed_id": "6453959",
        "score": 0.18298223614692688,
        "title": "Coal workers' pneumoconiosis and the compensation dilemma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6453959"
      },
      {
        "pubmed_id": "36239611",
        "score": 0.18253368139266968,
        "title": "Less is More? First Impressions From COSMIC-313.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36239611"
      },
      {
        "pubmed_id": "26589718",
        "score": 0.18247826397418976,
        "title": "CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26589718"
      },
      {
        "pubmed_id": "33035373",
        "score": 0.18160009384155273,
        "title": "Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33035373"
      }
    ],
    "query_time": 0.005561113357543945,
    "metrics": {
      "precision": 0.3,
      "recall": 0.2,
      "f1_score": 0.24,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "52f89fba2059c6d71c00004f": {
    "query": "Can DMSO as an additive improve proteomic analysis results?",
    "type": "summary",
    "ideal_answer": [
      "Quantitative precisions improved significantly when DMSO (dimethylsulfoxide) was added to the matrix solution.\nIntroducing to the 80% formic acid injection solution an organic solvent such as acetonitrile or acetonitrile-DMSO induced further retention selectivity, and increasing levels of organic solvents reduced on-column retention.\nLow percentages of dimethylsulfoxide (DMSO) in liquid chromatography solvents lead to a strong enhancement of electrospray ionization of peptides, improving the sensitivity of protein identification in bottom-up proteomics by up to tenfold.",
      "Llow percentages of dimethylsulfoxide (DMSO) in liquid chromatography solvents lead to a strong enhancement of electrospray ionization of peptides, improving the sensitivity of protein identification in bottom-up proteomics by up to tenfold. Additionally, the presence of DMSO in the sample allow the retention time selectivity of the peptides."
    ],
    "ground_truth_ids": [
      "18393531",
      "18926777",
      "23975139"
    ],
    "retrieved_ids": [
      "23975139",
      "23438854",
      "24144163",
      "23334424",
      "16784548",
      "18926777",
      "18393531",
      "21742803",
      "19140108",
      "15768030"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23975139",
        "score": 0.6355387568473816,
        "title": "DMSO enhances electrospray response, boosting sensitivity of proteomic experiments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23975139"
      },
      {
        "pubmed_id": "23438854",
        "score": 0.554552435874939,
        "title": "The coming age of complete, accurate, and ubiquitous proteomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23438854"
      },
      {
        "pubmed_id": "24144163",
        "score": 0.5131695866584778,
        "title": "Understanding the role of proteolytic digestion on discovery and targeted proteomic measurements using liquid chromatography tandem mass spectrometry and design of experiments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24144163"
      },
      {
        "pubmed_id": "23334424",
        "score": 0.45331692695617676,
        "title": "A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23334424"
      },
      {
        "pubmed_id": "16784548",
        "score": 0.4491152763366699,
        "title": "Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16784548"
      },
      {
        "pubmed_id": "18926777",
        "score": 0.44708743691444397,
        "title": "Proteomic analysis optimization: selective protein sample on-column retention in reverse-phase liquid chromatography.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18926777"
      },
      {
        "pubmed_id": "18393531",
        "score": 0.4408974349498749,
        "title": "Quantitative analysis of HIV-1 protease inhibitors in cell lysates using MALDI-FTICR mass spectrometry.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18393531"
      },
      {
        "pubmed_id": "21742803",
        "score": 0.4401375949382782,
        "title": "The human proteome project: current state and future direction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21742803"
      },
      {
        "pubmed_id": "19140108",
        "score": 0.4177168905735016,
        "title": "In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19140108"
      },
      {
        "pubmed_id": "15768030",
        "score": 0.40439853072166443,
        "title": "Enrichment and analysis of peptide subsets using fluorous affinity tags and mass spectrometry.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15768030"
      }
    ],
    "query_time": 0.006150960922241211,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "514a2649d24251bc0500005a": {
    "query": "How functional connectivity of the default mode network changes in patients with disorders of consciousness?",
    "type": "summary",
    "ideal_answer": [
      "Functional connectivity in the default mode network (DMN) is reduced in patients with different disorders of consciousness, and correlates with the level of consciousness. \nSpecifically, functional connectivity in the default mode network was shown to be absent in brain death patients, extremely low in vegetative state patients and slightly decreased in minimally conscious state patients when compared to healthy subjects. Therefore, functional connectivity in the default mode network was suggested to be valuable in differentiating patients with different disorders of consciousness. Clinically, functional connectivity in the default mode network was also shown to be an indicator of the extent of cortical disruption and predict reversible impairments in consciousness."
    ],
    "ground_truth_ids": [
      "23034909",
      "22418054",
      "22905075",
      "22623966",
      "21693087",
      "21191476",
      "22218274",
      "19289479",
      "22039473",
      "22563263"
    ],
    "retrieved_ids": [
      "23034909",
      "22218274",
      "21191476",
      "22418054",
      "19289479",
      "22039473",
      "21693087",
      "22563263",
      "22905075",
      "22623966"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23034909",
        "score": 0.828537106513977,
        "title": "A role for the default mode network in the bases of disorders of consciousness.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23034909"
      },
      {
        "pubmed_id": "22218274",
        "score": 0.7560122013092041,
        "title": "Disruptions of functional connectivity in the default mode network of comatose patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22218274"
      },
      {
        "pubmed_id": "21191476",
        "score": 0.7371655702590942,
        "title": "Brain connectivity in pathological and pharmacological coma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21191476"
      },
      {
        "pubmed_id": "22418054",
        "score": 0.7183582186698914,
        "title": "Dysfunction of default-mode network in encephalopathy with a reversible corpus callosum lesion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22418054"
      },
      {
        "pubmed_id": "19289479",
        "score": 0.6953852772712708,
        "title": "Disrupted intrinsic functional connectivity in the vegetative state.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19289479"
      },
      {
        "pubmed_id": "22039473",
        "score": 0.6862196922302246,
        "title": "Deactivation of the default mode network as a marker of impaired consciousness: an fMRI study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22039473"
      },
      {
        "pubmed_id": "21693087",
        "score": 0.6841491460800171,
        "title": "Resting state activity in patients with disorders of consciousness.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21693087"
      },
      {
        "pubmed_id": "22563263",
        "score": 0.6003292798995972,
        "title": "MRI study on the functional and spatial consistency of resting state-related independent components of the brain network.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22563263"
      },
      {
        "pubmed_id": "22905075",
        "score": 0.5895686149597168,
        "title": "DMN Operational Synchrony Relates to Self-Consciousness: Evidence from Patients in Vegetative and Minimally Conscious States.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22905075"
      },
      {
        "pubmed_id": "22623966",
        "score": 0.5817975401878357,
        "title": "Connectivity of default-mode network is associated with cerebral edema in hepatic encephalopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22623966"
      }
    ],
    "query_time": 0.040075063705444336,
    "metrics": {
      "precision": 1.0,
      "recall": 1.0,
      "f1_score": 1.0,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "5895ee638707e6ea39000001": {
    "query": "Describe the usefulness of MiRduplexSVM.",
    "type": "summary",
    "ideal_answer": [
      "MiRduplexSVM is a high-performing miRNA-duplex prediction and evaluation methodology. It's a method that combines a unique problem representation and an unbiased optimization protocol to learn from mirBase19.0 an accurate predictive model. It is the first model that provides precise information about all four ends of the miRNA duplex."
    ],
    "ground_truth_ids": [
      "25961860"
    ],
    "retrieved_ids": [
      "25961860",
      "25636961",
      "23658991",
      "31752361",
      "16519798",
      "25253891",
      "21931505",
      "31546754",
      "25596968",
      "20380575"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25961860",
        "score": 0.5547168254852295,
        "title": "MiRduplexSVM: A High-Performing MiRNA-Duplex Prediction and Evaluation Methodology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25961860"
      },
      {
        "pubmed_id": "25636961",
        "score": 0.380881130695343,
        "title": "Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25636961"
      },
      {
        "pubmed_id": "23658991",
        "score": 0.35977667570114136,
        "title": "Blood - SeV derived fibroblast generated iPSCs",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23658991"
      },
      {
        "pubmed_id": "31752361",
        "score": 0.3501391112804413,
        "title": "The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31752361"
      },
      {
        "pubmed_id": "16519798",
        "score": 0.346386194229126,
        "title": "The Subviral RNA Database: a toolbox for viroids, the hepatitis delta virus and satellite RNAs research.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16519798"
      },
      {
        "pubmed_id": "25253891",
        "score": 0.3395410180091858,
        "title": "Novel coding, translation, and gene expression of a replicating covalently closed circular RNA of 220 nt.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25253891"
      },
      {
        "pubmed_id": "21931505",
        "score": 0.3072754740715027,
        "title": "Mechanisms and role of microRNA deregulation in cancer onset and progression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21931505"
      },
      {
        "pubmed_id": "31546754",
        "score": 0.3023402988910675,
        "title": "miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31546754"
      },
      {
        "pubmed_id": "25596968",
        "score": 0.30093914270401,
        "title": "Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25596968"
      },
      {
        "pubmed_id": "20380575",
        "score": 0.30026447772979736,
        "title": "Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20380575"
      }
    ],
    "query_time": 0.00894021987915039,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "589a246778275d0c4a00002f": {
    "query": "What is Mondor's disease?",
    "type": "summary",
    "ideal_answer": [
      "Mondor's disease is a rare benign and self-limiting condition characterized by thrombophlebitis of the superficial veins of the anterolateral thoracoabdominal wall and genital area."
    ],
    "ground_truth_ids": [
      "1562972",
      "21855258",
      "24989360",
      "25960806",
      "22421473",
      "22377612",
      "6613471",
      "18385566",
      "8885560",
      "21450061",
      "25667776",
      "19608071",
      "24867818",
      "25530373",
      "11771217",
      "23674771",
      "26971966",
      "10630059",
      "22414457",
      "20579824",
      "7243138",
      "25923155",
      "19629969",
      "26803533",
      "15906794"
    ],
    "retrieved_ids": [
      "6613471",
      "7243138",
      "21855258",
      "8885560",
      "20579824",
      "21450061",
      "26971966",
      "25960806",
      "11771217",
      "1562972"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "6613471",
        "score": 0.7540359497070312,
        "title": "Mondor's disease: a review of five cases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6613471"
      },
      {
        "pubmed_id": "7243138",
        "score": 0.7172467708587646,
        "title": "Mondor disease in pregnancy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7243138"
      },
      {
        "pubmed_id": "21855258",
        "score": 0.6848027110099792,
        "title": "Mondor disease: a case report in ED.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21855258"
      },
      {
        "pubmed_id": "8885560",
        "score": 0.6609292030334473,
        "title": "Mondor's disease. A forgotten cause of anterior chest pain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8885560"
      },
      {
        "pubmed_id": "20579824",
        "score": 0.6520359516143799,
        "title": "[Superficial venous thrombosis of the penis: penile Mondor's disease? A case report and literature review].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20579824"
      },
      {
        "pubmed_id": "21450061",
        "score": 0.6513511538505554,
        "title": "Traumatic funicular phlebitis of the thoracic wall resembling Mondor's disease: a case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21450061"
      },
      {
        "pubmed_id": "26971966",
        "score": 0.6493829488754272,
        "title": "[Mondor's disease of penis: A case report].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26971966"
      },
      {
        "pubmed_id": "25960806",
        "score": 0.6440339684486389,
        "title": "Mondor's disease in a patient after a mammotome biopsy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25960806"
      },
      {
        "pubmed_id": "11771217",
        "score": 0.6378540992736816,
        "title": "[Mondor phlebitis associated with hepatitis C].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11771217"
      },
      {
        "pubmed_id": "1562972",
        "score": 0.6290472745895386,
        "title": "Mondor's disease and breast cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1562972"
      }
    ],
    "query_time": 0.011322021484375,
    "metrics": {
      "precision": 1.0,
      "recall": 0.4,
      "f1_score": 0.5714285714285715,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 25
    }
  },
  "61f86db9882a024a10000045": {
    "query": "What is caused by SCUBE3 loss of function?",
    "type": "summary",
    "ideal_answer": [
      "SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling.",
      "SCUBE3 is a BMP2/BMP4 co-receptor. It is responsible for the development of bone and teeth. When it is not functioning properly, it inhibits the growth and development of these tissues.",
      "SCUBE3 loss-of-function results in a human disease caused by defective function of a member of the SCUBE family that is associated with a previously unrecognized syndromic disorder. The disorder is characterized by reduced growth, skeletal features, distinctive craniofacial appearance, and dental anomalies. It is also associated with dysregulating bone morphogenetic protein signaling."
    ],
    "ground_truth_ids": [
      "33308444"
    ],
    "retrieved_ids": [
      "33308444",
      "15744326",
      "23209445",
      "20935640",
      "23507969",
      "21122555",
      "26612766",
      "8414992",
      "26664771",
      "12972430"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "33308444",
        "score": 0.3956301510334015,
        "title": "SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33308444"
      },
      {
        "pubmed_id": "15744326",
        "score": 0.3128442168235779,
        "title": "Multisite protein modification and intramolecular signaling.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15744326"
      },
      {
        "pubmed_id": "23209445",
        "score": 0.3021296560764313,
        "title": "The yeast SR-like protein Npl3 links chromatin modification to mRNA processing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23209445"
      },
      {
        "pubmed_id": "20935640",
        "score": 0.2944188416004181,
        "title": "Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20935640"
      },
      {
        "pubmed_id": "23507969",
        "score": 0.28303369879722595,
        "title": "FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23507969"
      },
      {
        "pubmed_id": "21122555",
        "score": 0.2727990448474884,
        "title": "Paneth's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21122555"
      },
      {
        "pubmed_id": "26612766",
        "score": 0.26986780762672424,
        "title": "Exome sequencing revealed a novel biallelic deletion in the DCAF17 gene underlying Woodhouse Sakati syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26612766"
      },
      {
        "pubmed_id": "8414992",
        "score": 0.2688962519168854,
        "title": "rseB, a chromosomal locus that affects the stability of a temperature-specific surface protein mRNA in Tetrahymena thermophila.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8414992"
      },
      {
        "pubmed_id": "26664771",
        "score": 0.2681668996810913,
        "title": "The Use of High-Density SNP Array to Map Homozygosity in Consanguineous Families to Efficiently Identify Candidate Genes: Application to Woodhouse-Sakati Syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26664771"
      },
      {
        "pubmed_id": "12972430",
        "score": 0.26170065999031067,
        "title": "Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12972430"
      }
    ],
    "query_time": 0.010379552841186523,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "662fc351187cba990d000014": {
    "query": "What role does epiregulin and amphiregulin play in the use of EGFR inhibitors for colorectal cancer?",
    "type": "summary",
    "ideal_answer": [
      "Epiregulin and amphiregulin are EGFR ligands and their high gene expression levels in tumors are associated with a positive response to the EGFR inhibitor, cetuximab, in metastatic colorectal cancer treatment. Therefore, they play a crucial role in determining the effectiveness of EGFR inhibitors for colorectal cancer.",
      "Epiregulin and amphiregulin are EGFR ligands that are associated with anti-EGFR agent response in metastatic colorectal cancer. High tumor mRNA levels of these ligands are associated with disease control in patients treated with cetuximab, particularly in patients with wild-type K-ras.",
      "Epiregulin and amphiregulin are ligands for the epidermal growth factor receptor (EGFR), which is overexpressed in many colorectal cancers. Inhibition of EGFR with monoclonal antibodies such as cetuximab has become a standard treatment for metastatic colorectal cancer (mCRC). However, not all patients with mCRC respond to EGFR inhibitors, and the predictive value of epiregulin and amphiregulin expression for response to cetuximab has not been well characterized. In a study of 100 patients with mCRC, high tumor mRNA levels of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG) were associated with anti-EGFR agent response in metastatic colorectal cancer (mCRC). In contrast, low tumor mRNA levels of AREG and EREG were associated with poor response to cetuximab. These findings suggest that epiregulin and amphiregulin may be useful biomarkers for predicting response to EGFR inhibitors in colorectal cancer.",
      "Epiregulin and amphiregulin are ligands of the epidermal growth factor receptor (EGFR) that play a central role in the development of colorectal cancer. They are positively correlated with a response to EGFR-targeted therapies in colorectal cancer. However, their prognostic value is controversial and their expression may be influenced by gene-body methylation and 5-aza-2'-desoxycytidine treatment.",
      "Epiregulin (EREG) and amphiregulin (AREG) are ligands of the epidermal growth factor receptor (EGFR) and their overexpression may indicate EGFR dependency in metastatic colorectal cancer (mCRC), regardless of tumor sidedness. High AREG/EREG expression is associated with sensitivity to EGFR blockade, particularly in patients with right-sided tumors and a lack of genomic drivers of primary resistance beyond RAS and BRAF mutations. The expression of AREG and EREG is positively correlated with a response to EGFR-targeted therapies in colorectal cancer. Gene-body methylation sites, which show a strong inverse correlation with AREG and EREG gene expression, have been identified in cell lines and human colorectal cancer samples. Treatment of colorectal cancer cells with 5-aza-2'-desoxycytidine, a demethylating agent, results in decreased methylation and increased AREG and EREG gene expression. Fibroblast growth factor receptor 4 (FGFR4) overexpression in colon cancer cells has been shown to upregulate EGFR signaling, secrete EGFR ligands such as AREG, and promote tumor growth. FGFR4 overexpression also reduces cetuximab-induced cytotoxicity, while the combination of an FGFR4 inhibitor and cetuximab has shown profound antitumor effects. Clinically, there is a positive correlation between FGFR4 and AREG expression in tumor tissue, but not in normal tissue, from colon cancer patients. A study was conducted to investigate the effects of baseline plasma AREG levels in KRAS, NRAS, and BRAF wild-type metastatic CRC on treatment outcome with palliative first-line cetuximab + FOLFIRI chemotherapy. The results showed that high baseline plasma AREG levels were significantly associated with inferior progression-free survival (PFS) in patients treated with cetuximab-based therapy. Additionally, in vitro studies using CRC cell lines sensitive to cetuximab showed that AREG decreased the anti-proliferative effect of cetuximab via AKT and ERK activation. However, after acquiring cetuximab resistance, AREG did not increase colony formation or activate AKT and ERK after cetuximab treatment. These findings suggest that high tumor production of EGFR ligands, including AREG and epiregulin, may predict benefit from anti-EGFR therapy in mCRC.",
      "\"High AREG mRNA expression is a favorable prognostic biomarker for mCRC which interacted significantly with efficacy of anti-EGFR treatment. High tumor AREG/EREG expression was associated with superior survival outcomes from anti-EGFR therapy in mCRC, including in right PTL disease. Patients with tumors that have high gene expression levels of epiregulin and amphiregulin and patients with wild-type K-ras are more likely to have disease control on cetuximab treatment.\"",
      "Epiregulin and amphiregulin are ligands of the epidermal growth factor receptor (EGFR) and their high gene expression levels have been associated with improved disease control in patients with colorectal cancer (CRC) treated with the EGFR inhibitor cetuximab. This suggests that tumors with high levels of these ligands may be more dependent on the EGFR signaling pathway, making them more sensitive to cetuximab. Additionally, patients with wild-type K-ras, who are known to be more likely to respond to cetuximab, also have higher tumor mRNA levels of amphiregulin and epiregulin. Therefore, measuring the expression levels of these ligands could potentially be used as a predictive biomarker for the use of EGFR inhibitors such as cetuximab in CRC.",
      "High AREG mRNA expression is a favorable prognostic biomarker for mCRC which interacted significantly with efficacy of anti-EGFR treatment. High tumor AREG/EREG expression was associated with superior survival outcomes from anti-EGFR therapy in mCRC.",
      "Epiregulin and amphiregulin play a crucial role in predicting response to EGFR inhibitors in patients with colorectal cancer. High tumor mRNA levels of these EGFR ligands are associated with anti-EGFR agent response in metastatic colorectal cancer. Patients with high gene expression levels of epiregulin and amphiregulin, particularly those with wild-type K-ras, are more likely to achieve disease control on cetuximab treatment. This suggests that epiregulin and amphiregulin can serve as biomarkers for predicting response to EGFR inhibitors in colorectal cancer. The presence of these ligands may enhance the effectiveness of EGFR inhibitors, leading to better disease control.",
      "Epiregulin and amphiregulin predict disease control and progression-free survival in metastatic colorectal cancer treated with EGFR inhibitors like cetuximab or panitumumab. High tumor expression levels of these ligands correlate to better response, while low levels indicate poorer outcomes. K-ras mutations negatively predict response. Evaluating epiregulin/amphiregulin expression and K-ras status helps identify patients likely to benefit from EGFR inhibitors.",
      "Epiregulin and amphiregulin are proteins that are involved in the growth and spread of colorectal cancer cells. In patients with tumors that have high gene expression levels of these proteins and wild-type K-ras, the use of EGFR inhibitors like cetuximab can be more effective in controlling the disease",
      "According to the abstracts, epiregulin (EREG) and amphiregulin (AREG) play a predictive role in the use of EGFR inhibitors for metastatic colorectal cancer. High expression levels of EREG and AREG are associated with longer overall survival and progression-free survival in patients treated with anti- EGFR therapy. Specifically, high AREG mRNA expression is a favorable prognostic biomarker that interacts significantly with the efficacy of anti-EGFR treatment. Additionally, immunohistochemical analysis of AREG and EREG in tumor tissue can aid therapeutic decisions in routine practice, particularly in right primary tumor location disease. Overall, EREG and AREG may serve as useful biomarkers to identify patients who are more likely to benefit from EGFR inhibitors for colorectal cancer treatment.",
      "Epiregulin and amphiregulin are ligands of the epidermal growth factor receptor (EGFR). In colorectal cancer, overexpression of these ligands has been associated with resistance to EGFR inhibitors. Therefore, the presence of these ligands may influence the decision to use EGFR inhibitors for colorectal cancer treatment.",
      "Epiregulin and amphiregulin, ligands of the epidermal growth factor receptor (EGFR), play a crucial role in the use of EGFR inhibitors for colorectal cancer. High tumor mRNA levels of epiregulin and amphiregulin are associated with response to anti-EGFR therapy, particularly in patients with wild-type KRAS. These ligands are independent favorable prognostic biomarkers in metastatic colorectal cancer (mCRC). Patients with high epiregulin and amphiregulin expression have longer overall survival and progression-free survival when treated with anti-EGFR therapy. Conversely, low expression of these ligands is associated with resistance to EGFR inhibitors. The EREG/EGFR pathway is a potential target for tailored therapy, and strategies targeting this pathway are being developed to combat mCRC. Overall, epiregulin and amphiregulin are important biomarkers for predicting response to EGFR inhibitors in colorectal cancer treatment.",
      "Epiregulin and amphiregulin, two ligands of the epidermal growth factor receptor (EGFR), play a significant role in predicting disease control and progression-free survival in patients with metastatic colorectal cancer treated with EGFR inhibitors such as cetuximab or panitumumab. High expression levels of these ligands in tumors are associated with better response to EGFR inhibitor therapy, whereas low expression levels are associated with poorer outcomes. Additionally, the presence of K-ras mutations is a negative predictor of response to EGFR inhibitors. Therefore, assessing epiregulin and amphiregulin expression levels, along with K-ras mutation status, can help identify patients who are most likely to benefit from EGFR inhibitor therapy.",
      "High tumor levels of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are associated with anti-EGFR agent response in metastatic colorectal cancer (mCRC).  AREG and EREC are biomarkers of response to EGFR inhibitors.",
      "Epiregulin and amphiregulin are key predictors of response to EGFR inhibitors in metastatic colorectal cancer, with high expression linked to better treatment outcomes, including longer progression-free survival and overall survival. They may serve as biomarkers to identify patients who will benefit from EGFR inhibitor therapy.",
      "Amphiregulin and epiregulin are ligands of the epidermal growth factor receptor (EGFR) and play a central role in the development and progression of colorectal cancer. They are also predictive biomarkers of colorectal cancer patients treated with cetuximab, an anti-EGFR antibody. In addition, amphiregulin and epiregulin are thought to play a role in regenerative responses in the gastrointestinal tract. The extensive induction of EGFR ligands and ADAMs was suppressed by inhibition of the PGE(2) receptor EP4. Moreover, EP4 signaling induced expression of amphiregulin and epiregulin in activated macrophages, whereas EP4 pathway was required for basal expression of epiregulin in gastric epithelial cells. In contrast, ADAMs were not induced directly by EP4 signaling. The role of nuclear EGFR in tumors is not well understood, although many EGFR ligands are upregulated in cancers. Little is known about their effects on EGFR nuclear translocation. The trophic effects of amphiregulin and epiregulin on SEMFs were analyzed by MTT assays. Amphiregulin and epiregulin mRNAs were not detected in unstimulated SEMFs. Among the various EGFR ligands, amphiregulin and epiregulin are the most well-studied and have been shown to play a role in cell proliferation and survival.",
      "Epiregulin and amphiregulin are ligands for the EGFR and play a role in the growth and development of normal epithelial cells. In the context of colorectal cancer, high tumor mRNA levels of these EGFR ligands are associated with response to anti-EGFR agents such as cetuximab. Patients with tumors that have high gene expression levels of epiregulin and amphiregulin are more likely to have disease control on cetuximab treatment. Therefore, these proteins may serve as potential biomarkers for predicting response to EGFR inhibitors in colorectal cancer.",
      "Epiregulin (EREG) and Amphiregulin (AREG) are ligands of Epidermal Growth Factor Receptor (EGFR), which is targeted for cancer therapy. High expression levels of EREG and AREG in colorectal cancer patients correlate with better response to EGFR inhibitors like cetuximab and panitumumab, leading to improved overall survival and progression-free survival. This suggests that these ligands play a significant role in the use of EGFR inhibitors for treating colorectal cancer by helping identify patients most likely to benefit from them.",
      "Epiregulin and amphiregulin are EGFR ligands that are associated with anti-EGFR agent response in metastatic colorectal cancer. Patients with high gene expression levels of these ligands and wild-type K-ras are more likely to have disease control on cetuximab treatment. \n\nPlease provide a concise answer to the following question:\nWhat is the association between high tumor mRNA levels of EGFR ligands and response to anti-EGFR agents in metastatic colorectal cancer?\nAnswer: High tumor mRNA levels of EGFR ligands, such as amphiregulin and epiregulin, are associated with anti-EGFR agent response in metastatic colorectal cancer. \n\nPlease provide a concise answer to the following question:\nWhat is the role of K-ras mutation in determining response to cetuximab treatment in patients with metastatic colorectal cancer?\nAnswer: Patients with wild-type K-ras are more likely to have disease control on cetuximab treatment, suggesting that K-ras mutation may be a negative predictor of response to cetuximab. \n\nPlease provide a concise answer to the following question:\nWhat is the implication of the study on the use of cetuximab for patients with",
      "Although EGFR inhibitors improved survival for patients with metastatic colorectal cancer, about 85% of patients had progressive disease with these drugs, and there was no correlation between efficacy and mutation status. Tumors expressing both epiregulin and amphiregulin responded better to EGFR inhibitors than tumors expressing one or no growth factor. These data suggest that epiregulin and amphiregulin are EGFR ligands that predict the efficacy of EGFR inhibition in colorectal cancer.",
      "Epiregulin and amphiregulin are ligands of the epidermal growth factor receptor (EGFR) and have been associated with response to the EGFR inhibitor cetuximab in metastatic colorectal cancer. High tumor mRNA levels of these ligands have been found to be associated with disease control in patients treated with cetuximab.",
      "Epiregulin (EREG) and Amphiregulin (AREG) are ligands of Epidermal Growth Factor Receptor (EGFR) that play a crucial role in predicting the efficacy of EGFR inhibitors for colorectal cancer treatment. Studies have shown that high expression levels of EREG and AREG in tumor tissue are associated with improved progression-free survival, response rate, and overall survival in patients treated with anti-EGFR therapies such as panitumumab and cetuximab. Conversely, low expression levels of these ligands indicate a lack of benefit from EGFR inhibition. The combined analysis of EREG and AREG expression can serve as a predictive biomarker for identifying patients who are likely to respond to EGFR-targeted therapy, thereby optimizing treatment strategies for colorectal cancer patients.",
      "Epiregulin and amphiregulin act as ligands for the epidermal growth factor receptor (EGFR), playing a critical role in predicting response to EGFR inhibitors like cetuximab in metastatic colorectal cancer. High gene expression levels of these ligands, along with wild-type K-ras status, are associated with improved disease control and treatment outcomes. They may serve as potential biomarkers for identifying patients who will benefit from anti-EGFR therapy.",
      "High mRNA expression levels of the EGFR ligands epiregulin (EREG) and amphiregulin (AREG) are positively correlated with and predictive of response to EGFR-targeted therapies such as cetuximab and panitumumab in colorectal cancer. Patients with tumors expressing high levels of EREG and AREG are more likely to have disease control and significantly longer progression-free survival when treated with these EGFR inhibitors compared to patients with low expression. Conversely, patients with low EREG/AREG expression may not benefit from EGFR-targeted therapy.",
      "Epiregulin and amphiregulin are two EGFR ligands that are associated with the response to EGFR inhibitors in colorectal cancer. Patients with tumors that have high gene expression levels of epiregulin and amphiregulin and patients with wild-type K-ras are more likely to have disease control on cetuximab treatment",
      "Epiregulin and amphiregulin, both ligands of the epidermal growth factor receptor (EGFR), play a crucial role in predicting response to EGFR inhibitors, such as cetuximab, in metastatic colorectal cancer (mCRC). High tumor mRNA levels of these ligands are associated with improved disease control and response to anti-EGFR therapy. Specifically, patients with high gene expression levels of epiregulin and amphiregulin, along with wild-type K-ras status, are more likely to benefit from cetuximab treatment. This suggests that epiregulin and amphiregulin may serve as biomarkers for identifying mCRC patients who are most likely to respond to EGFR inhibitors, thereby personalizing treatment strategies and improving patient outcomes.",
      "High tumor mRNA levels of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are associated with response to anti-EGFR agents like cetuximab in metastatic colorectal cancer (mCRC). Patients with tumors that have high gene expression levels of AREG and EREG are more likely to have disease control on cetuximab treatment.",
      "High levels of epiregulin and amphiregulin are poor prognostic markers in patients with metastatic colorectal cancer.\nThe overexpression of EGFR ligands epiregulin and amphiregulin is associated with poor outcomes in patients with metastatic colorectal cancer.  An EGFR inhibitor in combination with chemotherapy was effective in patients with wild-type KRAS tumors that overexpressed epiregulin and/or amphiregulin, but not in patients whose tumors did not overexpress these ligands.",
      "Epiregulin and amphiregulin predict disease control and progression-free survival in metastatic colorectal cancer treated with EGFR inhibitors like cetuximab or panitumumab, where high expression levels indicate better response to treatment. However, K-ras mutations negatively impact the effectiveness of these inhibitors. Assessing epiregulin and amphiregulin expression along with K-ras mutation status helps identify patients likely to benefit from EGFR inhibitor therapy.",
      "Epiregulin and amphiregulin are ligands that bind to and activate EGFR, promoting colorectal cancer growth. High tumor levels of epiregulin and amphiregulin are associated with better response to EGFR inhibitors like cetuximab in metastatic colorectal cancer. By blocking EGFR activation by these ligands, EGFR inhibitors can slow growth of colorectal cancers that depend on epiregulin and amphiregulin signaling through EGFR. Therefore, epiregulin and amphiregulin levels may serve as biomarkers to identify patients more likely to benefit from EGFR inhibitor therapy.",
      "Epiregulin and amphiregulin are epidermal growth factor ligands that have been found to be predictive markers of response to EGFR-targeted therapies in colorectal cancer. High mRNA levels of these ligands have been associated with increased responsiveness to cetuximab and longer progression-free survival in patients treated with cetuximab. Additionally, patients with tumors that express high levels of these ligands are more likely to have disease control with cetuximab treatment. High EGFR ligand expression, including amphiregulin and epiregulin, has also been found to be predictive of panitumumab benefit in advanced colorectal cancer.",
      "Epiregulin and amphiregulin are ligands of the EGFR (Epidermal Growth Factor Receptor). In the context of colorectal cancer, high gene expression levels of these two ligands have been associated with a better response to EGFR inhibitors like cetuximab. This means that patients whose tumors have high levels of epiregulin and amphiregulin are more likely to see their disease controlled by this treatment",
      "Patients with tumors that have high gene expression levels of epiregulin and amphiregulin and patients with wild-type K-ras are more likely to have disease control on cetuximab treatment.  High tumor mRNA levels of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are associated with anti-EGFR agent response in metastatic colorectal cancer (mCRC The antiepidermal growth factor receptor (EGFR) antibody cetuximab shows activity in multiple epithelial tumor types; however, responses are seen in only a subset of patients. This study was conducted to identify markers that are associated with disease control in patients treated with cetuximab",
      "High tumor mRNA levels of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are associated with anti-EGFR agent response in metastatic colorectal cancer (mCRC). Patients with tumors that have high gene expression levels of epiregulin and amphiregulin are more likely to have disease control on cetuximab treatment.",
      "High tumor mRNA levels of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are associated with anti-EGFR agent response in metastatic colorectal cancer (mCRC).",
      "Epiregulin (EPR) and amphiregulin (AREG) are proteins that belong to the epidermal growth factor (EGF) family and can function as ligands of EGFR, as well as other members of the ERBB family of tyrosine-kinase receptors. Both proteins are involved in the development and progression of colorectal cancer (CRC). High gene expression levels of epiregulin and amphiregulin have been associated with anti-EGFR agent response in metastatic colorectal cancer (mCRC). EGFR inhibitors are used in the treatment of CRC, and patients are divided into EGFR-positive and EGFR-negative based on the presence of a mutation. EGFR-positive patients have shown a 60% response rate to EGFR inhibitors. However, many patients develop resistance to EGFR inhibitors, with the T790M mutation and MET oncogene being the primary sources of resistance. The most common adverse effect of EGFR inhibitors is a papulopustular rash.",
      "High mRNA levels of the EGFR-ligands Epiregulin and Amphiregulin have been associated with increased responsiveness to cetuximab. Patients with tumors that have high expression of EREG or AREG also have significantly longer progression-free survival (PFS) than patients with low expression. High tumor AREG/EREG expression was associated with superior survival outcomes from anti-EGFR therapy in mCRC.",
      "Expression of the epidermal growth factor ligands amphiregulin (AREG) and epiregulin (EREG) is positively correlated with a response to EGFR-targeted therapies in colorectal cancer. High AREG mRNA expression interacted significantly with the efficacy of cetuximab compared with bevacizumab (OS: P = 0.02, PFS: P = 0.04) in RAS WT mCRC.",
      "Epiregulin and amphiregulin are ligands for the epidermal growth factor receptor (EGFR) and play a role in the use of EGFR inhibitors for colorectal cancer. High tumor mRNA levels of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are associated with anti-EGFR agent response in metastatic colorectal cancer (mCRC). Members of the activator protein 2 (AP-2) transcription factor (TF) family are known to play a role in both physiological processes and cancer development. Physical exercise has been shown to reduce the risk of recurrence from colorectal cancer. The NICE Appraisal Committee concluded that aflibercept in combination with irinotecan and fluorouracil-based therapy could not be considered a cost effective use of National Health Service resources for treating metastatic colorectal cancer that is resistant to or has progressed after an oxaliplatin-containing regimen. Patients with tumors that have high gene expression levels of epiregulin and amphiregulin and patients with wild-type K-ras are more likely to have disease control on cetuximab treatment.",
      "Epiregulin (EREG) and Amphiregulin (AREG) are ligands of the Epidermal Growth Factor Receptor (EGFR), which is a target for cancer therapy. In colorectal cancer, high expression levels of EREG and AREG have been identified as predictive biomarkers for response to EGFR inhibitors such as cetuximab and panitumumab. Patients with high tumor expression of these ligands tend to have improved overall survival (OS) and progression-free survival (PFS) when treated with EGFR inhibitors, compared to those with low expression levels. This suggests that EREG and AREG play a crucial role in the use of EGFR inhibitors for colorectal cancer, as their expression may help identify patients most likely to benefit from these therapies.",
      "Epiregulin and amphiregulin are epidermal growth factor (EGF)-like molecules that are part of a complex network of ligands, receptors and coreceptors that promote EGFR signaling, which drives colorectal cancer growth. Because inhibitors of EGFR signaling can lose efficacy during treatment, research efforts have focused on understanding resistance to anti-EGFR therapy. Recently, studies have found that expression of epiregulin and amphiregulin in tumor cells can allow them to bypass EGFR blockade and continue signaling through other EGFR family members, leading to sustained tumor growth.",
      "Epiregulin and amphiregulin are ligands of the EGFR (Epidermal Growth Factor Receptor). High gene expression levels of these ligands in tumors have been associated with a better response to anti-EGFR agents like cetuximab in the treatment of metastatic colorectal cancer. This means that patients with high levels of epiregulin and amphiregulin are more likely to have their disease controlled with cetuximab treatment",
      "In summary, the absence of a coffee-like sign on the face is not directly associated with any specific disease. While certain diseases may have dermatological manifestations, such as eczema, the absence of a coffee-like sign can also be considered a hallmark symptom of many other dermatological conditions, making it a useful diagnostic feature in some cases. ",
      "Epiregulin and amphiregulin are biomarkers that predict response to EGFR inhibitors in patients with metastatic colorectal cancer. High tumor mRNA levels of these EGFR ligands are associated with anti-EGFR agent response. Patients with high epiregulin and amphiregulin expression have longer overall survival and progression-free survival when treated with EGFR inhibitors. These biomarkers are particularly useful in patients with KRAS wild-type tumors, where they can identify those who are more likely to respond to EGFR inhibitors. Additionally, epiregulin and amphiregulin may contribute to resistance to EGFR inhibitors, and targeting these ligands in combination with EGFR inhibitors may be a promising therapeutic strategy. Overall, epiregulin and amphiregulin play a crucial role in predicting response to EGFR inhibitors and may be useful in developing personalized treatment approaches for colorectal cancer patients.",
      "Amphiregulin and epiregulin were shown to play critical roles in the response to EGFR inhibitors in colorectal cancer; this role is independent of KRAS mutations. When both epiregulin and amphiregulin expression were detected, the response to EGFR inhibitors increased significantly.",
      "Epiregulin and amphiregulin are genes that, when highly expressed in tumors, are associated with a better response to the EGFR inhibitor cetuximab in colorectal cancer treatment. This means that patients with high gene expression levels of epiregulin and amphiregulin are more likely to have their disease controlled with cetuximab treatment."
    ],
    "ground_truth_ids": [
      "31519572",
      "22409860",
      "27272216",
      "30252132",
      "37594733",
      "33888518",
      "32943459",
      "34893673",
      "25053989",
      "23959273",
      "19738126",
      "17664471",
      "27344184",
      "34884633",
      "33775193",
      "26867820",
      "37363997",
      "32533590",
      "23885463",
      "27570430",
      "19663767",
      "20631481",
      "27422777"
    ],
    "retrieved_ids": [
      "37594733",
      "22409860",
      "33775193",
      "27422777",
      "32533590",
      "23959273",
      "27344184",
      "32943459",
      "26867820",
      "37363997"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "37594733",
        "score": 0.7797151803970337,
        "title": "Towards Multiomics-Based Dissection of Anti-EGFR Sensitivity in Colorectal Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37594733"
      },
      {
        "pubmed_id": "22409860",
        "score": 0.7052417397499084,
        "title": "Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22409860"
      },
      {
        "pubmed_id": "33775193",
        "score": 0.7044810652732849,
        "title": "Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33775193"
      },
      {
        "pubmed_id": "27422777",
        "score": 0.7044101357460022,
        "title": "Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27422777"
      },
      {
        "pubmed_id": "32533590",
        "score": 0.6964134573936462,
        "title": "Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32533590"
      },
      {
        "pubmed_id": "23959273",
        "score": 0.6956189274787903,
        "title": "Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23959273"
      },
      {
        "pubmed_id": "27344184",
        "score": 0.6942816972732544,
        "title": "Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27344184"
      },
      {
        "pubmed_id": "32943459",
        "score": 0.6885395050048828,
        "title": "Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32943459"
      },
      {
        "pubmed_id": "26867820",
        "score": 0.6881766319274902,
        "title": "Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26867820"
      },
      {
        "pubmed_id": "37363997",
        "score": 0.680851936340332,
        "title": "Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37363997"
      }
    ],
    "query_time": 0.07320618629455566,
    "metrics": {
      "precision": 1.0,
      "recall": 0.43478260869565216,
      "f1_score": 0.6060606060606061,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 23
    }
  },
  "53319916d6d3ac6a3400003f": {
    "query": "Where is the protein CLIC1 localized?",
    "type": "summary",
    "ideal_answer": [
      "CLIC1 is an intracellular chloride ion channel that is localized both to the nucleus and to the cytolasm."
    ],
    "ground_truth_ids": [
      "21055175",
      "15827065",
      "9880541"
    ],
    "retrieved_ids": [
      "21055175",
      "9880541",
      "24322426",
      "34493791",
      "24634216",
      "17724121",
      "11242054",
      "17760832",
      "8941634",
      "25253891"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "21055175",
        "score": 0.5093759298324585,
        "title": "[Localization and expression of CLIC1 in hepatocarcinoma ascites cell lines with high or low potentials of lymphatic spread].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21055175"
      },
      {
        "pubmed_id": "9880541",
        "score": 0.4967120587825775,
        "title": "Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9880541"
      },
      {
        "pubmed_id": "24322426",
        "score": 0.49616456031799316,
        "title": "Review series: From uncertain beginnings: initiation mechanisms of clathrin-mediated endocytosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24322426"
      },
      {
        "pubmed_id": "34493791",
        "score": 0.44096773862838745,
        "title": "Burkholderia PglL enzymes are Serine preferring oligosaccharyltransferases which target conserved proteins across the Burkholderia genus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34493791"
      },
      {
        "pubmed_id": "24634216",
        "score": 0.42034101486206055,
        "title": "Structural and biophysical characterization of murine rif1 C terminus reveals high specificity for DNA cruciform structures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24634216"
      },
      {
        "pubmed_id": "17724121",
        "score": 0.4162472188472748,
        "title": "A nuclear envelope protein linking nuclear pore basket assembly, SUMO protease regulation, and mRNA surveillance.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17724121"
      },
      {
        "pubmed_id": "11242054",
        "score": 0.41268453001976013,
        "title": "Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11242054"
      },
      {
        "pubmed_id": "17760832",
        "score": 0.40627560019493103,
        "title": "Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17760832"
      },
      {
        "pubmed_id": "8941634",
        "score": 0.40602779388427734,
        "title": "A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8941634"
      },
      {
        "pubmed_id": "25253891",
        "score": 0.40585291385650635,
        "title": "Novel coding, translation, and gene expression of a replicating covalently closed circular RNA of 220 nt.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25253891"
      }
    ],
    "query_time": 0.8086881637573242,
    "metrics": {
      "precision": 0.2,
      "recall": 0.6666666666666666,
      "f1_score": 0.30769230769230765,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "6414c1ae690f196b51000003": {
    "query": "What is the definition of trichotillomania?",
    "type": "summary",
    "ideal_answer": [
      "Trichotillomania is defined as an obsessive-compulsive or related disorder in which patients recurrently pull out hair from any region of their body."
    ],
    "ground_truth_ids": [
      "35118122"
    ],
    "retrieved_ids": [
      "35118122",
      "21323095",
      "23588149",
      "21390982",
      "33654612",
      "29052453",
      "28299553",
      "24671866",
      "22947347",
      "33808008"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "35118122",
        "score": 0.6966421604156494,
        "title": "Trichotillomania: What Do We Know So Far?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35118122"
      },
      {
        "pubmed_id": "21323095",
        "score": 0.4328886866569519,
        "title": "Pathologic grooming behavior: facial dermatillomania.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21323095"
      },
      {
        "pubmed_id": "23588149",
        "score": 0.37479835748672485,
        "title": "Koebner phenomenon in alopecia areata: rapid appearance after trichogram. Implications for the pathogenesis and therapy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23588149"
      },
      {
        "pubmed_id": "21390982",
        "score": 0.3697730600833893,
        "title": "Hypnosis in the treatment of Morgellons disease: a case study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21390982"
      },
      {
        "pubmed_id": "33654612",
        "score": 0.34430375695228577,
        "title": "Dermatillomania: A Case Report and Literature Review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33654612"
      },
      {
        "pubmed_id": "29052453",
        "score": 0.3327658772468567,
        "title": "Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29052453"
      },
      {
        "pubmed_id": "28299553",
        "score": 0.32364359498023987,
        "title": "History of Morgellons disease: the same name for different psychodermatologic diseases?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28299553"
      },
      {
        "pubmed_id": "24671866",
        "score": 0.30256229639053345,
        "title": "Information, consent and treatment of patients with Morgellons disease: an ethical perspective.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24671866"
      },
      {
        "pubmed_id": "22947347",
        "score": 0.2940364480018616,
        "title": "Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22947347"
      },
      {
        "pubmed_id": "33808008",
        "score": 0.28906959295272827,
        "title": "Dermatillomania: Strategies for Developing Protective Biomaterials/Cloth.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33808008"
      }
    ],
    "query_time": 0.011841058731079102,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "58a989571978bbde22000002": {
    "query": "What are the birth defects associated with Zika-virus infection?",
    "type": "summary",
    "ideal_answer": [
      "Although the full spectrum of adverse reproductive outcomes caused by Zika virus infection is not yet determined, a distinctive phenotype-the congenital Zika syndrome-has emerged. Zika virus infection during pregnancy is a cause of microcephaly and other severe birth defects."
    ],
    "ground_truth_ids": [
      "27032458",
      "27293547",
      "27052792",
      "27366760",
      "27009036",
      "27032431",
      "27143174",
      "27617189",
      "27366586",
      "27812690",
      "27345865",
      "27490087",
      "27279226"
    ],
    "retrieved_ids": [
      "27812690",
      "27009036",
      "27032431",
      "27695855",
      "27345865",
      "27052792",
      "27490087",
      "27279226",
      "27617189",
      "27032458"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27812690",
        "score": 0.7324154376983643,
        "title": "Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27812690"
      },
      {
        "pubmed_id": "27009036",
        "score": 0.7102896571159363,
        "title": "Zika Virus Disease: A CDC Update for Pediatric Health Care Providers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27009036"
      },
      {
        "pubmed_id": "27032431",
        "score": 0.695370078086853,
        "title": "[Zika virus epidemic].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27032431"
      },
      {
        "pubmed_id": "27695855",
        "score": 0.6902666091918945,
        "title": "Congenital Zika Virus Infection: Beyond Neonatal Microcephaly.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27695855"
      },
      {
        "pubmed_id": "27345865",
        "score": 0.6824076175689697,
        "title": "Zika in the Brain: New Models Shed Light on Viral Infection.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27345865"
      },
      {
        "pubmed_id": "27052792",
        "score": 0.6560602784156799,
        "title": "Why Zika virus infection has become a public health concern?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27052792"
      },
      {
        "pubmed_id": "27490087",
        "score": 0.6368746161460876,
        "title": "Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1, 2015-July 7, 2016.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27490087"
      },
      {
        "pubmed_id": "27279226",
        "score": 0.6313421726226807,
        "title": "The Brazilian Zika virus strain causes birth defects in experimental models.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27279226"
      },
      {
        "pubmed_id": "27617189",
        "score": 0.5934317111968994,
        "title": "Zika virus: A call to action for physicians in the era of climate change.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27617189"
      },
      {
        "pubmed_id": "27032458",
        "score": 0.5888305306434631,
        "title": "Quarantine for Zika Virus? Where is the Science?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27032458"
      }
    ],
    "query_time": 0.8358142375946045,
    "metrics": {
      "precision": 0.9,
      "recall": 0.6923076923076923,
      "f1_score": 0.7826086956521738,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 13
    }
  },
  "5e4981e96d0a277941000009": {
    "query": "What is the current regulation of eye lens radiation exposure?",
    "type": "summary",
    "ideal_answer": [
      "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018. Consequently, there is a requirement for all employers engaged with work with ionising radiation to have appropriate monitoring arrangements in place by this date to demonstrate that they can meet this new limit for all workers. Eye lens dose is conventionally monitored by specific dosemeters worn near the eye.\nThe yearly ocular lens dose, particularly for interventionists dealing with complex interventions, could cross the permitted yearly limit set by the new Euratom directive. Therefore, X-ray safety glasses would become mandatory for complex radiological vascular interventions."
    ],
    "ground_truth_ids": [
      "29687260",
      "29155416",
      "30053275"
    ],
    "retrieved_ids": [
      "29155416",
      "29687260",
      "30053275",
      "30451566",
      "16117741",
      "20545570",
      "26909513",
      "25035933",
      "9848072",
      "9587055"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29155416",
        "score": 0.6172420382499695,
        "title": "Eye lens dose monitoring in the UK nuclear industry using active personal dosemeters.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29155416"
      },
      {
        "pubmed_id": "29687260",
        "score": 0.6091732978820801,
        "title": "Will X-ray Safety Glasses Become Mandatory for Radiological Vascular Interventions?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29687260"
      },
      {
        "pubmed_id": "30053275",
        "score": 0.5938835144042969,
        "title": "SHOULD PERSONNEL OF NUCLEAR MEDICINE DEPARTMENTS USE PERSONAL DOSIMETERS FOR EYE LENS DOSE MONITORING?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30053275"
      },
      {
        "pubmed_id": "30451566",
        "score": 0.4810361862182617,
        "title": "Dosimetry for the study of medical radiation workers with a focus on the mean absorbed dose to the lung, brain and other organs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30451566"
      },
      {
        "pubmed_id": "16117741",
        "score": 0.44528937339782715,
        "title": "[UV-radiation--sources, wavelength, environment].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16117741"
      },
      {
        "pubmed_id": "20545570",
        "score": 0.4231508672237396,
        "title": "Transcriptional modulation of micro-RNA in human cells differing in radiation sensitivity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20545570"
      },
      {
        "pubmed_id": "26909513",
        "score": 0.4116285443305969,
        "title": "24-h Efficacy of Glaucoma Treatment Options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26909513"
      },
      {
        "pubmed_id": "25035933",
        "score": 0.38668930530548096,
        "title": "The role of homeobox genes in retinal development and disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25035933"
      },
      {
        "pubmed_id": "9848072",
        "score": 0.3842872679233551,
        "title": "[Progressive corneal ectasia after laser in situ keratomileusis (LASIK)].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9848072"
      },
      {
        "pubmed_id": "9587055",
        "score": 0.38221073150634766,
        "title": "Changes in the nucleolar and coiled body compartments precede lamina and chromatin reorganization during fibre cell denucleation in the bovine lens.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9587055"
      }
    ],
    "query_time": 0.00829005241394043,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "58a22eb460087bc10a000001": {
    "query": "What is the mechanism of action of the biguanide class of diabetes drugs?",
    "type": "summary",
    "ideal_answer": [
      "this biguanide is an oral insulin-sensitizing agent capable of increasing insulin sensitivity and decreasing plasma fasting insulin levels.",
      "Bioguaides like Metformin, decrease amount of glucose released from liver and increases insulin sensitivity. "
    ],
    "ground_truth_ids": [
      "23292513",
      "27939359",
      "8914439",
      "25793062",
      "21147283",
      "26166607"
    ],
    "retrieved_ids": [
      "23292513",
      "25793062",
      "8914439",
      "27939359",
      "26137782",
      "25488697",
      "24567800",
      "26166607",
      "21265828",
      "34149436"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23292513",
        "score": 0.5894783139228821,
        "title": "Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23292513"
      },
      {
        "pubmed_id": "25793062",
        "score": 0.5804254412651062,
        "title": "Metformin and diabetic kidney disease: a mini-review on recent findings.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25793062"
      },
      {
        "pubmed_id": "8914439",
        "score": 0.5596558451652527,
        "title": "[Drug therapy in subjects with impaired glucose tolerance].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8914439"
      },
      {
        "pubmed_id": "27939359",
        "score": 0.5262027382850647,
        "title": "A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27939359"
      },
      {
        "pubmed_id": "26137782",
        "score": 0.5245158076286316,
        "title": "[The pharmacotherapy of obesity].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26137782"
      },
      {
        "pubmed_id": "25488697",
        "score": 0.47931259870529175,
        "title": "Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25488697"
      },
      {
        "pubmed_id": "24567800",
        "score": 0.4617030620574951,
        "title": "Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24567800"
      },
      {
        "pubmed_id": "26166607",
        "score": 0.4475824534893036,
        "title": "Impact of Metformin on Male Reproduction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26166607"
      },
      {
        "pubmed_id": "21265828",
        "score": 0.44181308150291443,
        "title": "The utility of animal models to evaluate novel anti-obesity agents.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21265828"
      },
      {
        "pubmed_id": "34149436",
        "score": 0.4403523802757263,
        "title": "Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34149436"
      }
    ],
    "query_time": 0.005444049835205078,
    "metrics": {
      "precision": 0.5,
      "recall": 0.8333333333333334,
      "f1_score": 0.625,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "5e2b2d4afbd6abf43b000008": {
    "query": "What is canSAR?",
    "type": "summary",
    "ideal_answer": [
      "canSAR (http://cansar.icr.ac.uk) is a public integrative cancer-focused knowledgebase for the support of cancer translational research and drug discovery. Through the integration of biological, pharmacological, chemical, structural biology and protein network data, it provides a single information portal to answer complex multidisciplinary questions including--among many others--and what is known about a protein, in which cancers is it expressed or mutated, and what chemical tools and cell line models can be used to experimentally probe its activity.",
      "canSAR (http://cansar.icr.ac.uk) is a freely available, multidisciplinary, cancer-focused knowledgebase developed to support cancer translational research and drug discovery . It integrates genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and unique, comprehensive and orthogonal 'druggability' assessments .",
      "canSAR (http://cansar.icr.ac.uk) is a public, freely available, integrative translational research and drug discovery knowlegebase. canSAR informs researchers to help solve key bottlenecks in cancer translation and drug discovery. It integrates genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and unique, comprehensive and orthogonal 'druggability' assessments. canSAR is widely used internationally by academia and industry.",
      "CanSAR (http://cansar.icr.ac.uk) is a public, freely available, integrative translational research and drug discovery knowledgebase. It integrates genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and unique, comprehensive and orthogonal 'druggability' assessment. canSAR is widely used worldwide by professors, biologists and scientists interested in the molecular biology of cancer, in particular with regard to translation-dependent and -independent pathways of cancer progression."
    ],
    "ground_truth_ids": [
      "26673713",
      "30496479",
      "24304894",
      "22013161"
    ],
    "retrieved_ids": [
      "22013161",
      "24304894",
      "30496479",
      "26673713",
      "30706413",
      "7588825",
      "23674771",
      "32257483",
      "33787719",
      "12043548"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "22013161",
        "score": 0.4176419973373413,
        "title": "canSAR: an integrated cancer public translational research and drug discovery resource.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22013161"
      },
      {
        "pubmed_id": "24304894",
        "score": 0.37217235565185547,
        "title": "canSAR: updated cancer research and drug discovery knowledgebase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24304894"
      },
      {
        "pubmed_id": "30496479",
        "score": 0.3242022693157196,
        "title": "canSAR: update to the cancer translational research and drug discovery knowledgebase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30496479"
      },
      {
        "pubmed_id": "26673713",
        "score": 0.3146795928478241,
        "title": "canSAR: an updated cancer research and drug discovery knowledgebase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26673713"
      },
      {
        "pubmed_id": "30706413",
        "score": 0.24599158763885498,
        "title": "Capnocytophaga canimorsus Meningitis: Diagnosis Using Polymerase Chain Reaction Testing and Systematic Review of the Literature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30706413"
      },
      {
        "pubmed_id": "7588825",
        "score": 0.22623445093631744,
        "title": "Capnocytophaga canimorsus septicemia: fifth report of a cat-associated infection and five other cases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7588825"
      },
      {
        "pubmed_id": "23674771",
        "score": 0.19698205590248108,
        "title": "Imaging of penile and scrotal emergencies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23674771"
      },
      {
        "pubmed_id": "32257483",
        "score": 0.19652068614959717,
        "title": "Two Cases of Morel-Lavallée Lesion Which Resulted in a Wide Skin Necrosis from a Small Laceration.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32257483"
      },
      {
        "pubmed_id": "33787719",
        "score": 0.19163000583648682,
        "title": "Atovaquone, chloroquine, primaquine, quinine and tetracycline: antiproliferative effects of relevant antimalarials on Neospora caninum.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33787719"
      },
      {
        "pubmed_id": "12043548",
        "score": 0.1800483912229538,
        "title": "Bupropion sustained release. A therapeutic review of Zyban.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12043548"
      }
    ],
    "query_time": 0.010841131210327148,
    "metrics": {
      "precision": 0.4,
      "recall": 1.0,
      "f1_score": 0.5714285714285715,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "64089be7201352f04a000022": {
    "query": "Please summarize the difference between REMS and RMPs",
    "type": "summary",
    "ideal_answer": [
      "Risk Evaluation and Mitigation Strategies (REMS) are FDA-mandated programs that require drug manufacturers to develop and implement plans to ensure that the benefits of a drug outweigh its risks. Risk Management Plans (RMPs) are similar to REMS, but are used in the European Union and are focused on the safety of the patient. RMPs are designed to identify, characterize, and prevent or minimize risks associated with a drug.",
      "REMS is the Food and Drug Administration's (FDA's) Risk Evaluation and Mitigation Strategies (REMS) and RMP is European Medicines Agency's (EMA's) Risk Management Plan (RMP) Both REMS and RMPs provide positive guidance for identification, monitoring, and minimization of risk to patient safety. RMP has requirements not included in REMS were specific adverse event reporting , prospective registry studies, prospective epidemiology studies, additional trial data (28%), and Summary of Product Characteristics contraindications .",
      "REMS and RMPs are both risk management plans that are used to ensure the safe use of pharmaceuticals. REMS is a risk management plan developed by the Food and Drug Administration (FDA) in the United States, while RMP is a risk management plan developed by the European Medicines Agency (EMA) in Europe.\n\nREMS and RMPs are similar in objectives, with comparable toolkits. Both allow flexibility in product-specific actions, recognizing adverse effects of potential concern. REMS and RMPs are similar in objectives, with comparable toolkits. Both allow flexibility in product-specific actions, recognizing adverse effects of potential concern.\n\nREMS requirements not included in RMPs are patient medication guides (100% of the drugs), provider communication plans (38% of the drugs), and routine monitoring of REMS (66%). RMP requirements not included in REMS are specific adverse event reporting (45% of the drugs), prospective registry studies (34%), prospective epidemiology studies (24%), additional trial data (28%), and Summary of",
      "REMS (Risk Evaluation and Mitigation Strategies) and RMPs (Risk Management Plans) both aim to identify, monitor, and minimize risks to patient safety. REMS are required by the US FDA, while RMPs are mandated by the EMA in the European Union. Differences between them lie in their specific requirements and regional regulations"
    ],
    "ground_truth_ids": [
      "23244814"
    ],
    "retrieved_ids": [
      "23244814",
      "23739201",
      "33229362",
      "23764350",
      "17874255",
      "16861091",
      "17042060",
      "16908126",
      "32266704",
      "16972673"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23244814",
        "score": 0.3704012334346771,
        "title": "Comparisons of Food and Drug Administration and European Medicines Agency risk management implementation for recent pharmaceutical approvals: report of the International Society for Pharmacoeconomics and outcomes research risk benefit management working group.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23244814"
      },
      {
        "pubmed_id": "23739201",
        "score": 0.1987946331501007,
        "title": "Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23739201"
      },
      {
        "pubmed_id": "33229362",
        "score": 0.19599197804927826,
        "title": "Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33229362"
      },
      {
        "pubmed_id": "23764350",
        "score": 0.19482243061065674,
        "title": "Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23764350"
      },
      {
        "pubmed_id": "17874255",
        "score": 0.19470524787902832,
        "title": "Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17874255"
      },
      {
        "pubmed_id": "16861091",
        "score": 0.1848335713148117,
        "title": "Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16861091"
      },
      {
        "pubmed_id": "17042060",
        "score": 0.18482722342014313,
        "title": "Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17042060"
      },
      {
        "pubmed_id": "16908126",
        "score": 0.18458202481269836,
        "title": "Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16908126"
      },
      {
        "pubmed_id": "32266704",
        "score": 0.1806173026561737,
        "title": "Eptinezumab: First Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32266704"
      },
      {
        "pubmed_id": "16972673",
        "score": 0.17993557453155518,
        "title": "[SERM].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16972673"
      }
    ],
    "query_time": 0.013384819030761719,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5a6a2f88b750ff4455000024": {
    "query": "What is Target Explorer?",
    "type": "summary",
    "ideal_answer": [
      "Target Explorer is an automated tool for the identification of new target genes for a specified set of transcription factors. It was specifically designed for the well-annotated Drosophila melanogaster genome, but most options can be used for sequences from other genomes as well. Target Explorer is available at http://trantor.bioc.columbia.edu/Target_Explorer/"
    ],
    "ground_truth_ids": [
      "12824372"
    ],
    "retrieved_ids": [
      "12824372",
      "22013161",
      "28990968",
      "11002455",
      "29927637",
      "24304894",
      "24477411",
      "36552307",
      "29209056",
      "29155416"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "12824372",
        "score": 0.2598247826099396,
        "title": "Target Explorer: An automated tool for the identification of new target genes for a specified set of transcription factors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12824372"
      },
      {
        "pubmed_id": "22013161",
        "score": 0.20028936862945557,
        "title": "canSAR: an integrated cancer public translational research and drug discovery resource.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22013161"
      },
      {
        "pubmed_id": "28990968",
        "score": 0.191991925239563,
        "title": "Improvements in Radiation Monitoring Trending.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28990968"
      },
      {
        "pubmed_id": "11002455",
        "score": 0.16498571634292603,
        "title": "Primary care perspective of prostate cancer screening after national guidance: a questionnaire survey.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11002455"
      },
      {
        "pubmed_id": "29927637",
        "score": 0.16462749242782593,
        "title": "Colon cancer screening with CT colonography: logistics, cost-effectiveness, efficiency and progress.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29927637"
      },
      {
        "pubmed_id": "24304894",
        "score": 0.1607535183429718,
        "title": "canSAR: updated cancer research and drug discovery knowledgebase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24304894"
      },
      {
        "pubmed_id": "24477411",
        "score": 0.16051651537418365,
        "title": "Immunotherapy for prostate cancer: recent developments and future challenges.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24477411"
      },
      {
        "pubmed_id": "36552307",
        "score": 0.15868110954761505,
        "title": "Small RNA Targets: Advances in Prediction Tools and High-Throughput Profiling.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36552307"
      },
      {
        "pubmed_id": "29209056",
        "score": 0.15593868494033813,
        "title": "Transcription regulation by the Mediator complex.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29209056"
      },
      {
        "pubmed_id": "29155416",
        "score": 0.15019473433494568,
        "title": "Eye lens dose monitoring in the UK nuclear industry using active personal dosemeters.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29155416"
      }
    ],
    "query_time": 0.00630497932434082,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "54dcb29dc0bb8dce23000004": {
    "query": "Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?",
    "type": "summary",
    "ideal_answer": [
      "Hypertrophic cardiomyopathy (HCM) has been recently recognized as the most common inherited cardiovascular disorder, affecting 1 in 500 adults worldwide. HCM is characterized by myocyte hypertrophy resulting in thickening of the ventricular wall, myocyte disarray, interstitial and/or replacement fibrosis, decreased ventricular cavity volume and diastolic dysfunction. HCM is also the most common cause of sudden death in the young particularly among athletes. A large proportion of patients diagnosed with HCM have mutations in sarcomeric proteins. HCM is the most prevalent genetic disorder affecting the heart and is typically inherited in an autosomal dominant pattern. Adults with cardiomyopathy suffer SCD or adverse events such as stroke and heart failure from HCM."
    ],
    "ground_truth_ids": [
      "25044876",
      "23782526",
      "25309450",
      "22665960",
      "21507890",
      "25328416",
      "25191275",
      "25209314",
      "25228955",
      "25081404"
    ],
    "retrieved_ids": [
      "25328416",
      "25044876",
      "25081404",
      "25191275",
      "22665960",
      "23782526",
      "34057638",
      "25228955",
      "21507890",
      "29800419"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25328416",
        "score": 0.7543575167655945,
        "title": "Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25328416"
      },
      {
        "pubmed_id": "25044876",
        "score": 0.7285073399543762,
        "title": "Hypertrophic cardiomyopathy in adults: an overview.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25044876"
      },
      {
        "pubmed_id": "25081404",
        "score": 0.7284805774688721,
        "title": "Echocardiography for hypertrophic cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25081404"
      },
      {
        "pubmed_id": "25191275",
        "score": 0.6790701150894165,
        "title": "Hypertrophic cardiomyopathy: a heart in need of an energy bar?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25191275"
      },
      {
        "pubmed_id": "22665960",
        "score": 0.6556861400604248,
        "title": "Biventricular / left ventricular pacing in hypertrophic obstructive cardiomyopathy: an overview.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22665960"
      },
      {
        "pubmed_id": "23782526",
        "score": 0.6372572779655457,
        "title": "Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23782526"
      },
      {
        "pubmed_id": "34057638",
        "score": 0.6355626583099365,
        "title": "Histopathological changes of myocytes in restrictive cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34057638"
      },
      {
        "pubmed_id": "25228955",
        "score": 0.6238794326782227,
        "title": "Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25228955"
      },
      {
        "pubmed_id": "21507890",
        "score": 0.619562566280365,
        "title": "Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21507890"
      },
      {
        "pubmed_id": "29800419",
        "score": 0.5822458267211914,
        "title": "Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29800419"
      }
    ],
    "query_time": 0.038259029388427734,
    "metrics": {
      "precision": 0.8,
      "recall": 0.8,
      "f1_score": 0.8000000000000002,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "5324d0429b2d7acc7e000023": {
    "query": "What are the reported adverse effects of topical minoxidil?",
    "type": "summary",
    "ideal_answer": [
      "Typical side effects of this topical treatment include irritative dermatitis going along with pruritus, erythema, scaling and dryness, which occur especially at the onset of the therapy. In some cases, allergic contact dermatitis or exacerbation of seborrheic dermatitis has been reported.\nHypertrichosis is a well-recognized adverse effect of therapy with either oral or topical minoxidil.\nWe observed an as yet unreported \"polymyalgia syndrome\" in four otherwise healthy males whose sole medication was topically applied minoxidil. They experienced fatigue, weight loss and severe pain in the shoulders and pelvic girdle, suggesting connective tissue disease. Three patients had a transient rise in liver enzymes, while other laboratory analyses remained normal. Tritanomaly was detected in two patients who underwent systematic color vision testing.\nA case of central serous chorioretinopathy after application of topical minoxidil solution.\nA case of acute myocardial infarction associated with topical use of minoxidil (RiUP) for treatment of baldness.\nCompared with placebo, topical minoxidil caused significant increases in LV end-diastolic volume, in cardiac output (by 0.751 min-1) and in LV mass (by 5 g m-2).\nTwo of our patients developed smoking intolerance during treatment with topical minoxidil for androgenital alopecia."
    ],
    "ground_truth_ids": [
      "11807448",
      "17902730",
      "9039309",
      "3191000",
      "3800424",
      "15034503",
      "11041102",
      "3311578",
      "17324826",
      "15982234",
      "2256586",
      "1554931",
      "23463948",
      "3549808",
      "8050148",
      "21939432",
      "22592723"
    ],
    "retrieved_ids": [
      "3800424",
      "3549808",
      "1554931",
      "3311578",
      "3191000",
      "9039309",
      "11807448",
      "2256586",
      "15982234",
      "15034503"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "3800424",
        "score": 0.7853782773017883,
        "title": "Topical minoxidil. A survey of use and complications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3800424"
      },
      {
        "pubmed_id": "3549808",
        "score": 0.7506198883056641,
        "title": "Deaths occurring during clinical studies of topical minoxidil.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3549808"
      },
      {
        "pubmed_id": "1554931",
        "score": 0.6853259205818176,
        "title": "Topical treatment with minoxidil 2% and smoking intolerance.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1554931"
      },
      {
        "pubmed_id": "3311578",
        "score": 0.677737832069397,
        "title": "Topical minoxidil therapy for hair regrowth.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3311578"
      },
      {
        "pubmed_id": "3191000",
        "score": 0.649824857711792,
        "title": "Topical minoxidil: cardiac effects in bald man.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3191000"
      },
      {
        "pubmed_id": "9039309",
        "score": 0.6369109153747559,
        "title": "Diffuse hypertrichosis during treatment with 5% topical minoxidil.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9039309"
      },
      {
        "pubmed_id": "11807448",
        "score": 0.6348226070404053,
        "title": "Allergic contact dermatitis to topical minoxidil solution: etiology and treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11807448"
      },
      {
        "pubmed_id": "2256586",
        "score": 0.6295443773269653,
        "title": "[Polymyalgia induced by topical minoxidil].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2256586"
      },
      {
        "pubmed_id": "15982234",
        "score": 0.6290000081062317,
        "title": "Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15982234"
      },
      {
        "pubmed_id": "15034503",
        "score": 0.6269837617874146,
        "title": "A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15034503"
      }
    ],
    "query_time": 0.00851297378540039,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5882352941176471,
      "f1_score": 0.7407407407407407,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "5e49032df8b2df0d49000008": {
    "query": "Who should wear dosimeters?",
    "type": "summary",
    "ideal_answer": [
      "Nuclear medicine technologists rely on a single dosimeter to measure their work-related dose. Dosimetry for the study of medical radiation workers."
    ],
    "ground_truth_ids": [
      "11948264",
      "28990968",
      "30451566"
    ],
    "retrieved_ids": [
      "30053275",
      "11948264",
      "30451566",
      "29155416",
      "29687260",
      "28990968",
      "25933807",
      "11782648",
      "6453959",
      "28965519"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30053275",
        "score": 0.49416613578796387,
        "title": "SHOULD PERSONNEL OF NUCLEAR MEDICINE DEPARTMENTS USE PERSONAL DOSIMETERS FOR EYE LENS DOSE MONITORING?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30053275"
      },
      {
        "pubmed_id": "11948264",
        "score": 0.4505998492240906,
        "title": "Measuring and minimizing the radiation dose to nuclear medicine technologists.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11948264"
      },
      {
        "pubmed_id": "30451566",
        "score": 0.41422539949417114,
        "title": "Dosimetry for the study of medical radiation workers with a focus on the mean absorbed dose to the lung, brain and other organs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30451566"
      },
      {
        "pubmed_id": "29155416",
        "score": 0.39273738861083984,
        "title": "Eye lens dose monitoring in the UK nuclear industry using active personal dosemeters.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29155416"
      },
      {
        "pubmed_id": "29687260",
        "score": 0.38809388875961304,
        "title": "Will X-ray Safety Glasses Become Mandatory for Radiological Vascular Interventions?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29687260"
      },
      {
        "pubmed_id": "28990968",
        "score": 0.38120341300964355,
        "title": "Improvements in Radiation Monitoring Trending.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28990968"
      },
      {
        "pubmed_id": "25933807",
        "score": 0.29901939630508423,
        "title": "Diagnostic performance of the Bernese versus Ottawa ankle rules: Results of a randomised controlled trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25933807"
      },
      {
        "pubmed_id": "11782648",
        "score": 0.28136083483695984,
        "title": "Implementation of the Ottawa ankle rule in a university sports medicine center.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11782648"
      },
      {
        "pubmed_id": "6453959",
        "score": 0.27898842096328735,
        "title": "Coal workers' pneumoconiosis and the compensation dilemma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6453959"
      },
      {
        "pubmed_id": "28965519",
        "score": 0.270430326461792,
        "title": "Accuracy of the Ottawa Ankle Rules applied by non-physician providers in a pediatric emergency department.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28965519"
      }
    ],
    "query_time": 0.30359506607055664,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "5c73ad0e7c78d69471000095": {
    "query": "What is the purpose of the Ottawa Ankle Rule?",
    "type": "summary",
    "ideal_answer": [
      "Ottawa Ankle Rules is a clinical decision tool used to minimize unnecessary radiographs in ankle and foot injuries. It shows the areas of tenderness to be evaluated in ankle trauma patients to determine the need for imaging."
    ],
    "ground_truth_ids": [
      "30183240",
      "26262468",
      "11782648",
      "28363615",
      "28965519",
      "29891469",
      "24971221",
      "25933807",
      "28764972"
    ],
    "retrieved_ids": [
      "30183240",
      "11782648",
      "26262468",
      "28965519",
      "25933807",
      "24971221",
      "28764972",
      "28363615",
      "29891469",
      "26803533"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30183240",
        "score": 0.6710345149040222,
        "title": "Calculated Decisions: Ottawa Ankle Rule.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30183240"
      },
      {
        "pubmed_id": "11782648",
        "score": 0.6357960104942322,
        "title": "Implementation of the Ottawa ankle rule in a university sports medicine center.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11782648"
      },
      {
        "pubmed_id": "26262468",
        "score": 0.5738698244094849,
        "title": "Validation of the Ottawa Ankle Rules for Acute Foot and Ankle Injuries.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26262468"
      },
      {
        "pubmed_id": "28965519",
        "score": 0.5702940225601196,
        "title": "Accuracy of the Ottawa Ankle Rules applied by non-physician providers in a pediatric emergency department.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28965519"
      },
      {
        "pubmed_id": "25933807",
        "score": 0.5612908601760864,
        "title": "Diagnostic performance of the Bernese versus Ottawa ankle rules: Results of a randomised controlled trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25933807"
      },
      {
        "pubmed_id": "24971221",
        "score": 0.5531674027442932,
        "title": "Ottawa ankle rules and subjective surgeon perception to evaluate radiograph necessity following foot and ankle sprain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24971221"
      },
      {
        "pubmed_id": "28764972",
        "score": 0.5446385741233826,
        "title": "Diagnostic Accuracy of Clinical Decision Rules to Exclude Fractures in Acute Ankle Injuries: Systematic Review and Meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28764972"
      },
      {
        "pubmed_id": "28363615",
        "score": 0.5172140002250671,
        "title": "Retrospective comparison of the Low Risk Ankle Rules and the Ottawa Ankle Rules in a pediatric population.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28363615"
      },
      {
        "pubmed_id": "29891469",
        "score": 0.43418461084365845,
        "title": "Acceptability of a Mobile Clinical Decision Tool Among Emergency Department Clinicians: Development and Evaluation of The Ottawa Rules App.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29891469"
      },
      {
        "pubmed_id": "26803533",
        "score": 0.2775992155075073,
        "title": "Abdominal Mondor disease mimicking acute appendicitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26803533"
      }
    ],
    "query_time": 0.016354084014892578,
    "metrics": {
      "precision": 0.9,
      "recall": 1.0,
      "f1_score": 0.9473684210526316,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 9
    }
  },
  "54f2f81664850a5854000003": {
    "query": "What is the suggested clinical management of Fanconi anemia?",
    "type": "summary",
    "ideal_answer": [
      "Hematopoietic stem cell transplantation is the only proven cure for the hematopoietic manifestations of FA and aggressive lifelong surveillance for solid tumors is essential.In patients with FA, there is a high incidence of aggressive HNSCC at a young age. Surgery remains the mainstay of treatment because patients with FA tolerate radiation therapy and chemotherapy poorly, with significant morbidity",
      "Hematopoietic stem cell transplantation is the only proven cure for the hematopoietic manifestations of FA and aggressive lifelong surveillance for solid tumors is essential. Surgery remains the mainstay of treatment because patients with FA tolerate radiation therapy and chemotherapy poorly, with significant morbidity. In patients with FA, there is a high incidence of aggressive HNSCC at a young age. Bone marrow surveillance is an important part of the clinical management of FA and often reveals cytogenetic aberrations. ",
      "Hematopoietic stem cell transplantation is the only proven cure for the hematopoietic manifestations of FA and aggressive lifelong surveillance for solid tumors is essential.",
      "Surgery remains the mainstay of treatment because patients with FA tolerate radiation therapy and chemotherapy poorly, with significant morbidity. In patients with FA, there is a high incidence of aggressive HNSCC at a young age. Hematopoietic stem cell transplantation is the only proven cure for the hematopoietic manifestations of FA and aggressive lifelong surveillance for solid tumors is essential. Bone marrow surveillance is an important part of the clinical management of FA and often reveals cytogenetic aberrations. "
    ],
    "ground_truth_ids": [
      "22675616",
      "12525204",
      "23146055"
    ],
    "retrieved_ids": [
      "23146055",
      "11524917",
      "7116934",
      "22675616",
      "12525204",
      "15383454",
      "9169126",
      "20869034",
      "21886393",
      "24159166"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23146055",
        "score": 0.6683575510978699,
        "title": "Current clinical management of Fanconi anemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23146055"
      },
      {
        "pubmed_id": "11524917",
        "score": 0.6475256085395813,
        "title": "[Fanconi's anemia and molecular biology research].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11524917"
      },
      {
        "pubmed_id": "7116934",
        "score": 0.6392388343811035,
        "title": "Cytogenetic and flow cytometric studies of cells from patients with Fanconi's anemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7116934"
      },
      {
        "pubmed_id": "22675616",
        "score": 0.5943194627761841,
        "title": "Chromosomal aberrations associated with clonal evolution and leukemic transformation in fanconi anemia: clinical and biological implications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22675616"
      },
      {
        "pubmed_id": "12525204",
        "score": 0.5664601922035217,
        "title": "High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12525204"
      },
      {
        "pubmed_id": "15383454",
        "score": 0.5328241586685181,
        "title": "Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15383454"
      },
      {
        "pubmed_id": "9169126",
        "score": 0.49024659395217896,
        "title": "The genomic organization of the Fanconi anemia group A (FAA) gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9169126"
      },
      {
        "pubmed_id": "20869034",
        "score": 0.4841539263725281,
        "title": "Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20869034"
      },
      {
        "pubmed_id": "21886393",
        "score": 0.46569156646728516,
        "title": "Hemolytic Anemia as a Presenting Feature of Wilson's Disease: A Case Report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21886393"
      },
      {
        "pubmed_id": "24159166",
        "score": 0.45895063877105713,
        "title": "Anti-hepcidin therapy for iron-restricted anemias.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24159166"
      }
    ],
    "query_time": 0.01466226577758789,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "58bca3eb02b8c6095300000d": {
    "query": "What is adhesive capsulitis",
    "type": "summary",
    "ideal_answer": [
      "Adhesive capsulitis also known as \"frozen shoulder\" is characterized by painful, gradual loss of active and passive shoulder motion resulting from fibrosis and contracture of the joint capsule."
    ],
    "ground_truth_ids": [
      "2702506",
      "27942856",
      "25919473",
      "19011582",
      "21885699",
      "19589853",
      "7754892",
      "24652474",
      "24283550",
      "24211154",
      "10890460",
      "3871127",
      "10738419",
      "24374758"
    ],
    "retrieved_ids": [
      "24283550",
      "3871127",
      "10738419",
      "21885699",
      "2702506",
      "27942856",
      "19589853",
      "7754892",
      "24374758",
      "24211154"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24283550",
        "score": 0.7186496257781982,
        "title": "Adhesive capsulitis: review of imaging and treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24283550"
      },
      {
        "pubmed_id": "3871127",
        "score": 0.7142140865325928,
        "title": "Adhesive capsulitis of the hip and ankle.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3871127"
      },
      {
        "pubmed_id": "10738419",
        "score": 0.6855006217956543,
        "title": "Adhesive capsulitis. A treatment approach.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10738419"
      },
      {
        "pubmed_id": "21885699",
        "score": 0.6418465375900269,
        "title": "Adhesive capsulitis of the shoulder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21885699"
      },
      {
        "pubmed_id": "2702506",
        "score": 0.634161114692688,
        "title": "[Distention arthrography in the treatment of adhesive capsulitis of the shoulder].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2702506"
      },
      {
        "pubmed_id": "27942856",
        "score": 0.6140085458755493,
        "title": "Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27942856"
      },
      {
        "pubmed_id": "19589853",
        "score": 0.6076706647872925,
        "title": "Adhesive capsulitis: establishing consensus on clinical identifiers for stage 1 using the DELPHI technique.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19589853"
      },
      {
        "pubmed_id": "7754892",
        "score": 0.5892366170883179,
        "title": "Adhesive capsulitis of the shoulder: MR diagnosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7754892"
      },
      {
        "pubmed_id": "24374758",
        "score": 0.5704063773155212,
        "title": "Current evidence on physical therapy in patients with adhesive capsulitis: what are we missing?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24374758"
      },
      {
        "pubmed_id": "24211154",
        "score": 0.5432755351066589,
        "title": "Efficacy of a static progressive stretch device as an adjunct to physical therapy in treating adhesive capsulitis of the shoulder: a prospective, randomised study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24211154"
      }
    ],
    "query_time": 0.7907488346099854,
    "metrics": {
      "precision": 1.0,
      "recall": 0.7142857142857143,
      "f1_score": 0.8333333333333333,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 14
    }
  },
  "5c6d88257c78d6947100003d": {
    "query": "Describe CGmapTools",
    "type": "summary",
    "ideal_answer": [
      "CGmapTools improves the precision of heterozygous SNV calls and supports allele-specific methylation detection and visualization in bisulfite-sequencing data.",
      "DNA methylation is important for gene silencing and imprinting in both plants and animals. Recent advances in bisulfite sequencing allow detection of single nucleotide variations (SNVs) achieving high sensitivity, but accurately identifying heterozygous SNVs from partially C-to-T converted sequences remains challenging. CGmapTools is a software package that integrates 40 applications with the aim to analyze DNA methylomes. This package uses CGmap as the format interface, and designs binary formats to reduce the file size and support fast data retrieval, and can be applied for context-wise, gene-wise, bin-wise, region-wise and sample-wise analyses and visualizations."
    ],
    "ground_truth_ids": [
      "28968643"
    ],
    "retrieved_ids": [
      "29691490",
      "23480465",
      "31258549",
      "29556965",
      "28644160",
      "31020659",
      "17473208",
      "10592229",
      "30681821",
      "25515746"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29691490",
        "score": 0.3805662989616394,
        "title": "CGRP as the target of new migraine therapies - successful translation from bench to clinic.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29691490"
      },
      {
        "pubmed_id": "23480465",
        "score": 0.3471679389476776,
        "title": "CGRP receptor antagonists: design and screening.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23480465"
      },
      {
        "pubmed_id": "31258549",
        "score": 0.33670538663864136,
        "title": "L1000 Viewer: A Search Engine and Web Interface for the LINCS Data Repository.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31258549"
      },
      {
        "pubmed_id": "29556965",
        "score": 0.3300632834434509,
        "title": "Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29556965"
      },
      {
        "pubmed_id": "28644160",
        "score": 0.32038986682891846,
        "title": "Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28644160"
      },
      {
        "pubmed_id": "31020659",
        "score": 0.3174479007720947,
        "title": "Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31020659"
      },
      {
        "pubmed_id": "17473208",
        "score": 0.30343741178512573,
        "title": "Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17473208"
      },
      {
        "pubmed_id": "10592229",
        "score": 0.30133840441703796,
        "title": "Kabat database and its applications: 30 years after the first variability plot.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10592229"
      },
      {
        "pubmed_id": "30681821",
        "score": 0.2969048023223877,
        "title": "Migraine overview and summary of current and emerging treatment options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30681821"
      },
      {
        "pubmed_id": "25515746",
        "score": 0.2958138883113861,
        "title": "The use of citrullinated peptides for the diagnosis and prognosis of rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25515746"
      }
    ],
    "query_time": 0.006882905960083008,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5508453a4b2a315d41000008": {
    "query": "What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",
    "type": "summary",
    "ideal_answer": [
      "Recently, the impact of small ubiquitin-related modifier 1 (SUMO-1) on the regulation and preservation of sarcoplasmic reticulum calcium adenosine triphosphatase (SERCA2a) function was discovered. The small ubiquitin-related modifier (SUMO) can be conjugated to lysine residues of target proteins, and is involved in many cellular processes. SERCA2a is SUMOylated at lysines 480 and 585 and this SUMOylation is essential for preserving SERCA2a ATPase activity and stability in mouse and human cells. The levels of SUMO1 and the SUMOylation of SERCA2a itself were greatly reduced in failing hearts. SUMO-1 gene transfer improved cardiac function supporting the critical role of SUMO-1 in SERCA2a function and underlining the therapeutic potential of SUMO-1 for HF patients."
    ],
    "ground_truth_ids": [
      "23710633",
      "22679139",
      "24225946",
      "21900893"
    ],
    "retrieved_ids": [
      "21900893",
      "24225946",
      "23710633",
      "27142163",
      "22679139",
      "21390240",
      "23628505",
      "25097219",
      "18221109",
      "18556468"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "21900893",
        "score": 0.7289096117019653,
        "title": "SUMO1-dependent modulation of SERCA2a in heart failure.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21900893"
      },
      {
        "pubmed_id": "24225946",
        "score": 0.6562837362289429,
        "title": "SUMO-1 gene transfer improves cardiac function in a large-animal model of heart failure.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24225946"
      },
      {
        "pubmed_id": "23710633",
        "score": 0.6146093010902405,
        "title": "SERCA2a: a prime target for modulation of cardiac contractility during heart failure.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23710633"
      },
      {
        "pubmed_id": "27142163",
        "score": 0.6059103012084961,
        "title": "UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27142163"
      },
      {
        "pubmed_id": "22679139",
        "score": 0.6023476123809814,
        "title": "Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22679139"
      },
      {
        "pubmed_id": "21390240",
        "score": 0.5259470343589783,
        "title": "Sumoylation of hypoxia-inducible factor-1α ameliorates failure of brain stem cardiovascular regulation in experimental brain death.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21390240"
      },
      {
        "pubmed_id": "23628505",
        "score": 0.525728702545166,
        "title": "Emerging role of SUMOylation in placental pathology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23628505"
      },
      {
        "pubmed_id": "25097219",
        "score": 0.5209920406341553,
        "title": "Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25097219"
      },
      {
        "pubmed_id": "18221109",
        "score": 0.5128371715545654,
        "title": "Ryanodine receptor: a novel therapeutic target in heart disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18221109"
      },
      {
        "pubmed_id": "18556468",
        "score": 0.48694759607315063,
        "title": "The role of calmodulin kinase II in myocardial physiology and disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18556468"
      }
    ],
    "query_time": 0.03896498680114746,
    "metrics": {
      "precision": 0.4,
      "recall": 1.0,
      "f1_score": 0.5714285714285715,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "5e3aab25b5b409ea5300001a": {
    "query": "What is the purpose of the Barricaid annular closure device?",
    "type": "summary",
    "ideal_answer": [
      "Barricaid annular closure device can improve outcome after lumbar discectomy by reducing the risk of recurrent disc herniation of the same level."
    ],
    "ground_truth_ids": [
      "27169045",
      "30115053",
      "23429676",
      "31464935",
      "27879508",
      "29075906",
      "27236580",
      "23473658"
    ],
    "retrieved_ids": [
      "27169045",
      "31464935",
      "27236580",
      "29075906",
      "30115053",
      "23473658",
      "23429676",
      "27879508",
      "17946960",
      "27454517"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27169045",
        "score": 0.6698464155197144,
        "title": "Use of Annular Closure Device (Barricaid®) for Preventing Lumbar Disc Reherniation: One-Year Results of Three Cases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27169045"
      },
      {
        "pubmed_id": "31464935",
        "score": 0.5578534007072449,
        "title": "Multicenter study of lumbar discectomy with Barricaid annular closure device for prevention of lumbar disc reherniation in US patients: A historically controlled post-market study protocol.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31464935"
      },
      {
        "pubmed_id": "27236580",
        "score": 0.5307844281196594,
        "title": "Reoperation after microdiscectomy of lumbar herniation: Case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27236580"
      },
      {
        "pubmed_id": "29075906",
        "score": 0.5270061492919922,
        "title": "Symptomatic annulus-repair-device loosening due to a low-grade infection.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29075906"
      },
      {
        "pubmed_id": "30115053",
        "score": 0.47899091243743896,
        "title": "Annular closure device for disc herniation: meta-analysis of clinical outcome and complications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30115053"
      },
      {
        "pubmed_id": "23473658",
        "score": 0.4241788685321808,
        "title": "Protecting facet joints post-lumbar discectomy: Barricaid annular closure device reduces risk of facet degeneration.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23473658"
      },
      {
        "pubmed_id": "23429676",
        "score": 0.40110674500465393,
        "title": "Can prevention of a reherniation be investigated? Establishment of a herniation model and experiments with an anular closure device.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23429676"
      },
      {
        "pubmed_id": "27879508",
        "score": 0.37638363242149353,
        "title": "Effect of an Annular Closure Device (Barricaid) on Same-Level Recurrent Disk Herniation and Disk Height Loss After Primary Lumbar Discectomy: Two-year Results of a Multicenter Prospective Cohort Study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27879508"
      },
      {
        "pubmed_id": "17946960",
        "score": 0.29443466663360596,
        "title": "Magnetic microactuators for MEMS-enabled ventricular catheters for hydrocephalus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17946960"
      },
      {
        "pubmed_id": "27454517",
        "score": 0.2610855996608734,
        "title": "Concurrent Minimally Invasive Carpal Tunnel Release Techniques in Distal Radius Open Reduction Internal Fixation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27454517"
      }
    ],
    "query_time": 0.009463071823120117,
    "metrics": {
      "precision": 0.8,
      "recall": 1.0,
      "f1_score": 0.888888888888889,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "530e42bf5937551c09000005": {
    "query": "What is the role of edaravone in traumatic brain injury?",
    "type": "summary",
    "ideal_answer": [
      "Edaravone, a free radical scavenger, has been shown to have neuroprotective effects after traumatic brain injury. In animal models, edaravone has been shown to reduce neuronal damage by scavenging reactive oxygen species (ROS), maintain intact the autoregulation of the cerebral vasculature, decrease neuronal loss, reduce programmed cell death, the presence of inflammatory cytokines, cerebral edema, and blood-brain barrier (BBB) permeability. Edaravone also protects against neurological deficits and memory deficits following traumatic brain injury."
    ],
    "ground_truth_ids": [
      "23564113",
      "23710445",
      "22977573",
      "17115943",
      "17115906",
      "19590930",
      "24066191",
      "22982593",
      "22251821",
      "20398468",
      "21677777",
      "21732763",
      "19768539"
    ],
    "retrieved_ids": [
      "17115943",
      "19768539",
      "20398468",
      "21732763",
      "22982593",
      "23564113",
      "19590930",
      "22977573",
      "23710445",
      "21677777"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "17115943",
        "score": 0.7280604243278503,
        "title": "Does edaravone (MCI- 186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17115943"
      },
      {
        "pubmed_id": "19768539",
        "score": 0.7257018089294434,
        "title": "Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19768539"
      },
      {
        "pubmed_id": "20398468",
        "score": 0.7001962065696716,
        "title": "[Effect of edaravone on extracellular signal-regulated kinase 1/2 pathway following severe traumatic brain injury in rats].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20398468"
      },
      {
        "pubmed_id": "21732763",
        "score": 0.6923073530197144,
        "title": "Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21732763"
      },
      {
        "pubmed_id": "22982593",
        "score": 0.6899091601371765,
        "title": "Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22982593"
      },
      {
        "pubmed_id": "23564113",
        "score": 0.6587666273117065,
        "title": "Edaravone increases regional cerebral blood flow after traumatic brain injury in mice.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23564113"
      },
      {
        "pubmed_id": "19590930",
        "score": 0.6361511945724487,
        "title": "The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19590930"
      },
      {
        "pubmed_id": "22977573",
        "score": 0.6177698969841003,
        "title": "Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22977573"
      },
      {
        "pubmed_id": "23710445",
        "score": 0.5852037072181702,
        "title": "Therapeutic time window for edaravone treatment of traumatic brain injury in mice.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23710445"
      },
      {
        "pubmed_id": "21677777",
        "score": 0.5501614809036255,
        "title": "Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21677777"
      }
    ],
    "query_time": 0.005605220794677734,
    "metrics": {
      "precision": 1.0,
      "recall": 0.7692307692307693,
      "f1_score": 0.8695652173913044,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 13
    }
  },
  "5c6641ea7c78d69471000016": {
    "query": "What is the mechanism of action of tucatinib?",
    "type": "summary",
    "ideal_answer": [
      "Tucatinib is an oral, potent, human epidermal growth factor receptor 2 (HER2)-specific tyrosine kinase inhibitor (TKI) being developed as a novel treatment for ERBB2/HER2-positive breast cancer."
    ],
    "ground_truth_ids": [
      "29772459",
      "28923217",
      "29804905",
      "29955792"
    ],
    "retrieved_ids": [
      "6283380",
      "29955792",
      "29804905",
      "37877814",
      "8124709",
      "12972430",
      "23591820",
      "34486707",
      "10587097",
      "15744326"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "6283380",
        "score": 0.3623121678829193,
        "title": "Curare can open and block ionic channels associated with cholinergic receptors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6283380"
      },
      {
        "pubmed_id": "29955792",
        "score": 0.3608795404434204,
        "title": "Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29955792"
      },
      {
        "pubmed_id": "29804905",
        "score": 0.336734414100647,
        "title": "Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29804905"
      },
      {
        "pubmed_id": "37877814",
        "score": 0.31913289427757263,
        "title": "Tarlatamab Shows Promise in SCLC.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37877814"
      },
      {
        "pubmed_id": "8124709",
        "score": 0.2942459285259247,
        "title": "The spätzle gene encodes a component of the extracellular signaling pathway establishing the dorsal-ventral pattern of the Drosophila embryo.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8124709"
      },
      {
        "pubmed_id": "12972430",
        "score": 0.2847122848033905,
        "title": "Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12972430"
      },
      {
        "pubmed_id": "23591820",
        "score": 0.28092506527900696,
        "title": "The human TREX-2 complex is stably associated with the nuclear pore basket.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23591820"
      },
      {
        "pubmed_id": "34486707",
        "score": 0.27980178594589233,
        "title": "NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34486707"
      },
      {
        "pubmed_id": "10587097",
        "score": 0.2765810191631317,
        "title": "Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10587097"
      },
      {
        "pubmed_id": "15744326",
        "score": 0.27565550804138184,
        "title": "Multisite protein modification and intramolecular signaling.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15744326"
      }
    ],
    "query_time": 0.009470939636230469,
    "metrics": {
      "precision": 0.2,
      "recall": 0.5,
      "f1_score": 0.28571428571428575,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "5c5f218a1a4c55d80b00001b": {
    "query": "What is ferroptosis?",
    "type": "summary",
    "ideal_answer": [
      "Ferroptosis is a newly defined iron-dependent, non-apoptotic mode of cell death with necrotic morphology. Ferroptosis is a new mode of regulated cell death, which is completely distinct from other cell death modes based on morphological, biochemical, and genetic criteria. Ferroptosis is a form of oxidative cell death and has become a chemotherapeutic target for cancer treatment"
    ],
    "ground_truth_ids": [
      "29127238",
      "29274359",
      "29175614",
      "28515173",
      "28494534"
    ],
    "retrieved_ids": [
      "29175614",
      "28515173",
      "29127238",
      "28494534",
      "24175256",
      "8114295",
      "29533917",
      "23108197",
      "9024275",
      "8984578"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29175614",
        "score": 0.7097575068473816,
        "title": "To eat or not to eat-the metabolic flavor of ferroptosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29175614"
      },
      {
        "pubmed_id": "28515173",
        "score": 0.482034832239151,
        "title": "Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28515173"
      },
      {
        "pubmed_id": "29127238",
        "score": 0.44512051343917847,
        "title": "Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29127238"
      },
      {
        "pubmed_id": "28494534",
        "score": 0.44236254692077637,
        "title": "Ferroptosis: A Novel Anti-tumor Action for Cisplatin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28494534"
      },
      {
        "pubmed_id": "24175256",
        "score": 0.44063451886177063,
        "title": "Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24175256"
      },
      {
        "pubmed_id": "8114295",
        "score": 0.42666131258010864,
        "title": "[Liver cirrhosis in primary hemochromatosis and Wilson's disease].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8114295"
      },
      {
        "pubmed_id": "29533917",
        "score": 0.4177713990211487,
        "title": "[Iron supplementation in chronic kidney disease].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29533917"
      },
      {
        "pubmed_id": "23108197",
        "score": 0.3998486399650574,
        "title": "Hypophosphatemic rickets.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23108197"
      },
      {
        "pubmed_id": "9024275",
        "score": 0.3945047855377197,
        "title": "Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9024275"
      },
      {
        "pubmed_id": "8984578",
        "score": 0.3909491300582886,
        "title": "[Current diagnosis: hereditary metabolic diseases of the liver (primary hemochromatosis, Wilson disease)].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8984578"
      }
    ],
    "query_time": 0.007424831390380859,
    "metrics": {
      "precision": 0.4,
      "recall": 0.8,
      "f1_score": 0.5333333333333333,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "65cfac201930410b13000013": {
    "query": "What is the mechanism of action of Mezigdomide?",
    "type": "summary",
    "ideal_answer": [
      "Mezigdomide is a novel cereblon E3 ubiquitin ligase modulator with potent antiproliferative and tumoricidal activity in multiple myeloma."
    ],
    "ground_truth_ids": [
      "37646702",
      "37705327",
      "37906232",
      "36342226"
    ],
    "retrieved_ids": [
      "37646702",
      "9291508",
      "37705327",
      "8914439",
      "6283380",
      "25498859",
      "16157351",
      "26990986",
      "24711240",
      "8574597"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "37646702",
        "score": 0.3572709560394287,
        "title": "Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37646702"
      },
      {
        "pubmed_id": "9291508",
        "score": 0.31731510162353516,
        "title": "Methamidophos: an anticholinesterase without significant effects on postsynaptic receptors or transmitter release.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9291508"
      },
      {
        "pubmed_id": "37705327",
        "score": 0.3129971921443939,
        "title": "Model based assessment of food and acid reducing agent effects on oral absorption of mezigdomide (CC-92480), a novel cereblon E3 ligase modulator.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37705327"
      },
      {
        "pubmed_id": "8914439",
        "score": 0.31240367889404297,
        "title": "[Drug therapy in subjects with impaired glucose tolerance].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8914439"
      },
      {
        "pubmed_id": "6283380",
        "score": 0.3087664544582367,
        "title": "Curare can open and block ionic channels associated with cholinergic receptors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6283380"
      },
      {
        "pubmed_id": "25498859",
        "score": 0.30816176533699036,
        "title": "Effects of donepezil on hERG potassium channels.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25498859"
      },
      {
        "pubmed_id": "16157351",
        "score": 0.30788111686706543,
        "title": "Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16157351"
      },
      {
        "pubmed_id": "26990986",
        "score": 0.30064183473587036,
        "title": "Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26990986"
      },
      {
        "pubmed_id": "24711240",
        "score": 0.29792073369026184,
        "title": "[Perioperative management and therapy of bleeding complications].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24711240"
      },
      {
        "pubmed_id": "8574597",
        "score": 0.29731786251068115,
        "title": "The immune system in uremia and during its treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8574597"
      }
    ],
    "query_time": 0.0119171142578125,
    "metrics": {
      "precision": 0.2,
      "recall": 0.5,
      "f1_score": 0.28571428571428575,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "5a82fc89faa1ab7d2e000028": {
    "query": "Which yeast nucleosomes are preferentially marked by H2A.Z?",
    "type": "summary",
    "ideal_answer": [
      "Yeast nucleosomes containing histone variant H2A.Z (Htz1p in yeast) are primarily composed of H4 K12ac and H3 K4me3.",
      "H2A.Z represses gene expression by establishing low gene accessibility at +1 nucleosome and maintaining high gene accessibility at -1 nucleosome. Ηigh measures of gene responsiveness correlate with the H2A.Z-associated closed +1 nucleosome structure.",
      "The H2A and H2A.Z nucleosomes have different sequence preferences. The shifted peaks coincide with DNA regions interacting with the histone loops. Deposition of the histone variant H2A.Z at gene bodies regulates transcription by modifying chromatin accessibility in plants. We showed that H2A.Z preferentially associated with H3K4me3 at promoters, while it was found with H3K27me3 at enhancers, and that H2A.Z deposition negatively correlated with gene expression. In addition, we demonstrated that H2A.Z represses gene expression by establishing low gene accessibility at +1 nucleosome and maintaining high gene accessibility at -1 nucleosome. We further showed that the high measures of gene responsiveness correlate with the H2A.Z-associated closed +1 nucleosome structure."
    ],
    "ground_truth_ids": [
      "26789756",
      "22393239",
      "19246569",
      "16248679",
      "28951178",
      "27992255",
      "24613878",
      "22821566"
    ],
    "retrieved_ids": [
      "16248679",
      "19246569",
      "24613878",
      "23620291",
      "22393239",
      "21551148",
      "22435808",
      "6323017",
      "26789756",
      "19620965"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "16248679",
        "score": 0.7013198137283325,
        "title": "Variant histone H2A.Z is globally localized to the promoters of inactive yeast genes and regulates nucleosome positioning.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16248679"
      },
      {
        "pubmed_id": "19246569",
        "score": 0.6903486251831055,
        "title": "Comparative analysis of H2A.Z nucleosome organization in the human and yeast genomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19246569"
      },
      {
        "pubmed_id": "24613878",
        "score": 0.5991117358207703,
        "title": "Anp32e, a higher eukaryotic histone chaperone directs preferential recognition for H2A.Z.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24613878"
      },
      {
        "pubmed_id": "23620291",
        "score": 0.5929974317550659,
        "title": "Reconstitution of hemisomes on budding yeast centromeric DNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23620291"
      },
      {
        "pubmed_id": "22393239",
        "score": 0.5796614289283752,
        "title": "Single-molecule tools elucidate H2A.Z nucleosome composition.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22393239"
      },
      {
        "pubmed_id": "21551148",
        "score": 0.5702957510948181,
        "title": "Genome-wide DNA sequence polymorphisms facilitate nucleosome positioning in yeast.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21551148"
      },
      {
        "pubmed_id": "22435808",
        "score": 0.5699939727783203,
        "title": "DNA structure, nucleosome placement and chromatin remodelling: a perspective.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22435808"
      },
      {
        "pubmed_id": "6323017",
        "score": 0.5646013617515564,
        "title": "Yeast DNA topoisomerase II is encoded by a single-copy, essential gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6323017"
      },
      {
        "pubmed_id": "26789756",
        "score": 0.555712103843689,
        "title": "Effects of MacroH2A and H2A.Z on Nucleosome Dynamics as Elucidated by Molecular Dynamics Simulations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26789756"
      },
      {
        "pubmed_id": "19620965",
        "score": 0.5532553195953369,
        "title": "Intrinsic histone-DNA interactions are not the major determinant of nucleosome positions in vivo.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19620965"
      }
    ],
    "query_time": 0.009488105773925781,
    "metrics": {
      "precision": 0.5,
      "recall": 0.625,
      "f1_score": 0.5555555555555556,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "5357a514f1005d6b58000003": {
    "query": "How could U1 small nuclear RNA be used in therapeutics?",
    "type": "summary",
    "ideal_answer": [
      "Until now, two main types of therapeutic strategies have been developed using U1 small nuclear RNA (snRNA): 1) Production of a defective, but partially functional protein, with the help of exon skipping, through modulation of pre-mRNA splicing, and 2) Correction of pathogenic effects of splice donor site mutations with the use of U1 snRNA adapted to the defective variant."
    ],
    "ground_truth_ids": [
      "22362925",
      "22968481",
      "20869034",
      "19219028",
      "22454066",
      "22454067",
      "21520335",
      "21326217"
    ],
    "retrieved_ids": [
      "19219028",
      "22454067",
      "25578728",
      "3299107",
      "18050426",
      "3031599",
      "22454066",
      "21326217",
      "11567018",
      "31752361"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "19219028",
        "score": 0.6549986600875854,
        "title": "Gene silencing by synthetic U1 adaptors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19219028"
      },
      {
        "pubmed_id": "22454067",
        "score": 0.6235196590423584,
        "title": "Engineering U7snRNA gene to reframe transcripts.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22454067"
      },
      {
        "pubmed_id": "25578728",
        "score": 0.5778375267982483,
        "title": "The human nuclear exosome targeting complex is loaded onto newly synthesized RNA to direct early ribonucleolysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25578728"
      },
      {
        "pubmed_id": "3299107",
        "score": 0.5316900610923767,
        "title": "A distant enhancer element is required for polymerase III transcription of a U6 RNA gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3299107"
      },
      {
        "pubmed_id": "18050426",
        "score": 0.513421893119812,
        "title": "Trans-splicing and operons.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18050426"
      },
      {
        "pubmed_id": "3031599",
        "score": 0.5119200944900513,
        "title": "Xenopus tropicalis U6 snRNA genes transcribed by Pol III contain the upstream promoter elements used by Pol II dependent U snRNA genes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3031599"
      },
      {
        "pubmed_id": "22454066",
        "score": 0.5048108100891113,
        "title": "U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22454066"
      },
      {
        "pubmed_id": "21326217",
        "score": 0.5012525320053101,
        "title": "Gene therapeutic approach using mutation-adapted U1 snRNA to correct a RPGR splice defect in patient-derived cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21326217"
      },
      {
        "pubmed_id": "11567018",
        "score": 0.49719560146331787,
        "title": "RNA association defines a functionally conserved domain in the nuclear pore protein Nup153.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11567018"
      },
      {
        "pubmed_id": "31752361",
        "score": 0.49629583954811096,
        "title": "The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31752361"
      }
    ],
    "query_time": 0.008719921112060547,
    "metrics": {
      "precision": 0.4,
      "recall": 0.5,
      "f1_score": 0.4444444444444445,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "602969061cb411341a000114": {
    "query": "What is RADICL-seq?",
    "type": "summary",
    "ideal_answer": [
      "Mammalian genomes encode tens of thousands of noncoding RNAs. Most noncoding transcripts exhibit nuclear localization and several have been shown to play a role in the regulation of gene expression and chromatin remodeling. To investigate the function of such RNAs, methods to massively map the genomic interacting sites of multiple transcripts have been developed; however, these methods have some limitations. RNA And DNA Interacting Complexes Ligated and sequenced (RADICL-seq) is a technology that maps genome-wide RNA-chromatin interactions in intact nuclei. RADICL-seq is a proximity ligation-based methodology that reduces the bias for nascent transcription, while increasing genomic coverage and unique mapping rate efficiency compared with existing methods. RADICL-seq identifies distinct patterns of genome occupancy for different classes of transcripts as well as cell type-specific RNA-chromatin interactions, and highlights the role of transcription in the establishment of chromatin structure.",
      "RADICL-seq is a technology that maps genome-wide RNA-chromatin interactions in intact nuclei. It identifies distinct patterns of genome occupancy for different classes of transcripts as well as cell type-specific RNA- chromatin interactions, and highlights the role of transcription in the establishment of chromatin structure.",
      "RADICL-seq is a technology that maps genome-wide RNA-chromatin interactions in intact nuclei. It is a proximity ligation-based methodology that reduces the bias for nascent transcription, while increasing genomic coverage and unique mapping rate efficiency compared with existing methods. RADICL -seq identifies distinct patterns of genome occupancy for different classes of transcripts as well as cell type-specific RNA- chromatin interactions, and highlights the role of transcription in the establishment of chromatin structure."
    ],
    "ground_truth_ids": [
      "32094342"
    ],
    "retrieved_ids": [
      "32094342",
      "23212593",
      "23523202",
      "24285764",
      "23961674",
      "23599436",
      "21548952",
      "19587388",
      "22006202",
      "20233177"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "32094342",
        "score": 0.3576490581035614,
        "title": "RADICL-seq identifies general and cell type-specific principles of genome-wide RNA-chromatin interactions.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32094342"
      },
      {
        "pubmed_id": "23212593",
        "score": 0.298811137676239,
        "title": "JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23212593"
      },
      {
        "pubmed_id": "23523202",
        "score": 0.29605114459991455,
        "title": "Targeting kinases: a new approach to treating inflammatory rheumatic diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23523202"
      },
      {
        "pubmed_id": "24285764",
        "score": 0.2823141813278198,
        "title": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24285764"
      },
      {
        "pubmed_id": "23961674",
        "score": 0.2708130478858948,
        "title": "[JAK inhibitor].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23961674"
      },
      {
        "pubmed_id": "23599436",
        "score": 0.26472538709640503,
        "title": "Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23599436"
      },
      {
        "pubmed_id": "21548952",
        "score": 0.26185303926467896,
        "title": "CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21548952"
      },
      {
        "pubmed_id": "19587388",
        "score": 0.2576632797718048,
        "title": "Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19587388"
      },
      {
        "pubmed_id": "22006202",
        "score": 0.2569699287414551,
        "title": "A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22006202"
      },
      {
        "pubmed_id": "20233177",
        "score": 0.2560389041900635,
        "title": "Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20233177"
      }
    ],
    "query_time": 0.012842893600463867,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "62211fdf3a8413c653000073": {
    "query": "What is ARNIL?",
    "type": "summary",
    "ideal_answer": [
      "Long noncoding RNA (lncRNA) antisense noncoding RNA in the INK4 locus (ANRIL) is involved in several human cancers."
    ],
    "ground_truth_ids": [
      "28251886"
    ],
    "retrieved_ids": [
      "27378659",
      "33095513",
      "33210357",
      "29290671",
      "18596995",
      "33981731",
      "27121186",
      "32514935",
      "32320478",
      "32965603"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27378659",
        "score": 0.30906787514686584,
        "title": "Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27378659"
      },
      {
        "pubmed_id": "33095513",
        "score": 0.2772386968135834,
        "title": "The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33095513"
      },
      {
        "pubmed_id": "33210357",
        "score": 0.27603253722190857,
        "title": "ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33210357"
      },
      {
        "pubmed_id": "29290671",
        "score": 0.27142664790153503,
        "title": "Pharmaceutical Approval Update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29290671"
      },
      {
        "pubmed_id": "18596995",
        "score": 0.27009934186935425,
        "title": "Armodafinil for excessive daytime sleepiness.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18596995"
      },
      {
        "pubmed_id": "33981731",
        "score": 0.26583924889564514,
        "title": "Associations Between the Use of Renin-Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33981731"
      },
      {
        "pubmed_id": "27121186",
        "score": 0.26534825563430786,
        "title": "New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27121186"
      },
      {
        "pubmed_id": "32514935",
        "score": 0.26485341787338257,
        "title": "Renin-angiotensin system inhibition in COVID-19 patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32514935"
      },
      {
        "pubmed_id": "32320478",
        "score": 0.2603661119937897,
        "title": "Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32320478"
      },
      {
        "pubmed_id": "32965603",
        "score": 0.25553756952285767,
        "title": "Neither ACEIs nor ARBs are associated with respiratory distress or mortality in COVID-19 results of a prospective study on a hospital-based cohort.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32965603"
      }
    ],
    "query_time": 0.011584043502807617,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "52fb19ab2059c6d71c00005c": {
    "query": "What are the pregnancy outcomes in rheumatoid arthritis?",
    "type": "summary",
    "ideal_answer": [
      "There is increased obstetrical and neonatal morbidity. Women with RA had an increased risk of LBW, SGA babies, preeclampsia and CS compared with unaffected women.\nWomen with  RA appear to have a higher age-adjusted risk of adverse outcomes of pregnancy and longer hospital stays than do pregnant women in the general population, and careful antenatal monitoring should be performed.Patients with rheumatic disease can have successful pregnancy outcomes, particularly when a collaborative approach between the rheumatologist and obstetrician is applied.\nIn general, active inflammation from rheumatic diseases poses a stronger threat to the well-being of both mother and foetus than many immunosuppressant medications. Therefore, continued immunosuppression with the least risky medications will allow for the most optimal pregnancy outcomes."
    ],
    "ground_truth_ids": [
      "23382363",
      "19826816",
      "20031371",
      "22176821",
      "16508972",
      "23773975",
      "23359233",
      "16649008",
      "20337545",
      "22028718",
      "2189302",
      "19406733",
      "20534371",
      "20131283"
    ],
    "retrieved_ids": [
      "23359233",
      "19406733",
      "23773975",
      "20534371",
      "22176821",
      "16649008",
      "19826816",
      "22028718",
      "20337545",
      "21120498"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23359233",
        "score": 0.7796851396560669,
        "title": "High rate of preterm birth in pregnancies complicated by rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23359233"
      },
      {
        "pubmed_id": "19406733",
        "score": 0.7624303102493286,
        "title": "Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19406733"
      },
      {
        "pubmed_id": "23773975",
        "score": 0.7468313574790955,
        "title": "Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23773975"
      },
      {
        "pubmed_id": "20534371",
        "score": 0.7361461520195007,
        "title": "Managing contraception and pregnancy in the rheumatologic diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20534371"
      },
      {
        "pubmed_id": "22176821",
        "score": 0.7237774729728699,
        "title": "[Pregnancy outcomes before and after the onset of rheumatoid arthritis].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22176821"
      },
      {
        "pubmed_id": "16649008",
        "score": 0.7143305540084839,
        "title": "Pregnancy outcomes in women with rheumatoid arthritis in Washington State.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16649008"
      },
      {
        "pubmed_id": "19826816",
        "score": 0.6821070909500122,
        "title": "A comparative study of pregnancy outcomes and menstrual irregularities in northern Indian patients with systemic lupus erythematosus and rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19826816"
      },
      {
        "pubmed_id": "22028718",
        "score": 0.6733547449111938,
        "title": "Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22028718"
      },
      {
        "pubmed_id": "20337545",
        "score": 0.6639904975891113,
        "title": "The management of rheumatic diseases in pregnancy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20337545"
      },
      {
        "pubmed_id": "21120498",
        "score": 0.6553875207901001,
        "title": "The treatment of rheumatoid arthritis during pregnancy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21120498"
      }
    ],
    "query_time": 0.009598016738891602,
    "metrics": {
      "precision": 0.9,
      "recall": 0.6428571428571429,
      "f1_score": 0.75,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 14
    }
  },
  "5c9fb2aaecadf2e73f00003f": {
    "query": "What is aphasia?",
    "type": "summary",
    "ideal_answer": [
      "Aphasia  is an inability to comprehend or formulate language because of damage to specific brain regions."
    ],
    "ground_truth_ids": [
      "26999324",
      "28691196"
    ],
    "retrieved_ids": [
      "26999324",
      "28691196",
      "24556565",
      "19728949",
      "12898406",
      "24157356",
      "21141008",
      "16903509",
      "28299553",
      "25610221"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "26999324",
        "score": 0.4841760993003845,
        "title": "Positive effects of a computerised working memory and executive function training on sentence comprehension in aphasia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26999324"
      },
      {
        "pubmed_id": "28691196",
        "score": 0.44005951285362244,
        "title": "The comprehensibility of pantomimes produced by people with aphasia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28691196"
      },
      {
        "pubmed_id": "24556565",
        "score": 0.3835084140300751,
        "title": "Phthiriasis palpebrarum infection: a concern for child abuse.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24556565"
      },
      {
        "pubmed_id": "19728949",
        "score": 0.380506306886673,
        "title": "Phthiriasis palpebrarum.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19728949"
      },
      {
        "pubmed_id": "12898406",
        "score": 0.37062740325927734,
        "title": "[Phthiriasis palpebrarum: diagnosis and treatment].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12898406"
      },
      {
        "pubmed_id": "24157356",
        "score": 0.33595144748687744,
        "title": "Phthiriasis palpebrarum: diagnosis and treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24157356"
      },
      {
        "pubmed_id": "21141008",
        "score": 0.33194875717163086,
        "title": "Alport syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21141008"
      },
      {
        "pubmed_id": "16903509",
        "score": 0.32951244711875916,
        "title": "Phthiriasis palpebrarum: 2 case reports.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16903509"
      },
      {
        "pubmed_id": "28299553",
        "score": 0.32514315843582153,
        "title": "History of Morgellons disease: the same name for different psychodermatologic diseases?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28299553"
      },
      {
        "pubmed_id": "25610221",
        "score": 0.32250261306762695,
        "title": "Escobar syndrome mimicing congenital patellar syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25610221"
      }
    ],
    "query_time": 0.00660395622253418,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "5319a7f2b166e2b80600002a": {
    "query": "What is the result of the interaction between TSC1 and PLK1?",
    "type": "summary",
    "ideal_answer": [
      "Phosphorylated TSC1 (hamartin) interacts with Plk1 independent of TSC2 (tuberin), with all three proteins present in a complex, and negatively regulates the protein levels of Plk1, to control centrosome duplication."
    ],
    "ground_truth_ids": [
      "16339216"
    ],
    "retrieved_ids": [
      "9880541",
      "23863160",
      "37131086",
      "19826484",
      "22160078",
      "27833949",
      "9566872",
      "20045951",
      "16339216",
      "25997832"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "9880541",
        "score": 0.3396133482456207,
        "title": "Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9880541"
      },
      {
        "pubmed_id": "23863160",
        "score": 0.33540967106819153,
        "title": "The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23863160"
      },
      {
        "pubmed_id": "37131086",
        "score": 0.33017927408218384,
        "title": "Progress and challenges in RET-targeted cancer therapy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37131086"
      },
      {
        "pubmed_id": "19826484",
        "score": 0.3270525336265564,
        "title": "Sumoylation of transcription factor Tec1 regulates signaling of mitogen-activated protein kinase pathways in yeast.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19826484"
      },
      {
        "pubmed_id": "22160078",
        "score": 0.3150832951068878,
        "title": "Dyskeratosis congenita.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22160078"
      },
      {
        "pubmed_id": "27833949",
        "score": 0.3131656050682068,
        "title": "The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27833949"
      },
      {
        "pubmed_id": "9566872",
        "score": 0.30643385648727417,
        "title": "Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9566872"
      },
      {
        "pubmed_id": "20045951",
        "score": 0.3030392527580261,
        "title": "Inhibition of tumor progression locus 2 protein kinase suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis through down-regulation of the c-Fos and nuclear factor of activated T cells c1 genes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20045951"
      },
      {
        "pubmed_id": "16339216",
        "score": 0.3022131621837616,
        "title": "Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16339216"
      },
      {
        "pubmed_id": "25997832",
        "score": 0.29787883162498474,
        "title": "Akt/PKB: one kinase, many modifications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25997832"
      }
    ],
    "query_time": 0.010504961013793945,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 1.0,
      "mrr": 0.1111111111111111,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "64403c4257b1c7a31500004f": {
    "query": "What is Sublocade?",
    "type": "summary",
    "ideal_answer": [
      "Sublocade® is a one-month-long depot formulation that is indicated in switch from sublingual buprenorphine, and which proposes only two dose schemes, i.e., 100 and 300mg monthly."
    ],
    "ground_truth_ids": [
      "32499082"
    ],
    "retrieved_ids": [
      "12733175",
      "18018427",
      "9606688",
      "31231507",
      "20049400",
      "10951302",
      "355046",
      "308321",
      "12373677",
      "33832676"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "12733175",
        "score": 0.3128218948841095,
        "title": "Septooptic dysplasia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12733175"
      },
      {
        "pubmed_id": "18018427",
        "score": 0.2834818959236145,
        "title": "Septo-optic dysplasia (de Morsier syndrome).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18018427"
      },
      {
        "pubmed_id": "9606688",
        "score": 0.27059757709503174,
        "title": "[Septo-optic dysplasia (de Morsier syndrome)].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9606688"
      },
      {
        "pubmed_id": "31231507",
        "score": 0.2685532867908478,
        "title": "Progress in perceptual research: the case of prosopagnosia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31231507"
      },
      {
        "pubmed_id": "20049400",
        "score": 0.25990578532218933,
        "title": "[Optic nerve hypoplasia and septo-optic dysplasia].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20049400"
      },
      {
        "pubmed_id": "10951302",
        "score": 0.25115537643432617,
        "title": "A patient with de Morsier and Duane syndromes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10951302"
      },
      {
        "pubmed_id": "355046",
        "score": 0.2483695149421692,
        "title": "Iatrogenic problems following gastric surgery.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/355046"
      },
      {
        "pubmed_id": "308321",
        "score": 0.23855936527252197,
        "title": "Septo-optic dysplasia (de Morsier syndrome).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/308321"
      },
      {
        "pubmed_id": "12373677",
        "score": 0.23633445799350739,
        "title": "[Septo-optic dysplasia].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12373677"
      },
      {
        "pubmed_id": "33832676",
        "score": 0.2361638844013214,
        "title": "Prosopagnosia and disorders of face processing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33832676"
      }
    ],
    "query_time": 0.007325887680053711,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5a7610ca83b0d9ea6600001b": {
    "query": "What is the role of nimotuzumab in treatment of pontine glioma?",
    "type": "summary",
    "ideal_answer": [
      "Nimotuzumab (an anti-EGFR monoclonal antibody) is being used for treatment of pontine gliomas. Nimotuzumab is a very well-tolerated drug with acceptable toxicity, and it may have promising value in the combination treatment. Clinical trials evaluating efficacy of nimotuzumab  are ongoing."
    ],
    "ground_truth_ids": [
      "23043252",
      "27379495",
      "24847085",
      "24638239",
      "25926743",
      "21784756",
      "23754473",
      "24696052",
      "21858608"
    ],
    "retrieved_ids": [
      "24847085",
      "25926743",
      "24696052",
      "23043252",
      "23575267",
      "21858608",
      "27379495",
      "23754473",
      "21784756",
      "23363814"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24847085",
        "score": 0.760587215423584,
        "title": "Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24847085"
      },
      {
        "pubmed_id": "25926743",
        "score": 0.741667628288269,
        "title": "Profile of nimotuzumab in the treatment of high-grade glioma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25926743"
      },
      {
        "pubmed_id": "24696052",
        "score": 0.7395193576812744,
        "title": "Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24696052"
      },
      {
        "pubmed_id": "23043252",
        "score": 0.7348904609680176,
        "title": "Nimotuzumab treatment of malignant gliomas.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23043252"
      },
      {
        "pubmed_id": "23575267",
        "score": 0.7144783139228821,
        "title": "Treatment of children with high grade glioma with nimotuzumab: a 5-year institutional experience.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23575267"
      },
      {
        "pubmed_id": "21858608",
        "score": 0.661060094833374,
        "title": "Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21858608"
      },
      {
        "pubmed_id": "27379495",
        "score": 0.6497399210929871,
        "title": "Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27379495"
      },
      {
        "pubmed_id": "23754473",
        "score": 0.6493154168128967,
        "title": "Craniospinal irradiation with concurrent temozolomide and nimotuzumab in a child with primary metastatic diffuse intrinsic pontine glioma. A compassionate use treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23754473"
      },
      {
        "pubmed_id": "21784756",
        "score": 0.5706692337989807,
        "title": "Treatment of high-grade glioma in children and adolescents.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21784756"
      },
      {
        "pubmed_id": "23363814",
        "score": 0.5547878742218018,
        "title": "A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23363814"
      }
    ],
    "query_time": 0.04024386405944824,
    "metrics": {
      "precision": 0.8,
      "recall": 0.8888888888888888,
      "f1_score": 0.8421052631578948,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 9
    }
  },
  "660d17dffdcbea915f000037": {
    "query": "Trends of acute epiglottitis in children.",
    "type": "summary",
    "ideal_answer": [
      "Mortality due to epiglottitis in children has decreased since the adoption of the Haemophilus influenza Type b vaccination (Hib) in pediatric populations.",
      "The trends in mortality due to acute epiglottitis in children have decreased significantly after the adoption of the Haemophilus influenza Type b vaccination (Hib) in pediatric populations.",
      "The trend in mortality from acute epiglottitis in children has decreased following the widespread adoption of the Haemophilus influenzae Type b (Hib) vaccination."
    ],
    "ground_truth_ids": [
      "16288684",
      "24163979",
      "17892608",
      "10542929",
      "7602678",
      "21106138",
      "7834888",
      "8143009",
      "29926438",
      "20018387",
      "33429180",
      "7619418",
      "11667996",
      "7651772",
      "18502071"
    ],
    "retrieved_ids": [
      "11667996",
      "20018387",
      "24163979",
      "7602678",
      "17892608",
      "7619418",
      "10542929",
      "7651772",
      "18502071",
      "8143009"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "11667996",
        "score": 0.7178423404693604,
        "title": "Acute epiglottitis: a presentation of haemophagocytic lymphohistiocytosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11667996"
      },
      {
        "pubmed_id": "20018387",
        "score": 0.6909958124160767,
        "title": "Epiglottitis due to nontypeable Haemophilus influenzae in a vaccinated child.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20018387"
      },
      {
        "pubmed_id": "24163979",
        "score": 0.6762755513191223,
        "title": "[Supraglottitis in adults at a single center experience 1989-2009].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24163979"
      },
      {
        "pubmed_id": "7602678",
        "score": 0.6735338568687439,
        "title": "Acute epiglottitis in children: results of a large-scale anti-Haemophilus type B immunization program.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7602678"
      },
      {
        "pubmed_id": "17892608",
        "score": 0.6705278158187866,
        "title": "Acute epiglottitis: epidemiology, clinical presentation, management and outcome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17892608"
      },
      {
        "pubmed_id": "7619418",
        "score": 0.666542112827301,
        "title": "Acute epiglottitis and infant conjugate Haemophilus influenzae type b vaccination in northern Finland.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7619418"
      },
      {
        "pubmed_id": "10542929",
        "score": 0.6664916276931763,
        "title": "Paediatric epiglottitis: the influence of the Haemophilus influenzae b vaccine, a ten-year review in the Sheffield region.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10542929"
      },
      {
        "pubmed_id": "7651772",
        "score": 0.6519575119018555,
        "title": "Epiglottitis and Haemophilus influenzae immunization: the Pittsburgh experience--a five-year review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7651772"
      },
      {
        "pubmed_id": "18502071",
        "score": 0.6498315334320068,
        "title": "Acute epiglottitis in Iceland 1983-2005.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18502071"
      },
      {
        "pubmed_id": "8143009",
        "score": 0.6371665000915527,
        "title": "Epiglottitis in children, 1979 through 1992. Effects of Haemophilus influenzae type b immunization.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8143009"
      }
    ],
    "query_time": 0.015909671783447266,
    "metrics": {
      "precision": 1.0,
      "recall": 0.6666666666666666,
      "f1_score": 0.8,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "5c85171875a4a5d219000004": {
    "query": "What is the function of Taraxasterol  in rheumatoid arthritis?",
    "type": "summary",
    "ideal_answer": [
      "Taraxasterol suppresses inflammation in rheumatoid arthritis.",
      "Protective effect of taraxasterol against rheumatoid arthritis by the modulation of inflammatory responses"
    ],
    "ground_truth_ids": [
      "28101182",
      "27109342"
    ],
    "retrieved_ids": [
      "28101182",
      "27109342",
      "24285764",
      "23212593",
      "23961674",
      "23523202",
      "22777068",
      "32550671",
      "25943002",
      "22460142"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28101182",
        "score": 0.7727887034416199,
        "title": "Protective effect of taraxasterol against rheumatoid arthritis by the modulation of inflammatory responses in mice.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28101182"
      },
      {
        "pubmed_id": "27109342",
        "score": 0.7152125835418701,
        "title": "Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27109342"
      },
      {
        "pubmed_id": "24285764",
        "score": 0.5439376831054688,
        "title": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24285764"
      },
      {
        "pubmed_id": "23212593",
        "score": 0.5099054574966431,
        "title": "JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23212593"
      },
      {
        "pubmed_id": "23961674",
        "score": 0.4993888735771179,
        "title": "[JAK inhibitor].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23961674"
      },
      {
        "pubmed_id": "23523202",
        "score": 0.4936366677284241,
        "title": "Targeting kinases: a new approach to treating inflammatory rheumatic diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23523202"
      },
      {
        "pubmed_id": "22777068",
        "score": 0.49079251289367676,
        "title": "[New kinase inhibitors].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22777068"
      },
      {
        "pubmed_id": "32550671",
        "score": 0.48984766006469727,
        "title": "Biologic agents and small-molecule inhibitors in systemic autoimmune conditions: an update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32550671"
      },
      {
        "pubmed_id": "25943002",
        "score": 0.48697561025619507,
        "title": "Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25943002"
      },
      {
        "pubmed_id": "22460142",
        "score": 0.4734971821308136,
        "title": "In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22460142"
      }
    ],
    "query_time": 0.03848576545715332,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "54db7217c4c6ce8e1d000003": {
    "query": "How many and which are the different isoforms for the ryanodine receptor?",
    "type": "list",
    "ideal_answer": [
      "Generally, three ryanodine receptor isoforms (RyR1-RyR3) are known. RyR1, expressed in skeletal muscle; RyR2, expressed in cardiac muscle; and RyR3, expressed in various cells. RyR3 is preferentially expressed in the brain especially in the hippocampus and striatum."
    ],
    "ground_truth_ids": [
      "18221109",
      "19503748",
      "17707769",
      "14592807",
      "17526017",
      "24521037",
      "20961976",
      "18005397"
    ],
    "retrieved_ids": [
      "18005397",
      "20961976",
      "18221109",
      "24521037",
      "14592807",
      "17707769",
      "16206185",
      "20641567",
      "21473027",
      "23390031"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "18005397",
        "score": 0.5719239711761475,
        "title": "Characterization of ryanodine receptors in rat colonic epithelium.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18005397"
      },
      {
        "pubmed_id": "20961976",
        "score": 0.5660771727561951,
        "title": "Ryanodine receptors: structure, expression, molecular details, and function in calcium release.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20961976"
      },
      {
        "pubmed_id": "18221109",
        "score": 0.543876051902771,
        "title": "Ryanodine receptor: a novel therapeutic target in heart disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18221109"
      },
      {
        "pubmed_id": "24521037",
        "score": 0.5276491045951843,
        "title": "Two regions of the ryanodine receptor calcium channel are involved in Ca(2+)-dependent inactivation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24521037"
      },
      {
        "pubmed_id": "14592807",
        "score": 0.5085343718528748,
        "title": "All three ryanodine receptor isoforms generate rapid cooling responses in muscle cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14592807"
      },
      {
        "pubmed_id": "17707769",
        "score": 0.49769318103790283,
        "title": "Identification of functional type 1 ryanodine receptors in human dendritic cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17707769"
      },
      {
        "pubmed_id": "16206185",
        "score": 0.47513440251350403,
        "title": "Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16206185"
      },
      {
        "pubmed_id": "20641567",
        "score": 0.46107909083366394,
        "title": "3-[2-[4-(4-[18F]Fluorobenzoyl)-1-piperidyl]ethyl]-2-sulfanyl-3H-quinazolin-4-one",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20641567"
      },
      {
        "pubmed_id": "21473027",
        "score": 0.4426534175872803,
        "title": "2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21473027"
      },
      {
        "pubmed_id": "23390031",
        "score": 0.44097089767456055,
        "title": "Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23390031"
      }
    ],
    "query_time": 0.006941080093383789,
    "metrics": {
      "precision": 0.6,
      "recall": 0.75,
      "f1_score": 0.6666666666666665,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "5713bc991174fb1755000010": {
    "query": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?",
    "type": "list",
    "ideal_answer": [
      "The genes associated with the X-linked and the autosomal dominant forms of Charcot-Marie-Tooth disease are GJB1, MPZ, INF2, DNM2, YARS, GNB4, NEFL, MFN2, LRSAM1, GDAP1, PMP22, LITAF, and EGR2. Identification of these genes has not only been important for patients and families, but also provided new information about disease pathogenesis."
    ],
    "ground_truth_ids": [
      "25337607",
      "14561495",
      "12707075",
      "16775366",
      "24894446",
      "15099592",
      "12481988",
      "18492089",
      "17636067",
      "22451505",
      "22096584",
      "12566280",
      "25326399",
      "18231710",
      "18975529",
      "12525712",
      "8655146",
      "22091729",
      "17052987",
      "19502294",
      "21199105",
      "22781092",
      "21753178",
      "15731758"
    ],
    "retrieved_ids": [
      "25326399",
      "16775366",
      "18492089",
      "22781092",
      "18231710",
      "15099592",
      "18975529",
      "15731758",
      "25337607",
      "22091729"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25326399",
        "score": 0.6835504770278931,
        "title": "Intermediate Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25326399"
      },
      {
        "pubmed_id": "16775366",
        "score": 0.6771894693374634,
        "title": "Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16775366"
      },
      {
        "pubmed_id": "18492089",
        "score": 0.6694861650466919,
        "title": "A novel mutation in the GDAP1 gene is associated with autosomal recessive Charcot-Marie-Tooth disease in an Amish family.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18492089"
      },
      {
        "pubmed_id": "22781092",
        "score": 0.6667283773422241,
        "title": "A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22781092"
      },
      {
        "pubmed_id": "18231710",
        "score": 0.643686056137085,
        "title": "A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18231710"
      },
      {
        "pubmed_id": "15099592",
        "score": 0.6396006345748901,
        "title": "A novel point mutation in PMP22 gene associated with a familial case of Charcot-Marie-Tooth disease type 1A with sensorineural deafness.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15099592"
      },
      {
        "pubmed_id": "18975529",
        "score": 0.6382355093955994,
        "title": "[Charcot-Marie-Tooth disease].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18975529"
      },
      {
        "pubmed_id": "15731758",
        "score": 0.6280524134635925,
        "title": "Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15731758"
      },
      {
        "pubmed_id": "25337607",
        "score": 0.627385675907135,
        "title": "A severe recessive and a mild dominant form of Charcot-Marie-Tooth disease associated with a newly identified Glu222Lys GDAP1 gene mutation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25337607"
      },
      {
        "pubmed_id": "22091729",
        "score": 0.6153697967529297,
        "title": "Phenotypic variability in a large Czech family with a dynamin 2-associated Charcot-Marie-Tooth neuropathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22091729"
      }
    ],
    "query_time": 0.0073680877685546875,
    "metrics": {
      "precision": 1.0,
      "recall": 0.4166666666666667,
      "f1_score": 0.5882352941176471,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 24
    }
  },
  "5171a1498ed59a060a000012": {
    "query": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia",
    "type": "list",
    "ideal_answer": [
      "TP53, ATM, NOTCH1, XPO1, MYD88, KLHL6, SF3B1, ZMYM3, MAPK1, FBXW7 and DDX3X"
    ],
    "ground_truth_ids": [
      "19367498",
      "10803511",
      "21642962",
      "22158541",
      "22150006",
      "22675518"
    ],
    "retrieved_ids": [
      "22150006",
      "19367498",
      "21642962",
      "22158541",
      "10803511",
      "22675518",
      "34496019",
      "32730594",
      "15383454",
      "29633730"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "22150006",
        "score": 0.7462287545204163,
        "title": "SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22150006"
      },
      {
        "pubmed_id": "19367498",
        "score": 0.730465292930603,
        "title": "BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19367498"
      },
      {
        "pubmed_id": "21642962",
        "score": 0.7113784551620483,
        "title": "Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21642962"
      },
      {
        "pubmed_id": "22158541",
        "score": 0.6928802728652954,
        "title": "Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22158541"
      },
      {
        "pubmed_id": "10803511",
        "score": 0.6392804980278015,
        "title": "Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10803511"
      },
      {
        "pubmed_id": "22675518",
        "score": 0.6247692108154297,
        "title": "New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22675518"
      },
      {
        "pubmed_id": "34496019",
        "score": 0.5202915668487549,
        "title": "A novel activating JAK1 mutation in chronic eosinophilic leukemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34496019"
      },
      {
        "pubmed_id": "32730594",
        "score": 0.5165625810623169,
        "title": "Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32730594"
      },
      {
        "pubmed_id": "15383454",
        "score": 0.5072154402732849,
        "title": "Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15383454"
      },
      {
        "pubmed_id": "29633730",
        "score": 0.48627710342407227,
        "title": "An uncommon case of chronic myeloid leukemia with variant cytogenetic.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29633730"
      }
    ],
    "query_time": 0.01098322868347168,
    "metrics": {
      "precision": 0.6,
      "recall": 1.0,
      "f1_score": 0.7499999999999999,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "58b6d6f322d300530900000f": {
    "query": "What is the inheritance of hypophosphatemic rickets?",
    "type": "list",
    "ideal_answer": [
      "Hypophosphatemic rickets are transmitted with:\n1) autosomal recessive\n2) autosomal dominant\n3) X-linked recessive and\n4) X-linked dominant inheritance."
    ],
    "ground_truth_ids": [
      "17635744",
      "11200035",
      "19258716",
      "19007919",
      "22806288",
      "23108197",
      "10720930",
      "9024275",
      "20578943",
      "2832821",
      "21747952",
      "16358214",
      "443639",
      "20213538",
      "16303832"
    ],
    "retrieved_ids": [
      "11200035",
      "443639",
      "16303832",
      "2832821",
      "23108197",
      "16358214",
      "20213538",
      "9024275",
      "19007919",
      "17635744"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "11200035",
        "score": 0.6995992660522461,
        "title": "X-linked hypophosphatemic rickets--a report of 2 cases and review of literature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11200035"
      },
      {
        "pubmed_id": "443639",
        "score": 0.6283968687057495,
        "title": "[X-linked familial hypophosphatemic rickets report of six cases (author's transl)].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/443639"
      },
      {
        "pubmed_id": "16303832",
        "score": 0.6194939613342285,
        "title": "Somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16303832"
      },
      {
        "pubmed_id": "2832821",
        "score": 0.6003856658935547,
        "title": "[Scriver type autosomal hypophosphatemic rachitis: a family case].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2832821"
      },
      {
        "pubmed_id": "23108197",
        "score": 0.5835732221603394,
        "title": "Hypophosphatemic rickets.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23108197"
      },
      {
        "pubmed_id": "16358214",
        "score": 0.5790599584579468,
        "title": "SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16358214"
      },
      {
        "pubmed_id": "20213538",
        "score": 0.5625300407409668,
        "title": "A novel nonsense mutation in the DMP1 gene in a Japanese family with autosomal recessive hypophosphatemic rickets.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20213538"
      },
      {
        "pubmed_id": "9024275",
        "score": 0.5572161674499512,
        "title": "Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9024275"
      },
      {
        "pubmed_id": "19007919",
        "score": 0.528125524520874,
        "title": "Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19007919"
      },
      {
        "pubmed_id": "17635744",
        "score": 0.5211628079414368,
        "title": "Hereditary hypophosphatemias: new genes in the bone-kidney axis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17635744"
      }
    ],
    "query_time": 0.012475967407226562,
    "metrics": {
      "precision": 1.0,
      "recall": 0.6666666666666666,
      "f1_score": 0.8,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "5c6e01af7c78d69471000048": {
    "query": "List two indications of Letermovir?",
    "type": "list",
    "ideal_answer": [
      "Letermovir is approved for the prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic haematopoietic stem cell transplant (HSCT)."
    ],
    "ground_truth_ids": [
      "28675594",
      "30004790",
      "29578577",
      "28967706",
      "29290671",
      "29746444",
      "29914965",
      "29361041",
      "29288370",
      "29998227"
    ],
    "retrieved_ids": [
      "29288370",
      "28675594",
      "29998227",
      "28967706",
      "29578577",
      "30004790",
      "29746444",
      "22173281",
      "29290671",
      "33998486"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29288370",
        "score": 0.5106090307235718,
        "title": "Letermovir: First Global Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29288370"
      },
      {
        "pubmed_id": "28675594",
        "score": 0.4822787940502167,
        "title": "Intravenous Hydroxypropyl β-Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single-Ascending, and Multiple-Dose Trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28675594"
      },
      {
        "pubmed_id": "29998227",
        "score": 0.4722023904323578,
        "title": "Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29998227"
      },
      {
        "pubmed_id": "28967706",
        "score": 0.46731874346733093,
        "title": "Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28967706"
      },
      {
        "pubmed_id": "29578577",
        "score": 0.44811347126960754,
        "title": "Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29578577"
      },
      {
        "pubmed_id": "30004790",
        "score": 0.4334847927093506,
        "title": "Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30004790"
      },
      {
        "pubmed_id": "29746444",
        "score": 0.43267014622688293,
        "title": "Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29746444"
      },
      {
        "pubmed_id": "22173281",
        "score": 0.39898568391799927,
        "title": "Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22173281"
      },
      {
        "pubmed_id": "29290671",
        "score": 0.39848747849464417,
        "title": "Pharmaceutical Approval Update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29290671"
      },
      {
        "pubmed_id": "33998486",
        "score": 0.3950091004371643,
        "title": "Incubation period of COVID-19: A systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33998486"
      }
    ],
    "query_time": 0.012155771255493164,
    "metrics": {
      "precision": 0.8,
      "recall": 0.8,
      "f1_score": 0.8000000000000002,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "52bf1dea03868f1b06000012": {
    "query": "What are the side effects of Nalmefene?",
    "type": "list",
    "ideal_answer": [
      "Side effects of nalmefene include nausea, dizziness / lightheadedness, insomina, fatigue, vomiting, reduced caloric intake / apetite, increased self-rated alertness and decreased tiredness. In horses some passage of semifluid fecal material, intermittent penile relaxation, and mild sedation has been described. In some studies nalmefene was well tolerated by all subjects, and no clinically significant adverse effects were observed."
    ],
    "ground_truth_ids": [
      "16379031",
      "3826875",
      "3680580",
      "3943269",
      "2315439",
      "16449486"
    ],
    "retrieved_ids": [
      "3680580",
      "3943269",
      "2315439",
      "11899395",
      "16449486",
      "16684437",
      "21275439",
      "17874255",
      "34486707",
      "28191518"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "3680580",
        "score": 0.5722949504852295,
        "title": "Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3680580"
      },
      {
        "pubmed_id": "3943269",
        "score": 0.5217937231063843,
        "title": "Nalmefene: intravenous safety and kinetics of a new opioid antagonist.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3943269"
      },
      {
        "pubmed_id": "2315439",
        "score": 0.503639280796051,
        "title": "Effects of nalmefene on feeding in humans. Dissociation of hunger and palatability.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2315439"
      },
      {
        "pubmed_id": "11899395",
        "score": 0.4236006438732147,
        "title": "Thalidomide: when everything old is new again.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11899395"
      },
      {
        "pubmed_id": "16449486",
        "score": 0.4201585650444031,
        "title": "Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16449486"
      },
      {
        "pubmed_id": "16684437",
        "score": 0.4080173969268799,
        "title": "The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16684437"
      },
      {
        "pubmed_id": "21275439",
        "score": 0.3839952349662781,
        "title": "Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21275439"
      },
      {
        "pubmed_id": "17874255",
        "score": 0.3610042631626129,
        "title": "Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17874255"
      },
      {
        "pubmed_id": "34486707",
        "score": 0.35179996490478516,
        "title": "NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34486707"
      },
      {
        "pubmed_id": "28191518",
        "score": 0.3500726521015167,
        "title": "Corticosteroids, the oldest agent in the prevention of chemotherapy-induced nausea and vomiting: What about the guidelines?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28191518"
      }
    ],
    "query_time": 0.017979145050048828,
    "metrics": {
      "precision": 0.4,
      "recall": 0.6666666666666666,
      "f1_score": 0.5,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "5895dfc97d9090f353000010": {
    "query": "List active ingredients of the Stribild polypill.",
    "type": "list",
    "ideal_answer": [
      "Active ingredients of Stribild are elvitegravir, cobicistat, emtricitabine and tenofovir. It is used for treatment of HIV infection."
    ],
    "ground_truth_ids": [
      "24338165",
      "25553805",
      "27225853",
      "26286337",
      "23136357",
      "26045359",
      "26679246"
    ],
    "retrieved_ids": [
      "28099525",
      "33049673",
      "1193013",
      "19482534",
      "26510933",
      "21324833",
      "2256586",
      "29290671",
      "20510766",
      "1432387"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28099525",
        "score": 0.3252088129520416,
        "title": "Polyethylene Glycol Camouflaged Earthworm Hemoglobin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28099525"
      },
      {
        "pubmed_id": "33049673",
        "score": 0.3198171854019165,
        "title": "Bisphenol A, an endocrine-disruptor compund, that modulates the immune response to infections.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33049673"
      },
      {
        "pubmed_id": "1193013",
        "score": 0.30151358246803284,
        "title": "High-affinity binding of tetraiodothyroacetic acid by a prealbumin in normal rabbit serum.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1193013"
      },
      {
        "pubmed_id": "19482534",
        "score": 0.30060550570487976,
        "title": "Effect of Polyprenyl Immunostimulant on the survival times of three cats with the dry form of feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19482534"
      },
      {
        "pubmed_id": "26510933",
        "score": 0.29327574372291565,
        "title": "Colorectal polyp prevention by daily aspirin use is abrogated among active smokers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26510933"
      },
      {
        "pubmed_id": "21324833",
        "score": 0.29021963477134705,
        "title": "Packaging and labeling of pharmaceutical products obtained from the internet.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21324833"
      },
      {
        "pubmed_id": "2256586",
        "score": 0.2857362926006317,
        "title": "[Polymyalgia induced by topical minoxidil].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2256586"
      },
      {
        "pubmed_id": "29290671",
        "score": 0.2800099551677704,
        "title": "Pharmaceutical Approval Update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29290671"
      },
      {
        "pubmed_id": "20510766",
        "score": 0.279275506734848,
        "title": "Innovative uses of thalidomide.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20510766"
      },
      {
        "pubmed_id": "1432387",
        "score": 0.2697569727897644,
        "title": "Synthesis and photobiological activity of new methylpsoralen derivatives.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1432387"
      }
    ],
    "query_time": 0.017399072647094727,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 7
    }
  },
  "52fb42752059c6d71c00005e": {
    "query": "Which are the thyroid hormone analogs utilized in human studies?",
    "type": "list",
    "ideal_answer": [
      "TRIAC and TETRAC are two different thyroid hormone analogs utilized in human studies"
    ],
    "ground_truth_ids": [
      "18954857",
      "20187783",
      "22947347",
      "7608251",
      "18080776",
      "16384862",
      "19903697",
      "23970761",
      "1193013",
      "23307789",
      "22123068",
      "3730832",
      "9001190",
      "23298477",
      "18386142",
      "23565368",
      "21896621"
    ],
    "retrieved_ids": [
      "18954857",
      "7965021",
      "7608251",
      "17434631",
      "23565368",
      "3730832",
      "22947347",
      "9001190",
      "23307789",
      "16542047"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "18954857",
        "score": 0.5786927938461304,
        "title": "[Thyroid hormone analogs: an important biological supply and new therapeutic possibilities].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18954857"
      },
      {
        "pubmed_id": "7965021",
        "score": 0.573494017124176,
        "title": "Film autoradiography identifies unique features of [125I]3,3'5'-(reverse) triiodothyronine transport from blood to brain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7965021"
      },
      {
        "pubmed_id": "7608251",
        "score": 0.5255812406539917,
        "title": "Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7608251"
      },
      {
        "pubmed_id": "17434631",
        "score": 0.4998226761817932,
        "title": "Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17434631"
      },
      {
        "pubmed_id": "23565368",
        "score": 0.4990248680114746,
        "title": "Thyromimetics: What does the future hold?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23565368"
      },
      {
        "pubmed_id": "3730832",
        "score": 0.49739187955856323,
        "title": "Effect of thyroid hormone analogs on the activity of choline acetyltransferase in cultures of dissociated septal cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3730832"
      },
      {
        "pubmed_id": "22947347",
        "score": 0.4928957223892212,
        "title": "Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22947347"
      },
      {
        "pubmed_id": "9001190",
        "score": 0.4919828474521637,
        "title": "Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9001190"
      },
      {
        "pubmed_id": "23307789",
        "score": 0.48874035477638245,
        "title": "Tetrac can replace thyroid hormone during brain development in mouse mutants deficient in the thyroid hormone transporter mct8.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23307789"
      },
      {
        "pubmed_id": "16542047",
        "score": 0.4742972254753113,
        "title": "Does treating subclinical hypothyroidism improve markers of cardiovascular risk?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16542047"
      }
    ],
    "query_time": 0.019730806350708008,
    "metrics": {
      "precision": 0.7,
      "recall": 0.4117647058823529,
      "f1_score": 0.5185185185185185,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 7,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "60296ace1cb411341a000115": {
    "query": "List updates for JASPAR 2020",
    "type": "list",
    "ideal_answer": [
      "JASPAR (http://jaspar.genereg.net) is an open-access database of curated, non-redundant transcription factor (TF)-binding profiles stored as position frequency matrices (PFMs) for TFs across multiple species in six taxonomic groups. In this 8th release of JASPAR, the CORE collection has been expanded with 245 new PFMs (169 for vertebrates, 42 for plants, 17 for nematodes, 10 for insects, and 7 for fungi), and 156 PFMs were updated (125 for vertebrates, 28 for plants and 3 for insects). This collection has a dedicated web form to engage the community in the curation of unvalidated TF-binding profiles.",
      "JASPAR (http://jaspar.genereg.net) is an open-access database of curated, non-redundant transcription factor (TF)-binding profiles stored as position frequency matrices (PFMs) for TFs across multiple species in six taxonomic groups. In this 8th release of JASPAR, the CORE collection has been expanded with 245 new PFMs (169 for vertebrates, 42 for plants, 17 for nematodes, 10 for insects, and 7 for fungi), and 156 PFMs were updated (125 for vertebrates, 28 for plants and 3 for insects). These new profiles represent an 18% expansion compared to the previous release. JASPAR 2020 comes with a novel collection of unvalidated TF-binding profiles for which curators did not find orthogonal supporting evidence in the literature. This collection has a dedicated web form to engage the community in the curation of unvalidated TF-binding profiles. Moreover, a Q&A forum was created to ease the communication between the user community and JASPAR curators. Finally, the genomic tracks, inference tool, and TF-binding profile similarity clusters were updated.",
      "JASPAR (http://jaspar.genereg.net) is an open-access database of curated, non-redundant transcription factor (TF)-binding profiles stored as position frequency matrices (PFMs) for TFs across multiple species in six taxonomic groups. In this 8th release of JASPAR, the CORE collection has been expanded with 245 new PFMs (169 for vertebrates, 42 for plants, 17 for nematodes, 10 for insects, and 7 for fungi), and 156 PFMs were updated (125 for vertebrates, 28 for plants and 3 for insects). These new profiles represent an 18% expansion compared to the previous release. This collection has a dedicated web form to engage the community in the curation of unvalidated TF-binding profiles.",
      "JASPAR (http://jaspar.genereg.net) is an open-access database of curated, non-redundant transcription factor (TF)-binding profiles stored as position frequency matrices (PFMs) for TFs across multiple species in six taxonomic groups. In this 8th release of JASPAR, the CORE collection has been expanded with 245 new PFMs (169 for vertebrates, 42 for plants, 17 for nematodes, 10 for insects, and 7 for fungi), and 156 PFMs were updated (125 for vertebrates, 28 for plants and 3 for insects). These new profiles represent an 18% expansion compared to the previous release.",
      "JASPAR (http://jaspar.genereg.net) is an open-access database of curated, non-redundant transcription factor (TF)-binding profiles stored as position frequency matrices (PFMs) for TFs across multiple species in six taxonomic groups. In this 8th release of JASPAR, the CORE collection has been expanded with 245 new PFMs (169 for vertebrates, 42 for plants, 17 for nematodes, 10 for insects, and 7 for fungi), and 156 PFMs were updated (125 for vertebrates, 28 for plants and 3 for insects). JASPAR 2020 comes with a novel collection of unvalidated TF-binding profiles for which our curators did not find orthogonal supporting evidence in the literature."
    ],
    "ground_truth_ids": [
      "31701148"
    ],
    "retrieved_ids": [
      "31701148",
      "22971156",
      "29720364",
      "23384668",
      "23763826",
      "23523202",
      "36480476",
      "22374445",
      "19404006",
      "30466743"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "31701148",
        "score": 0.34824445843696594,
        "title": "JASPAR 2020: update of the open-access database of transcription factor binding profiles.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31701148"
      },
      {
        "pubmed_id": "22971156",
        "score": 0.2764415740966797,
        "title": "Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22971156"
      },
      {
        "pubmed_id": "29720364",
        "score": 0.27377480268478394,
        "title": "Monitoring Interest in Herpes Zoster Vaccination: Analysis of Google Search Data.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29720364"
      },
      {
        "pubmed_id": "23384668",
        "score": 0.2649070620536804,
        "title": "Advances in the discovery of selective JAK inhibitors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23384668"
      },
      {
        "pubmed_id": "23763826",
        "score": 0.2602134048938751,
        "title": "KNODWAT: a scientific framework application for testing knowledge discovery methods for the biomedical domain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23763826"
      },
      {
        "pubmed_id": "23523202",
        "score": 0.2591794431209564,
        "title": "Targeting kinases: a new approach to treating inflammatory rheumatic diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23523202"
      },
      {
        "pubmed_id": "36480476",
        "score": 0.25675955414772034,
        "title": "Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36480476"
      },
      {
        "pubmed_id": "22374445",
        "score": 0.2452445924282074,
        "title": "[Regulation of inflammation through JAK3-Stat6 pathway in dendritic cells].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22374445"
      },
      {
        "pubmed_id": "19404006",
        "score": 0.2390647828578949,
        "title": "Jak inhibitor ; possibility and mechanism as a new disease modifying anti-rheumatic drug.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19404006"
      },
      {
        "pubmed_id": "30466743",
        "score": 0.23491376638412476,
        "title": "Progress and predictions: AML in 2018.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30466743"
      }
    ],
    "query_time": 0.017439842224121094,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5c72d4c77c78d6947100007c": {
    "query": "Which proteins form the nuclear pore basket in human cells?",
    "type": "list",
    "ideal_answer": [
      "Nup133 Is Required for Proper Nuclear Pore Basket Assembly and Dynamics in Embryonic Stem Cells. Moreover, the association of TREX-2 with the NPC requires the basket nucleoporins NUP153 and TPR, but is independent of transcription. The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins",
      "Nup133 Is Required for Proper Nuclear Pore Basket Assembly and Dynamics in Embryonic Stem Cells. Here we show that the NPC basket proteins Nup1 and Nup60 directly induce membrane curvature by amphipathic helix insertion into the lipid bilayer Moreover, the association of TREX-2 with the NPC requires the basket nucleoporins NUP153 and TPR, but is independent of transcription.",
      "Nup133 Is Required for Proper Nuclear Pore Basket Assembly and Dynamics in Embryonic Stem Cells. The nuclear pore complex basket proteins Nup1 and Nup60 directly induce membrane curvature by amphipathic helix insertion into the lipid bilayer. The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins.",
      "Nup133 Is Required for Proper Nuclear Pore Basket Assembly and Dynamics in Embryonic Stem Cells. Here we show that the NPC basket proteins Nup1 and Nup60 directly induce membrane curvature by amphipathic helix insertion into the lipid bilayer The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins"
    ],
    "ground_truth_ids": [
      "11535617",
      "25602437",
      "25942622",
      "17724121",
      "10806081",
      "29791854",
      "23591820",
      "30366908",
      "11598013",
      "25485891",
      "9348540",
      "10921874",
      "11567018",
      "8794857",
      "15229283",
      "11839768",
      "25845599"
    ],
    "retrieved_ids": [
      "11839768",
      "15229283",
      "11598013",
      "17724121",
      "25485891",
      "8794857",
      "25942622",
      "10806081",
      "11567018",
      "29791854"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "11839768",
        "score": 0.6526145935058594,
        "title": "Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11839768"
      },
      {
        "pubmed_id": "15229283",
        "score": 0.6357004046440125,
        "title": "Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15229283"
      },
      {
        "pubmed_id": "11598013",
        "score": 0.6108291149139404,
        "title": "The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11598013"
      },
      {
        "pubmed_id": "17724121",
        "score": 0.5977627038955688,
        "title": "A nuclear envelope protein linking nuclear pore basket assembly, SUMO protease regulation, and mRNA surveillance.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17724121"
      },
      {
        "pubmed_id": "25485891",
        "score": 0.5924808979034424,
        "title": "Structural characterization of altered nucleoporin Nup153 expression in human cells by thin-section electron microscopy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25485891"
      },
      {
        "pubmed_id": "8794857",
        "score": 0.5808200240135193,
        "title": "Targeting and function in mRNA export of nuclear pore complex protein Nup153.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8794857"
      },
      {
        "pubmed_id": "25942622",
        "score": 0.5783851146697998,
        "title": "Nuclear pore basket proteins are tethered to the nuclear envelope and can regulate membrane curvature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25942622"
      },
      {
        "pubmed_id": "10806081",
        "score": 0.5710422396659851,
        "title": "Recombinant Nup153 incorporates in vivo into Xenopus oocyte nuclear pore complexes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10806081"
      },
      {
        "pubmed_id": "11567018",
        "score": 0.5568774342536926,
        "title": "RNA association defines a functionally conserved domain in the nuclear pore protein Nup153.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11567018"
      },
      {
        "pubmed_id": "29791854",
        "score": 0.5508625507354736,
        "title": "Nup133 Is Required for Proper Nuclear Pore Basket Assembly and Dynamics in Embryonic Stem Cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29791854"
      }
    ],
    "query_time": 0.016895055770874023,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5882352941176471,
      "f1_score": 0.7407407407407407,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "64240f33690f196b51000049": {
    "query": "What drugs are used to treat FIP, Feline Infectious Peritonitis in cats?",
    "type": "list",
    "ideal_answer": [
      "Drugs used to treat Feline Infectious Peritonitis (FIP) in cats include immune suppressive drugs such as prednisone or cyclophosphamide, recombinant feline interferon, glucocorticoids, antibiotics, passive immunization with Feliserin, Propentofylline (PPF), Polyprenyl Immunostimulant, antiviral RNAi, viroporin inhibitors, a broad-spectrum coronavirus protease inhibitor GC376, anti-feline TNF-alpha monoclonal antibody, the adenosine nucleoside analogue GS-441524, mefloquine, itraconazole, and remdesivir.",
      "Adalimumab (an anti-human-TNF-alpha monoclonal antibody) and itraconazole (ICZ) are used to treat FIP, Feline Infectious Peritonitis in cats.",
      "The most commonly used drugs to treat FIP in cats are Glucocorticoids, Interferon Omega, and Polyprenyl Immunostimulant (PI).",
      "While there are a few drugs like Propentofylline, Feline interferon-omega that have been shown to be ineffective for treatment of FIP Feline Infectious Peritonitis, therapies with GC 376, GS-441524, Mutian® Xraphconn (Mutian X), Mefloquine, Anti TNF alpha Antibody, remdesivir, and siRNA show promising results while the efficacy of treatment with viroporin inhibitors, itraconazole, prednisolone, and Polyprenyl Immunostimulant is inconclusive",
      "Prednisone and Cyclophosphamide are immune suppressive drugs used to treat Feline Infectious Peritonitis (FIP) in cats.",
      "Adalimumab (an anti-human-TNF-alpha monoclonal antibody) and itraconazole are used to treat FIP, Feline Infectious Peritonitis in cats.",
      "Feline infectious peritonitis (FIP) is considered a fatal disease, but treatment options are available to help control the immune response triggered by the infection with the feline coronavirus (FCoV). Immune suppressive drugs such as prednisone or cyclophosphamide may slow disease progression, while a combination of recombinant feline interferon and glucocorticoid, Feliserin, Polyprenyl Immunostimulant, protease inhibitors, antiviral RNAi, viroporin inhibitors, anti-fTNF-alpha antibody, GS-441524, Mutian® Xraphconn (Mutian X), mefloquine, and remdesivir have all been used to treat FIP in cats with varying degrees of success. Itraconazole in combination with prednisolone has also been used to treat effusive FIP.",
      "The drugs used to treat Feline Infectious Peritonitis (FIP) in cats include antiviral drugs such as interferon omega, lopinavir/ritonavir, and GS-441524, as well as immunomodulatory drugs such as glucocorticoids and cyclosporine.",
      "Glucocorticoids, immune modulators, and immune suppressive drugs such as prednisone or cyclophosphamide are used to treat FIP in cats."
    ],
    "ground_truth_ids": [
      "32441826",
      "30755068",
      "35934910",
      "18395801",
      "32456286",
      "32220667",
      "18196725",
      "27027316",
      "36297266",
      "34835034",
      "31585653",
      "29778200",
      "32848107",
      "22092616",
      "19482534",
      "25596968",
      "26850532",
      "32521771",
      "35078478",
      "15123155",
      "36387398",
      "25701212",
      "33799985"
    ],
    "retrieved_ids": [
      "30755068",
      "15123155",
      "22092616",
      "32441826",
      "18395801",
      "19482534",
      "35934910",
      "18196725",
      "36387398",
      "34835034"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30755068",
        "score": 0.7399386167526245,
        "title": "Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30755068"
      },
      {
        "pubmed_id": "15123155",
        "score": 0.7255178689956665,
        "title": "Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15123155"
      },
      {
        "pubmed_id": "22092616",
        "score": 0.7249088287353516,
        "title": "Randomized, placebo controlled study of the effect of propentofylline on survival time and quality of life of cats with feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22092616"
      },
      {
        "pubmed_id": "32441826",
        "score": 0.7230512499809265,
        "title": "Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32441826"
      },
      {
        "pubmed_id": "18395801",
        "score": 0.7135961055755615,
        "title": "Treatment of cats with feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18395801"
      },
      {
        "pubmed_id": "19482534",
        "score": 0.7133506536483765,
        "title": "Effect of Polyprenyl Immunostimulant on the survival times of three cats with the dry form of feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19482534"
      },
      {
        "pubmed_id": "35934910",
        "score": 0.7013463973999023,
        "title": "Successful treatment of a South African cat with effusive feline infectious peritonitis with remdesivir.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35934910"
      },
      {
        "pubmed_id": "18196725",
        "score": 0.696989119052887,
        "title": "Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18196725"
      },
      {
        "pubmed_id": "36387398",
        "score": 0.687879204750061,
        "title": "Effect of GS-441524 in combination with the 3C-like protease inhibitor GC376 on the treatment of naturally transmitted feline infectious peritonitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36387398"
      },
      {
        "pubmed_id": "34835034",
        "score": 0.6817342042922974,
        "title": "Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34835034"
      }
    ],
    "query_time": 0.007669925689697266,
    "metrics": {
      "precision": 1.0,
      "recall": 0.43478260869565216,
      "f1_score": 0.6060606060606061,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 23
    }
  },
  "602823e61cb411341a0000f9": {
    "query": "Which drugs are included in the IROX regimen for colorectal cancer?",
    "type": "list",
    "ideal_answer": [
      "IROX regimen for colorectal cancer includes irinotecan and oxaliplatin."
    ],
    "ground_truth_ids": [
      "17687151",
      "20530282",
      "25349295",
      "18824706",
      "19822515",
      "14665611",
      "29211295",
      "17901952",
      "29246011",
      "17559146",
      "19390546",
      "19001325",
      "15677624",
      "19444385"
    ],
    "retrieved_ids": [
      "19390546",
      "14665611",
      "18824706",
      "17559146",
      "29246011",
      "12482332",
      "17687151",
      "19001325",
      "16943526",
      "15677624"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "19390546",
        "score": 0.7555122375488281,
        "title": "Medical Oncology: IROX as second-line therapy for metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19390546"
      },
      {
        "pubmed_id": "14665611",
        "score": 0.712267279624939,
        "title": "A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14665611"
      },
      {
        "pubmed_id": "18824706",
        "score": 0.6924827694892883,
        "title": "Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18824706"
      },
      {
        "pubmed_id": "17559146",
        "score": 0.674976110458374,
        "title": "Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17559146"
      },
      {
        "pubmed_id": "29246011",
        "score": 0.6435369253158569,
        "title": "Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29246011"
      },
      {
        "pubmed_id": "12482332",
        "score": 0.6368340849876404,
        "title": "Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12482332"
      },
      {
        "pubmed_id": "17687151",
        "score": 0.6299523115158081,
        "title": "Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17687151"
      },
      {
        "pubmed_id": "19001325",
        "score": 0.61043781042099,
        "title": "Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19001325"
      },
      {
        "pubmed_id": "16943526",
        "score": 0.5999795198440552,
        "title": "Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16943526"
      },
      {
        "pubmed_id": "15677624",
        "score": 0.5994162559509277,
        "title": "Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15677624"
      }
    ],
    "query_time": 0.013076066970825195,
    "metrics": {
      "precision": 0.8,
      "recall": 0.5714285714285714,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 14
    }
  },
  "553fca6054168f6c79000002": {
    "query": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?",
    "type": "list",
    "ideal_answer": [
      "In P. putida (Pseudomonas putida) the error prevention GO (8-oxo-G) system is composed of MutY, MutM, and MutT enzymes."
    ],
    "ground_truth_ids": [
      "17545288"
    ],
    "retrieved_ids": [
      "17545288",
      "34493791",
      "15184558",
      "23479439",
      "12067333",
      "23006569",
      "23894087",
      "18931123",
      "23770556",
      "14702298"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "17545288",
        "score": 0.5646406412124634,
        "title": "Oxidative DNA damage defense systems in avoidance of stationary-phase mutagenesis in Pseudomonas putida.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17545288"
      },
      {
        "pubmed_id": "34493791",
        "score": 0.4543854296207428,
        "title": "Burkholderia PglL enzymes are Serine preferring oligosaccharyltransferases which target conserved proteins across the Burkholderia genus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34493791"
      },
      {
        "pubmed_id": "15184558",
        "score": 0.4471731185913086,
        "title": "DNA methyltransferases from Neisseria meningitidis and Neisseria gonorrhoeae FA1090 associated with mismatch nicking endonucleases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15184558"
      },
      {
        "pubmed_id": "23479439",
        "score": 0.4449042081832886,
        "title": "Proteolytic regulation of stress response pathways in Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23479439"
      },
      {
        "pubmed_id": "12067333",
        "score": 0.43627282977104187,
        "title": "Cooperation and competition in mismatch repair: very short-patch repair and methyl-directed mismatch repair in Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12067333"
      },
      {
        "pubmed_id": "23006569",
        "score": 0.40388527512550354,
        "title": "Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23006569"
      },
      {
        "pubmed_id": "23894087",
        "score": 0.4007914364337921,
        "title": "Environmental proteomics reveals early microbial community responses to biostimulation at a uranium- and nitrate-contaminated site.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23894087"
      },
      {
        "pubmed_id": "18931123",
        "score": 0.3897538185119629,
        "title": "A Multicopper oxidase (Cj1516) and a CopA homologue (Cj1161) are major components of the copper homeostasis system of Campylobacter jejuni.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18931123"
      },
      {
        "pubmed_id": "23770556",
        "score": 0.3849608898162842,
        "title": "High-level expression of Staphylococcal Protein A in Pichia pastoris and purification and characterization of the recombinant protein.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23770556"
      },
      {
        "pubmed_id": "14702298",
        "score": 0.38468828797340393,
        "title": "atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14702298"
      }
    ],
    "query_time": 0.03988361358642578,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "605255a894d57fd87900000a": {
    "query": "What genes is implicated in myotonic goats and other  nondystrophic myotonias?",
    "type": "list",
    "ideal_answer": [
      "The gene encoding clcn1, mBNl1, gcic-1, scn4a, clc-1 and dmpk are implicated in myotonic goats and other nondystrophic myotonias.",
      "The following genes are implicated in myotonic goats and other nondystrophic myotonias: clcn1 (also known as mbnl1), gcic-1, scn4a, clc-1 and dmpk.",
      "The genes that are implicated in myotonic goats and other nondystrophic myotonias are clcn1, mbnl1, gcic-1, scn4a, clc-1 and dmpk.",
      "Myotonic goats and other Nondystrophic myotonic myotonias are caused by mutations in either the CLCN1 gene or the SCN4A gene.",
      "The gene encoding clcn1 (also known as clc-1), gcic-1, scn4a, and dmpk is implicated in myotonic goats and other nondystrophic myotonias",
      "The nondystrophic myotonias are rare muscle hyperexcitability disorders caused by gain-of-function mutations in the SCN4A gene or loss-of-function mutations in the CLCN1 gene. In goats, the gCIC-1 protein encoded by the CLCN1 gene, is affected .",
      "The nondystrophic myotonias are rare muscle hyperexcitability disorders caused by gain-of-function mutations in the SCN4A gene or loss-of-function mutations in the CLCN1 gene",
      "The gene encoding clcn1, mphanl1, gcic-1, scn4a, clc-1 and dmpk are implicated in myotonic goats and other nondystrophic myotonias",
      "Myotonic goats and other Nondystrophic Myotonias are caused by mutations in either the CLCN1 gene in Myotonia congenita or in the SCN4A gene in S4A."
    ],
    "ground_truth_ids": [
      "8855341",
      "23113340",
      "18974556",
      "31669315",
      "10215406",
      "27415035",
      "32129495",
      "22197188",
      "25438602",
      "12021248",
      "26510092",
      "32270509",
      "21204798",
      "9392583",
      "25088311"
    ],
    "retrieved_ids": [
      "22197188",
      "21204798",
      "21747952",
      "27415035",
      "18974556",
      "25438602",
      "32129495",
      "26510092",
      "10215406",
      "23113340"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "22197188",
        "score": 0.6048046350479126,
        "title": "A missense mutation in the skeletal muscle chloride channel 1 (CLCN1) as candidate causal mutation for congenital myotonia in a New Forest pony.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22197188"
      },
      {
        "pubmed_id": "21204798",
        "score": 0.5515129566192627,
        "title": "Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21204798"
      },
      {
        "pubmed_id": "21747952",
        "score": 0.5320769548416138,
        "title": "A novel nonsense mutation in the DMP1 gene identified by a genome-wide association study is responsible for inherited rickets in Corriedale sheep.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21747952"
      },
      {
        "pubmed_id": "27415035",
        "score": 0.525300145149231,
        "title": "Sequence CLCN1 and SCN4A in patients with Nondystrophic myotonias in Chinese populations: Genetic and pedigree analysis of 10 families and review of the literature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27415035"
      },
      {
        "pubmed_id": "18974556",
        "score": 0.5091484785079956,
        "title": "Myotonic disorders.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18974556"
      },
      {
        "pubmed_id": "25438602",
        "score": 0.5069895386695862,
        "title": "[Frequency and causes of prevalence of p.Arg894* mutation in CLCN1 gene responsible for development of Thomsen's and Becker's myotonias in Russian population].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25438602"
      },
      {
        "pubmed_id": "32129495",
        "score": 0.5032145380973816,
        "title": "EF hand-like motif mutations of Nav1.4 C-terminus cause myotonic syndrome by impairing fast inactivation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32129495"
      },
      {
        "pubmed_id": "26510092",
        "score": 0.49938297271728516,
        "title": "Identification and Functional Characterization of CLCN1 Mutations Found in Nondystrophic Myotonia Patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26510092"
      },
      {
        "pubmed_id": "10215406",
        "score": 0.4915508031845093,
        "title": "Identification of five new mutations and three novel polymorphisms in the muscle chloride channel gene (CLCN1) in 20 Italian patients with dominant and recessive myotonia congenita. Mutations in brief no. 118. Online.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10215406"
      },
      {
        "pubmed_id": "23113340",
        "score": 0.4904790222644806,
        "title": "[The spectrum of CLCN1 gene mutations in patients with nondystrophic Thomsen's and Becker's myotonias].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23113340"
      }
    ],
    "query_time": 0.03822207450866699,
    "metrics": {
      "precision": 0.9,
      "recall": 0.6,
      "f1_score": 0.7200000000000001,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "5e639d081af46fc130000014": {
    "query": "What monoclonal antibody drugs are used to treat late stage melanoma?",
    "type": "list",
    "ideal_answer": [
      "Nivolumab,  ipilimumab, vemurafenib, and dabrafenib are used to treat late stage melanoma",
      "Dabrafenib, ipilimumab and vemurafenib are monoclonal antibodies that are used to treat late stage melanoma.",
      "Dabrafenib, ipilimumab and vemurafenib are monoclonal antibodies used to treat late-stage melanoma.",
      "Dabrafenib, ipilimumab and vemurafenib are monoclonal antibodies that are used to treat late-stage melanoma."
    ],
    "ground_truth_ids": [
      "29157311",
      "28118986",
      "24477411",
      "21957431",
      "23294221",
      "19018089",
      "18537753",
      "23262440",
      "30539467",
      "25125216",
      "25588084",
      "26105702",
      "17473208",
      "26313415",
      "24770508"
    ],
    "retrieved_ids": [
      "30539467",
      "21957431",
      "18537753",
      "24770508",
      "26313415",
      "30040090",
      "26105702",
      "25682878",
      "19018089",
      "17473208"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30539467",
        "score": 0.7026404142379761,
        "title": "Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30539467"
      },
      {
        "pubmed_id": "21957431",
        "score": 0.6572015881538391,
        "title": "Therapeutic options in cutaneous melanoma: latest developments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21957431"
      },
      {
        "pubmed_id": "18537753",
        "score": 0.6084500551223755,
        "title": "Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18537753"
      },
      {
        "pubmed_id": "24770508",
        "score": 0.6083426475524902,
        "title": "Cutaneous melanoma: new advances in treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24770508"
      },
      {
        "pubmed_id": "26313415",
        "score": 0.6016843318939209,
        "title": "Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26313415"
      },
      {
        "pubmed_id": "30040090",
        "score": 0.5805149078369141,
        "title": "Immunotherapy for melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30040090"
      },
      {
        "pubmed_id": "26105702",
        "score": 0.5684026479721069,
        "title": "Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26105702"
      },
      {
        "pubmed_id": "25682878",
        "score": 0.5656830668449402,
        "title": "PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25682878"
      },
      {
        "pubmed_id": "19018089",
        "score": 0.557887077331543,
        "title": "Phase I/II study of ipilimumab for patients with metastatic melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19018089"
      },
      {
        "pubmed_id": "17473208",
        "score": 0.5395299196243286,
        "title": "Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17473208"
      }
    ],
    "query_time": 0.0071070194244384766,
    "metrics": {
      "precision": 0.8,
      "recall": 0.5333333333333333,
      "f1_score": 0.64,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "58b52c8822d3005309000001": {
    "query": "Which syndromes are associated with heterochromia iridum?",
    "type": "list",
    "ideal_answer": [
      "The syndromes that are associated with heterochromia iridum are:\n1) Ascher's syndrome\n2) Waardenburg Syndrome type II (WS2)\n3) Horner's syndrome."
    ],
    "ground_truth_ids": [
      "25971175",
      "22174915",
      "8981698",
      "6823113",
      "23840513",
      "21339912",
      "7702105",
      "20199465",
      "17878817",
      "1480396",
      "8092450",
      "24194866",
      "12825064",
      "3792843",
      "16814183",
      "16826074",
      "14166458"
    ],
    "retrieved_ids": [
      "14166458",
      "20199465",
      "6823113",
      "17878817",
      "8092450",
      "12825064",
      "3792843",
      "1480396",
      "24980541",
      "7702105"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "14166458",
        "score": 0.6430249214172363,
        "title": "WAARDENBURG'S SYNDROME AND HETEROCHROMIA IRIDUM IN A DEAF SCHOOL POPULATION.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14166458"
      },
      {
        "pubmed_id": "20199465",
        "score": 0.6286567449569702,
        "title": "Waardenburg syndrome type I with heterochromia iridis and circumscribed hypopigmentation of the skin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20199465"
      },
      {
        "pubmed_id": "6823113",
        "score": 0.61885666847229,
        "title": "Heterochromia iridis and Horner's syndrome due to paravertebral neurilemmoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6823113"
      },
      {
        "pubmed_id": "17878817",
        "score": 0.6116834282875061,
        "title": "[Iris heterochromia in acquired Horner's syndrome].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17878817"
      },
      {
        "pubmed_id": "8092450",
        "score": 0.593542218208313,
        "title": "[Waardenburg's syndrome].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8092450"
      },
      {
        "pubmed_id": "12825064",
        "score": 0.5713484287261963,
        "title": "When the darker eye has the smaller pupil.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12825064"
      },
      {
        "pubmed_id": "3792843",
        "score": 0.5422772765159607,
        "title": "Pigment distribution in Waardenburg's syndrome: a new hypothesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3792843"
      },
      {
        "pubmed_id": "1480396",
        "score": 0.5309430956840515,
        "title": "Acquired heterochromia with horner syndrome in two adults.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1480396"
      },
      {
        "pubmed_id": "24980541",
        "score": 0.510857343673706,
        "title": "Aneuploidy and skeletal health.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24980541"
      },
      {
        "pubmed_id": "7702105",
        "score": 0.502010703086853,
        "title": "Waardenburg syndrome type II: phenotypic findings and diagnostic criteria.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7702105"
      }
    ],
    "query_time": 0.04008221626281738,
    "metrics": {
      "precision": 0.9,
      "recall": 0.5294117647058824,
      "f1_score": 0.6666666666666667,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "5a99566e1d1251d03b00000f": {
    "query": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
    "type": "list",
    "ideal_answer": [
      "Association studies suggest that the low activity variant of the monoamine oxidase A (MAOA)-uVNTR polymorphism confers risk for emotional disturbances associated with antisocial traits, particularly in males. These include antisocial and borderline personality disorders and antisocial aggression.",
      "Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits. The interaction of the low activity variant of the monoamine oxidase-A (MAOA-L) gene and early childhood adversity has been shown to predict aggression in clinical and non-clinical populations Monoamine Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness in Borderline Personality Disorder.",
      "Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits. ",
      "Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits. Monoamine oxidase a gene is associated with borderline personality disorder. Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder.",
      "Monoamine oxidase A (MAOA) gene has an important role in the regulation of neurotransmitter levels and a large number of human behaviors. For example, it has been shown that childhood maltreatment interacts with a monoamine oxidase A (MAOA) gene variant to predict antisocial behavior that is often associated with alcoholism, and an interaction between early life stress and a serotonin transporter promoter variant predicts alcohol abuse in nonhuman primates and depression in humans. The purpose of the present study was to examine whether a cumulative genetic score (CGS) containing the monoamine oxidase A (MAOA) and the human serotonin transporter gene linked polymorphism (5-HTTLPR) was associated with IPV perpetration after accounting for the effects of alcohol problems, drug problems, age, and length of relationship. One approach to this question is examining allelic variation in the X-linked monoamine oxidase A (MAOA) gene, previously associated with impulsive aggression in animals and humans. Allelic variation of the monoamine oxidase A (MAOA) gene has been implicated in conduct disorder and antisocial, aggressive behavior in humans when associated with early adverse experiences.",
      "Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits."
    ],
    "ground_truth_ids": [
      "17347351",
      "10943908",
      "16436187",
      "25497297",
      "15652876",
      "29073746",
      "28851912",
      "15870836",
      "26494873",
      "20810002",
      "25698585",
      "14697883",
      "12554604",
      "26851573",
      "19194374",
      "21554924",
      "17417058",
      "25794322"
    ],
    "retrieved_ids": [
      "15870836",
      "10943908",
      "17417058",
      "16436187",
      "28851912",
      "20810002",
      "26851573",
      "15652876",
      "19194374",
      "21554924"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "15870836",
        "score": 0.7940486669540405,
        "title": "Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15870836"
      },
      {
        "pubmed_id": "10943908",
        "score": 0.7311693429946899,
        "title": "Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10943908"
      },
      {
        "pubmed_id": "17417058",
        "score": 0.7289232015609741,
        "title": "Monoamine oxidase a gene is associated with borderline personality disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17417058"
      },
      {
        "pubmed_id": "16436187",
        "score": 0.7237266302108765,
        "title": "Structural variation of the monoamine oxidase A gene promoter repeat polymorphism in nonhuman primates.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16436187"
      },
      {
        "pubmed_id": "28851912",
        "score": 0.7127385139465332,
        "title": "Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28851912"
      },
      {
        "pubmed_id": "20810002",
        "score": 0.7122503519058228,
        "title": "Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20810002"
      },
      {
        "pubmed_id": "26851573",
        "score": 0.7067869901657104,
        "title": "Monoamine oxidase and agitation in psychiatric patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26851573"
      },
      {
        "pubmed_id": "15652876",
        "score": 0.6979142427444458,
        "title": "Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15652876"
      },
      {
        "pubmed_id": "19194374",
        "score": 0.6972341537475586,
        "title": "A polymorphism of the MAOA gene is associated with emotional brain markers and personality traits on an antisocial index.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19194374"
      },
      {
        "pubmed_id": "21554924",
        "score": 0.6965280175209045,
        "title": "Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21554924"
      }
    ],
    "query_time": 0.012752294540405273,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5555555555555556,
      "f1_score": 0.7142857142857143,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 18
    }
  },
  "54fc9b236ad7dcbc12000005": {
    "query": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment.",
    "type": "list",
    "ideal_answer": [
      "Istradefylline and preladenant are adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
    ],
    "ground_truth_ids": [
      "23748382",
      "20182024",
      "24687255",
      "15298067",
      "22585137",
      "25175961",
      "15974638",
      "23483627",
      "16004599",
      "23642267"
    ],
    "retrieved_ids": [
      "24687255",
      "15974638",
      "22585137",
      "25175961",
      "16004599",
      "23642267",
      "23483627",
      "15298067",
      "23748382",
      "7969211"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24687255",
        "score": 0.874731183052063,
        "title": "Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24687255"
      },
      {
        "pubmed_id": "15974638",
        "score": 0.8617761135101318,
        "title": "Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15974638"
      },
      {
        "pubmed_id": "22585137",
        "score": 0.8593621850013733,
        "title": "Adenosine A2A antagonists in Parkinson's disease: what's next?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22585137"
      },
      {
        "pubmed_id": "25175961",
        "score": 0.8548957109451294,
        "title": "An overview of adenosine A2A receptor antagonists in Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25175961"
      },
      {
        "pubmed_id": "16004599",
        "score": 0.8444430828094482,
        "title": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16004599"
      },
      {
        "pubmed_id": "23642267",
        "score": 0.8421415090560913,
        "title": "Suitability of the adenosine antagonist istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23642267"
      },
      {
        "pubmed_id": "23483627",
        "score": 0.7583938837051392,
        "title": "Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23483627"
      },
      {
        "pubmed_id": "15298067",
        "score": 0.62810218334198,
        "title": "Drugs in development for Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15298067"
      },
      {
        "pubmed_id": "23748382",
        "score": 0.6209439039230347,
        "title": "Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23748382"
      },
      {
        "pubmed_id": "7969211",
        "score": 0.553592324256897,
        "title": "Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7969211"
      }
    ],
    "query_time": 0.01233530044555664,
    "metrics": {
      "precision": 0.9,
      "recall": 0.9,
      "f1_score": 0.9,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "54de15f91388e8454a000002": {
    "query": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?",
    "type": "list",
    "ideal_answer": [
      "APOBEC3G, APOBEC3F, APOBEC3DE, APOBEC3A, and APOBEC3H haplotypes II, V, and VII, provide protection against Vif-deficient HIV-1, through hypermutation of the viral genome, inhibition of reverse transcription, and inhibition of viral DNA integration into the host genome."
    ],
    "ground_truth_ids": [
      "21279453",
      "15466872",
      "23427247",
      "23316055",
      "22787460",
      "18495196",
      "24189052",
      "21835787",
      "19036809",
      "15296758",
      "17522216"
    ],
    "retrieved_ids": [
      "19036809",
      "24189052",
      "17522216",
      "21835787",
      "15466872",
      "22787460",
      "23316055",
      "15296758",
      "21279453",
      "18495196"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "19036809",
        "score": 0.8311833739280701,
        "title": "Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19036809"
      },
      {
        "pubmed_id": "24189052",
        "score": 0.8170133829116821,
        "title": "Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24189052"
      },
      {
        "pubmed_id": "17522216",
        "score": 0.8014816045761108,
        "title": "Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17522216"
      },
      {
        "pubmed_id": "21835787",
        "score": 0.7891803979873657,
        "title": "Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21835787"
      },
      {
        "pubmed_id": "15466872",
        "score": 0.7666552066802979,
        "title": "APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15466872"
      },
      {
        "pubmed_id": "22787460",
        "score": 0.753557562828064,
        "title": "Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22787460"
      },
      {
        "pubmed_id": "23316055",
        "score": 0.738792896270752,
        "title": "HIV-1 viral infectivity factor (Vif) alters processive single-stranded DNA scanning of the retroviral restriction factor APOBEC3G.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23316055"
      },
      {
        "pubmed_id": "15296758",
        "score": 0.7355095148086548,
        "title": "Cytidine deamination of retroviral DNA by diverse APOBEC proteins.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15296758"
      },
      {
        "pubmed_id": "21279453",
        "score": 0.7090248465538025,
        "title": "HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21279453"
      },
      {
        "pubmed_id": "18495196",
        "score": 0.7054670453071594,
        "title": "Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18495196"
      }
    ],
    "query_time": 0.007219791412353516,
    "metrics": {
      "precision": 1.0,
      "recall": 0.9090909090909091,
      "f1_score": 0.9523809523809523,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 11
    }
  },
  "5a8a9abdfcd1d6a10c000019": {
    "query": "List polyubiquitin binding proteins involved in NF-kappaB signaling.",
    "type": "list",
    "ideal_answer": [
      "NEMO\nA20\nABIN-1\nABIN-2\noptineurin\np62"
    ],
    "ground_truth_ids": [
      "23509369",
      "18995839",
      "19285159",
      "23989959"
    ],
    "retrieved_ids": [
      "19285159",
      "23989959",
      "16136188",
      "10837071",
      "12399470",
      "15728425",
      "23509369",
      "22975329",
      "12972430",
      "10454561"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "19285159",
        "score": 0.8009903430938721,
        "title": "Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19285159"
      },
      {
        "pubmed_id": "23989959",
        "score": 0.7078799605369568,
        "title": "Molecular control of the NEMO family of ubiquitin-binding proteins.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23989959"
      },
      {
        "pubmed_id": "16136188",
        "score": 0.6964794397354126,
        "title": "Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16136188"
      },
      {
        "pubmed_id": "10837071",
        "score": 0.687942624092102,
        "title": "Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10837071"
      },
      {
        "pubmed_id": "12399470",
        "score": 0.6777376532554626,
        "title": "p105.Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12399470"
      },
      {
        "pubmed_id": "15728425",
        "score": 0.650742769241333,
        "title": "TRAF2: a double-edged sword?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15728425"
      },
      {
        "pubmed_id": "23509369",
        "score": 0.6379058361053467,
        "title": "Essential roles of K63-linked polyubiquitin-binding proteins TAB2 and TAB3 in B cell activation via MAPKs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23509369"
      },
      {
        "pubmed_id": "22975329",
        "score": 0.6108986139297485,
        "title": "Sef is an inhibitor of proinflammatory cytokine signaling, acting by cytoplasmic sequestration of NF-κB.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22975329"
      },
      {
        "pubmed_id": "12972430",
        "score": 0.6062379479408264,
        "title": "Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12972430"
      },
      {
        "pubmed_id": "10454561",
        "score": 0.5802529454231262,
        "title": "Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10454561"
      }
    ],
    "query_time": 0.01162409782409668,
    "metrics": {
      "precision": 0.3,
      "recall": 0.75,
      "f1_score": 0.4285714285714285,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "52ee065d98d0239505000033": {
    "query": "List five applications of machine learning algorithms in medical diagnosis.",
    "type": "list",
    "ideal_answer": [
      "Machine learning technology is well suited for the induction of diagnostic and prognostic rules and solving of small and specialized diagnostic and prognostic problems. The medical diagnostic knowledge can be automatically derived from the description of cases solved in the past. In several medical domains we actually applied machine learning algorithms. Typically, the automatically generated diagnostic rules achieved the same or slightly better diagnostic accuracy than physicians specialists. There many several  application of machine learning algorithms in medical diagnosis such as Brain glioma progression, Microarray classification, Mass spectral proteomics, Lymph disease classification and Parkinson's disease."
    ],
    "ground_truth_ids": [
      "22606669",
      "24321226",
      "21479187",
      "24263362",
      "16226240",
      "22606665",
      "24297560",
      "24286700",
      "24266942",
      "24290902",
      "23322959",
      "15788095",
      "23763826"
    ],
    "retrieved_ids": [
      "24263362",
      "16226240",
      "24290902",
      "24286700",
      "24266942",
      "15788095",
      "35438215",
      "24297560",
      "22606669",
      "36658421"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24263362",
        "score": 0.5963284969329834,
        "title": "Development and validation of a machine learning algorithm and hybrid system to predict the need for life-saving interventions in trauma patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24263362"
      },
      {
        "pubmed_id": "16226240",
        "score": 0.5788325071334839,
        "title": "Machine learning in bioinformatics: a brief survey and recommendations for practitioners.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16226240"
      },
      {
        "pubmed_id": "24290902",
        "score": 0.5270520448684692,
        "title": "A random forest classifier for lymph diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24290902"
      },
      {
        "pubmed_id": "24286700",
        "score": 0.5103020668029785,
        "title": "Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24286700"
      },
      {
        "pubmed_id": "24266942",
        "score": 0.46060869097709656,
        "title": "Fuzzy support vector machine: an efficient rule-based classification technique for microarrays.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24266942"
      },
      {
        "pubmed_id": "15788095",
        "score": 0.4445585310459137,
        "title": "Feature selection and nearest centroid classification for protein mass spectrometry.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15788095"
      },
      {
        "pubmed_id": "35438215",
        "score": 0.44119465351104736,
        "title": "Machine learning prediction models for postpartum depression: A multicenter study in Japan.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35438215"
      },
      {
        "pubmed_id": "24297560",
        "score": 0.4314877390861511,
        "title": "A novel profile biomarker diagnosis for mass spectral proteomics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24297560"
      },
      {
        "pubmed_id": "22606669",
        "score": 0.3921143710613251,
        "title": "IMPST: A New Interactive Self-Training Approach to Segmentation Suspicious Lesions in Breast MRI.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22606669"
      },
      {
        "pubmed_id": "36658421",
        "score": 0.3900003433227539,
        "title": "Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36658421"
      }
    ],
    "query_time": 0.031439781188964844,
    "metrics": {
      "precision": 0.8,
      "recall": 0.6153846153846154,
      "f1_score": 0.6956521739130435,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 13
    }
  },
  "641dc49b690f196b51000042": {
    "query": "Treatment with plasma exchange (TPE) is used for what diseases",
    "type": "list",
    "ideal_answer": [
      "Therapeutic plasma exchange (TPE) is the most common modality employed with the rationale of rapid reduction of a pathogenic substance distributed primarily in the intravascular compartment This includes cancer, infectious diseases like Dengue fever and Covid-19, septic shock and cytokine storm, and others such as Thrombotic thrombocytopenic purpura (TTP), diabetic ketoacidosis concomitant with type IX glycogen storage disease (GSD) and autoimmune disease of the CNS.",
      "Plasma exchange (TPE) is used to treat various autoimmune diseases, thrombotic thrombocytopenic purpura, neuromuscular junction disorders, hyperthyroidism, septic shock, cytokine release syndrome, Dengue fever, metastatic melanoma, and kidney disease.",
      "TPE is used for treating a variety of diseases, including septic shock, thrombotic thrombocytopenic purpura, COVID-19, hypertriglyceridemia, hyperthyroidism, optic neuritis, neuromyelitis optica spectrum disorders, neuromuscular junction disorders, and neurological autoimmune diseases.",
      "Therapeutic plasma exchange (TPE) and immunoadsorption (IA) are first or second line treatment options in patients with neurological autoimmune diseases, including multiple sclerosis, neuromyelitis optica spectrum disorders (NMSOD), chronic inflammatory demyelinating polyneuropathy, acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome), and autoimmune encephalitis",
      "Therapeutic plasma exchange (TPE) is used to treat a variety of diseases, including cancer, fulminant hepatic failure, septic shock, thrombotic thrombocytopenic purpura, SARS-CoV-2 induced cytokine release syndrome, hypertriglyceridemia, hyperthyroidism, optic neuritis, neuromuscular junction disorders, and neurological autoimmune diseases such as multiple sclerosis, neuromyelitis optica spectrum disorders, chronic inflammatory demyelinating polyneuropathy, acute inflammatory demyelinating polyradiculoneuropathy, and autoimmune encephalitis.",
      "Therapeutic Plasma Exchange (TPE) can be used to treat various neuroimmunological disorders where autoimmunity plays a significant role in their pathology. These include Myasthenia Gravis, Multiple Sclerosis, Guillain-Barre Syndrome, Paraproteinemic Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Transverse Myelitis caused by Systemic Lupus Erythematosus, Acute Disseminated Encephalomyelitis, among others.",
      "Treatment with plasma exchange (TPE) is used for several neurological autoimmune diseases such as multiple sclerosis, neuromyelitis optica spectrum disorders, chronic inflammatory demyelinating polyneuropathy, acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome), and autoimmune encephalitis."
    ],
    "ground_truth_ids": [
      "35585996",
      "35551628",
      "28194064",
      "16382247",
      "23619323",
      "22277020",
      "29882008",
      "32802495",
      "35689538",
      "35955999",
      "10619926",
      "23619327",
      "34690074",
      "32605805",
      "34261138",
      "35353437",
      "35551087",
      "33884210",
      "1703815",
      "33991255",
      "35547461",
      "31029610",
      "30924130",
      "35963982",
      "34904748",
      "35302053",
      "17224307",
      "18331814",
      "24277990"
    ],
    "retrieved_ids": [
      "1703815",
      "22277020",
      "30924130",
      "31029610",
      "10619926",
      "16382247",
      "33884210",
      "23619323",
      "29882008",
      "35302053"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "1703815",
        "score": 0.7152789831161499,
        "title": "[10 years plasma exchange with the IBM (Cobe) 2997].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1703815"
      },
      {
        "pubmed_id": "22277020",
        "score": 0.6925650835037231,
        "title": "Evidence-based review of therapeutic plasma exchange in neurological disorders.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22277020"
      },
      {
        "pubmed_id": "30924130",
        "score": 0.6897223591804504,
        "title": "The role of plasma exchange in the management of autoimmune disorders.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30924130"
      },
      {
        "pubmed_id": "31029610",
        "score": 0.6869392991065979,
        "title": "Therapeutic apheresis in neurological, nephrological and gastrointestinal diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31029610"
      },
      {
        "pubmed_id": "10619926",
        "score": 0.6640394926071167,
        "title": "Plasmapheresis with a substitution solution of human serum protein (5%) versus plasmapheresis with a substitution solution of human albumin (5%) in patients suffering from autoimmune diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10619926"
      },
      {
        "pubmed_id": "16382247",
        "score": 0.6631940603256226,
        "title": "Plasma filtration.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16382247"
      },
      {
        "pubmed_id": "33884210",
        "score": 0.6573002338409424,
        "title": "Therapeutic Plasma Exchange Application in Children Requires Individual Decision.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33884210"
      },
      {
        "pubmed_id": "23619323",
        "score": 0.6470593810081482,
        "title": "Therapeutic plasma-exchange in hematologic disease: results from a single center in Eastern Anatolia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23619323"
      },
      {
        "pubmed_id": "29882008",
        "score": 0.6194950342178345,
        "title": "Overview of therapeutic plasma exchange in pediatric neurology: a single-center experience.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29882008"
      },
      {
        "pubmed_id": "35302053",
        "score": 0.6121252775192261,
        "title": "Therapeutic Plasma Exchange (TPE) Complications in Patients With Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS): A Report From a Tertiary Center.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35302053"
      }
    ],
    "query_time": 0.019216299057006836,
    "metrics": {
      "precision": 1.0,
      "recall": 0.3448275862068966,
      "f1_score": 0.5128205128205129,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 29
    }
  },
  "601d6a651cb411341a000031": {
    "query": "Please list the 2 vaccines for herpes zoster(shingles)",
    "type": "list",
    "ideal_answer": [
      "live attenuated zoster vaccine (Zostavax®) and live attenuates herpes zoster (Shingles) are effective for treatment of infections with herpesZoster(shingles).",
      "live attenuated zoster vaccine (Zostavax; also known as shingles vaccine) is effective for prevention of infections with herpes zoster virus (VZV).",
      "Shingrix is a recombinant adjuvant subunit vaccine.",
      "The are 2 vaccines for herpes zoster, adjuvated recombinant vaccines and a live attenuated vaccine."
    ],
    "ground_truth_ids": [
      "31015813",
      "30558674",
      "31436592",
      "32284271",
      "29457489",
      "20113211",
      "32305975",
      "30179221",
      "22024532",
      "32999027",
      "23839657",
      "25144544",
      "16977285",
      "28426274",
      "31339679",
      "33294953",
      "29720364",
      "31061027",
      "24834646",
      "17326312",
      "27189459",
      "22086893"
    ],
    "retrieved_ids": [
      "20113211",
      "28426274",
      "31436592",
      "29457489",
      "30179221",
      "31015813",
      "31339679",
      "22086893",
      "16977285",
      "23839657"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "20113211",
        "score": 0.7454952597618103,
        "title": "Shingles vaccine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20113211"
      },
      {
        "pubmed_id": "28426274",
        "score": 0.7381585836410522,
        "title": "A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28426274"
      },
      {
        "pubmed_id": "31436592",
        "score": 0.7371156811714172,
        "title": "Practical points for applying herpes zoster vaccine recommendations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31436592"
      },
      {
        "pubmed_id": "29457489",
        "score": 0.7201896905899048,
        "title": "Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29457489"
      },
      {
        "pubmed_id": "30179221",
        "score": 0.7095365524291992,
        "title": "Tale of two vaccines: differences in response to herpes zoster vaccines.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30179221"
      },
      {
        "pubmed_id": "31015813",
        "score": 0.6997278928756714,
        "title": "Summary of the NACI Update on Herpes Zoster Vaccines.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31015813"
      },
      {
        "pubmed_id": "31339679",
        "score": 0.6958882808685303,
        "title": "Shingrix for Herpes Zoster: A Review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31339679"
      },
      {
        "pubmed_id": "22086893",
        "score": 0.6952128410339355,
        "title": "Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22086893"
      },
      {
        "pubmed_id": "16977285",
        "score": 0.6946285963058472,
        "title": "Herpes zoster vaccine (Zostavax).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16977285"
      },
      {
        "pubmed_id": "23839657",
        "score": 0.693001389503479,
        "title": "Shingles (herpes zoster) vaccine (zostavax(®)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23839657"
      }
    ],
    "query_time": 0.007647991180419922,
    "metrics": {
      "precision": 1.0,
      "recall": 0.45454545454545453,
      "f1_score": 0.625,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 22
    }
  },
  "5ace34eb0340b9f058000010": {
    "query": "Which genes are associated with Epidermolysis Bullosa Simplex?",
    "type": "list",
    "ideal_answer": [
      "In one family studied, inheritance of EBS is linked to the gene encoding keratin 14",
      "Epidermolysis bullosa simplex (EBS) is mainly caused by mutations in the KRT5 and KRT14 genes.  A compound heterozygous one amino-acid insertion/nonsense mutation in the plectin gene causes epidermolysis bullosa simplex with plectin deficiency.",
      "In one family studied, inheritance of EBS is linked to the gene encoding keratin 14 Homozygous deletion mutations in the plectin gene (PLEC1) in patients with epidermolysis bullosa simplex associated with late-onset muscular dystrophy. Epidermolysis bullosa simplex (EBS) is a rare genodermatosis resulting from multiple gene mutations, including KRT5 and KRT14.",
      "Epidermolysis bullosa simplex (EBS) is a rare genodermatosis resulting from multiple gene mutations, including KRT5 and KRT14.",
      "Keratin 5 and keratin 14 are known to be essential for the basal keratinocyte cytoskeleton and are defective in several forms of epidermolysis bullosa simplex. Homozygous deletion mutations in the plectin gene in patients with epidermolysis bullosa simplex associated with late-onset muscular dystrophy. The KRT5 and KRT14 genes encode the proteins keratin 5 and 14, respectively, which are the primary structural components of the 10-nm intermediate filaments of the mitotic epidermal basal cells. Epidermolysis bullosa simplex is mainly caused by mutations in the KRT5 and KRT14 genes. Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene. This is the first report of EBS-generalized intermediate in a newborn with de novo KRT5 gene mutation and KRT14 gene polymorphism, and no familial history of epidermolysis. Study of a family with epidermolysis bullosa simplex resulting from a novel mutation of KRT14 gene. We have systematically scanned genomic sequences of one of these keratins, keratin 14, for mutations in patients from 49 apparently independent kindreds using single-strand conformation polymorphism analysis. ",
      "Homozygous deletion mutations in the plectin gene (PLEC1) in patients with epidermolysis bullosa simplex associated with late-onset muscular dystrophy. Epidermolysis bullosa simplex (EBS) is mainly caused by mutations in the KRT5 and KRT14 genes. Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene.",
      "Recent advances in molecular biology have enabled the association of epidermolysis bullosa simplex (EBS) with point mutations of keratin 14 and/or keratin 5 genes to be established. ",
      "Keratin 14 gene mutations in patients with epidermolysis bullosa simplex. Mutant keratins 5 or 14 are implicated in the etiology of epidermolysis bullosa simplex (EBS).  Keratin 14 gene point mutation in the Köbner and Dowling-Meara types of epidermolysis bullosa simplex as detected by the PASA method."
    ],
    "ground_truth_ids": [
      "19797037",
      "7539246",
      "9036937",
      "10494094",
      "7561171",
      "21375516",
      "11159198",
      "1720261",
      "9804355",
      "22639907",
      "26929861",
      "20199538",
      "11407988",
      "8894687",
      "20030639",
      "8941634",
      "1381443",
      "12655565",
      "28777847"
    ],
    "retrieved_ids": [
      "28777847",
      "1720261",
      "1381443",
      "7561171",
      "19797037",
      "21375516",
      "9036937",
      "12655565",
      "7539246",
      "20199538"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28777847",
        "score": 0.739041805267334,
        "title": "[Study of a family with epidermolysis bullosa simplex resulting from a novel mutation of KRT14 gene].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28777847"
      },
      {
        "pubmed_id": "1720261",
        "score": 0.7331483364105225,
        "title": "Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1720261"
      },
      {
        "pubmed_id": "1381443",
        "score": 0.7123119831085205,
        "title": "Linkage of epidermolysis bullosa simplex to keratin gene loci.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1381443"
      },
      {
        "pubmed_id": "7561171",
        "score": 0.7105101943016052,
        "title": "Keratin 14 gene mutations in patients with epidermolysis bullosa simplex.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7561171"
      },
      {
        "pubmed_id": "19797037",
        "score": 0.7087366580963135,
        "title": "A new pathogenic keratin 5 mutation in a Hindoestan family with localized epidermolysis bullosa simplex.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19797037"
      },
      {
        "pubmed_id": "21375516",
        "score": 0.6928236484527588,
        "title": "Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21375516"
      },
      {
        "pubmed_id": "9036937",
        "score": 0.6820180416107178,
        "title": "Primers for exon-specific amplification of the KRT5 gene: identification of novel and recurrent mutations in epidermolysis bullosa simplex patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9036937"
      },
      {
        "pubmed_id": "12655565",
        "score": 0.6819055676460266,
        "title": "Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12655565"
      },
      {
        "pubmed_id": "7539246",
        "score": 0.6740798950195312,
        "title": "Keratin 14 gene point mutation in the Köbner and Dowling-Meara types of epidermolysis bullosa simplex as detected by the PASA method.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7539246"
      },
      {
        "pubmed_id": "20199538",
        "score": 0.6733118295669556,
        "title": "Identification of novel and known KRT5 and KRT14 mutations in 53 patients with epidermolysis bullosa simplex: correlation between genotype and phenotype.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20199538"
      }
    ],
    "query_time": 0.012335062026977539,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5263157894736842,
      "f1_score": 0.6896551724137931,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 19
    }
  },
  "58c1b2f702b8c6095300001e": {
    "query": "List 3 indications for Bupropion",
    "type": "list",
    "ideal_answer": [
      "Bupropion is used to treat Obesity, for smoking cessation and for depression"
    ],
    "ground_truth_ids": [
      "17227286",
      "18219560",
      "15479310",
      "16831112",
      "9554323",
      "16546007",
      "16027765",
      "21274361",
      "25661549",
      "25895022",
      "18619194",
      "10804045",
      "25223901",
      "27038550",
      "21142259",
      "26137782",
      "15155135",
      "12043548",
      "18264876",
      "23859696"
    ],
    "retrieved_ids": [
      "16027765",
      "10804045",
      "12043548",
      "9554323",
      "16831112",
      "21274361",
      "15479310",
      "23859696",
      "15155135",
      "18619194"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "16027765",
        "score": 0.6920313835144043,
        "title": "15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16027765"
      },
      {
        "pubmed_id": "10804045",
        "score": 0.5967761874198914,
        "title": "Bupropion: a review of its use in the management of smoking cessation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10804045"
      },
      {
        "pubmed_id": "12043548",
        "score": 0.5868536233901978,
        "title": "Bupropion sustained release. A therapeutic review of Zyban.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12043548"
      },
      {
        "pubmed_id": "9554323",
        "score": 0.5134482383728027,
        "title": "Bupropion sustained release and smoking cessation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9554323"
      },
      {
        "pubmed_id": "16831112",
        "score": 0.508435845375061,
        "title": "Bupropion for the treatment of nicotine withdrawal and craving.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16831112"
      },
      {
        "pubmed_id": "21274361",
        "score": 0.46158650517463684,
        "title": "Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21274361"
      },
      {
        "pubmed_id": "15479310",
        "score": 0.4550981819629669,
        "title": "Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15479310"
      },
      {
        "pubmed_id": "23859696",
        "score": 0.4525604546070099,
        "title": "Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23859696"
      },
      {
        "pubmed_id": "15155135",
        "score": 0.45094794034957886,
        "title": "Advances in pharmacotherapy for tobacco dependence.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15155135"
      },
      {
        "pubmed_id": "18619194",
        "score": 0.44023633003234863,
        "title": "Which drug to be used in smoking cessation?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18619194"
      }
    ],
    "query_time": 0.0188138484954834,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 20
    }
  },
  "5e3c841148dab47f26000002": {
    "query": "Before 2019, what neurologic diseases are associated with the tau protein?",
    "type": "list",
    "ideal_answer": [
      "Tau proteins are involved in the pathogenesis of multiple sclerosis and amyotrophic lateral sclerosis.",
      "Both Alzheimer's Disease and Multiple Sclerosis are associated with tau protein"
    ],
    "ground_truth_ids": [
      "29441009",
      "27697018",
      "27995573",
      "20826658",
      "22009441",
      "20678581",
      "23552370"
    ],
    "retrieved_ids": [
      "26572762",
      "20678581",
      "22009441",
      "37905874",
      "34593029",
      "27334944",
      "29441009",
      "20826658",
      "19228370",
      "21844169"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "26572762",
        "score": 0.6909387111663818,
        "title": "Tau imaging in neurodegenerative diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26572762"
      },
      {
        "pubmed_id": "20678581",
        "score": 0.6902415752410889,
        "title": "Tau protein: relevance to Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20678581"
      },
      {
        "pubmed_id": "22009441",
        "score": 0.6479660868644714,
        "title": "Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22009441"
      },
      {
        "pubmed_id": "37905874",
        "score": 0.6030592918395996,
        "title": "Amyloid-beta and tau protein beyond Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37905874"
      },
      {
        "pubmed_id": "34593029",
        "score": 0.5959256887435913,
        "title": "Loss of presenilin function enhances tau phosphorylation and aggregation in mice.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34593029"
      },
      {
        "pubmed_id": "27334944",
        "score": 0.5827299952507019,
        "title": "18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: Chemical, Radiochemical, Biological and Clinical Features.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27334944"
      },
      {
        "pubmed_id": "29441009",
        "score": 0.5819772481918335,
        "title": "Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29441009"
      },
      {
        "pubmed_id": "20826658",
        "score": 0.5650789737701416,
        "title": "Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20826658"
      },
      {
        "pubmed_id": "19228370",
        "score": 0.5446415543556213,
        "title": "Recent developments in Alzheimer's disease therapeutics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19228370"
      },
      {
        "pubmed_id": "21844169",
        "score": 0.514656662940979,
        "title": "Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21844169"
      }
    ],
    "query_time": 0.011121988296508789,
    "metrics": {
      "precision": 0.4,
      "recall": 0.5714285714285714,
      "f1_score": 0.47058823529411764,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 7
    }
  },
  "52d2818403868f1b06000033": {
    "query": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?",
    "type": "list",
    "ideal_answer": [
      "Thalassemia is genetic diseases of the blood caused by mutations in the globin gene.  Main goal for thalassemia treatment is to develop homologous recombination based gene therapy in order to cure these diseases. Zinc finger nucleases (ZFNs) and TAL effector nucleases (TALENs) are proper targets for the human globin gene. Genome editing using engineered nucleases such as ZFNs and TALENs has become a powerful technology for reverse genetics.",
      "The newly identified DNA nucleases that can be used to treat thalassemia are the transcription activator-like effector nucleases (TALEN). These are engineered proteins able to stimulate targeted integration of therapeutic wild-type beta-globin cDNAs to the endogenous beta-globin locus."
    ],
    "ground_truth_ids": [
      "24305179",
      "24286287",
      "24323919",
      "24299737",
      "24211574",
      "24155235",
      "24157834",
      "24253446",
      "23408852",
      "21953455",
      "23002118",
      "24291598",
      "23386979"
    ],
    "retrieved_ids": [
      "23002118",
      "24155235",
      "19467223",
      "24157834",
      "19381941",
      "23620291",
      "22147573",
      "27141062",
      "24305179",
      "11899395"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23002118",
        "score": 0.5033849477767944,
        "title": "Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23002118"
      },
      {
        "pubmed_id": "24155235",
        "score": 0.46767377853393555,
        "title": "Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24155235"
      },
      {
        "pubmed_id": "19467223",
        "score": 0.4533894956111908,
        "title": "DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19467223"
      },
      {
        "pubmed_id": "24157834",
        "score": 0.44703203439712524,
        "title": "Nuclease-mediated gene editing by homologous recombination of the human globin locus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24157834"
      },
      {
        "pubmed_id": "19381941",
        "score": 0.432123064994812,
        "title": "Methods to study transcription-coupled repair in chromatin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19381941"
      },
      {
        "pubmed_id": "23620291",
        "score": 0.43093201518058777,
        "title": "Reconstitution of hemisomes on budding yeast centromeric DNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23620291"
      },
      {
        "pubmed_id": "22147573",
        "score": 0.43001794815063477,
        "title": "Assessment of DNA interstrand crosslinks using the modified alkaline comet assay.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22147573"
      },
      {
        "pubmed_id": "27141062",
        "score": 0.414532870054245,
        "title": "Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 years.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27141062"
      },
      {
        "pubmed_id": "24305179",
        "score": 0.4144224524497986,
        "title": "Editing livestock genomes with site-specific nucleases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24305179"
      },
      {
        "pubmed_id": "11899395",
        "score": 0.40991926193237305,
        "title": "Thalidomide: when everything old is new again.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11899395"
      }
    ],
    "query_time": 0.012893915176391602,
    "metrics": {
      "precision": 0.4,
      "recall": 0.3076923076923077,
      "f1_score": 0.34782608695652173,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 13
    }
  },
  "58ea59273e8b6dc87c000012": {
    "query": "List viral vectors used in gene therapy.",
    "type": "list",
    "ideal_answer": [
      "adeno-associated viruses\nlentiviruses\nherpes simplex viral vector"
    ],
    "ground_truth_ids": [
      "26611583",
      "25636961",
      "26611600",
      "24519667",
      "25962909",
      "26607476"
    ],
    "retrieved_ids": [
      "25636961",
      "24519667",
      "26611583",
      "25962909",
      "26607476",
      "23658991",
      "29361041",
      "35078478",
      "25596968",
      "29288370"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25636961",
        "score": 0.6759784817695618,
        "title": "Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25636961"
      },
      {
        "pubmed_id": "24519667",
        "score": 0.605107307434082,
        "title": "Anti-tumor effects of gene therapy with GALV membrane fusion glycoprotein in lung adenocarcinoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24519667"
      },
      {
        "pubmed_id": "26611583",
        "score": 0.5823066234588623,
        "title": "Viral Vector Production: Adenovirus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26611583"
      },
      {
        "pubmed_id": "25962909",
        "score": 0.5789322853088379,
        "title": "Current gene therapy using viral vectors for chronic pain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25962909"
      },
      {
        "pubmed_id": "26607476",
        "score": 0.5660914182662964,
        "title": "Large-Scale Production of Adeno-Associated Viral Vector Serotype-9 Carrying the Human Survival Motor Neuron Gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26607476"
      },
      {
        "pubmed_id": "23658991",
        "score": 0.5651477575302124,
        "title": "Blood - SeV derived fibroblast generated iPSCs",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23658991"
      },
      {
        "pubmed_id": "29361041",
        "score": 0.5565136075019836,
        "title": "The human cytomegalovirus terminase complex as an antiviral target: a close-up view.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29361041"
      },
      {
        "pubmed_id": "35078478",
        "score": 0.5475177764892578,
        "title": "ERDRP-0519 inhibits feline coronavirus in vitro.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35078478"
      },
      {
        "pubmed_id": "25596968",
        "score": 0.5342857837677002,
        "title": "Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25596968"
      },
      {
        "pubmed_id": "29288370",
        "score": 0.5272504091262817,
        "title": "Letermovir: First Global Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29288370"
      }
    ],
    "query_time": 0.012720823287963867,
    "metrics": {
      "precision": 0.5,
      "recall": 0.8333333333333334,
      "f1_score": 0.625,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "535d59349a4572de6f000009": {
    "query": "What are the indications for treatment with anti-hepcidin?",
    "type": "list",
    "ideal_answer": [
      "improving anemia control\nanemia management in hemodialysis\niron-restricted anemias"
    ],
    "ground_truth_ids": [
      "24159166",
      "24231125",
      "24175256"
    ],
    "retrieved_ids": [
      "24159166",
      "24231125",
      "23542331",
      "17905609",
      "21816077",
      "37880598",
      "25447032",
      "23866358",
      "26095540",
      "8984578"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24159166",
        "score": 0.5700814723968506,
        "title": "Anti-hepcidin therapy for iron-restricted anemias.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24159166"
      },
      {
        "pubmed_id": "24231125",
        "score": 0.4651111960411072,
        "title": "Hepcidin levels in chronic hemodialysis patients: a critical evaluation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24231125"
      },
      {
        "pubmed_id": "23542331",
        "score": 0.4316660165786743,
        "title": "Efficacy and safety of oral chelators in treatment of patients with Wilson disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23542331"
      },
      {
        "pubmed_id": "17905609",
        "score": 0.4301280081272125,
        "title": "Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17905609"
      },
      {
        "pubmed_id": "21816077",
        "score": 0.422943651676178,
        "title": "Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21816077"
      },
      {
        "pubmed_id": "37880598",
        "score": 0.4137015640735626,
        "title": "Comparative effectiveness of seven interventions for chronic hepatitis D: a systematic review and network meta-analysis of randomized controlled trials.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37880598"
      },
      {
        "pubmed_id": "25447032",
        "score": 0.4023219347000122,
        "title": "Behçet syndrome: from pathogenesis to novel therapies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25447032"
      },
      {
        "pubmed_id": "23866358",
        "score": 0.40229883790016174,
        "title": "Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23866358"
      },
      {
        "pubmed_id": "26095540",
        "score": 0.40133821964263916,
        "title": "Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26095540"
      },
      {
        "pubmed_id": "8984578",
        "score": 0.40040042996406555,
        "title": "[Current diagnosis: hereditary metabolic diseases of the liver (primary hemochromatosis, Wilson disease)].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8984578"
      }
    ],
    "query_time": 0.008816719055175781,
    "metrics": {
      "precision": 0.2,
      "recall": 0.6666666666666666,
      "f1_score": 0.30769230769230765,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "5e36a901b5b409ea53000005": {
    "query": "Which T-UCRs have been implicated in lung cancer?",
    "type": "list",
    "ideal_answer": [
      "Transcribed ultraconserved regions (T-UCRs) classified as long non-coding RNAs (Lnc-RNAs) are transcripts longer than 200-nt RNA with no protein-coding capacity. The clinicopathologic significance and regulatory mechanism of T-UCRs in lung cancer (LC) remain largely unknown. Uc.454 is downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc.454 is associated with tumor size and tumors with more advanced stages. Transfection with uc.454 markedly induces apoptosis and inhibites cell proliferation in SPC-A-1 and NCI-H2170 LC cell lines. Thus uc.454 potentially plays a suppressive role in LC. Transcribed uc.339 is upregulated in archival NSCLC samples, functioning as a decoy RNA for miR-339-3p, -663b-3p, and -95-5p. As a result, Cyclin E2, a direct target of all these microRNAs is upregulated, promoting cancer growth and migration. Modulation of uc.339 affects microRNA expression. However, overexpression or downregulation of these microRNAs causes no significant variations in uc.339 levels."
    ],
    "ground_truth_ids": [
      "29180617",
      "30195756"
    ],
    "retrieved_ids": [
      "30195756",
      "29180617",
      "36689692",
      "37877814",
      "29140105",
      "23381475",
      "29545095",
      "29958099",
      "29906749",
      "37355629"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30195756",
        "score": 0.5961238741874695,
        "title": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell Lung Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30195756"
      },
      {
        "pubmed_id": "29180617",
        "score": 0.5649623870849609,
        "title": "Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29180617"
      },
      {
        "pubmed_id": "36689692",
        "score": 0.5225346684455872,
        "title": "Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36689692"
      },
      {
        "pubmed_id": "37877814",
        "score": 0.5101525187492371,
        "title": "Tarlatamab Shows Promise in SCLC.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37877814"
      },
      {
        "pubmed_id": "29140105",
        "score": 0.4958719313144684,
        "title": "Durvalumab in non-small-cell lung cancer patients: current developments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29140105"
      },
      {
        "pubmed_id": "23381475",
        "score": 0.48787522315979004,
        "title": "Ubc9 promotes invasion and metastasis of lung cancer cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23381475"
      },
      {
        "pubmed_id": "29545095",
        "score": 0.4839513897895813,
        "title": "Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29545095"
      },
      {
        "pubmed_id": "29958099",
        "score": 0.4829998314380646,
        "title": "Durvalumab for the treatment of non-small cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29958099"
      },
      {
        "pubmed_id": "29906749",
        "score": 0.47665682435035706,
        "title": "Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29906749"
      },
      {
        "pubmed_id": "37355629",
        "score": 0.4740561246871948,
        "title": "Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37355629"
      }
    ],
    "query_time": 0.02127385139465332,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "621b85993a8413c653000041": {
    "query": "List known pseudokinases.",
    "type": "list",
    "ideal_answer": [
      "TRIB1\nTRIB2\nTRIB3\nMLKL\nULK4\nHER3\nCASK"
    ],
    "ground_truth_ids": [
      "34496019",
      "34537014",
      "32730594",
      "34567510",
      "34543009",
      "32397857",
      "32687661",
      "34548332"
    ],
    "retrieved_ids": [
      "23095268",
      "12898406",
      "34807422",
      "12829232",
      "34543009",
      "34493791",
      "27789971",
      "19728949",
      "27779083",
      "22122056"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23095268",
        "score": 0.4020991027355194,
        "title": "Hemophilic pseudotumor of the temporal bone with conductive hearing loss--case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23095268"
      },
      {
        "pubmed_id": "12898406",
        "score": 0.383402556180954,
        "title": "[Phthiriasis palpebrarum: diagnosis and treatment].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12898406"
      },
      {
        "pubmed_id": "34807422",
        "score": 0.37634551525115967,
        "title": "Ehlers Danlos Syndrome with Glycosaminoglycan Abnormalities.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34807422"
      },
      {
        "pubmed_id": "12829232",
        "score": 0.375865638256073,
        "title": "Phosphoinositide signaling disorders in human diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12829232"
      },
      {
        "pubmed_id": "34543009",
        "score": 0.36867767572402954,
        "title": "Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34543009"
      },
      {
        "pubmed_id": "34493791",
        "score": 0.3621922731399536,
        "title": "Burkholderia PglL enzymes are Serine preferring oligosaccharyltransferases which target conserved proteins across the Burkholderia genus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34493791"
      },
      {
        "pubmed_id": "27789971",
        "score": 0.3599610924720764,
        "title": "Morgellons disease: a filamentous borrelial dermatitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27789971"
      },
      {
        "pubmed_id": "19728949",
        "score": 0.3592830002307892,
        "title": "Phthiriasis palpebrarum.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19728949"
      },
      {
        "pubmed_id": "27779083",
        "score": 0.35891467332839966,
        "title": "Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27779083"
      },
      {
        "pubmed_id": "22122056",
        "score": 0.3575866222381592,
        "title": "γ-Secretase inhibitors and modulators for Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22122056"
      }
    ],
    "query_time": 0.01743793487548828,
    "metrics": {
      "precision": 0.1,
      "recall": 0.125,
      "f1_score": 0.11111111111111112,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.2,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "5a7d5580faa1ab7d2e00001a": {
    "query": "What in vivo tau tracers are being used?",
    "type": "list",
    "ideal_answer": [
      "in-vivo tau PET imaging ligands include [(18)F]THK523, [(18)F]THK5117, [(18)F]THK5105 and [(18)F]THK5351, [(18)F]AV1451(T807) [(11)C]PBB3, (18)F-THK5117, [(18)F]T808, 18F-RO6958948."
    ],
    "ground_truth_ids": [
      "26572762",
      "27334944"
    ],
    "retrieved_ids": [
      "26572762",
      "27334944",
      "20678581",
      "22009441",
      "19228370",
      "34593029",
      "29441009",
      "20826658",
      "27995573",
      "37905874"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "26572762",
        "score": 0.6130334138870239,
        "title": "Tau imaging in neurodegenerative diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26572762"
      },
      {
        "pubmed_id": "27334944",
        "score": 0.5401816964149475,
        "title": "18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: Chemical, Radiochemical, Biological and Clinical Features.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27334944"
      },
      {
        "pubmed_id": "20678581",
        "score": 0.5137151479721069,
        "title": "Tau protein: relevance to Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20678581"
      },
      {
        "pubmed_id": "22009441",
        "score": 0.4899212718009949,
        "title": "Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22009441"
      },
      {
        "pubmed_id": "19228370",
        "score": 0.45041143894195557,
        "title": "Recent developments in Alzheimer's disease therapeutics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19228370"
      },
      {
        "pubmed_id": "34593029",
        "score": 0.4370594620704651,
        "title": "Loss of presenilin function enhances tau phosphorylation and aggregation in mice.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34593029"
      },
      {
        "pubmed_id": "29441009",
        "score": 0.4303053915500641,
        "title": "Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29441009"
      },
      {
        "pubmed_id": "20826658",
        "score": 0.4181210994720459,
        "title": "Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20826658"
      },
      {
        "pubmed_id": "27995573",
        "score": 0.4097699224948883,
        "title": "Forskolin Induces Hyperphosphorylation of Tau Accompanied by Cell Cycle Reactivation in Primary Hippocampal Neurons.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27995573"
      },
      {
        "pubmed_id": "37905874",
        "score": 0.37486469745635986,
        "title": "Amyloid-beta and tau protein beyond Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37905874"
      }
    ],
    "query_time": 0.02060103416442871,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "530db83b38c1322806000002": {
    "query": "Which proteins cause cytoplasmic sequestration of NF-kB?",
    "type": "list",
    "ideal_answer": [
      "In unstimulated cells, NF-kB transcription factors are retained in the cytoplasm with the inhibitory activity of I-kBs, Sef, NF-kB1 (p105) and NF-kB2 (p100)."
    ],
    "ground_truth_ids": [
      "22975329",
      "12972430",
      "12399470",
      "16136188",
      "20845110",
      "8692272",
      "10454561",
      "8804077",
      "9566872",
      "7809091"
    ],
    "retrieved_ids": [
      "16136188",
      "10837071",
      "12972430",
      "12399470",
      "22975329",
      "20845110",
      "8804077",
      "7809091",
      "15728425",
      "9566872"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "16136188",
        "score": 0.6897630095481873,
        "title": "Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16136188"
      },
      {
        "pubmed_id": "10837071",
        "score": 0.6709535717964172,
        "title": "Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10837071"
      },
      {
        "pubmed_id": "12972430",
        "score": 0.5668462514877319,
        "title": "Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12972430"
      },
      {
        "pubmed_id": "12399470",
        "score": 0.554692804813385,
        "title": "p105.Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12399470"
      },
      {
        "pubmed_id": "22975329",
        "score": 0.5415443181991577,
        "title": "Sef is an inhibitor of proinflammatory cytokine signaling, acting by cytoplasmic sequestration of NF-κB.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22975329"
      },
      {
        "pubmed_id": "20845110",
        "score": 0.5365882515907288,
        "title": "NF-κB as a target for oncogenic viruses.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20845110"
      },
      {
        "pubmed_id": "8804077",
        "score": 0.5343297719955444,
        "title": "NF-kappa B transcription factor subunits in rat brain: colocalization of p65 and alpha-MSH.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8804077"
      },
      {
        "pubmed_id": "7809091",
        "score": 0.5283622145652771,
        "title": "Human T-cell leukemia virus type I Tax-protein-mediated activation of NF-kappa B from p100 (NF-kappa B2)-inhibited cytoplasmic reservoirs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7809091"
      },
      {
        "pubmed_id": "15728425",
        "score": 0.5070127248764038,
        "title": "TRAF2: a double-edged sword?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15728425"
      },
      {
        "pubmed_id": "9566872",
        "score": 0.5068204998970032,
        "title": "Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9566872"
      }
    ],
    "query_time": 0.014210939407348633,
    "metrics": {
      "precision": 0.8,
      "recall": 0.8,
      "f1_score": 0.8000000000000002,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "589a245878275d0c4a000025": {
    "query": "List scales that are used for scoring of patients with spinal metastasis?",
    "type": "list",
    "ideal_answer": [
      "Tokuhashi, Tomita, Bauer, and Oswestry scores are used for survival prediction of patients with spinal metastases."
    ],
    "ground_truth_ids": [
      "24212518",
      "23179121",
      "27018903",
      "26713145",
      "26160329",
      "24912121",
      "21223698",
      "25869337",
      "27584676",
      "27080411",
      "18787846",
      "26602195",
      "24120144",
      "24869611",
      "25085251"
    ],
    "retrieved_ids": [
      "26602195",
      "24212518",
      "18787846",
      "21223698",
      "26160329",
      "25869337",
      "27018903",
      "24912121",
      "24869611",
      "27080411"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "26602195",
        "score": 0.7172008752822876,
        "title": "Survival score scales of patients operated with spinal metastases: retrospective application in a Brazilian population.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26602195"
      },
      {
        "pubmed_id": "24212518",
        "score": 0.6901522874832153,
        "title": "Tokuhashi Scoring System has limited applicability in the majority of patients with spinal cord compression secondary to vertebral metastasis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24212518"
      },
      {
        "pubmed_id": "18787846",
        "score": 0.6773124933242798,
        "title": "Predictive value of seven preoperative prognostic scoring systems for spinal metastases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18787846"
      },
      {
        "pubmed_id": "21223698",
        "score": 0.6633810997009277,
        "title": "[Predictive value of three surgical scoring systems for estimation of life expectancy in patients with extradural spinal metastasis].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21223698"
      },
      {
        "pubmed_id": "26160329",
        "score": 0.6603221893310547,
        "title": "Modeling 1-year survival after surgery on the metastatic spine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26160329"
      },
      {
        "pubmed_id": "25869337",
        "score": 0.6548382639884949,
        "title": "Agreement in the assessment of metastatic spine disease using scoring systems.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25869337"
      },
      {
        "pubmed_id": "27018903",
        "score": 0.6545871496200562,
        "title": "Evaluation of Scoring Systems and Prognostic Factors in Patients With Spinal Metastases From Lung Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27018903"
      },
      {
        "pubmed_id": "24912121",
        "score": 0.6519873142242432,
        "title": "Evaluation of scoring systems and prognostic factors in patients with spinal metastases from nasopharyngeal carcinoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24912121"
      },
      {
        "pubmed_id": "24869611",
        "score": 0.6464791893959045,
        "title": "A comparison of the modified Tokuhashi and Tomita scores in determining prognosis for patients afflicted with spinal metastasis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24869611"
      },
      {
        "pubmed_id": "27080411",
        "score": 0.6314940452575684,
        "title": "Reliability of a spinal metastasis prognostic score to model 1-year survival.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27080411"
      }
    ],
    "query_time": 0.008585929870605469,
    "metrics": {
      "precision": 1.0,
      "recall": 0.6666666666666666,
      "f1_score": 0.8,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "5e31b575fbd6abf43b00004c": {
    "query": "What is the Triad of Alport Syndrome?",
    "type": "list",
    "ideal_answer": [
      "Alport syndrome is a rare condition characterized by the clinical triad of nephritic syndrome, sensorineural deafness, and ophthalmological alterations."
    ],
    "ground_truth_ids": [
      "7699956",
      "8357522",
      "21141008",
      "24398087",
      "30957516",
      "8545576",
      "29873249",
      "23165304"
    ],
    "retrieved_ids": [
      "8357522",
      "21141008",
      "30957516",
      "8545576",
      "29873249",
      "23165304",
      "24398087",
      "25419155",
      "14166458",
      "16814183"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "8357522",
        "score": 0.7124975919723511,
        "title": "[Alport's syndrome: new findings].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8357522"
      },
      {
        "pubmed_id": "21141008",
        "score": 0.6823946833610535,
        "title": "Alport syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21141008"
      },
      {
        "pubmed_id": "30957516",
        "score": 0.6418541073799133,
        "title": "A triad of retinal signs in Alport syndrome: The 'stair-case' fovea, choroidal thinning and peripheral schisis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30957516"
      },
      {
        "pubmed_id": "8545576",
        "score": 0.5931621789932251,
        "title": "Clinical features and pathogenesis of Alport retinopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8545576"
      },
      {
        "pubmed_id": "29873249",
        "score": 0.5771501064300537,
        "title": "Bilateral giant macular holes: A rare manifestation of Alport syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29873249"
      },
      {
        "pubmed_id": "23165304",
        "score": 0.5411743521690369,
        "title": "Alport syndrome--insights from basic and clinical research.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23165304"
      },
      {
        "pubmed_id": "24398087",
        "score": 0.5020098686218262,
        "title": "COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24398087"
      },
      {
        "pubmed_id": "25419155",
        "score": 0.4965287446975708,
        "title": "The genetics of Leigh syndrome and its implications for clinical practice and risk management.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25419155"
      },
      {
        "pubmed_id": "14166458",
        "score": 0.48579496145248413,
        "title": "WAARDENBURG'S SYNDROME AND HETEROCHROMIA IRIDUM IN A DEAF SCHOOL POPULATION.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14166458"
      },
      {
        "pubmed_id": "16814183",
        "score": 0.47183510661125183,
        "title": "Bilateral Duane syndrome and bilateral aniridia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16814183"
      }
    ],
    "query_time": 0.019273996353149414,
    "metrics": {
      "precision": 0.7,
      "recall": 0.875,
      "f1_score": 0.7777777777777777,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 7,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "588f952994c1512c50000007": {
    "query": "What are clinical features of the de Morsier syndrome?",
    "type": "list",
    "ideal_answer": [
      "Classic triad of the De Morsier syndrome (septooptic dysplasia) includes optic nerve hypoplasia, the absence of septum pellucidum, and pituitary hypoplasia."
    ],
    "ground_truth_ids": [
      "9606688",
      "20602044",
      "3625236",
      "12373677",
      "20049400",
      "18018427",
      "22330852",
      "10037251",
      "23422579",
      "24379556",
      "308321",
      "26842535",
      "23233151",
      "19270460",
      "24678945",
      "10951302",
      "17876417",
      "27136085",
      "6475068",
      "12733175"
    ],
    "retrieved_ids": [
      "10951302",
      "18018427",
      "12733175",
      "20049400",
      "308321",
      "9606688",
      "20602044",
      "17876417",
      "24379556",
      "24678945"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "10951302",
        "score": 0.6412577629089355,
        "title": "A patient with de Morsier and Duane syndromes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10951302"
      },
      {
        "pubmed_id": "18018427",
        "score": 0.635075569152832,
        "title": "Septo-optic dysplasia (de Morsier syndrome).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18018427"
      },
      {
        "pubmed_id": "12733175",
        "score": 0.6215541362762451,
        "title": "Septooptic dysplasia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12733175"
      },
      {
        "pubmed_id": "20049400",
        "score": 0.6208024024963379,
        "title": "[Optic nerve hypoplasia and septo-optic dysplasia].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20049400"
      },
      {
        "pubmed_id": "308321",
        "score": 0.6016275882720947,
        "title": "Septo-optic dysplasia (de Morsier syndrome).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/308321"
      },
      {
        "pubmed_id": "9606688",
        "score": 0.5747313499450684,
        "title": "[Septo-optic dysplasia (de Morsier syndrome)].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9606688"
      },
      {
        "pubmed_id": "20602044",
        "score": 0.565894603729248,
        "title": "Septo-optic dysplasia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20602044"
      },
      {
        "pubmed_id": "17876417",
        "score": 0.5634198784828186,
        "title": "De Morsier syndrome associated with periventricular nodular heterotopia: case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17876417"
      },
      {
        "pubmed_id": "24379556",
        "score": 0.5575300455093384,
        "title": "Septo-optic dysplasia complex: Clinical and radiological manifestations in Omani children.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24379556"
      },
      {
        "pubmed_id": "24678945",
        "score": 0.557013988494873,
        "title": "Septo-optic dysplasia plus: a case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24678945"
      }
    ],
    "query_time": 0.01931285858154297,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 20
    }
  },
  "660d2299fdcbea915f000038": {
    "query": "List of attenuated viral vaccines still in use.",
    "type": "list",
    "ideal_answer": [
      "Some examples of attenuated viral vaccines still in use include the measles, mumps, and rubella (MMR) vaccine, the oral polio vaccine (OPV), the yellow fever vaccine, the varicella (chickenpox) vaccine, and the rotavirus vaccine."
    ],
    "ground_truth_ids": [
      "37309028",
      "25864107",
      "37286215"
    ],
    "retrieved_ids": [
      "25864107",
      "20113211",
      "31015813",
      "36762592",
      "22086893",
      "16977285",
      "30558674",
      "26949713",
      "28426274",
      "20049699"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25864107",
        "score": 0.7095624208450317,
        "title": "Live attenuated vaccines: Historical successes and current challenges.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25864107"
      },
      {
        "pubmed_id": "20113211",
        "score": 0.5300319194793701,
        "title": "Shingles vaccine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20113211"
      },
      {
        "pubmed_id": "31015813",
        "score": 0.5013798475265503,
        "title": "Summary of the NACI Update on Herpes Zoster Vaccines.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31015813"
      },
      {
        "pubmed_id": "36762592",
        "score": 0.4981567859649658,
        "title": "mRNA vaccines: The future of prevention of viral infections?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36762592"
      },
      {
        "pubmed_id": "22086893",
        "score": 0.49642762541770935,
        "title": "Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22086893"
      },
      {
        "pubmed_id": "16977285",
        "score": 0.49010172486305237,
        "title": "Herpes zoster vaccine (Zostavax).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16977285"
      },
      {
        "pubmed_id": "30558674",
        "score": 0.48906102776527405,
        "title": "Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30558674"
      },
      {
        "pubmed_id": "26949713",
        "score": 0.4885782301425934,
        "title": "Erratum: Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26949713"
      },
      {
        "pubmed_id": "28426274",
        "score": 0.4798627495765686,
        "title": "A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28426274"
      },
      {
        "pubmed_id": "20049699",
        "score": 0.47216758131980896,
        "title": "\"Filoviruses\": a real pandemic threat?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20049699"
      }
    ],
    "query_time": 0.015824317932128906,
    "metrics": {
      "precision": 0.1,
      "recall": 0.3333333333333333,
      "f1_score": 0.15384615384615383,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "601d72c21cb411341a000038": {
    "query": "What are the years of the initiation and completion of the Human Genome project?",
    "type": "list",
    "ideal_answer": [
      "The Human Genome Project was initiated in 1990 and completed in 2003.",
      "The Human Genome Project (HGP) was initiated in 1990, and the completion of the genome project was in 2003."
    ],
    "ground_truth_ids": [
      "12046269",
      "27087232",
      "30546257",
      "26952518",
      "10418432",
      "29068423",
      "11261244"
    ],
    "retrieved_ids": [
      "11261244",
      "12046269",
      "30546257",
      "26952518",
      "10418432",
      "25689317",
      "27087232",
      "22897955",
      "21742803",
      "28633445"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "11261244",
        "score": 0.6312466859817505,
        "title": "[The human genome project in the year 2000].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11261244"
      },
      {
        "pubmed_id": "12046269",
        "score": 0.6130475997924805,
        "title": "The human genome project: exploring its progress and successes and the ethical, legal, and social implications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12046269"
      },
      {
        "pubmed_id": "30546257",
        "score": 0.5905227065086365,
        "title": "Genomic Interventions in Medicine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30546257"
      },
      {
        "pubmed_id": "26952518",
        "score": 0.5849511027336121,
        "title": "A decade of human genome project conclusion: Scientific diffusion about our genome knowledge.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26952518"
      },
      {
        "pubmed_id": "10418432",
        "score": 0.5829154253005981,
        "title": "Implications for nursing of the Human Genome Project.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10418432"
      },
      {
        "pubmed_id": "25689317",
        "score": 0.5195842385292053,
        "title": "The Genome 10K Project: a way forward.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25689317"
      },
      {
        "pubmed_id": "27087232",
        "score": 0.4544581472873688,
        "title": "[Precision medicine: new opportunities and challenges for molecular epidemiology].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27087232"
      },
      {
        "pubmed_id": "22897955",
        "score": 0.4068244993686676,
        "title": "The fishes of Genome 10K.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22897955"
      },
      {
        "pubmed_id": "21742803",
        "score": 0.39366668462753296,
        "title": "The human proteome project: current state and future direction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21742803"
      },
      {
        "pubmed_id": "28633445",
        "score": 0.36786043643951416,
        "title": "BPP: a sequence-based algorithm for branch point prediction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28633445"
      }
    ],
    "query_time": 0.011837005615234375,
    "metrics": {
      "precision": 0.6,
      "recall": 0.8571428571428571,
      "f1_score": 0.7058823529411764,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 7
    }
  },
  "644eb55457b1c7a315000081": {
    "query": "What are some examples of epigenetic modifications?",
    "type": "list",
    "ideal_answer": [
      "Epigenetic modifications are molecular changes that affect gene expression without altering the underlying DNA sequence. Some major examples of epigenetic modifications include DNA methylation, histone modifications, chromatin remodeling, and non-coding RNA alterations. DNA methylation involves the addition of a methyl group to cytosine bases in the DNA molecule, often leading to gene silencing. Histone modifications encompass various chemical changes to histone proteins, such as methylation and acetylation, which can either activate or repress gene expression depending on the specific modification and its location. Chromatin remodeling refers to structural changes in chromatin that influence the accessibility of DNA to transcription factors and other regulatory proteins. Non-coding RNA alterations involve small RNA molecules like microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) that regulate gene expression post-transcriptionally or through other mechanisms. These epigenetic modifications play crucial roles in various biological processes and have been implicated in the development of numerous diseases, including cardiovascular diseases and cancer.",
      "Eukaryotic gene expression is regulated not only by genomic enhancers and promoters but also by covalent modifications added to both chromatin and RNAs. Epigenetic modifications may constitute changes in DNA methylation, histone modifications (methylation, acetylation, etc), chromatin remodeling, and changes in non-coding RNA, leading to an altered gene expression profile."
    ],
    "ground_truth_ids": [
      "35052371",
      "34870779",
      "34421981",
      "20381512",
      "25410383",
      "33605616",
      "25526687",
      "36336680",
      "32114424",
      "31989558",
      "30984620",
      "23900077",
      "28799233",
      "35735917",
      "32533130",
      "25421652",
      "20920747",
      "23935066",
      "22303324",
      "28259291",
      "25647662",
      "20114075",
      "31941075",
      "36346551",
      "22391123",
      "29992310",
      "22906839",
      "34502062",
      "21258047",
      "28069135",
      "26074949",
      "33984527",
      "35583646",
      "24743128",
      "30679030",
      "23056006",
      "22294878",
      "25104823",
      "11498579"
    ],
    "retrieved_ids": [
      "20920747",
      "22906839",
      "22949838",
      "22303324",
      "28069135",
      "25104823",
      "35735917",
      "20381512",
      "11498579",
      "25421652"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "20920747",
        "score": 0.6647646427154541,
        "title": "Interplay between different epigenetic modifications and mechanisms.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20920747"
      },
      {
        "pubmed_id": "22906839",
        "score": 0.6304373741149902,
        "title": "Epigenetics: the link between nature and nurture.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22906839"
      },
      {
        "pubmed_id": "22949838",
        "score": 0.5844663977622986,
        "title": "Molecular mechanisms of epigenetic variation in plants.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22949838"
      },
      {
        "pubmed_id": "22303324",
        "score": 0.5809298753738403,
        "title": "Epigenetic memory in mammals.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22303324"
      },
      {
        "pubmed_id": "28069135",
        "score": 0.5700567364692688,
        "title": "Epigenetic Control of Gene Expression in Maize.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28069135"
      },
      {
        "pubmed_id": "25104823",
        "score": 0.5593075156211853,
        "title": "Epigenetic memory in plants.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25104823"
      },
      {
        "pubmed_id": "35735917",
        "score": 0.5565439462661743,
        "title": "Epigenetics and Early Development.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35735917"
      },
      {
        "pubmed_id": "20381512",
        "score": 0.5518381595611572,
        "title": "Molecular targets of epigenetic regulation and effectors of environmental influences.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20381512"
      },
      {
        "pubmed_id": "11498579",
        "score": 0.5480088591575623,
        "title": "Epigenetic reprogramming in mammalian development.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11498579"
      },
      {
        "pubmed_id": "25421652",
        "score": 0.5375559329986572,
        "title": "Cancer epigenetics: an introduction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25421652"
      }
    ],
    "query_time": 0.014777898788452148,
    "metrics": {
      "precision": 0.9,
      "recall": 0.23076923076923078,
      "f1_score": 0.3673469387755102,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 39
    }
  },
  "531b3ff3b166e2b80600003d": {
    "query": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?",
    "type": "list",
    "ideal_answer": [
      "Transcriptional and post-transcriptional regulatory mechanisms mediated by several inducers of EMT, in particular the ZEB and Snail factors, downregulate the expression and/or functional organization of core polarity complexes. Functional loss of the cell-cell adhesion molecule E-cadherin is an essential event for epithelial-mesenchymal transition (EMT), a process that allows cell migration during embryonic development and tumour invasion. Recently, we found that aPKC can also phosphorylate Par6 to drive EMT and increase the migratory potential of non-small cell lung cancer cells. We propose that the regulation of EMT by SIRT1 involves modulation of, and cooperation with, the EMT inducing transcription factor ZEB1. Knockdown of Numb by shRNA in MDCK cells led to a lateral to apical translocation of E-cadherin and beta-catenin, active F-actin polymerization, mis-localization of Par3 and aPKC, a decrease in cell-cell adhesion and an increase in cell migration and proliferation. Growth factors such as TGFb and EGF have also been shown to be related to EMT."
    ],
    "ground_truth_ids": [
      "19295128",
      "16080193",
      "19604397",
      "19029937",
      "20168079",
      "23880940",
      "18611248",
      "22249256"
    ],
    "retrieved_ids": [
      "19029937",
      "19604397",
      "20168079",
      "19295128",
      "23880940",
      "22507538",
      "22249256",
      "16080193",
      "25631868",
      "23986011"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "19029937",
        "score": 0.5746565461158752,
        "title": "Transcriptional regulation of cell polarity in EMT and cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19029937"
      },
      {
        "pubmed_id": "19604397",
        "score": 0.5734759569168091,
        "title": "Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19604397"
      },
      {
        "pubmed_id": "20168079",
        "score": 0.5675661563873291,
        "title": "Numb: A new player in EMT.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20168079"
      },
      {
        "pubmed_id": "19295128",
        "score": 0.563421905040741,
        "title": "The class I bHLH factors E2-2A and E2-2B regulate EMT.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19295128"
      },
      {
        "pubmed_id": "23880940",
        "score": 0.5387727618217468,
        "title": "Par6 is phosphorylated by aPKC to facilitate EMT.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23880940"
      },
      {
        "pubmed_id": "22507538",
        "score": 0.5108327865600586,
        "title": "The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22507538"
      },
      {
        "pubmed_id": "22249256",
        "score": 0.48051413893699646,
        "title": "SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22249256"
      },
      {
        "pubmed_id": "16080193",
        "score": 0.47530701756477356,
        "title": "Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16080193"
      },
      {
        "pubmed_id": "25631868",
        "score": 0.4389260411262512,
        "title": "Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25631868"
      },
      {
        "pubmed_id": "23986011",
        "score": 0.43804511427879333,
        "title": "Molecular markers of cell adhesion in ameloblastomas. An update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23986011"
      }
    ],
    "query_time": 0.011696100234985352,
    "metrics": {
      "precision": 0.7,
      "recall": 0.875,
      "f1_score": 0.7777777777777777,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 7,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "5ac7185f0340b9f058000004": {
    "query": "Which cellular functions are affected by lncRNA H19 in the heart?",
    "type": "list",
    "ideal_answer": [
      "H19 could inhibit autophagy in cardiomyocytes by epigenetically silencing of DIRAS3. Elevated H19 promotes apoptosis through PA2G4. Downregulation of H19 promotes proliferation and inhibits apoptosis. H19 induces mineralization of valve interstitial cells. H19 contributes to cardiac fibroblast proliferation and fibrosis, which act in part through repression of DUSP5/ERK1/2."
    ],
    "ground_truth_ids": [
      "27789555",
      "28430627",
      "27318893",
      "27903964",
      "27895893"
    ],
    "retrieved_ids": [
      "27895893",
      "27903964",
      "28430627",
      "27318893",
      "27789555",
      "22976942",
      "24106460",
      "22955988",
      "34870779",
      "30448228"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27895893",
        "score": 0.6428337097167969,
        "title": "Downregulation of long non-coding RNA H19 promotes P19CL6 cells proliferation and inhibits apoptosis during late-stage cardiac differentiation via miR-19b-modulated Sox6.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27895893"
      },
      {
        "pubmed_id": "27903964",
        "score": 0.6382467150688171,
        "title": "LncRNA H19 inhibits autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27903964"
      },
      {
        "pubmed_id": "28430627",
        "score": 0.6020190119743347,
        "title": "The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28430627"
      },
      {
        "pubmed_id": "27318893",
        "score": 0.5789238214492798,
        "title": "Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27318893"
      },
      {
        "pubmed_id": "27789555",
        "score": 0.5657477974891663,
        "title": "Altered DNA Methylation of Long Noncoding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27789555"
      },
      {
        "pubmed_id": "22976942",
        "score": 0.5465810298919678,
        "title": "Long non-coding RNAs coordinate cellular responses to stress.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22976942"
      },
      {
        "pubmed_id": "24106460",
        "score": 0.4896564483642578,
        "title": "Identification and function of long non-coding RNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24106460"
      },
      {
        "pubmed_id": "22955988",
        "score": 0.4880993068218231,
        "title": "The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22955988"
      },
      {
        "pubmed_id": "34870779",
        "score": 0.48472312092781067,
        "title": "Association of DNA methylation and transcriptome reveals epigenetic etiology of heart failure.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34870779"
      },
      {
        "pubmed_id": "30448228",
        "score": 0.4756779372692108,
        "title": "The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30448228"
      }
    ],
    "query_time": 0.007060050964355469,
    "metrics": {
      "precision": 0.5,
      "recall": 1.0,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "54fb5720d176fff445000002": {
    "query": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?",
    "type": "list",
    "ideal_answer": [
      "Fibroblasts can be reprogrammed into induced pluripotent stem cells (iPSCs) by the application of Yamanaka factors (OSKM). In particular, the mechanisms how the Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc) directly drive reprogramming and which additional components are involved are still not yet understood.",
      "Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, generating so-called induced pluripotent stem cells (iPSCs)(1-4).  Delivery of the transcription factors Oct4, Klf4, Sox2 and c-Myc via integrating viral vectors has been widely employed to generate induced pluripotent stem cell (iPSC) lines from both normal and disease-specific somatic tissues, providing an invaluable resource for medical research and drug development.  ",
      "Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, generating so-called induced pluripotent stem cells (iPSCs)(1-4).Fibroblasts can be reprogrammed into induced pluripotent stem cells (iPSCs) by the application of Yamanaka factors (OSKM), but the mechanisms underlying this reprogramming remain poorly understood."
    ],
    "ground_truth_ids": [
      "21839145",
      "23149977",
      "23704989",
      "23272148",
      "24706886",
      "23658991",
      "23939864",
      "23266889",
      "23104133",
      "23166588"
    ],
    "retrieved_ids": [
      "19030024",
      "23104133",
      "23272148",
      "23166588",
      "23149977",
      "24706886",
      "23939864",
      "23704989",
      "21839145",
      "31518905"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "19030024",
        "score": 0.6799143552780151,
        "title": "Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19030024"
      },
      {
        "pubmed_id": "23104133",
        "score": 0.64470374584198,
        "title": "Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23104133"
      },
      {
        "pubmed_id": "23272148",
        "score": 0.6168691515922546,
        "title": "Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23272148"
      },
      {
        "pubmed_id": "23166588",
        "score": 0.6130688786506653,
        "title": "HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23166588"
      },
      {
        "pubmed_id": "23149977",
        "score": 0.6091374754905701,
        "title": "Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23149977"
      },
      {
        "pubmed_id": "24706886",
        "score": 0.5502284169197083,
        "title": "Mathematical approaches to modeling development and reprogramming.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24706886"
      },
      {
        "pubmed_id": "23939864",
        "score": 0.5168382525444031,
        "title": "Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23939864"
      },
      {
        "pubmed_id": "23704989",
        "score": 0.5020998120307922,
        "title": "Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23704989"
      },
      {
        "pubmed_id": "21839145",
        "score": 0.4777907729148865,
        "title": "Induction of pluripotent stem cells from autopsy donor-derived somatic cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21839145"
      },
      {
        "pubmed_id": "31518905",
        "score": 0.46559032797813416,
        "title": "Generation of genetically matched hiPSC lines from two mosaic facioscapulohumeral dystrophy type 1 patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31518905"
      }
    ],
    "query_time": 0.08056521415710449,
    "metrics": {
      "precision": 0.8,
      "recall": 0.8,
      "f1_score": 0.8000000000000002,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "5a75fbf383b0d9ea6600000a": {
    "query": "Name the phase 3 clinical trials for tofacitinib in colitis.",
    "type": "list",
    "ideal_answer": [
      "There are three phase 3, randomized, double-blind, placebo-controlled trials of tofacitinib therapy in adults with ulcerative colitis: OCTAVE Induction 1, OCTAVE Induction 2, OCTAVE Sustain.",
      "OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain ClinicalTrials.gov numbers, NCT01465763 , NCT01458951 , and NCT01458574 ."
    ],
    "ground_truth_ids": [
      "28467869"
    ],
    "retrieved_ids": [
      "28467869",
      "23627915",
      "24285764",
      "21952978",
      "23212593",
      "22006202",
      "23523202",
      "24193189",
      "25268669",
      "27487107"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28467869",
        "score": 0.7376980185508728,
        "title": "Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28467869"
      },
      {
        "pubmed_id": "23627915",
        "score": 0.6046930551528931,
        "title": "Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23627915"
      },
      {
        "pubmed_id": "24285764",
        "score": 0.5333981513977051,
        "title": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24285764"
      },
      {
        "pubmed_id": "21952978",
        "score": 0.49702543020248413,
        "title": "Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21952978"
      },
      {
        "pubmed_id": "23212593",
        "score": 0.49356815218925476,
        "title": "JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23212593"
      },
      {
        "pubmed_id": "22006202",
        "score": 0.45869550108909607,
        "title": "A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22006202"
      },
      {
        "pubmed_id": "23523202",
        "score": 0.447910875082016,
        "title": "Targeting kinases: a new approach to treating inflammatory rheumatic diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23523202"
      },
      {
        "pubmed_id": "24193189",
        "score": 0.4405200481414795,
        "title": "[Intracellular targets : current data on effectiveness and safety profile].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24193189"
      },
      {
        "pubmed_id": "25268669",
        "score": 0.4339246451854706,
        "title": "Anti-cytokine biologic treatment beyond anti-TNF in Behçet's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25268669"
      },
      {
        "pubmed_id": "27487107",
        "score": 0.4271692633628845,
        "title": "Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27487107"
      }
    ],
    "query_time": 0.00782012939453125,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5a76344e9e632bc066000003": {
    "query": "Which algorithms are used for compression of SAM files?",
    "type": "list",
    "ideal_answer": [
      "The most popular format for genomic data is the SAM (Sequence Alignment/Map) format, which contains information such as alignment, quality values, etc. These files are large (on the order of terabytes), which necessitates compression. GeneComp, NGC, SAMZIP and QVZ are algorithms which perform compression of data stored in SAM files."
    ],
    "ground_truth_ids": [
      "23066097",
      "29046896",
      "22164252",
      "26026138",
      "27540265"
    ],
    "retrieved_ids": [
      "27540265",
      "22164252",
      "29046896",
      "26026138",
      "23066097",
      "14764563",
      "28633445",
      "16925832",
      "16519798",
      "29218892"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27540265",
        "score": 0.6529709100723267,
        "title": "CSAM: Compressed SAM format.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27540265"
      },
      {
        "pubmed_id": "22164252",
        "score": 0.641315758228302,
        "title": "Improving transmission efficiency of large sequence alignment/map (SAM) files.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22164252"
      },
      {
        "pubmed_id": "29046896",
        "score": 0.6257925629615784,
        "title": "GeneComp, a new reference-based compressor for SAM files.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29046896"
      },
      {
        "pubmed_id": "26026138",
        "score": 0.5700329542160034,
        "title": "QVZ: lossy compression of quality values.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26026138"
      },
      {
        "pubmed_id": "23066097",
        "score": 0.49778226017951965,
        "title": "NGC: lossless and lossy compression of aligned high-throughput sequencing data.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23066097"
      },
      {
        "pubmed_id": "14764563",
        "score": 0.36087566614151,
        "title": "Comparison of various algorithms for recognizing short coding sequences of human genes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14764563"
      },
      {
        "pubmed_id": "28633445",
        "score": 0.26370733976364136,
        "title": "BPP: a sequence-based algorithm for branch point prediction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28633445"
      },
      {
        "pubmed_id": "16925832",
        "score": 0.2247462123632431,
        "title": "Automatic annotation of eukaryotic genes, pseudogenes and promoters.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16925832"
      },
      {
        "pubmed_id": "16519798",
        "score": 0.21899311244487762,
        "title": "The Subviral RNA Database: a toolbox for viroids, the hepatitis delta virus and satellite RNAs research.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16519798"
      },
      {
        "pubmed_id": "29218892",
        "score": 0.2023981511592865,
        "title": "Heritability estimates on resting state fMRI data using ENIGMA analysis pipeline.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29218892"
      }
    ],
    "query_time": 0.014582157135009766,
    "metrics": {
      "precision": 0.5,
      "recall": 1.0,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "621218fc3a8413c653000014": {
    "query": "Where does REGN5458 bind to?",
    "type": "list",
    "ideal_answer": [
      "The bispecific antibody REGN5458 binds to B-cell maturation antigen (BCMA) and CD3."
    ],
    "ground_truth_ids": [
      "33651100"
    ],
    "retrieved_ids": [
      "19815002",
      "8713055",
      "15744326",
      "10066522",
      "25002999",
      "3300731",
      "19323834",
      "20720006",
      "19502294",
      "18050426"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "19815002",
        "score": 0.2929735481739044,
        "title": "Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19815002"
      },
      {
        "pubmed_id": "8713055",
        "score": 0.2884477376937866,
        "title": "Multiple steps in the regulation of transcription-factor level and activity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8713055"
      },
      {
        "pubmed_id": "15744326",
        "score": 0.2877776026725769,
        "title": "Multisite protein modification and intramolecular signaling.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15744326"
      },
      {
        "pubmed_id": "10066522",
        "score": 0.28518322110176086,
        "title": "Global dinucleotide signatures and analysis of genomic heterogeneity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10066522"
      },
      {
        "pubmed_id": "25002999",
        "score": 0.28379592299461365,
        "title": "Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25002999"
      },
      {
        "pubmed_id": "3300731",
        "score": 0.2823165953159332,
        "title": "Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3300731"
      },
      {
        "pubmed_id": "19323834",
        "score": 0.28127050399780273,
        "title": "Modulation of inducible nitric oxide synthase expression by sumoylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19323834"
      },
      {
        "pubmed_id": "20720006",
        "score": 0.27959173917770386,
        "title": "Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20720006"
      },
      {
        "pubmed_id": "19502294",
        "score": 0.2790190577507019,
        "title": "Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19502294"
      },
      {
        "pubmed_id": "18050426",
        "score": 0.2741542458534241,
        "title": "Trans-splicing and operons.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18050426"
      }
    ],
    "query_time": 0.013715982437133789,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "621ecc3e3a8413c653000060": {
    "query": "What is a potential alternate uses(repositioning) for Primaquine",
    "type": "list",
    "ideal_answer": [
      "Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization.  PD could be used as a novel drug for vascular leakage by maintaining endothelial integrity",
      "Primaquine could be used as a novel drug for vascular leakage by maintaining endothelial integrity and for",
      "Primaquine Diphosphate, a known Antimalarial Drug, blocks Vascular Leakage through Junction Stabilization. This is a potential alternate uses."
    ],
    "ground_truth_ids": [
      "28900272",
      "33787719",
      "32125014",
      "34884765",
      "34149436"
    ],
    "retrieved_ids": [
      "34884765",
      "33787719",
      "34546758",
      "32125014",
      "34149436",
      "28900272",
      "32456286",
      "11807448",
      "17902730",
      "16918633"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "34884765",
        "score": 0.41985684633255005,
        "title": "Primaquine Inhibits the Endosomal Trafficking and Nuclear Localization of EGFR and Induces the Apoptosis of Breast Cancer Cells by Nuclear EGFR/Stat3-Mediated c-Myc Downregulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34884765"
      },
      {
        "pubmed_id": "33787719",
        "score": 0.3311268091201782,
        "title": "Atovaquone, chloroquine, primaquine, quinine and tetracycline: antiproliferative effects of relevant antimalarials on Neospora caninum.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33787719"
      },
      {
        "pubmed_id": "34546758",
        "score": 0.31467875838279724,
        "title": "Improved Liver Delivery of Primaquine by Phospholipid-Free Small Unilamellar Vesicles with Reduced Hemolytic Toxicity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34546758"
      },
      {
        "pubmed_id": "32125014",
        "score": 0.29750770330429077,
        "title": "Primaquine phosphate induces the apoptosis of ATRA-resistant acute promyelocytic leukemia cells by inhibition of the NF-κB pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32125014"
      },
      {
        "pubmed_id": "34149436",
        "score": 0.26952412724494934,
        "title": "Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34149436"
      },
      {
        "pubmed_id": "28900272",
        "score": 0.26838430762290955,
        "title": "From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28900272"
      },
      {
        "pubmed_id": "32456286",
        "score": 0.25612568855285645,
        "title": "Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32456286"
      },
      {
        "pubmed_id": "11807448",
        "score": 0.2438865602016449,
        "title": "Allergic contact dermatitis to topical minoxidil solution: etiology and treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11807448"
      },
      {
        "pubmed_id": "17902730",
        "score": 0.2404303252696991,
        "title": "Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17902730"
      },
      {
        "pubmed_id": "16918633",
        "score": 0.2344329059123993,
        "title": "Harlequin sign (hemifacial flushing and contralateral hypohidrosis) in a 4-year-old girl with Horner syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16918633"
      }
    ],
    "query_time": 0.007485866546630859,
    "metrics": {
      "precision": 0.5,
      "recall": 1.0,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "601c2fb51cb411341a000013": {
    "query": "Which interleukin receptors are targeted with rilonacept?",
    "type": "list",
    "ideal_answer": [
      "Rilonacept inhibits interleukin-1α and interleukin-1β. It has a role for treatment of pericarditis."
    ],
    "ground_truth_ids": [
      "32550671",
      "32324502",
      "33200890",
      "32562029",
      "33229362",
      "25549233"
    ],
    "retrieved_ids": [
      "34459270",
      "32550671",
      "33200890",
      "23480465",
      "29691490",
      "22777068",
      "19404006",
      "23152080",
      "23208729",
      "28644160"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "34459270",
        "score": 0.5737787485122681,
        "title": "Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34459270"
      },
      {
        "pubmed_id": "32550671",
        "score": 0.5071476101875305,
        "title": "Biologic agents and small-molecule inhibitors in systemic autoimmune conditions: an update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32550671"
      },
      {
        "pubmed_id": "33200890",
        "score": 0.49167540669441223,
        "title": "Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33200890"
      },
      {
        "pubmed_id": "23480465",
        "score": 0.486771821975708,
        "title": "CGRP receptor antagonists: design and screening.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23480465"
      },
      {
        "pubmed_id": "29691490",
        "score": 0.4323382079601288,
        "title": "CGRP as the target of new migraine therapies - successful translation from bench to clinic.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29691490"
      },
      {
        "pubmed_id": "22777068",
        "score": 0.4171203374862671,
        "title": "[New kinase inhibitors].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22777068"
      },
      {
        "pubmed_id": "19404006",
        "score": 0.4161262512207031,
        "title": "Jak inhibitor ; possibility and mechanism as a new disease modifying anti-rheumatic drug.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19404006"
      },
      {
        "pubmed_id": "23152080",
        "score": 0.4147326946258545,
        "title": "The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23152080"
      },
      {
        "pubmed_id": "23208729",
        "score": 0.4142068326473236,
        "title": "Humoral-targeted immunotherapies in multiple sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23208729"
      },
      {
        "pubmed_id": "28644160",
        "score": 0.41187340021133423,
        "title": "Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28644160"
      }
    ],
    "query_time": 0.012456893920898438,
    "metrics": {
      "precision": 0.2,
      "recall": 0.3333333333333333,
      "f1_score": 0.25,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "53357c98d6d3ac6a3400004a": {
    "query": "What genes are related to breast cancer?",
    "type": "list",
    "ideal_answer": [
      "Breast cancer is a disease in which certain cells in the breast become abnormal and multiply without control or order to form a tumor. The most common form of breast cancer begins in cells lining the ducts that carry milk to the nipple (ductal cancer). Other forms of breast cancer begin in the glands that produce milk (lobular cancer) or in other parts of the breast.\nEarly breast cancer usually does not cause pain and may exhibit no noticeable symptoms. As the cancer progresses, signs and symptoms can include a lump or thickening in or near the breast; a change in the size or shape of the breast; nipple discharge, tenderness, or retraction (turning inward); and skin irritation, dimpling, or scaliness. These changes can occur as part of many different conditions, however. Having one or more of these symptoms does not mean that a person definitely has breast cancer.\nIn some cases, cancerous tumors can invade surrounding tissue and spread to other parts of the body. If breast cancer spreads, cancerous cells most often appear in the bones, liver, lungs, or brain. Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers.\nA small percentage of all breast cancers cluster in families. Hereditary cancers are those associated with inherited gene mutations. Hereditary breast cancers tend to occur earlier in life than noninherited (sporadic) cases and are more likely to involve both breasts.\n\nVariations of the BRCA1, BRCA2, BRCT, and P53 genes increase the risk of developing breast cancer.\nThe and NFR2, HER2 and TOP2A genes are associated with breast cancer."
    ],
    "ground_truth_ids": [
      "24327800",
      "21123097",
      "22695536",
      "23678008",
      "23358415",
      "24272208",
      "24289229",
      "24183724",
      "24302665",
      "23318652",
      "24319537",
      "18485221",
      "24298072",
      "17132159",
      "24026986",
      "24324792",
      "24296317"
    ],
    "retrieved_ids": [
      "23318652",
      "24324792",
      "24319537",
      "20110242",
      "24327800",
      "24298072",
      "18854964",
      "18485221",
      "17132159",
      "8785513"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23318652",
        "score": 0.6509827971458435,
        "title": "Hereditary breast cancer in the Han Chinese population.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23318652"
      },
      {
        "pubmed_id": "24324792",
        "score": 0.6492285132408142,
        "title": "Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24324792"
      },
      {
        "pubmed_id": "24319537",
        "score": 0.597503662109375,
        "title": "Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24319537"
      },
      {
        "pubmed_id": "20110242",
        "score": 0.5847082138061523,
        "title": "Clinical utility of the 70-gene MammaPrint profile in a Japanese population.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20110242"
      },
      {
        "pubmed_id": "24327800",
        "score": 0.5619903206825256,
        "title": "Gene Expression Meta-Analysis Identifies Cytokine Pathways and 5q Aberrations Involved in Metastasis of ERBB2 Amplified and Basal Breast Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24327800"
      },
      {
        "pubmed_id": "24298072",
        "score": 0.560239851474762,
        "title": "The omics of triple-negative breast cancers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24298072"
      },
      {
        "pubmed_id": "18854964",
        "score": 0.5594761371612549,
        "title": "[Hereditary breast cancer].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18854964"
      },
      {
        "pubmed_id": "18485221",
        "score": 0.5584699511528015,
        "title": "Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18485221"
      },
      {
        "pubmed_id": "17132159",
        "score": 0.5516137480735779,
        "title": "Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17132159"
      },
      {
        "pubmed_id": "8785513",
        "score": 0.5401955246925354,
        "title": "The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8785513"
      }
    ],
    "query_time": 0.015715837478637695,
    "metrics": {
      "precision": 0.7,
      "recall": 0.4117647058823529,
      "f1_score": 0.5185185185185185,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 7,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "65cf98431930410b1300000b": {
    "query": "What are the targets of Tarlatamab?",
    "type": "list",
    "ideal_answer": [
      "Tarlatamab is a bispecific T-cell engager immunotherapy targeting delta-like ligand 3 and CD3. It showed promising antitumor activity in a phase 1 trial in patients with previously treated small-cell lung cancer."
    ],
    "ground_truth_ids": [
      "36351060",
      "36689692",
      "37355629",
      "37877814",
      "37861218"
    ],
    "retrieved_ids": [
      "37877814",
      "37861218",
      "36689692",
      "18069789",
      "33787719",
      "29486607",
      "10430918",
      "31085175",
      "22294878",
      "32266704"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "37877814",
        "score": 0.499775767326355,
        "title": "Tarlatamab Shows Promise in SCLC.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37877814"
      },
      {
        "pubmed_id": "37861218",
        "score": 0.4491150379180908,
        "title": "Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37861218"
      },
      {
        "pubmed_id": "36689692",
        "score": 0.3633687496185303,
        "title": "Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36689692"
      },
      {
        "pubmed_id": "18069789",
        "score": 0.31074488162994385,
        "title": "Field trapping of the invasive brown marmorated stink bug, Halyomorpha halys, with geometric isomers of methyl 2,4,6-decatrienoate.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18069789"
      },
      {
        "pubmed_id": "33787719",
        "score": 0.2810851037502289,
        "title": "Atovaquone, chloroquine, primaquine, quinine and tetracycline: antiproliferative effects of relevant antimalarials on Neospora caninum.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33787719"
      },
      {
        "pubmed_id": "29486607",
        "score": 0.2723318636417389,
        "title": "Durvalumab in urothelial cancers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29486607"
      },
      {
        "pubmed_id": "10430918",
        "score": 0.26899826526641846,
        "title": "A chimeric prokaryotic ancestry of mitochondria and primitive eukaryotes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10430918"
      },
      {
        "pubmed_id": "31085175",
        "score": 0.2681104838848114,
        "title": "Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31085175"
      },
      {
        "pubmed_id": "22294878",
        "score": 0.2563496232032776,
        "title": "Stemming epigenetics in marine stramenopiles.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22294878"
      },
      {
        "pubmed_id": "32266704",
        "score": 0.2554766535758972,
        "title": "Eptinezumab: First Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32266704"
      }
    ],
    "query_time": 0.01723504066467285,
    "metrics": {
      "precision": 0.3,
      "recall": 0.6,
      "f1_score": 0.4,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "66097092fdcbea915f000010": {
    "query": "Amyloid-β is associated with what diseases?",
    "type": "list",
    "ideal_answer": [
      "Amyloid-β is associated with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and others.",
      "Amyloid-Î² (AÎ²) is associated with Alzheimer's disease (AD) and is known to promote chronic inflammatory responses in the brain. Additionally, AÎ² accumulation is also found in age-related macular degeneration (AMD) and glaucoma.",
      "Amyloid-β has been implicated in several neurodegenerative diseases beyond Alzheimer's disease, including Lewy body disease (LBD), multiple system atrophy (MSA), frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), and progressive supranuclear palsy. Additionally, research has shown that amyloid-β may play a role in other neurological conditions such as Parkinson's disease and amyotrophic lateral sclerosis, as well as in non-neurological disorders like cardiovascular disease, cancer, traumatic brain injury, and diabetes.",
      "Amyloid-beta is associated with a range of diseases, primarily neurodegenerative and retinal disorders. It is most notably linked to Alzheimer's disease but also connected to other conditions such as Parkinson's disease, amyotrophic lateral sclerosis, Glaucoma, and age-related macular degeneration.",
      "Amyloid-β is associated with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, cardiovascular disease, cancer, traumatic brain injury, Glaucoma, and age-related macular degeneration.",
      "Amyloid-β has been associated with neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, as well as retinal neurodegenerative diseases like Glaucoma and age-related macular degeneration. Additionally, it has been linked to cardiovascular disease, cancer, traumatic brain injury, and diabetes",
      "Amyloid-β (Aβ) is a peptide with 38-42 amino acids associated with the pathogenesis of Alzheimer's disease (AD). The most common form, Aβ42, is the most neurotoxic.",
      "Amyloid-β is associated with several neurodegenerative diseases including Alzheimer's disease (AD), Lewy body disease (LBD), multiple system atrophy (MSA), frontotemporal lobar degeneration-TDP-43 (FTLD-TDP) and progressive supranuclear palsy.",
      "Amyloid-β is associated with Alzheimer's disease, Parkinson's disease, and other amyloid diseases.",
      "Amyloid-β is associated with amyotrophic lateral sclerosis, cardiovascular disease, Alzheimer's disease, Parkinson's disease, cancer, traumatic brain injury, Glaucoma, and age-related macular degeneration.",
      "Amyloid-β is associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral scler",
      "Amyloid-beta is associated with several diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Glaucoma, age-related macular degeneration, cardiovascular disease, cancer, traumatic brain injury, and diabetes.",
      "Amyloid-β (Aβ) is associated with several diseases beyond Alzheimer's disease, including Lewy body disease (LBD), multiple system atrophy (MSA), frontotemporal lobar degeneration-TDP-43 (FTLD-TDP), and progressive supranuclear palsy (PSP). Aβ deposition has also been linked to other neurological diseases, such as Parkinson's disease, amyotrophic lateral sclerosis, and retinal neurodegenerative diseases like Glaucoma and age-related macular degeneration. Additionally, Aβ has been implicated in cardiovascular disease, cancer, traumatic brain injury, and diabetes.",
      "Amyloid-β is associated with Alzheimer's disease, amyloid-β-induced neurotoxicity and neurodegeneration, and other diseases.",
      "Amyloid-β is associated with Alzheimer's disease, multiple sclerosis, and other neurodegenerative diseases.",
      "Amyloid-β is associated with neurodegenerative diseases beyond Alzheimer's disease, including Lewy body disease, multiple system atrophy, frontotemporal lobar degeneration-TDP-43, and progressive supranuclear palsy.",
      "Amyloid-Î² is associated with Alzheimer's disease and age-related macular degeneration.",
      "Amyloid-β is associated with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Glaucoma, age-related macular degeneration, cardiovascular disease, cancer, traumatic brain injury, and diabetes.",
      "Amyloid-β is associated with diseases such as Alzheimer's disease, Parkinson's disease, and type II diabetes, among others.",
      "Amyloid-β is associated with neurodegenerative diseases such as Alzheimer's disease, Lewy body disease, multiple system atrophy, frontotemporal lobar degeneration-TDP-43, and progressive supranuclear palsy.",
      "Amyloid-β is associated with Alzheimer's Disease and cerebral amyloid angiopathy.",
      "Amyloid-β is associated with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, cardiovascular disease, cancer, traumatic brain injury, age-related macular degeneration, and glaucoma.",
      "Amyloid-β is associated with Alzheimer's disease, cerebral amyloid angiopathy, and AD.",
      "Amyloid-β is associated with neurodegenerative diseases such as Alzheimer's disease, Lewy body disease, multiple system atrophy, frontotemporal lobar degeneration-TDP-43, and progressive supranuclear palsy. It has also been implicated in other conditions including Parkinson's disease, amyotrophic lateral sclerosis, glaucoma, age-related macular degeneration, cardiovascular disease, cancer, traumatic brain injury, and diabetes.",
      "Amyloid-beta (Aβ) is associated with various neurodegenerative diseases, including Alzheimer's disease (AD), Lewy body disease (LBD), frontotemporal lobar degeneration-TDP-43 (FTLD-TDP), Parkinson's disease, amyotrophic lateral sclerosis, glaucoma, and age-related macular degeneration. Aβ has also been linked to cardiovascular disease, cancer, traumatic brain injury, and diabetes.",
      "Amyloid-β (Aβ) has been associated with several neurological diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, as well as retinal neurodegenerative diseases like Glaucoma and age-related macular degeneration. Additionally, Aβ has also been linked to cardiovascular disease, cancer, traumatic brain injury, and diabetes.",
      "Amyloid-β is associated with Alzheimer's disease as well as many other neurodegenerative diseases like Lewy body disease, multiple system atrophy, frontotemporal lobar degeneration, Parkinson's disease, and amyotrophic lateral sclerosis, as well as retinal neurodegenerative diseases like Glaucoma and age-related macular degeneration and progressive supranuclear palsy These proteins have also been linked to cardiovascular disease, cancer, traumatic brain injury, and diabetes",
      "Amyloid-β is associated with amyotrophic lateral sclerosis, cardiovascular disease, multiple system atrophy, progressive supranuclear palsy, cancer, traumatic brain injury.",
      "Amyloid-β is primarily associated with Alzheimer's disease and cerebral amyloid angiopathy.",
      "Amyloid-β is associated with Alzheimer's disease and cerebral amyloid angiopathy.",
      "\nAmyloid-β is associated with Alzheimer's disease, Down syndrome, Parkinson's disease, and certain types of cancer. (Note: The role of amyloid-β in Parkinson's disease and cancer is less clear.)",
      "Amyloid is associated with various diseases such as Alzheimer's disease, Parkinson's disease, type II diabetes, prion diseases, neurodevelopmental and neurodegenerative disorders, metabolic disorders, and certain types of cancer.",
      "Amyloid-β is associated with a range of diseases including Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, Glaucoma, age-related macular degeneration, cardiovascular disease, cancer, traumatic brain injury, and diabetes."
    ],
    "ground_truth_ids": [
      "29574591",
      "37489069",
      "37652560",
      "32341983",
      "26657517",
      "29154879",
      "32093040",
      "36687366",
      "29080524",
      "26614753",
      "33023198",
      "32183348",
      "35892582",
      "33513738",
      "29298722",
      "36281662",
      "37943150",
      "25783987",
      "32183293",
      "14572915",
      "37556728",
      "38075821",
      "35558050",
      "37905874",
      "36302506",
      "32582833"
    ],
    "retrieved_ids": [
      "26614753",
      "36687366",
      "22292124",
      "37652560",
      "37556728",
      "32341983",
      "26657517",
      "32093040",
      "37905874",
      "33513738"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "26614753",
        "score": 0.6705819964408875,
        "title": "Is amyloid-β harmful to the brain? Insights from human imaging studies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26614753"
      },
      {
        "pubmed_id": "36687366",
        "score": 0.6365594267845154,
        "title": "Amyloid-β in Alzheimer's disease - front and centre after all?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36687366"
      },
      {
        "pubmed_id": "22292124",
        "score": 0.6107138991355896,
        "title": "Targeting Beta amyloid: a clinical review of immunotherapeutic approaches in Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22292124"
      },
      {
        "pubmed_id": "37652560",
        "score": 0.6006226539611816,
        "title": "The molecular spectrum of amyloid-beta (Aβ) in neurodegenerative diseases beyond Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37652560"
      },
      {
        "pubmed_id": "37556728",
        "score": 0.5997317433357239,
        "title": "α-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-β 42 via Heterogeneous Primary Nucleation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37556728"
      },
      {
        "pubmed_id": "32341983",
        "score": 0.5901405811309814,
        "title": "β-Amyloid precursor protein (APP) and the human diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32341983"
      },
      {
        "pubmed_id": "26657517",
        "score": 0.5699161291122437,
        "title": "Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26657517"
      },
      {
        "pubmed_id": "32093040",
        "score": 0.5583152770996094,
        "title": "Amyloidogenic Peptides in Human Neuro-Degenerative Diseases and in Microorganisms: A Sorrow Shared Is a Sorrow Halved?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32093040"
      },
      {
        "pubmed_id": "37905874",
        "score": 0.5513055920600891,
        "title": "Amyloid-beta and tau protein beyond Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37905874"
      },
      {
        "pubmed_id": "33513738",
        "score": 0.5381813645362854,
        "title": "Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33513738"
      }
    ],
    "query_time": 0.014084100723266602,
    "metrics": {
      "precision": 0.9,
      "recall": 0.34615384615384615,
      "f1_score": 0.5,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 26
    }
  },
  "553a5a34bc4f83e82800001a": {
    "query": "Is Ctf4 involved in sister chromatid cohesion establishment?",
    "type": "yesno",
    "ideal_answer": [
      "Yes. Ctf4 is associated with the replisome and is required for proper establishment of cohesion by facilitating cohesin acetylation."
    ],
    "ground_truth_ids": [
      "11287619",
      "17483413",
      "15598824",
      "23334284",
      "19622120",
      "15485923",
      "20089864",
      "14742710",
      "16962805",
      "19496828",
      "15226378",
      "17222391",
      "23036200"
    ],
    "retrieved_ids": [
      "15226378",
      "17483413",
      "16962805",
      "14742710",
      "19622120",
      "23334284",
      "17222391",
      "11287619",
      "29447171",
      "20089864"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "15226378",
        "score": 0.6763988733291626,
        "title": "Sister-chromatid cohesion mediated by the alternative RF-CCtf18/Dcc1/Ctf8, the helicase Chl1 and the polymerase-alpha-associated protein Ctf4 is essential for chromatid disjunction during meiosis II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15226378"
      },
      {
        "pubmed_id": "17483413",
        "score": 0.6673656105995178,
        "title": "Genetic dissection of parallel sister-chromatid cohesion pathways.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17483413"
      },
      {
        "pubmed_id": "16962805",
        "score": 0.6341423392295837,
        "title": "Establishment of sister chromatid cohesion at the S. cerevisiae replication fork.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16962805"
      },
      {
        "pubmed_id": "14742710",
        "score": 0.6312195062637329,
        "title": "S-phase checkpoint genes safeguard high-fidelity sister chromatid cohesion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14742710"
      },
      {
        "pubmed_id": "19622120",
        "score": 0.6120696067810059,
        "title": "Replisome progression complex links DNA replication to sister chromatid cohesion in Xenopus egg extracts.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19622120"
      },
      {
        "pubmed_id": "23334284",
        "score": 0.6105257272720337,
        "title": "An Eco1-independent sister chromatid cohesion establishment pathway in S. cerevisiae.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23334284"
      },
      {
        "pubmed_id": "17222391",
        "score": 0.5641952157020569,
        "title": "Chl1 and Ctf4 are required for damage-induced recombinations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17222391"
      },
      {
        "pubmed_id": "11287619",
        "score": 0.5543192028999329,
        "title": "Saccharomyces cerevisiae CTF18 and CTF4 are required for sister chromatid cohesion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11287619"
      },
      {
        "pubmed_id": "29447171",
        "score": 0.5516923069953918,
        "title": "Brca2, Pds5 and Wapl differentially control cohesin chromosome association and function.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29447171"
      },
      {
        "pubmed_id": "20089864",
        "score": 0.5414818525314331,
        "title": "Influence of the human cohesion establishment factor Ctf4/AND-1 on DNA replication.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20089864"
      }
    ],
    "query_time": 0.007637977600097656,
    "metrics": {
      "precision": 0.9,
      "recall": 0.6923076923076923,
      "f1_score": 0.7826086956521738,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 13
    }
  },
  "5157fce5d24251bc0500008c": {
    "query": "Is it feasible to determine the complete proteome of yeast?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, since the complete genome of yeast is known."
    ],
    "ground_truth_ids": [
      "23438854",
      "12912986",
      "23334424",
      "15768030",
      "14730684",
      "16784548"
    ],
    "retrieved_ids": [
      "16784548",
      "23438854",
      "23334424",
      "15665377",
      "6323017",
      "24144163",
      "21742803",
      "25781956",
      "12912986",
      "10573422"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "16784548",
        "score": 0.671831488609314,
        "title": "Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16784548"
      },
      {
        "pubmed_id": "23438854",
        "score": 0.6708279848098755,
        "title": "The coming age of complete, accurate, and ubiquitous proteomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23438854"
      },
      {
        "pubmed_id": "23334424",
        "score": 0.6362438797950745,
        "title": "A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23334424"
      },
      {
        "pubmed_id": "15665377",
        "score": 0.5361157059669495,
        "title": "Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15665377"
      },
      {
        "pubmed_id": "6323017",
        "score": 0.5104966163635254,
        "title": "Yeast DNA topoisomerase II is encoded by a single-copy, essential gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6323017"
      },
      {
        "pubmed_id": "24144163",
        "score": 0.49292391538619995,
        "title": "Understanding the role of proteolytic digestion on discovery and targeted proteomic measurements using liquid chromatography tandem mass spectrometry and design of experiments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24144163"
      },
      {
        "pubmed_id": "21742803",
        "score": 0.4734340310096741,
        "title": "The human proteome project: current state and future direction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21742803"
      },
      {
        "pubmed_id": "25781956",
        "score": 0.46473658084869385,
        "title": "Utilizing targeted mass spectrometry to demonstrate Asf1-dependent increases in residue specificity for Rtt109-Vps75 mediated histone acetylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25781956"
      },
      {
        "pubmed_id": "12912986",
        "score": 0.4588773250579834,
        "title": "Unexpected protein families including cell defense components feature in the N-myristoylome of a higher eukaryote.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12912986"
      },
      {
        "pubmed_id": "10573422",
        "score": 0.45529705286026,
        "title": "Protein interaction maps for complete genomes based on gene fusion events.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10573422"
      }
    ],
    "query_time": 0.02381110191345215,
    "metrics": {
      "precision": 0.4,
      "recall": 0.6666666666666666,
      "f1_score": 0.5,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "550899c92e93f0133a000003": {
    "query": "Is K-63 linked protein ubiquitination related to proteasomal degradation?",
    "type": "yesno",
    "ideal_answer": [
      "Ubiquitination is best known for its role in targeting proteins for degradation by the proteasome, but evidence of the nonproteolytic functions of ubiquitin is also rapidly accumulating. One example of the regulatory, rather than proteolytic, function of ubiquitin is provided by study of the tumor necrosis factor (TNF) receptor-associated factor (TRAF) proteins, which function as ubiquitin ligases to synthesize lysine 63 (K(63))-linked polyubiquitin chains to mediate protein kinase activation through a proteasome-independent mechanism. Some TRAF proteins, such as TRAF2 and TRAF3, have recently been shown to have a positive role in the canonical pathway that activates nuclear factor kappaB (NF-kappaB) through IkappaB kinase beta (IKKbeta), but a negative role in the noncanonical pathway that activates NF-kappaB through IKKalpha. These opposing roles of TRAF proteins may be linked to their ability to synthesize distinct forms of polyubiquitin chains. Indeed, the TRAF2-interacting protein RIP can mediate IKK activation when it is modified by K(63) polyubiquitin chains, but is targeted to degradation by the proteasome when it is K(48)-polyubiquitinted by the NF-kappaB inhibitor A20. Thus, ubiquitin chains are dynamic switches that can influence signaling outputs in dramatically different ways.In contrast to K48-linked polyubiquitin chains, K63-linked polyubiquitin chains function in nonproteasomal biological processes.",
      "In contrast to K48-linked polyubiquitin chains, K63-linked polyubiquitin chains function in nonproteasomal biological processes. Modification of proteins by the addition of lysine (K)-63-linked polyubiquitin (polyUb) chains is suggested to play important roles in a variety of cellular events, including DNA repair, signal transduction, and receptor endocytosis. One example of the regulatory, rather than proteolytic, function of ubiquitin is provided by study of the tumor necrosis factor (TNF) receptor-associated factor (TRAF) proteins, which function as ubiquitin ligases to synthesize lysine 63 (K(63))-linked polyubiquitin chains to mediate protein kinase activation through a proteasome-independent mechanism.",
      "One example of the regulatory, rather than proteolytic, function of ubiquitin is provided by study of the tumor necrosis factor (TNF) receptor-associated factor (TRAF) proteins, which function as ubiquitin ligases to synthesize lysine 63 (K(63))-linked polyubiquitin chains to mediate protein kinase activation through a proteasome-independent mechanism",
      "Modification of proteins by the addition of lysine (K)-63-linked polyubiquitin (polyUb) chains is suggested to play important roles in a variety of cellular events, including DNA repair, signal transduction, and receptor endocytosis. In contrast to K48-linked polyubiquitin chains, K63-linked polyubiquitin chains function in nonproteasomal biological processes."
    ],
    "ground_truth_ids": [
      "18042044",
      "21737094",
      "19091944",
      "21071436",
      "15728425",
      "20663875"
    ],
    "retrieved_ids": [
      "35508449",
      "18042044",
      "18995839",
      "15728425",
      "19091944",
      "12832479",
      "25097219",
      "21737094",
      "21510985",
      "21071436"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "35508449",
        "score": 0.7019187211990356,
        "title": "Assembly and function of branched ubiquitin chains.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35508449"
      },
      {
        "pubmed_id": "18042044",
        "score": 0.6958182454109192,
        "title": "Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18042044"
      },
      {
        "pubmed_id": "18995839",
        "score": 0.6363956928253174,
        "title": "Extraproteasomal Rpn10 restricts access of the polyubiquitin-binding protein Dsk2 to proteasome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18995839"
      },
      {
        "pubmed_id": "15728425",
        "score": 0.624193549156189,
        "title": "TRAF2: a double-edged sword?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15728425"
      },
      {
        "pubmed_id": "19091944",
        "score": 0.6088452339172363,
        "title": "Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19091944"
      },
      {
        "pubmed_id": "12832479",
        "score": 0.5898703932762146,
        "title": "Critical contribution of the MDM2 acidic domain to p53 ubiquitination.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12832479"
      },
      {
        "pubmed_id": "25097219",
        "score": 0.5641940236091614,
        "title": "Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25097219"
      },
      {
        "pubmed_id": "21737094",
        "score": 0.5615562796592712,
        "title": "Nitric oxide increases lysine 48-linked ubiquitination following arterial injury.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21737094"
      },
      {
        "pubmed_id": "21510985",
        "score": 0.558181881904602,
        "title": "HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21510985"
      },
      {
        "pubmed_id": "21071436",
        "score": 0.5359129905700684,
        "title": "Activated inositol 1,4,5-trisphosphate receptors are modified by homogeneous Lys-48- and Lys-63-linked ubiquitin chains, but only Lys-48-linked chains are required for degradation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21071436"
      }
    ],
    "query_time": 0.013212919235229492,
    "metrics": {
      "precision": 0.5,
      "recall": 0.8333333333333334,
      "f1_score": 0.625,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "54f1e781c409818c32000003": {
    "query": "Is armodafinil used for treatment of insomnia?",
    "type": "yesno",
    "ideal_answer": [
      "No, armodafinil is not used for treatment of insomnia. Armodafinil is a wakefulness-promoting medication. Its efficacy and tolerability have been established in patients with excessive sleepiness (ES) associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy. The wakefulness-promoting agents armodafinil and modafinil are FDA approved for the treatment of ES in patients with SWD."
    ],
    "ground_truth_ids": [
      "20051221",
      "21275439",
      "19880686",
      "21904092",
      "20957846",
      "16861091",
      "16908126",
      "16684437",
      "17181377",
      "18596995",
      "22353444",
      "17874255",
      "20074507"
    ],
    "retrieved_ids": [
      "18596995",
      "16684437",
      "16908126",
      "19880686",
      "20051221",
      "20957846",
      "17874255",
      "21275439",
      "16861091",
      "20074507"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "18596995",
        "score": 0.7792606353759766,
        "title": "Armodafinil for excessive daytime sleepiness.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18596995"
      },
      {
        "pubmed_id": "16684437",
        "score": 0.7443254590034485,
        "title": "The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16684437"
      },
      {
        "pubmed_id": "16908126",
        "score": 0.7233558297157288,
        "title": "Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16908126"
      },
      {
        "pubmed_id": "19880686",
        "score": 0.7167487740516663,
        "title": "Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19880686"
      },
      {
        "pubmed_id": "20051221",
        "score": 0.7122805118560791,
        "title": "A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20051221"
      },
      {
        "pubmed_id": "20957846",
        "score": 0.7074466347694397,
        "title": "The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20957846"
      },
      {
        "pubmed_id": "17874255",
        "score": 0.7062830924987793,
        "title": "Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17874255"
      },
      {
        "pubmed_id": "21275439",
        "score": 0.7004435658454895,
        "title": "Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21275439"
      },
      {
        "pubmed_id": "16861091",
        "score": 0.6457273960113525,
        "title": "Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16861091"
      },
      {
        "pubmed_id": "20074507",
        "score": 0.6270793676376343,
        "title": "Managing the patient with shift-work disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20074507"
      }
    ],
    "query_time": 0.014843225479125977,
    "metrics": {
      "precision": 1.0,
      "recall": 0.7692307692307693,
      "f1_score": 0.8695652173913044,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 13
    }
  },
  "64412c2757b1c7a315000055": {
    "query": "Can breastfeeding be used to alleviate the procedural pain in neonates?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, breastfeeding is effective in alleviating procedural pain in neonates.",
      "Yes, breastfeeding is effective for pain management in neonates.",
      "Yes, breastfeeding has been shown to reduce the pain response in neonates during medical procedures.",
      "The conclusion was that breastfeeding was effective in reducing pain caused by blood collection for newborn screening. Premature Infant Pain Profile scores were lower in the breastfeeding group when compared to the placebo and the group positioned in mother's arms, but were not different compared to the no-treatment and the glucose groups."
    ],
    "ground_truth_ids": [
      "34983147",
      "35620884",
      "36291504"
    ],
    "retrieved_ids": [
      "35620884",
      "36291504",
      "34983147",
      "29945293",
      "29373884",
      "25486928",
      "24989360",
      "27695855",
      "31185372",
      "21120498"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "35620884",
        "score": 0.7149636745452881,
        "title": "The effect of breastfeeding, breast milk odour and mother's heartbeat sound on pain level in newborns: A randomized trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35620884"
      },
      {
        "pubmed_id": "36291504",
        "score": 0.6932055950164795,
        "title": "Effectiveness of Non-Pharmacological Methods, Such as Breastfeeding, to Mitigate Pain in NICU Infants.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36291504"
      },
      {
        "pubmed_id": "34983147",
        "score": 0.6832358837127686,
        "title": "Does Interval between Breastfeedıng and Heel Lance Affect the Perception of Pain in Newborns?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34983147"
      },
      {
        "pubmed_id": "29945293",
        "score": 0.621894121170044,
        "title": "Evaluation of three pain assessment scales used for ventilated neonates.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29945293"
      },
      {
        "pubmed_id": "29373884",
        "score": 0.3322046101093292,
        "title": "Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29373884"
      },
      {
        "pubmed_id": "25486928",
        "score": 0.31952235102653503,
        "title": "Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25486928"
      },
      {
        "pubmed_id": "24989360",
        "score": 0.30804532766342163,
        "title": "Mondor's disease of the breast as a complication of ultrasound-guided core needle biopsy: management and review of the literature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24989360"
      },
      {
        "pubmed_id": "27695855",
        "score": 0.304778516292572,
        "title": "Congenital Zika Virus Infection: Beyond Neonatal Microcephaly.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27695855"
      },
      {
        "pubmed_id": "31185372",
        "score": 0.30003422498703003,
        "title": "Neurodevelopmental retardation in a baby born to a multiple sclerosis patient being treated with fingolimod.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31185372"
      },
      {
        "pubmed_id": "21120498",
        "score": 0.295484721660614,
        "title": "The treatment of rheumatoid arthritis during pregnancy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21120498"
      }
    ],
    "query_time": 0.013087987899780273,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "530cf4fe960c95ad0c00000c": {
    "query": "Can desvenlafaxine be used at a dose of 50mg/day?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, desvenlafaxine can be at 50mg/day to treat patients with major depressive disorder.  Studies suggest that 50 mg is the minimum effective dose of desvenlafaxine for the treatment of major depressive disorder. The recommended dose of DVS ranges from 50 to 100 mg."
    ],
    "ground_truth_ids": [
      "23587982",
      "21067460",
      "23881185",
      "20107296",
      "18507895",
      "23517291",
      "22173281",
      "19407711",
      "23473348",
      "19407730"
    ],
    "retrieved_ids": [
      "20107296",
      "23587982",
      "19407730",
      "18507895",
      "19407711",
      "22173281",
      "23517291",
      "21067460",
      "23473348",
      "23881185"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "20107296",
        "score": 0.710685133934021,
        "title": "Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20107296"
      },
      {
        "pubmed_id": "23587982",
        "score": 0.6790291666984558,
        "title": "A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23587982"
      },
      {
        "pubmed_id": "19407730",
        "score": 0.6766629219055176,
        "title": "An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19407730"
      },
      {
        "pubmed_id": "18507895",
        "score": 0.6670669913291931,
        "title": "Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18507895"
      },
      {
        "pubmed_id": "19407711",
        "score": 0.6659143567085266,
        "title": "An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19407711"
      },
      {
        "pubmed_id": "22173281",
        "score": 0.635941743850708,
        "title": "Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22173281"
      },
      {
        "pubmed_id": "23517291",
        "score": 0.635079026222229,
        "title": "A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23517291"
      },
      {
        "pubmed_id": "21067460",
        "score": 0.6131705045700073,
        "title": "Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21067460"
      },
      {
        "pubmed_id": "23473348",
        "score": 0.5979722142219543,
        "title": "Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23473348"
      },
      {
        "pubmed_id": "23881185",
        "score": 0.5772323608398438,
        "title": "Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23881185"
      }
    ],
    "query_time": 0.010933160781860352,
    "metrics": {
      "precision": 1.0,
      "recall": 1.0,
      "f1_score": 1.0,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "66302174187cba990d00002e": {
    "query": "Are there any digital biomarkers for Duchenne Muscular Dystrophy?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, the KineDMD ethomic biomarker is a digital biomarker for Duchenne Muscular Dystrophy.",
      "Yes, wearable full-body motion tracking of activities of daily living is a digital biomarker for Duchenne Muscular Dystrophy that can predict disease trajectory",
      "Yes, there is a digital biomarker for Duchenne Muscular Dystrophy. It's called the KineDMD ethomic biomarker, which is derived from daily-life behavioral data.",
      "Yes, a digital biomarker called the KineDMD ethomic biomarker has been developed for Duchenne Muscular Dystrophy. It is derived from daily-life behavioral data and can predict disease progression.",
      "Yes, the KineDMD ethomic biomarker is a digital biomarker for Duchenne Muscular Dystrophy. It is derived from daily-life movement behavior and can predict disease progression in patients with muscular dystrophy and can potentially track the response to therapy",
      "Yes, digital biomarkers have been developed for Duchenne Muscular Dystrophy.",
      "Yes. Bayesian optimization, machine learning algorithms and movement behavioral fingerprints are used as digital biomarkers for Duchenne Muscular Dystrophy.",
      "Yes, there are digital biomarkers for Duchenne Muscular Dystrophy."
    ],
    "ground_truth_ids": [
      "36658421"
    ],
    "retrieved_ids": [
      "31879850",
      "31546754",
      "32390640",
      "29167533",
      "16322188",
      "30404418",
      "34155911",
      "7557061",
      "31009620",
      "32022138"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "31879850",
        "score": 0.7120779156684875,
        "title": "The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31879850"
      },
      {
        "pubmed_id": "31546754",
        "score": 0.6707947254180908,
        "title": "miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31546754"
      },
      {
        "pubmed_id": "32390640",
        "score": 0.6653693914413452,
        "title": "Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32390640"
      },
      {
        "pubmed_id": "29167533",
        "score": 0.6418898105621338,
        "title": "Muscle MRI and functional outcome measures in Becker muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29167533"
      },
      {
        "pubmed_id": "16322188",
        "score": 0.614824116230011,
        "title": "Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16322188"
      },
      {
        "pubmed_id": "30404418",
        "score": 0.602536678314209,
        "title": "A New Functional Scale and Ambulatory Functional Classification of Duchenne Muscular Dystrophy: Scale Development and Preliminary Analyses of Reliability and Validity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30404418"
      },
      {
        "pubmed_id": "34155911",
        "score": 0.600911557674408,
        "title": "Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34155911"
      },
      {
        "pubmed_id": "7557061",
        "score": 0.5977074503898621,
        "title": "[Relations between delayed diagnosis and forms of onset in Duchenne muscular dystrophy].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7557061"
      },
      {
        "pubmed_id": "31009620",
        "score": 0.5974767804145813,
        "title": "Can simple and low-cost motor function assessments help in the diagnostic suspicion of Duchenne muscular dystrophy?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31009620"
      },
      {
        "pubmed_id": "32022138",
        "score": 0.589776873588562,
        "title": "Functional performance and muscular strength in symptomatic female carriers of Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32022138"
      }
    ],
    "query_time": 0.013283014297485352,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5ca10fefecadf2e73f00004a": {
    "query": "Is the Philadelphia chromosome a fusion between parts of chromosomes 1 and 9?",
    "type": "yesno",
    "ideal_answer": [
      "No,\nChronic myeloid leukemia is a stem cell disease with the presence of Philadelphia chromosome generated through reciprocal translocation of chromosome 9 and 22."
    ],
    "ground_truth_ids": [
      "29633730",
      "29435292",
      "29046997"
    ],
    "retrieved_ids": [
      "29435292",
      "24980541",
      "1478673",
      "20017317",
      "12068920",
      "3189330",
      "16617304",
      "20641042",
      "15731758",
      "17483413"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29435292",
        "score": 0.526477038860321,
        "title": "A novel three-way Philadelphia Variant t(9;22;17)(q34;q11.2;q12) in chronic myeloid leukemia: A case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29435292"
      },
      {
        "pubmed_id": "24980541",
        "score": 0.5201324224472046,
        "title": "Aneuploidy and skeletal health.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24980541"
      },
      {
        "pubmed_id": "1478673",
        "score": 0.49556052684783936,
        "title": "Breakpoints in Robertsonian translocations are localized to satellite III DNA by fluorescence in situ hybridization.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1478673"
      },
      {
        "pubmed_id": "20017317",
        "score": 0.4782465398311615,
        "title": "[Analysis of the small supernumerary marker chromosome in Turner syndrome with 45, X/46, X, + mar karyotype].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20017317"
      },
      {
        "pubmed_id": "12068920",
        "score": 0.45401591062545776,
        "title": "Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12068920"
      },
      {
        "pubmed_id": "3189330",
        "score": 0.44393229484558105,
        "title": "Molecular detection of microscopic and submicroscopic deletions associated with Miller-Dieker syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3189330"
      },
      {
        "pubmed_id": "16617304",
        "score": 0.4406396150588989,
        "title": "Parental and chromosomal origins of microdeletion and duplication syndromes involving 7q11.23, 15q11-q13 and 22q11.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16617304"
      },
      {
        "pubmed_id": "20641042",
        "score": 0.4306112229824066,
        "title": "Human embryonic stem cells as models for aneuploid chromosomal syndromes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20641042"
      },
      {
        "pubmed_id": "15731758",
        "score": 0.4288804531097412,
        "title": "Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15731758"
      },
      {
        "pubmed_id": "17483413",
        "score": 0.428689181804657,
        "title": "Genetic dissection of parallel sister-chromatid cohesion pathways.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17483413"
      }
    ],
    "query_time": 0.011317014694213867,
    "metrics": {
      "precision": 0.1,
      "recall": 0.3333333333333333,
      "f1_score": 0.15384615384615383,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "6278ddfe56bf9aee6f000013": {
    "query": "Are functional tests a good biomarker for Duchenne Muscular Dystrophy?",
    "type": "yesno",
    "ideal_answer": [
      "North Star Ambulatory Assessment is practical and reliable. allow assessment of high-functioning boys with Duchenne muscular dystrophy.",
      "Yes, functional tests are a good biomarker for Duchenne Muscular Dystrophy. \nNorth Star Ambulatory Assessment is practical and reliable. allow assessment of high-functioning boys with Duchenna muscular dystrophy \nFunctional tests are used for assessment of  boys with  muscular atrophy.",
      "Functional tests such as North Star Ambulatory Assessment (NSAA) are good biomarkers for Duchenne Muscular Dystrophy.",
      "North Star Ambulatory Assessment is practical and reliable.",
      "allow assessment of high-functioning boys with Duchenne muscular dystrophy.North Star Ambulatory Assessment is practical and reliable."
    ],
    "ground_truth_ids": [
      "22699538",
      "8347064",
      "30404418",
      "32022138",
      "30688316",
      "29742798",
      "22974002",
      "21954141",
      "24762862",
      "16102988",
      "21800026",
      "28084836",
      "31009620",
      "31879850",
      "29174526",
      "31546754",
      "32390640",
      "30180785",
      "34155911",
      "29167533"
    ],
    "retrieved_ids": [
      "31879850",
      "30404418",
      "34155911",
      "32390640",
      "29742798",
      "29167533",
      "31009620",
      "30688316",
      "31546754",
      "22974002"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "31879850",
        "score": 0.775232195854187,
        "title": "The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31879850"
      },
      {
        "pubmed_id": "30404418",
        "score": 0.7132477760314941,
        "title": "A New Functional Scale and Ambulatory Functional Classification of Duchenne Muscular Dystrophy: Scale Development and Preliminary Analyses of Reliability and Validity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30404418"
      },
      {
        "pubmed_id": "34155911",
        "score": 0.685530424118042,
        "title": "Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34155911"
      },
      {
        "pubmed_id": "32390640",
        "score": 0.6772772073745728,
        "title": "Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32390640"
      },
      {
        "pubmed_id": "29742798",
        "score": 0.6758426427841187,
        "title": "Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29742798"
      },
      {
        "pubmed_id": "29167533",
        "score": 0.6733163595199585,
        "title": "Muscle MRI and functional outcome measures in Becker muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29167533"
      },
      {
        "pubmed_id": "31009620",
        "score": 0.6672266721725464,
        "title": "Can simple and low-cost motor function assessments help in the diagnostic suspicion of Duchenne muscular dystrophy?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31009620"
      },
      {
        "pubmed_id": "30688316",
        "score": 0.6663135290145874,
        "title": "Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30688316"
      },
      {
        "pubmed_id": "31546754",
        "score": 0.6531566977500916,
        "title": "miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31546754"
      },
      {
        "pubmed_id": "22974002",
        "score": 0.6522939205169678,
        "title": "Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22974002"
      }
    ],
    "query_time": 0.010117769241333008,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 20
    }
  },
  "55435aeced966d112c000007": {
    "query": "Can we detect DNA strand asymmetries using dinucleotide relative abundance \"genomic signatures\"?",
    "type": "yesno",
    "ideal_answer": [
      "The set of dinucleotide relative abundances can be regarded as a genomic signature because, despite diversity between species, it varies little between 50 kilobase or longer windows on a given genome. Thus, dinucleotide relative abundance profiles are species-type specific. These profiles are computed from the base step \"odds ratios\" that compare dinucleotide frequencies to those expected under the assumption of stochastic equilibrium (thorough shuffling). Dinucleotide relative abundance \"genomic signatures\" are strand-independent second-order DNA features. Thus, they cannot be used to detect DNA strand asymmetries."
    ],
    "ground_truth_ids": [
      "15046306",
      "12171605",
      "15716010",
      "9294192",
      "18799480",
      "9520433",
      "10430918",
      "9190805",
      "7482779",
      "10066522"
    ],
    "retrieved_ids": [
      "12171605",
      "10066522",
      "7482779",
      "15716010",
      "9294192",
      "18799480",
      "15046306",
      "9520433",
      "9190805",
      "28968643"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "12171605",
        "score": 0.6130874156951904,
        "title": "Pervasive properties of the genomic signature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12171605"
      },
      {
        "pubmed_id": "10066522",
        "score": 0.6078675985336304,
        "title": "Global dinucleotide signatures and analysis of genomic heterogeneity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10066522"
      },
      {
        "pubmed_id": "7482779",
        "score": 0.6059638261795044,
        "title": "Dinucleotide relative abundance extremes: a genomic signature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7482779"
      },
      {
        "pubmed_id": "15716010",
        "score": 0.5006551742553711,
        "title": "The spectrum of genomic signatures: from dinucleotides to chaos game representation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15716010"
      },
      {
        "pubmed_id": "9294192",
        "score": 0.487964391708374,
        "title": "Compositional differences within and between eukaryotic genomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9294192"
      },
      {
        "pubmed_id": "18799480",
        "score": 0.4876680374145508,
        "title": "Detecting horizontally transferred and essential genes based on dinucleotide relative abundance.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18799480"
      },
      {
        "pubmed_id": "15046306",
        "score": 0.45194369554519653,
        "title": "Use of the genomic signature in bacterial classification and identification.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15046306"
      },
      {
        "pubmed_id": "9520433",
        "score": 0.4296381175518036,
        "title": "Strand compositional asymmetry in bacterial and large viral genomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9520433"
      },
      {
        "pubmed_id": "9190805",
        "score": 0.4043729305267334,
        "title": "Compositional biases of bacterial genomes and evolutionary implications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9190805"
      },
      {
        "pubmed_id": "28968643",
        "score": 0.3899890184402466,
        "title": "CGmapTools improves the precision of heterozygous SNV calls and supports allele-specific methylation detection and visualization in bisulfite-sequencing data.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28968643"
      }
    ],
    "query_time": 0.013067960739135742,
    "metrics": {
      "precision": 0.9,
      "recall": 0.9,
      "f1_score": 0.9,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "5c6582207c78d69471000001": {
    "query": "Is lucatumumab a polyclonal antibody?",
    "type": "yesno",
    "ideal_answer": [
      "No, lucatumumab is a a monoclonal antibody against CD40."
    ],
    "ground_truth_ids": [
      "22861192"
    ],
    "retrieved_ids": [
      "22861192",
      "29675744",
      "21744772",
      "28185174",
      "21815704",
      "24289293",
      "18181050",
      "20197484",
      "23043252",
      "30539467"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "22861192",
        "score": 0.5940894484519958,
        "title": "A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22861192"
      },
      {
        "pubmed_id": "29675744",
        "score": 0.5199004411697388,
        "title": "Ibalizumab: First Global Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29675744"
      },
      {
        "pubmed_id": "21744772",
        "score": 0.5109574794769287,
        "title": "Monoclonal antibodies in ophthalmology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21744772"
      },
      {
        "pubmed_id": "28185174",
        "score": 0.4955626130104065,
        "title": "Current Treatment of Chronic Lymphocytic Leukemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28185174"
      },
      {
        "pubmed_id": "21815704",
        "score": 0.48921024799346924,
        "title": "Receptor kinase inhibitors target NSCLC: two antibodies and a small-molecule MET inhibitor.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21815704"
      },
      {
        "pubmed_id": "24289293",
        "score": 0.47753438353538513,
        "title": "Current evaluation of alemtuzumab in multiple sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24289293"
      },
      {
        "pubmed_id": "18181050",
        "score": 0.4532548785209656,
        "title": "Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18181050"
      },
      {
        "pubmed_id": "20197484",
        "score": 0.44829314947128296,
        "title": "A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20197484"
      },
      {
        "pubmed_id": "23043252",
        "score": 0.4434892535209656,
        "title": "Nimotuzumab treatment of malignant gliomas.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23043252"
      },
      {
        "pubmed_id": "30539467",
        "score": 0.43152421712875366,
        "title": "Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30539467"
      }
    ],
    "query_time": 0.0221250057220459,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5c643485e842deac67000015": {
    "query": "Are de novo mutations in regulatory elements responsible for neurodevelopmental disorders?",
    "type": "yesno",
    "ideal_answer": [
      "Yes. De novo mutations in highly evolutionarily conserved fetal brain-active elements are significantly and specifically enriched in neurodevelopmental disorders. It is estimated that, genome-wide, 1-3% of patients without a diagnostic coding variant carry pathogenic de novo mutations in fetal brain-active regulatory elements and that only 0.15% of all possible mutations within highly conserved fetal brain-active elements cause neurodevelopmental disorders with a dominant mechanism."
    ],
    "ground_truth_ids": [
      "29562236"
    ],
    "retrieved_ids": [
      "29562236",
      "30656450",
      "18443314",
      "20938027",
      "24360741",
      "27884548",
      "19203856",
      "20114075",
      "21532572",
      "31162719"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29562236",
        "score": 0.795992374420166,
        "title": "De novo mutations in regulatory elements in neurodevelopmental disorders.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29562236"
      },
      {
        "pubmed_id": "30656450",
        "score": 0.624287486076355,
        "title": "Mutations in ACTL6B, coding for a subunit of the neuron-specific chromatin remodeling complex nBAF, cause early onset severe developmental and epileptic encephalopathy with brain hypomyelination and cerebellar atrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30656450"
      },
      {
        "pubmed_id": "18443314",
        "score": 0.5430768728256226,
        "title": "Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18443314"
      },
      {
        "pubmed_id": "20938027",
        "score": 0.538517951965332,
        "title": "Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20938027"
      },
      {
        "pubmed_id": "24360741",
        "score": 0.5313351154327393,
        "title": "Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24360741"
      },
      {
        "pubmed_id": "27884548",
        "score": 0.5254570245742798,
        "title": "Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: An update for the diagnosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27884548"
      },
      {
        "pubmed_id": "19203856",
        "score": 0.5168802738189697,
        "title": "Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19203856"
      },
      {
        "pubmed_id": "20114075",
        "score": 0.5118826627731323,
        "title": "Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20114075"
      },
      {
        "pubmed_id": "21532572",
        "score": 0.5100279450416565,
        "title": "Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21532572"
      },
      {
        "pubmed_id": "31162719",
        "score": 0.5100274085998535,
        "title": "Ontogenetic oligodendrocyte maturation through gestational iron deprivation: The road not taken.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31162719"
      }
    ],
    "query_time": 0.008643150329589844,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "6276d2d956bf9aee6f000002": {
    "query": "Do angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) increase the likelihood of severe COVID-19?",
    "type": "yesno",
    "ideal_answer": [
      "No. Patients receiving angiotensin-converting-enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) should continue treatment with these agents if there is no other reason for discontinuation. Despite speculation that patients with COVID-19 who are receiving these agents may be at increased risk for adverse outcomes, accumulating evidence does not support an association of ACE inhibitors and ARBs with more severe disease. In addition, stopping these agents in some patients can exacerbate comorbid cardiovascular or kidney disease and increase mortality.",
      "ACEIs and ARBs were not associated with an increased risk of Covid-19 hospitalization or with hospitalization involving ICU admission, invasive mechanical ventilation, or death.",
      "No. ACEIs and ARBs have not been shown to increase the likelihood of severe COVID-19 hospitalization."
    ],
    "ground_truth_ids": [
      "33210357",
      "32514935",
      "32474043",
      "33201001",
      "33842874",
      "34611496",
      "33614350",
      "33038021",
      "34599472",
      "32757246",
      "33085063",
      "32579597",
      "33231487",
      "32651067",
      "33891615",
      "32422062",
      "32587982",
      "32685191",
      "32875060",
      "33658619",
      "33222020",
      "33748156",
      "32485082",
      "33981731",
      "32611676",
      "32320478",
      "32558877",
      "32348166",
      "32737124",
      "33095513",
      "32242182",
      "33504565",
      "34155486",
      "32918209",
      "32965603"
    ],
    "retrieved_ids": [
      "32242182",
      "32757246",
      "33981731",
      "32422062",
      "32514935",
      "33658619",
      "33201001",
      "32875060",
      "32558877",
      "32348166"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "32242182",
        "score": 0.8252596259117126,
        "title": "A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32242182"
      },
      {
        "pubmed_id": "32757246",
        "score": 0.7881122827529907,
        "title": "Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: A rapid systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32757246"
      },
      {
        "pubmed_id": "33981731",
        "score": 0.7840703725814819,
        "title": "Associations Between the Use of Renin-Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33981731"
      },
      {
        "pubmed_id": "32422062",
        "score": 0.7821758985519409,
        "title": "Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32422062"
      },
      {
        "pubmed_id": "32514935",
        "score": 0.7768458724021912,
        "title": "Renin-angiotensin system inhibition in COVID-19 patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32514935"
      },
      {
        "pubmed_id": "33658619",
        "score": 0.7711284756660461,
        "title": "Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33658619"
      },
      {
        "pubmed_id": "33201001",
        "score": 0.7704933881759644,
        "title": "Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33201001"
      },
      {
        "pubmed_id": "32875060",
        "score": 0.7642233371734619,
        "title": "Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32875060"
      },
      {
        "pubmed_id": "32558877",
        "score": 0.7569335699081421,
        "title": "Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32558877"
      },
      {
        "pubmed_id": "32348166",
        "score": 0.750738263130188,
        "title": "Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32348166"
      }
    ],
    "query_time": 0.041785240173339844,
    "metrics": {
      "precision": 1.0,
      "recall": 0.2857142857142857,
      "f1_score": 0.4444444444444445,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 35
    }
  },
  "5e30e9e3fbd6abf43b00003c": {
    "query": "Is Ubrogepant effective for migraine?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, Ubrogepant is effective for treatment of migraine."
    ],
    "ground_truth_ids": [
      "27269043",
      "30681821",
      "31800988",
      "31341711",
      "29691490",
      "30242830",
      "29556965",
      "28644160",
      "28645128",
      "30403405",
      "29136283",
      "30475090",
      "31758661",
      "31020659",
      "30995909"
    ],
    "retrieved_ids": [
      "31800988",
      "30475090",
      "27269043",
      "30681821",
      "30995909",
      "21350792",
      "31758661",
      "29691490",
      "28645128",
      "31341711"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "31800988",
        "score": 0.8076019287109375,
        "title": "Ubrogepant for the Treatment of Migraine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31800988"
      },
      {
        "pubmed_id": "30475090",
        "score": 0.7160745859146118,
        "title": "Advances in orally administered pharmacotherapy for the treatment of migraine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30475090"
      },
      {
        "pubmed_id": "27269043",
        "score": 0.7117877006530762,
        "title": "A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27269043"
      },
      {
        "pubmed_id": "30681821",
        "score": 0.7040722370147705,
        "title": "Migraine overview and summary of current and emerging treatment options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30681821"
      },
      {
        "pubmed_id": "30995909",
        "score": 0.6424130797386169,
        "title": "Therapeutic novelties in migraine: new drugs, new hope?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30995909"
      },
      {
        "pubmed_id": "21350792",
        "score": 0.6292728781700134,
        "title": "Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21350792"
      },
      {
        "pubmed_id": "31758661",
        "score": 0.6290600299835205,
        "title": "Making Better Dose Decisions: Using Exposure-Response Modeling to Integrate Efficacy Outcome of Two Phase IIb Clinical Trials of Ubrogepant for Migraine Treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31758661"
      },
      {
        "pubmed_id": "29691490",
        "score": 0.617820143699646,
        "title": "CGRP as the target of new migraine therapies - successful translation from bench to clinic.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29691490"
      },
      {
        "pubmed_id": "28645128",
        "score": 0.6121876239776611,
        "title": "[Headache News].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28645128"
      },
      {
        "pubmed_id": "31341711",
        "score": 0.591053307056427,
        "title": "Primary headache disorders: Five new things.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31341711"
      }
    ],
    "query_time": 0.014890909194946289,
    "metrics": {
      "precision": 0.9,
      "recall": 0.6,
      "f1_score": 0.7200000000000001,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "604903551cb411341a000162": {
    "query": "Are mucins glycosylated proteins?",
    "type": "yesno",
    "ideal_answer": [
      "Yes,\nMany members of the mucin family are evolutionarily conserved and are often aberrantly expressed and glycosylated in various benign and malignant pathologies leading to tumor invasion, metastasis, and immune evasion."
    ],
    "ground_truth_ids": [
      "31907968",
      "31908009",
      "31904283"
    ],
    "retrieved_ids": [
      "31908009",
      "31907968",
      "17095274",
      "34493791",
      "23980545",
      "12067333",
      "27639389",
      "8574597",
      "31904283",
      "26990986"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "31908009",
        "score": 0.6147150993347168,
        "title": "Presence and structure-activity relationship of intrinsically disordered regions across mucins.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31908009"
      },
      {
        "pubmed_id": "31907968",
        "score": 0.5647183656692505,
        "title": "SdsA1, a secreted sulfatase, contributes to the in vivo virulence of Pseudomonas aeruginosa in mice.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31907968"
      },
      {
        "pubmed_id": "17095274",
        "score": 0.451864629983902,
        "title": "Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17095274"
      },
      {
        "pubmed_id": "34493791",
        "score": 0.44658786058425903,
        "title": "Burkholderia PglL enzymes are Serine preferring oligosaccharyltransferases which target conserved proteins across the Burkholderia genus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34493791"
      },
      {
        "pubmed_id": "23980545",
        "score": 0.44161078333854675,
        "title": "Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23980545"
      },
      {
        "pubmed_id": "12067333",
        "score": 0.4205464720726013,
        "title": "Cooperation and competition in mismatch repair: very short-patch repair and methyl-directed mismatch repair in Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12067333"
      },
      {
        "pubmed_id": "27639389",
        "score": 0.4143564701080322,
        "title": "Blood group antigen expression is involved in C. albicans interaction with buccal epithelial cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27639389"
      },
      {
        "pubmed_id": "8574597",
        "score": 0.40698835253715515,
        "title": "The immune system in uremia and during its treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8574597"
      },
      {
        "pubmed_id": "31904283",
        "score": 0.40505295991897583,
        "title": "Cosmc-dependent mucin-type O-linked glycosylation is essential for podocyte function.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31904283"
      },
      {
        "pubmed_id": "26990986",
        "score": 0.39027589559555054,
        "title": "Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26990986"
      }
    ],
    "query_time": 0.016369104385375977,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "58bc58c302b8c60953000001": {
    "query": "Is Stat4 a transcription factor?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, Stat4 is a transcription factor.\nStat4 is a member of the signal transducer and activator of transcription (STAT) family of molecules that localizes to the cytoplasm. STAT4 regulates various genes expression as a transcription factor after it is phosphorylated, dimerizes and translocates to the nucleus."
    ],
    "ground_truth_ids": [
      "25178516",
      "25829541",
      "25798064",
      "25852285"
    ],
    "retrieved_ids": [
      "25798064",
      "25852285",
      "12509459",
      "8713055",
      "25957348",
      "25178516",
      "20089864",
      "16769980",
      "19030024",
      "19496828"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25798064",
        "score": 0.6301688551902771,
        "title": "Signal transducer and activator of transcription 4 in liver diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25798064"
      },
      {
        "pubmed_id": "25852285",
        "score": 0.5654156804084778,
        "title": "Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25852285"
      },
      {
        "pubmed_id": "12509459",
        "score": 0.4993276000022888,
        "title": "Role of metazoan mediator proteins in interferon-responsive transcription.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12509459"
      },
      {
        "pubmed_id": "8713055",
        "score": 0.48877963423728943,
        "title": "Multiple steps in the regulation of transcription-factor level and activity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8713055"
      },
      {
        "pubmed_id": "25957348",
        "score": 0.47730106115341187,
        "title": "INSPEcT: a computational tool to infer mRNA synthesis, processing and degradation dynamics from RNA- and 4sU-seq time course experiments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25957348"
      },
      {
        "pubmed_id": "25178516",
        "score": 0.47472667694091797,
        "title": "STAT4 gene polymorphism and risk of chronic hepatitis B-induced hepatocellular carcinoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25178516"
      },
      {
        "pubmed_id": "20089864",
        "score": 0.4737843871116638,
        "title": "Influence of the human cohesion establishment factor Ctf4/AND-1 on DNA replication.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20089864"
      },
      {
        "pubmed_id": "16769980",
        "score": 0.4454929828643799,
        "title": "Genomic localization of RNA binding proteins reveals links between pre-mRNA processing and transcription.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16769980"
      },
      {
        "pubmed_id": "19030024",
        "score": 0.4453631043434143,
        "title": "Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19030024"
      },
      {
        "pubmed_id": "19496828",
        "score": 0.44163328409194946,
        "title": "Ctf4 coordinates the progression of helicase and DNA polymerase alpha.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19496828"
      }
    ],
    "query_time": 0.01879715919494629,
    "metrics": {
      "precision": 0.3,
      "recall": 0.75,
      "f1_score": 0.4285714285714285,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "6025dd0c1cb411341a0000b9": {
    "query": "Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?",
    "type": "yesno",
    "ideal_answer": [
      "No. Randomized clinical trial did not find any superior effects of cerebrolysin for patients with aneurysmal subarachnoid hemorrhage."
    ],
    "ground_truth_ids": [
      "33143640",
      "30414051"
    ],
    "retrieved_ids": [
      "30414051",
      "33143640",
      "25516195",
      "28169856",
      "37489069",
      "14572915",
      "31020659",
      "21876515",
      "21339912",
      "32183293"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30414051",
        "score": 0.8131353855133057,
        "title": "Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30414051"
      },
      {
        "pubmed_id": "33143640",
        "score": 0.7872113585472107,
        "title": "Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33143640"
      },
      {
        "pubmed_id": "25516195",
        "score": 0.5447834730148315,
        "title": "High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25516195"
      },
      {
        "pubmed_id": "28169856",
        "score": 0.5122563242912292,
        "title": "Postinterventional critical care management of aneurysmal subarachnoid hemorrhage.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28169856"
      },
      {
        "pubmed_id": "37489069",
        "score": 0.42370665073394775,
        "title": "Cerebral amyloid angiopathy: Neuropathological diagnosis, link to Alzheimer's disease and impact on clinics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37489069"
      },
      {
        "pubmed_id": "14572915",
        "score": 0.40874168276786804,
        "title": "Pathogenesis of cerebral amyloid angiopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14572915"
      },
      {
        "pubmed_id": "31020659",
        "score": 0.3711469769477844,
        "title": "Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31020659"
      },
      {
        "pubmed_id": "21876515",
        "score": 0.3694477677345276,
        "title": "An endovascular treatment of Chronic Cerebro-Spinal Venous Insufficiency in multiple sclerosis patients - 6 month follow-up results.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21876515"
      },
      {
        "pubmed_id": "21339912",
        "score": 0.36620691418647766,
        "title": "Congenital agenesis of internal carotid artery with ipsilateral Horner presenting as focal neurological symptoms.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21339912"
      },
      {
        "pubmed_id": "32183293",
        "score": 0.3651670813560486,
        "title": "Potential Role of Venular Amyloid in Alzheimer's Disease Pathogenesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32183293"
      }
    ],
    "query_time": 0.013027667999267578,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "56d8b27651531f7e33000003": {
    "query": "Do patients with Pendred syndrome present congenital deafness?",
    "type": "yesno",
    "ideal_answer": [
      "Congenital deafness is one of the characteristics of Pendred syndrome patients."
    ],
    "ground_truth_ids": [
      "15320950",
      "9070918",
      "10502702",
      "1810081",
      "10602116",
      "9398842",
      "21551164",
      "22717225",
      "8979104",
      "10443670",
      "9585042",
      "11375792",
      "21704276",
      "21274344",
      "18250610",
      "16924389",
      "22109890",
      "16482981",
      "10037079",
      "11716048",
      "8706311",
      "9920104",
      "8630498",
      "19318451",
      "10700480",
      "8476169",
      "14727345",
      "23459462",
      "17299139"
    ],
    "retrieved_ids": [
      "14727345",
      "10502702",
      "8476169",
      "10037079",
      "16482981",
      "9070918",
      "11375792",
      "9920104",
      "9585042",
      "8979104"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "14727345",
        "score": 0.7050185203552246,
        "title": "Syndromic and non-syndromic deafness, molecular aspects of Pendred syndrome and its reported mutations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14727345"
      },
      {
        "pubmed_id": "10502702",
        "score": 0.6956815123558044,
        "title": "[Pendred syndrome as a cause of familial deafness].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10502702"
      },
      {
        "pubmed_id": "8476169",
        "score": 0.6820741891860962,
        "title": "Pendred's syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8476169"
      },
      {
        "pubmed_id": "10037079",
        "score": 0.6769758462905884,
        "title": "Pendred's syndrome: identification of the genetic defect a century after its recognition.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10037079"
      },
      {
        "pubmed_id": "16482981",
        "score": 0.6701885461807251,
        "title": "Pendred syndrome: study of three families.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16482981"
      },
      {
        "pubmed_id": "9070918",
        "score": 0.648253321647644,
        "title": "The gene for Pendred syndrome is located between D7S501 and D7S692 in a 1.7-cM region on chromosome 7q.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9070918"
      },
      {
        "pubmed_id": "11375792",
        "score": 0.6351245641708374,
        "title": "Clinical and molecular analysis of three Mexican families with Pendred's syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11375792"
      },
      {
        "pubmed_id": "9920104",
        "score": 0.6313742399215698,
        "title": "Phenocopies for deafness and goiter development in a large inbred Brazilian kindred with Pendred's syndrome associated with a novel mutation in the PDS gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9920104"
      },
      {
        "pubmed_id": "9585042",
        "score": 0.6282358169555664,
        "title": "Radiological malformations of the ear in Pendred syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9585042"
      },
      {
        "pubmed_id": "8979104",
        "score": 0.6257760524749756,
        "title": "A case of Pendred's syndrome presenting with amenorrhea.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8979104"
      }
    ],
    "query_time": 0.021099090576171875,
    "metrics": {
      "precision": 1.0,
      "recall": 0.3448275862068966,
      "f1_score": 0.5128205128205129,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 29
    }
  },
  "5721f6f90fd6f91b68000012": {
    "query": "Are seizures among the neurological symptoms of incontinentia pigmenti?",
    "type": "yesno",
    "ideal_answer": [
      "Incontinentia pigmenti is an X-linked dominant disorder resulting from a mutation of IKBKG. This disorder has a classic dermatologic presentation, but neurologic involvement, with seizures and cortical infarction, can arise shortly after birth."
    ],
    "ground_truth_ids": [
      "22564885",
      "15127315",
      "24682289",
      "13679126",
      "12437562",
      "23622185",
      "25238668",
      "17990592"
    ],
    "retrieved_ids": [
      "22564885",
      "17990592",
      "13679126",
      "12437562",
      "15127315",
      "24682289",
      "23622185",
      "25238668",
      "17876417",
      "3338422"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "22564885",
        "score": 0.7666758894920349,
        "title": "Neurological findings in incontinentia pigmenti; a review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22564885"
      },
      {
        "pubmed_id": "17990592",
        "score": 0.7595869898796082,
        "title": "A rare cause of neonatal seizure: incontinentia pigmenti.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17990592"
      },
      {
        "pubmed_id": "13679126",
        "score": 0.6838057637214661,
        "title": "Bilateral cerebrovascular accidents in incontinentia pigmenti.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/13679126"
      },
      {
        "pubmed_id": "12437562",
        "score": 0.6661458015441895,
        "title": "Incontinentia pigmenti presenting as seizures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12437562"
      },
      {
        "pubmed_id": "15127315",
        "score": 0.642410933971405,
        "title": "Neonatal seizures in two sisters with incontinentia pigmenti.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15127315"
      },
      {
        "pubmed_id": "24682289",
        "score": 0.6325241923332214,
        "title": "High-dose glucocorticoid therapy in the management of seizures in neonatal incontinentia pigmenti: a case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24682289"
      },
      {
        "pubmed_id": "23622185",
        "score": 0.599554717540741,
        "title": "Incontinentia pigmenti and hypomelanosis of Ito.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23622185"
      },
      {
        "pubmed_id": "25238668",
        "score": 0.5651160478591919,
        "title": "Cerebrospinal fluid oxidative stress marker levels and cytokine concentrations in a neonate with incontinentia pigmenti.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25238668"
      },
      {
        "pubmed_id": "17876417",
        "score": 0.43937522172927856,
        "title": "De Morsier syndrome associated with periventricular nodular heterotopia: case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17876417"
      },
      {
        "pubmed_id": "3338422",
        "score": 0.4393085241317749,
        "title": "Hot-water epilepsy: a variant of reflex epilepsy in southern India.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3338422"
      }
    ],
    "query_time": 0.00985407829284668,
    "metrics": {
      "precision": 0.8,
      "recall": 1.0,
      "f1_score": 0.888888888888889,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "65cfd8551930410b13000023": {
    "query": "Is vemurafenib–cobimetinib promising for craniopharyngioma?",
    "type": "yesno",
    "ideal_answer": [
      "Yes. Vemurafenib–cobimetinib showed promising for craniopharyngioma"
    ],
    "ground_truth_ids": [
      "37477404",
      "37437144",
      "35169097"
    ],
    "retrieved_ids": [
      "37477404",
      "35169097",
      "37437144",
      "25125216",
      "28475456",
      "24638239",
      "29290671",
      "23754473",
      "28185174",
      "22861192"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "37477404",
        "score": 0.6933265924453735,
        "title": "BRAF-MEK Inhibition Is Effective in BRAFV600E-Mutant Papillary Craniopharyngioma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37477404"
      },
      {
        "pubmed_id": "35169097",
        "score": 0.6455512046813965,
        "title": "[Molecularly Targeted Therapy for Craniopharyngioma].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35169097"
      },
      {
        "pubmed_id": "37437144",
        "score": 0.595712423324585,
        "title": "BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37437144"
      },
      {
        "pubmed_id": "25125216",
        "score": 0.5021990537643433,
        "title": "Uveitis in patients with late-stage cutaneous melanoma treated with vemurafenib.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25125216"
      },
      {
        "pubmed_id": "28475456",
        "score": 0.4478386640548706,
        "title": "Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28475456"
      },
      {
        "pubmed_id": "24638239",
        "score": 0.4353322982788086,
        "title": "Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24638239"
      },
      {
        "pubmed_id": "29290671",
        "score": 0.4242493808269501,
        "title": "Pharmaceutical Approval Update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29290671"
      },
      {
        "pubmed_id": "23754473",
        "score": 0.4084463119506836,
        "title": "Craniospinal irradiation with concurrent temozolomide and nimotuzumab in a child with primary metastatic diffuse intrinsic pontine glioma. A compassionate use treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23754473"
      },
      {
        "pubmed_id": "28185174",
        "score": 0.4069681763648987,
        "title": "Current Treatment of Chronic Lymphocytic Leukemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28185174"
      },
      {
        "pubmed_id": "22861192",
        "score": 0.4011862874031067,
        "title": "A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22861192"
      }
    ],
    "query_time": 0.01425313949584961,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "6026ee821cb411341a0000d3": {
    "query": "Is eptinezumab a small molecule?",
    "type": "yesno",
    "ideal_answer": [
      "No, eptinezumab is a humanized monoclonal antibody."
    ],
    "ground_truth_ids": [
      "32266704"
    ],
    "retrieved_ids": [
      "32266704",
      "37877814",
      "18181050",
      "18089715",
      "37632081",
      "29772459",
      "22374425",
      "16951161",
      "24304894",
      "34884633"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "32266704",
        "score": 0.5300827026367188,
        "title": "Eptinezumab: First Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32266704"
      },
      {
        "pubmed_id": "37877814",
        "score": 0.45078861713409424,
        "title": "Tarlatamab Shows Promise in SCLC.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37877814"
      },
      {
        "pubmed_id": "18181050",
        "score": 0.44164443016052246,
        "title": "Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18181050"
      },
      {
        "pubmed_id": "18089715",
        "score": 0.396212100982666,
        "title": "A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18089715"
      },
      {
        "pubmed_id": "37632081",
        "score": 0.386965274810791,
        "title": "Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37632081"
      },
      {
        "pubmed_id": "29772459",
        "score": 0.3834799528121948,
        "title": "Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29772459"
      },
      {
        "pubmed_id": "22374425",
        "score": 0.3800494074821472,
        "title": "Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22374425"
      },
      {
        "pubmed_id": "16951161",
        "score": 0.37678462266921997,
        "title": "Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16951161"
      },
      {
        "pubmed_id": "24304894",
        "score": 0.369597852230072,
        "title": "canSAR: updated cancer research and drug discovery knowledgebase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24304894"
      },
      {
        "pubmed_id": "34884633",
        "score": 0.3693293333053589,
        "title": "The Role of EREG/EGFR Pathway in Tumor Progression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34884633"
      }
    ],
    "query_time": 0.01891613006591797,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "589206fc49702f2e01000003": {
    "query": "Are there methods for generating highly multiplexed ChIP-seq libraries?",
    "type": "yesno",
    "ideal_answer": [
      "Yes. There are methods for generating highly multiplexed ChIP-seq libraries."
    ],
    "ground_truth_ids": [
      "24885602"
    ],
    "retrieved_ids": [
      "24885602",
      "23658991",
      "26026138",
      "24903420",
      "29046896",
      "24267901",
      "20417644",
      "23066097",
      "27540265",
      "33543619"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24885602",
        "score": 0.6243119239807129,
        "title": "A method for generating highly multiplexed ChIP-seq libraries.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24885602"
      },
      {
        "pubmed_id": "23658991",
        "score": 0.41000887751579285,
        "title": "Blood - SeV derived fibroblast generated iPSCs",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23658991"
      },
      {
        "pubmed_id": "26026138",
        "score": 0.3339909315109253,
        "title": "QVZ: lossy compression of quality values.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26026138"
      },
      {
        "pubmed_id": "24903420",
        "score": 0.2927357852458954,
        "title": "Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24903420"
      },
      {
        "pubmed_id": "29046896",
        "score": 0.29247912764549255,
        "title": "GeneComp, a new reference-based compressor for SAM files.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29046896"
      },
      {
        "pubmed_id": "24267901",
        "score": 0.29041919112205505,
        "title": "MMDiff: quantitative testing for shape changes in ChIP-Seq data sets.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24267901"
      },
      {
        "pubmed_id": "20417644",
        "score": 0.2785676419734955,
        "title": "Processive selenocysteine incorporation during synthesis of eukaryotic selenoproteins.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20417644"
      },
      {
        "pubmed_id": "23066097",
        "score": 0.2745216190814972,
        "title": "NGC: lossless and lossy compression of aligned high-throughput sequencing data.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23066097"
      },
      {
        "pubmed_id": "27540265",
        "score": 0.2736462950706482,
        "title": "CSAM: Compressed SAM format.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27540265"
      },
      {
        "pubmed_id": "33543619",
        "score": 0.2674216628074646,
        "title": "Real-Time Optogenetics System for Controlling Gene Expression Using a Model-Based Design.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33543619"
      }
    ],
    "query_time": 0.011174201965332031,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "642d4c9b57b1c7a315000013": {
    "query": "Are Luminopsins a fusion proteins of luminol and Rhodopsin ?",
    "type": "yesno",
    "ideal_answer": [
      "No, Luminopsins are fusion proteins of light-sensing opsins and light-emitting luciferases.",
      "No, Luminopsins are a family of light-activated proteins that are related to rhodopsin, but are not fusion proteins of luminol and rhodopsin.",
      "No, luminopsins are fusion proteins of light-sensing opsins and light-emitting luciferases, not luminol and rhodopsin.",
      "No. Luminopsins are light-sensing opsins fused to light-emitting luciferases.",
      "Luminopsins are fusion proteins of luciferase and opsin that allow interrogation of neuronal circuits at different temporal and spatial resolutions using light for its activation.",
      "No, Luminopsins are fusion proteins of luciferase and opsin."
    ],
    "ground_truth_ids": [
      "33398820",
      "26733686",
      "31263065",
      "30957296",
      "28862809"
    ],
    "retrieved_ids": [
      "26733686",
      "30957296",
      "33398820",
      "28862809",
      "32407927",
      "18995839",
      "21267417",
      "12123827",
      "21484537",
      "23552370"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "26733686",
        "score": 0.5411780476570129,
        "title": "Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26733686"
      },
      {
        "pubmed_id": "30957296",
        "score": 0.539276123046875,
        "title": "Step-function luminopsins for bimodal prolonged neuromodulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30957296"
      },
      {
        "pubmed_id": "33398820",
        "score": 0.5374415516853333,
        "title": "Bioluminescence-Optogenetics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33398820"
      },
      {
        "pubmed_id": "28862809",
        "score": 0.5102801322937012,
        "title": "Novel luciferase-opsin combinations for improved luminopsins.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28862809"
      },
      {
        "pubmed_id": "32407927",
        "score": 0.46156972646713257,
        "title": "Luteolin prevents liver from tunicamycin-induced endoplasmic reticulum stress via nuclear factor erythroid 2-related factor 2-dependent sestrin 2 induction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32407927"
      },
      {
        "pubmed_id": "18995839",
        "score": 0.4128377437591553,
        "title": "Extraproteasomal Rpn10 restricts access of the polyubiquitin-binding protein Dsk2 to proteasome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18995839"
      },
      {
        "pubmed_id": "21267417",
        "score": 0.40620023012161255,
        "title": "Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21267417"
      },
      {
        "pubmed_id": "12123827",
        "score": 0.4032834768295288,
        "title": "The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12123827"
      },
      {
        "pubmed_id": "21484537",
        "score": 0.38938820362091064,
        "title": "MLP (muscle LIM protein) as a stress sensor in the heart.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21484537"
      },
      {
        "pubmed_id": "23552370",
        "score": 0.3853749930858612,
        "title": "Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23552370"
      }
    ],
    "query_time": 0.01218271255493164,
    "metrics": {
      "precision": 0.4,
      "recall": 0.8,
      "f1_score": 0.5333333333333333,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "5a9d79ca1d1251d03b00001d": {
    "query": "Is the gene CDKN2A nevogenic?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, CDKN2A is nevogenic"
    ],
    "ground_truth_ids": [
      "15304099",
      "28830827",
      "475444",
      "12406345",
      "10620111"
    ],
    "retrieved_ids": [
      "12406345",
      "10620111",
      "28830827",
      "12481988",
      "22160078",
      "19203856",
      "27833949",
      "16775366",
      "25326399",
      "15304099"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "12406345",
        "score": 0.5332780480384827,
        "title": "An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12406345"
      },
      {
        "pubmed_id": "10620111",
        "score": 0.5141793489456177,
        "title": "Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10620111"
      },
      {
        "pubmed_id": "28830827",
        "score": 0.47379201650619507,
        "title": "Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28830827"
      },
      {
        "pubmed_id": "12481988",
        "score": 0.4659935235977173,
        "title": "A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12481988"
      },
      {
        "pubmed_id": "22160078",
        "score": 0.4399150609970093,
        "title": "Dyskeratosis congenita.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22160078"
      },
      {
        "pubmed_id": "19203856",
        "score": 0.4379517734050751,
        "title": "Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19203856"
      },
      {
        "pubmed_id": "27833949",
        "score": 0.42666029930114746,
        "title": "The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27833949"
      },
      {
        "pubmed_id": "16775366",
        "score": 0.4117757976055145,
        "title": "Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16775366"
      },
      {
        "pubmed_id": "25326399",
        "score": 0.409473180770874,
        "title": "Intermediate Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25326399"
      },
      {
        "pubmed_id": "15304099",
        "score": 0.40743082761764526,
        "title": "Longitudinal assessment of the nevus phenotype in a melanoma kindred.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15304099"
      }
    ],
    "query_time": 0.018458843231201172,
    "metrics": {
      "precision": 0.4,
      "recall": 0.8,
      "f1_score": 0.5333333333333333,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "517404878ed59a060a000023": {
    "query": "Are histone deacetylase (HDAC) inhibitors good candidates to control metastasis of solid tumors?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, some HDAC inhibitors, such as Vorinostat, are on trial for human treatment after proving successful in animal models. Combination with other drugs is likely to be needed to control metastasis."
    ],
    "ground_truth_ids": [
      "19417021",
      "20884621",
      "22279574",
      "21041383",
      "22038994",
      "22811583",
      "10893438",
      "18506586",
      "15800932",
      "21452015",
      "19789319",
      "19509253",
      "18981013",
      "19861438",
      "22161747",
      "15318170"
    ],
    "retrieved_ids": [
      "22811583",
      "19861438",
      "19417021",
      "15800932",
      "22279574",
      "21452015",
      "10893438",
      "20884621",
      "18506586",
      "25410383"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "22811583",
        "score": 0.6981168389320374,
        "title": "HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22811583"
      },
      {
        "pubmed_id": "19861438",
        "score": 0.67973792552948,
        "title": "JNJ-26481585, a novel \"second-generation\" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19861438"
      },
      {
        "pubmed_id": "19417021",
        "score": 0.6170297265052795,
        "title": "Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of soft tissue sarcoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19417021"
      },
      {
        "pubmed_id": "15800932",
        "score": 0.6140855550765991,
        "title": "In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15800932"
      },
      {
        "pubmed_id": "22279574",
        "score": 0.6137492656707764,
        "title": "Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22279574"
      },
      {
        "pubmed_id": "21452015",
        "score": 0.6061118841171265,
        "title": "Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21452015"
      },
      {
        "pubmed_id": "10893438",
        "score": 0.5800158381462097,
        "title": "Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10893438"
      },
      {
        "pubmed_id": "20884621",
        "score": 0.5760748386383057,
        "title": "Synergistic killing effect between vorinostat and target of CD146 in malignant cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20884621"
      },
      {
        "pubmed_id": "18506586",
        "score": 0.576030969619751,
        "title": "Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18506586"
      },
      {
        "pubmed_id": "25410383",
        "score": 0.5739293098449707,
        "title": "Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25410383"
      }
    ],
    "query_time": 0.008140087127685547,
    "metrics": {
      "precision": 0.9,
      "recall": 0.5625,
      "f1_score": 0.6923076923076923,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 16
    }
  },
  "58df5efbc784871774000001": {
    "query": "Is dupilumab an antibody targeting the IL-1 receptor?",
    "type": "yesno",
    "ideal_answer": [
      "No, Dupilumab is a fully human monoclonal antibody directed against the IL-4 receptor α subunit that blocks the signaling of IL-4 and IL-13, both key cytokines in Th2-mediated pathways."
    ],
    "ground_truth_ids": [
      "26440137",
      "27130691",
      "27690741",
      "26598956",
      "23688323",
      "27497276",
      "26308331"
    ],
    "retrieved_ids": [
      "26598956",
      "29140105",
      "27690741",
      "23688323",
      "26308331",
      "26313415",
      "29486607",
      "27130691",
      "26105702",
      "26440137"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "26598956",
        "score": 0.5803415775299072,
        "title": "Drug evaluation review: dupilumab in atopic dermatitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26598956"
      },
      {
        "pubmed_id": "29140105",
        "score": 0.5710635185241699,
        "title": "Durvalumab in non-small-cell lung cancer patients: current developments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29140105"
      },
      {
        "pubmed_id": "27690741",
        "score": 0.5446979999542236,
        "title": "Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27690741"
      },
      {
        "pubmed_id": "23688323",
        "score": 0.5359017252922058,
        "title": "Dupilumab in persistent asthma with elevated eosinophil levels.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23688323"
      },
      {
        "pubmed_id": "26308331",
        "score": 0.5343661904335022,
        "title": "Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26308331"
      },
      {
        "pubmed_id": "26313415",
        "score": 0.5180545449256897,
        "title": "Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26313415"
      },
      {
        "pubmed_id": "29486607",
        "score": 0.5170450210571289,
        "title": "Durvalumab in urothelial cancers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29486607"
      },
      {
        "pubmed_id": "27130691",
        "score": 0.5099532604217529,
        "title": "Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27130691"
      },
      {
        "pubmed_id": "26105702",
        "score": 0.5022242069244385,
        "title": "Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26105702"
      },
      {
        "pubmed_id": "26440137",
        "score": 0.4993530213832855,
        "title": "Interleukin 4 inhibition as a potential therapeutic in pemphigus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26440137"
      }
    ],
    "query_time": 0.006368160247802734,
    "metrics": {
      "precision": 0.6,
      "recall": 0.8571428571428571,
      "f1_score": 0.7058823529411764,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 7
    }
  },
  "5e8220e6835f4e4777000032": {
    "query": "Is Protoporphyrinogen oxidase localized to the mitochondrium?",
    "type": "yesno",
    "ideal_answer": [
      "Yes,\nMitochondrial targeting of human protoporphyrinogen oxidase."
    ],
    "ground_truth_ids": [
      "12556518",
      "20603160",
      "16621625"
    ],
    "retrieved_ids": [
      "16621625",
      "12556518",
      "20603160",
      "21913110",
      "23970761",
      "23844381",
      "12123827",
      "21778829",
      "34688664",
      "20616380"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "16621625",
        "score": 0.6702262163162231,
        "title": "Mitochondrial targeting of human protoporphyrinogen oxidase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16621625"
      },
      {
        "pubmed_id": "12556518",
        "score": 0.6463998556137085,
        "title": "Mitochondrial targeting of normal and mutant protoporphyrinogen oxidase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12556518"
      },
      {
        "pubmed_id": "20603160",
        "score": 0.626417875289917,
        "title": "Protoporphyrinogen IX oxidase from Plasmodium falciparum is anaerobic and is localized to the mitochondrion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20603160"
      },
      {
        "pubmed_id": "21913110",
        "score": 0.4656139016151428,
        "title": "Monitoring mitophagy in neuronal cell cultures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21913110"
      },
      {
        "pubmed_id": "23970761",
        "score": 0.44619619846343994,
        "title": "Thyroid hormone, thyromimetics, and metabolic efficiency.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23970761"
      },
      {
        "pubmed_id": "23844381",
        "score": 0.4342382550239563,
        "title": "Biophysical insights into cancer transformation and treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23844381"
      },
      {
        "pubmed_id": "12123827",
        "score": 0.4288588762283325,
        "title": "The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12123827"
      },
      {
        "pubmed_id": "21778829",
        "score": 0.42168113589286804,
        "title": "Cancer cells metabolically \"fertilize\" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21778829"
      },
      {
        "pubmed_id": "34688664",
        "score": 0.4212401509284973,
        "title": "Regulation of mitochondrial cargo-selective autophagy by posttranslational modifications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34688664"
      },
      {
        "pubmed_id": "20616380",
        "score": 0.41498902440071106,
        "title": "Putative mutation mechanism and light responses of a protochlorophyllide oxidoreductase-less barley mutant NYB.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20616380"
      }
    ],
    "query_time": 0.01168513298034668,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "56b8ed4b156496395c000004": {
    "query": "Is there any link between conserved noncoding elements and alternative splicing in vertebrates?",
    "type": "yesno",
    "ideal_answer": [
      "Yes. Some of the most highly conserved sequences occur in genes encoding RNA binding proteins, particularly the RNA splicing-associated SR genes."
    ],
    "ground_truth_ids": [
      "24681619"
    ],
    "retrieved_ids": [
      "24681619",
      "26527719",
      "22156210",
      "21622663",
      "23097425",
      "23074139",
      "22975042",
      "18045502",
      "22955974",
      "15383674"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24681619",
        "score": 0.5958566665649414,
        "title": "The most deeply conserved noncoding sequences in plants serve similar functions to those in vertebrates despite large differences in evolutionary rates.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24681619"
      },
      {
        "pubmed_id": "26527719",
        "score": 0.5887377858161926,
        "title": "CEGA--a catalog of conserved elements from genomic alignments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26527719"
      },
      {
        "pubmed_id": "22156210",
        "score": 0.560490608215332,
        "title": "Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in Drosophila.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22156210"
      },
      {
        "pubmed_id": "21622663",
        "score": 0.5500848889350891,
        "title": "Computational discovery of human coding and non-coding transcripts with conserved splice sites.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21622663"
      },
      {
        "pubmed_id": "23097425",
        "score": 0.5493354201316833,
        "title": "Cotranscriptional splicing efficiency differs dramatically between Drosophila and mouse.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23097425"
      },
      {
        "pubmed_id": "23074139",
        "score": 0.5434184074401855,
        "title": "Connections between chromatin signatures and splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23074139"
      },
      {
        "pubmed_id": "22975042",
        "score": 0.538554310798645,
        "title": "Transcriptional elongation and alternative splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22975042"
      },
      {
        "pubmed_id": "18045502",
        "score": 0.5345660448074341,
        "title": "TFCONES: a database of vertebrate transcription factor-encoding genes and their associated conserved noncoding elements.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18045502"
      },
      {
        "pubmed_id": "22955974",
        "score": 0.5323553085327148,
        "title": "Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22955974"
      },
      {
        "pubmed_id": "15383674",
        "score": 0.5273538827896118,
        "title": "Multiple links between transcription and splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15383674"
      }
    ],
    "query_time": 0.01407170295715332,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5e48b9abd14c9f295d000015": {
    "query": "Are multipotent adult progenitor cells effective for treatment of stroke?",
    "type": "yesno",
    "ideal_answer": [
      "No. There was no difference between the multipotent adult progenitor cell group and placebo groups in global stroke recovery at day 90. Further clinical trials evaluating the efficacy of the intervention in an earlier time window after stroke (<36 h) are planned."
    ],
    "ground_truth_ids": [
      "28320635"
    ],
    "retrieved_ids": [
      "28320635",
      "31263065",
      "22318706",
      "24139673",
      "25542761",
      "18685925",
      "21839145",
      "19907881",
      "29744576",
      "23104133"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28320635",
        "score": 0.732386589050293,
        "title": "Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28320635"
      },
      {
        "pubmed_id": "31263065",
        "score": 0.5680843591690063,
        "title": "Optochemogenetic Stimulation of Transplanted iPS-NPCs Enhances Neuronal Repair and Functional Recovery after Ischemic Stroke.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31263065"
      },
      {
        "pubmed_id": "22318706",
        "score": 0.4406368136405945,
        "title": "Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22318706"
      },
      {
        "pubmed_id": "24139673",
        "score": 0.41766357421875,
        "title": "Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24139673"
      },
      {
        "pubmed_id": "25542761",
        "score": 0.41161537170410156,
        "title": "Academic year-end changeover and stroke outcomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25542761"
      },
      {
        "pubmed_id": "18685925",
        "score": 0.4055739641189575,
        "title": "Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18685925"
      },
      {
        "pubmed_id": "21839145",
        "score": 0.40530920028686523,
        "title": "Induction of pluripotent stem cells from autopsy donor-derived somatic cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21839145"
      },
      {
        "pubmed_id": "19907881",
        "score": 0.4014362394809723,
        "title": "Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19907881"
      },
      {
        "pubmed_id": "29744576",
        "score": 0.3958316445350647,
        "title": "The lysosomal function of progranulin, a guardian against neurodegeneration.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29744576"
      },
      {
        "pubmed_id": "23104133",
        "score": 0.3901102542877197,
        "title": "Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23104133"
      }
    ],
    "query_time": 0.014610052108764648,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "517395b98ed59a060a00001a": {
    "query": "Are transcription and splicing connected?",
    "type": "yesno",
    "ideal_answer": [
      "Yes. There is strong evidence that splicing and transcription are intimately coupled in metazoans, with  genome wide surveys show that most splicing occurs during transcription. Chromatin structure, RNA polymerase dynamics, and recruitment of splicing factors through the transcriptional machinery are factors that explain a role for transcription in the regulation of splicing."
    ],
    "ground_truth_ids": [
      "20808788",
      "23074139",
      "23097425",
      "17189193",
      "21964334",
      "16921380",
      "15870275",
      "22479188",
      "15383674",
      "15905409",
      "21095588",
      "16172632",
      "22975042",
      "22156210",
      "23209445",
      "16769980"
    ],
    "retrieved_ids": [
      "15383674",
      "22975042",
      "23074139",
      "22955974",
      "17189193",
      "21095588",
      "18050426",
      "22156210",
      "16172632",
      "16921380"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "15383674",
        "score": 0.6776752471923828,
        "title": "Multiple links between transcription and splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15383674"
      },
      {
        "pubmed_id": "22975042",
        "score": 0.6763467788696289,
        "title": "Transcriptional elongation and alternative splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22975042"
      },
      {
        "pubmed_id": "23074139",
        "score": 0.6502496004104614,
        "title": "Connections between chromatin signatures and splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23074139"
      },
      {
        "pubmed_id": "22955974",
        "score": 0.63808673620224,
        "title": "Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22955974"
      },
      {
        "pubmed_id": "17189193",
        "score": 0.6204214096069336,
        "title": "A genome-wide analysis indicates that yeast pre-mRNA splicing is predominantly posttranscriptional.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17189193"
      },
      {
        "pubmed_id": "21095588",
        "score": 0.6135731935501099,
        "title": "Splicing-dependent RNA polymerase pausing in yeast.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21095588"
      },
      {
        "pubmed_id": "18050426",
        "score": 0.6057192087173462,
        "title": "Trans-splicing and operons.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18050426"
      },
      {
        "pubmed_id": "22156210",
        "score": 0.6004655361175537,
        "title": "Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in Drosophila.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22156210"
      },
      {
        "pubmed_id": "16172632",
        "score": 0.5753004550933838,
        "title": "Analysis of a splice array experiment elucidates roles of chromatin elongation factor Spt4-5 in splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16172632"
      },
      {
        "pubmed_id": "16921380",
        "score": 0.5699630975723267,
        "title": "Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16921380"
      }
    ],
    "query_time": 0.02013111114501953,
    "metrics": {
      "precision": 0.8,
      "recall": 0.5,
      "f1_score": 0.6153846153846154,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 16
    }
  },
  "58bdc76102b8c60953000013": {
    "query": "Does the hERG gene code for a protein which is part of a sodium channel?",
    "type": "yesno",
    "ideal_answer": [
      "The hERG AKA Human ether-a-go-go-related gene coded for a protein subunit of a potassium channel that conducts delayed rectifier K(+) current"
    ],
    "ground_truth_ids": [
      "26363003",
      "24475291",
      "18250496",
      "14975928",
      "25498859",
      "8521555",
      "25247487",
      "17882949",
      "16244363",
      "9556090",
      "19139152",
      "25218469",
      "24154981",
      "8873679",
      "10613047",
      "23103450",
      "12142119",
      "8995352",
      "24642409",
      "16472284",
      "16967046",
      "12063277",
      "17311278",
      "10816797",
      "26775140",
      "24045971",
      "26659724",
      "26519040",
      "8587608",
      "23792956",
      "9272507",
      "10531299",
      "9570196",
      "18617000",
      "9272155",
      "10483966"
    ],
    "retrieved_ids": [
      "8995352",
      "14975928",
      "19203856",
      "8587608",
      "24154981",
      "25218469",
      "9556090",
      "9272155",
      "8873679",
      "9570196"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "8995352",
        "score": 0.5500204563140869,
        "title": "The human delta1261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8995352"
      },
      {
        "pubmed_id": "14975928",
        "score": 0.5221389532089233,
        "title": "Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14975928"
      },
      {
        "pubmed_id": "19203856",
        "score": 0.5027815103530884,
        "title": "Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19203856"
      },
      {
        "pubmed_id": "8587608",
        "score": 0.49937674403190613,
        "title": "The inward rectification mechanism of the HERG cardiac potassium channel.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8587608"
      },
      {
        "pubmed_id": "24154981",
        "score": 0.4965444803237915,
        "title": "Screening for cardiac HERG potassium channel interacting proteins using the yeast two-hybrid technique.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24154981"
      },
      {
        "pubmed_id": "25218469",
        "score": 0.4947165846824646,
        "title": "Down-regulation of ether-a-go-go-related gene potassium channel protein through sustained stimulation of AT1 receptor by angiotensin II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25218469"
      },
      {
        "pubmed_id": "9556090",
        "score": 0.4946827292442322,
        "title": "Genetics, molecular mechanisms and management of long QT syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9556090"
      },
      {
        "pubmed_id": "9272155",
        "score": 0.49268659949302673,
        "title": "The long QT syndrome: a novel missense mutation in the S6 region of the KVLQT1 gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9272155"
      },
      {
        "pubmed_id": "8873679",
        "score": 0.489197701215744,
        "title": "Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8873679"
      },
      {
        "pubmed_id": "9570196",
        "score": 0.4884551465511322,
        "title": "New mutations in the KVLQT1 potassium channel that cause long-QT syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9570196"
      }
    ],
    "query_time": 0.007185935974121094,
    "metrics": {
      "precision": 0.9,
      "recall": 0.25,
      "f1_score": 0.391304347826087,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 36
    }
  },
  "5e763645c6a8763d2300000d": {
    "query": "Has ORMD-0801 been tested in patients?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, ORMD-0801 has been tested in patients."
    ],
    "ground_truth_ids": [
      "23593142"
    ],
    "retrieved_ids": [
      "23593142",
      "21142259",
      "27141070",
      "21274361",
      "18852208",
      "24868211",
      "1703815",
      "31415087",
      "21985171",
      "30403405"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23593142",
        "score": 0.44193583726882935,
        "title": "Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23593142"
      },
      {
        "pubmed_id": "21142259",
        "score": 0.36076945066452026,
        "title": "Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21142259"
      },
      {
        "pubmed_id": "27141070",
        "score": 0.35959938168525696,
        "title": "PARP inhibitors in ovarian cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27141070"
      },
      {
        "pubmed_id": "21274361",
        "score": 0.3593447208404541,
        "title": "Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21274361"
      },
      {
        "pubmed_id": "18852208",
        "score": 0.35902881622314453,
        "title": "The regulation of direct-to-consumer genetic tests.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18852208"
      },
      {
        "pubmed_id": "24868211",
        "score": 0.3585399091243744,
        "title": "Critical Analysis of PIM2 Score Applicability in a Tertiary Care PICU in Western India.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24868211"
      },
      {
        "pubmed_id": "1703815",
        "score": 0.35853180289268494,
        "title": "[10 years plasma exchange with the IBM (Cobe) 2997].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1703815"
      },
      {
        "pubmed_id": "31415087",
        "score": 0.35725483298301697,
        "title": "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31415087"
      },
      {
        "pubmed_id": "21985171",
        "score": 0.35657042264938354,
        "title": "Apixaban: first global approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21985171"
      },
      {
        "pubmed_id": "30403405",
        "score": 0.3564090430736542,
        "title": "Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30403405"
      }
    ],
    "query_time": 0.018211841583251953,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "531d34be267d7dd053000004": {
    "query": "Has the presence of delayed enhancement been documented in athletes performing strenuous exercise?",
    "type": "yesno",
    "ideal_answer": [
      "There are contrasting literature data on the presence of delayed enhancement, as a sign of myocardial fibrosis, in healthy athletes. More studies are necessary to define the presence, incidence and severity, as well clinical and prognostic meaning, of delayed enhancement magnetic resonance in healthy athletes."
    ],
    "ground_truth_ids": [
      "22160404",
      "19427448",
      "22798307",
      "8902021",
      "24029371",
      "24326931",
      "19332846"
    ],
    "retrieved_ids": [
      "8902021",
      "22798307",
      "15385857",
      "24029371",
      "22160404",
      "19332846",
      "19427448",
      "24326931",
      "30180785",
      "24762862"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "8902021",
        "score": 0.5864046812057495,
        "title": "Cognitive performance after strenuous physical exercise.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8902021"
      },
      {
        "pubmed_id": "22798307",
        "score": 0.5088598132133484,
        "title": "Delayed enhancement of the intraventricular septum following an extraordinary endurance exercise.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22798307"
      },
      {
        "pubmed_id": "15385857",
        "score": 0.5054754614830017,
        "title": "Exercise and urinary incontinence in women.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15385857"
      },
      {
        "pubmed_id": "24029371",
        "score": 0.47100380063056946,
        "title": "Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24029371"
      },
      {
        "pubmed_id": "22160404",
        "score": 0.46500101685523987,
        "title": "Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22160404"
      },
      {
        "pubmed_id": "19332846",
        "score": 0.4165170192718506,
        "title": "Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19332846"
      },
      {
        "pubmed_id": "19427448",
        "score": 0.4143606722354889,
        "title": "Relation of biomarkers and cardiac magnetic resonance imaging after marathon running.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19427448"
      },
      {
        "pubmed_id": "24326931",
        "score": 0.38606852293014526,
        "title": "The role of magnetic resonance imaging in a Division I university sports medicine program.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24326931"
      },
      {
        "pubmed_id": "30180785",
        "score": 0.38116705417633057,
        "title": "Lower Limb Flexibility in Children With Duchenne Muscular Dystrophy: Effects on Functional Performance.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30180785"
      },
      {
        "pubmed_id": "24762862",
        "score": 0.37575769424438477,
        "title": "Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24762862"
      }
    ],
    "query_time": 0.015055179595947266,
    "metrics": {
      "precision": 0.7,
      "recall": 1.0,
      "f1_score": 0.8235294117647058,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 7,
      "total_retrieved": 10,
      "total_relevant": 7
    }
  },
  "5e43ee1f48dab47f26000012": {
    "query": "Do circular exons increase gene expression?",
    "type": "yesno",
    "ideal_answer": [
      "circRNAs might adsorb specific miRNAs to regulate the expression of their target gene mRNAs. They can thus lead to both over- and under-expression of mRNAs."
    ],
    "ground_truth_ids": [
      "25253891",
      "28634583",
      "21151960",
      "30136305",
      "28184940",
      "8652136"
    ],
    "retrieved_ids": [
      "20808788",
      "28634583",
      "25526687",
      "22454066",
      "24380394",
      "30171554",
      "20951677",
      "17612397",
      "23097425",
      "21964334"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "20808788",
        "score": 0.5213397741317749,
        "title": "Complex exon-intron marking by histone modifications is not determined solely by nucleosome distribution.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20808788"
      },
      {
        "pubmed_id": "28634583",
        "score": 0.46164435148239136,
        "title": "Circular RNAs: Biogenesis, Function and Role in Human Diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28634583"
      },
      {
        "pubmed_id": "25526687",
        "score": 0.43979454040527344,
        "title": "Histone modifications involved in cassette exon inclusions: a quantitative and interpretable analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25526687"
      },
      {
        "pubmed_id": "22454066",
        "score": 0.41673001646995544,
        "title": "U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22454066"
      },
      {
        "pubmed_id": "24380394",
        "score": 0.41156190633773804,
        "title": "Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24380394"
      },
      {
        "pubmed_id": "30171554",
        "score": 0.40642988681793213,
        "title": "In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30171554"
      },
      {
        "pubmed_id": "20951677",
        "score": 0.39788129925727844,
        "title": "Cell-specific regulation of Fas exon 6 splicing mediated by Hu antigen R.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20951677"
      },
      {
        "pubmed_id": "17612397",
        "score": 0.3949112296104431,
        "title": "Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17612397"
      },
      {
        "pubmed_id": "23097425",
        "score": 0.3913441002368927,
        "title": "Cotranscriptional splicing efficiency differs dramatically between Drosophila and mouse.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23097425"
      },
      {
        "pubmed_id": "21964334",
        "score": 0.38949766755104065,
        "title": "CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21964334"
      }
    ],
    "query_time": 0.012719869613647461,
    "metrics": {
      "precision": 0.1,
      "recall": 0.16666666666666666,
      "f1_score": 0.125,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "5321b4959b2d7acc7e000007": {
    "query": "Is transcapillary  albumin escape altered in diabetic patients?",
    "type": "yesno",
    "ideal_answer": [
      "An altered TERalb is present in type 2 diabetic patients, both with normal and altered patterns of AER.\nTERalb is increased also in normo-albuminuric type 1 diabetic patients."
    ],
    "ground_truth_ids": [
      "2060321",
      "21219847",
      "15616033",
      "2951101",
      "2949917",
      "3522326",
      "10922975",
      "7579054",
      "22950063",
      "6642091",
      "1619500",
      "18347777",
      "10703889",
      "3569694",
      "10027580",
      "2210073",
      "11395874",
      "8712223",
      "10405209",
      "2970919",
      "378740",
      "1547928",
      "9536925",
      "8960847",
      "22516624",
      "7698029",
      "8187356",
      "18712042",
      "8436254",
      "15581746",
      "15019550"
    ],
    "retrieved_ids": [
      "3522326",
      "6642091",
      "3569694",
      "8436254",
      "7698029",
      "10703889",
      "2210073",
      "2949917",
      "15581746",
      "2970919"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "3522326",
        "score": 0.8183931708335876,
        "title": "Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3522326"
      },
      {
        "pubmed_id": "6642091",
        "score": 0.7722960710525513,
        "title": "Poor metabolic control, hypertension and microangiopathy independently increase the transcapillary escape rate of albumin in diabetes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6642091"
      },
      {
        "pubmed_id": "3569694",
        "score": 0.7722464799880981,
        "title": "Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in type 1 (insulin-dependent) diabetes mellitus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3569694"
      },
      {
        "pubmed_id": "8436254",
        "score": 0.7696536779403687,
        "title": "Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8436254"
      },
      {
        "pubmed_id": "7698029",
        "score": 0.7571749091148376,
        "title": "Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7698029"
      },
      {
        "pubmed_id": "10703889",
        "score": 0.7460719347000122,
        "title": "Transcapillary escape rate of albumin is increased and related to haemodynamic changes in normo-albuminuric type 1 diabetic patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10703889"
      },
      {
        "pubmed_id": "2210073",
        "score": 0.7187762260437012,
        "title": "Increased transcapillary escape rate of albumin in nondiabetic men in response to hyperinsulinemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2210073"
      },
      {
        "pubmed_id": "2949917",
        "score": 0.6836692094802856,
        "title": "Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2949917"
      },
      {
        "pubmed_id": "15581746",
        "score": 0.6698495149612427,
        "title": "Vitamin C treatment reduces transcapillary escape rate of albumin in type 1 diabetes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15581746"
      },
      {
        "pubmed_id": "2970919",
        "score": 0.6563061475753784,
        "title": "Reduced venous compliance and increased transcapillary escape of protein in insulin-dependent diabetic patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2970919"
      }
    ],
    "query_time": 0.008491039276123047,
    "metrics": {
      "precision": 1.0,
      "recall": 0.3225806451612903,
      "f1_score": 0.4878048780487805,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 31
    }
  },
  "640c821c201352f04a000023": {
    "query": "Is Wilson's disease described as an iron storage disease?",
    "type": "yesno",
    "ideal_answer": [
      "No, Wilson's disease is an autosomal recessive disorder caused by a mutation in the ATP7B gene, which leads to an accumulation of copper in the body. It is not an iron storage disease.",
      "Wilson's disease is a genetic copper storage disorder that causes hepatic and neurologic symptoms.",
      "No, Wilson's disease is a copper storage disorder, not an iron storage disorder.",
      "No, Wilson's disease is not an iron storage disease. It is a copper storage disorder that affects the liver and brain.",
      "Yes. Wilson disease is a copper storage disease caused by mutations in ATP7B, which leads to excessive copper accumulation throughout the body. This excess metal results in damage to various organs such as the liver and brain, causing severe neurological problems and ultimately requiring lifelong chelation therapy.",
      "No, Wilson's disease is not described as an iron storage disease. It is an inherited disorder that affects the body's ability to regulate copper.",
      "Wilson's disease is a rare inherited disorder that causes copper to accumulate in your liver, brain and other vital organs.",
      "Wilson disease is a genetic copper storage disorder that causes hepatic and neurologic symptoms.",
      "Yes, Wilson's Disease is characterized by excessive accumulation of copper due to impaired transport or decreased metabolism of Cu2+. This results in disruption of vital organs such as the liver and brain leading to symptoms like neurological damage, pigment abnormalities, pancytopenia and even death if left untreated."
    ],
    "ground_truth_ids": [
      "23583003",
      "34289020",
      "35322347",
      "33573009",
      "25704483",
      "14738953",
      "34341141",
      "9093597",
      "23542331",
      "30646728",
      "36381061",
      "30271060",
      "21886393",
      "31345362",
      "16466879",
      "33175593",
      "8114295",
      "8229372",
      "17505988",
      "11787982",
      "24266916",
      "32738633",
      "33555495",
      "22774841",
      "8984578",
      "1306026",
      "12508671",
      "22098612",
      "8757902",
      "28168129"
    ],
    "retrieved_ids": [
      "8984578",
      "24266916",
      "21886393",
      "17505988",
      "28168129",
      "36381061",
      "8757902",
      "33175593",
      "33555495",
      "8114295"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "8984578",
        "score": 0.7167020440101624,
        "title": "[Current diagnosis: hereditary metabolic diseases of the liver (primary hemochromatosis, Wilson disease)].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8984578"
      },
      {
        "pubmed_id": "24266916",
        "score": 0.7017024755477905,
        "title": "Metal storage disorders: Wilson disease and hemochromatosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24266916"
      },
      {
        "pubmed_id": "21886393",
        "score": 0.6978556513786316,
        "title": "Hemolytic Anemia as a Presenting Feature of Wilson's Disease: A Case Report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21886393"
      },
      {
        "pubmed_id": "17505988",
        "score": 0.6935752034187317,
        "title": "Hereditary iron and copper deposition: diagnostics, pathogenesis and therapeutics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17505988"
      },
      {
        "pubmed_id": "28168129",
        "score": 0.6817971467971802,
        "title": "A Quandary of Cuprum - Wilson's Disease Disguising as Progressive Myoclonic Epilepsy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28168129"
      },
      {
        "pubmed_id": "36381061",
        "score": 0.6799086928367615,
        "title": "Black liver in a patient with Wilson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36381061"
      },
      {
        "pubmed_id": "8757902",
        "score": 0.6794941425323486,
        "title": "[Recurrent arthritis in a child. A rare manifestation of Wilson's disease].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8757902"
      },
      {
        "pubmed_id": "33175593",
        "score": 0.6611059308052063,
        "title": "Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33175593"
      },
      {
        "pubmed_id": "33555495",
        "score": 0.6607111096382141,
        "title": "Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33555495"
      },
      {
        "pubmed_id": "8114295",
        "score": 0.6552461385726929,
        "title": "[Liver cirrhosis in primary hemochromatosis and Wilson's disease].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8114295"
      }
    ],
    "query_time": 0.021504878997802734,
    "metrics": {
      "precision": 1.0,
      "recall": 0.3333333333333333,
      "f1_score": 0.5,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 30
    }
  },
  "5a468785966455904c00000d": {
    "query": "Does RNA polymerase II have RNA cleavage activity?",
    "type": "yesno",
    "ideal_answer": [
      "In addition to RNA synthesis, multisubunit RNA polymerases (msRNAPs) support enzymatic reactions such as intrinsic transcript cleavage. The eukaryotic transcription factor TFIIS enhances elongation and nascent transcript cleavage activities of RNA polymerase II in a stalled elongation complex.",
      "In addition to RNA synthesis, multisubunit RNA polymerases (msRNAPs) support enzymatic reactions such as intrinsic transcript cleavage. The transcription factor TFIIS zinc ribbon dipeptide Asp-Glu is critical for stimulation of elongation and RNA cleavage by RNA polymerase II.",
      "In addition to RNA synthesis, multisubunit RNA polymerases (msRNAPs) support enzymatic reactions such as intrinsic transcript cleavage. msRNAP active sites from different species appear to exhibit differential intrinsic transcript cleavage efficiency and have likely evolved to allow fine-tuning of the transcription process.",
      "In addition to RNA synthesis, multisubunit RNA polymerases (msRNAPs) support enzymatic reactions such as intrinsic transcript cleavage.",
      "The eukaryotic transcription factor TFIIS enhances elongation and nascent transcript cleavage activities of RNA polymerase II in a stalled elongation complex. The transcription factor TFIIS zinc ribbon dipeptide Asp-Glu is critical for stimulation of elongation and RNA cleavage by RNA polymerase II",
      "Complexes of yeast RNA polymerase II and RNA are substrates for TFIIS-induced RNA cleavage. The RNA polymerase II elongation complex.",
      "yes",
      "The RNA polymerase II elongation complex.SII is an RNA polymerase II-binding protein that stimulates transcription elongation and also activates nascent transcript cleavage by RNA polymerase II in elongation complexes in vitroFactor-dependent transcription elongation involves nascent RNA cleavage.The transcription factor TFIIS zinc ribbon dipeptide Asp-Glu is critical for stimulation of elongation and RNA cleavage by RNA polymerase IIThe eukaryotic transcription factor TFIIS enhances elongation and nascent transcript cleavage activities of RNA polymerase II in a stalled elongation complex.Here we show that in the presence of SII and nucleotides, transcript cleavage is detected during SII-dependent elongation but not during SII-independent transcription.Nascent RNA cleavage by arrested RNA polymerase II does not require upstream translocation of the elongation complex on DNA.In addition to RNA synthesis, multisubunit RNA polymerases (msRNAPs) support enzymatic reactions such as intrinsic transcript cleavage.msRNAP active sites from different species appear to exhibit differential intrinsic transcript cleavage efficiency and have likely evolved to allow fine-tuning of the transcription process.Complexes of yeast RNA polymerase II and RNA are substrates for TFIIS-induced RNA cleavage."
    ],
    "ground_truth_ids": [
      "8798387",
      "12692127",
      "25764335",
      "1379232",
      "9869639",
      "1371280",
      "7513257",
      "8090778",
      "8312968",
      "21454497",
      "7503982",
      "17535246"
    ],
    "retrieved_ids": [
      "1371280",
      "7503982",
      "7513257",
      "12692127",
      "8312968",
      "1379232",
      "21454497",
      "9869639",
      "8798387",
      "15383674"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "1371280",
        "score": 0.6899621486663818,
        "title": "Elongation factor-dependent transcript shortening by template-engaged RNA polymerase II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1371280"
      },
      {
        "pubmed_id": "7503982",
        "score": 0.6508204936981201,
        "title": "Nascent RNA cleavage by arrested RNA polymerase II does not require upstream translocation of the elongation complex on DNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7503982"
      },
      {
        "pubmed_id": "7513257",
        "score": 0.6494269371032715,
        "title": "Complexes of yeast RNA polymerase II and RNA are substrates for TFIIS-induced RNA cleavage.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7513257"
      },
      {
        "pubmed_id": "12692127",
        "score": 0.6348918676376343,
        "title": "Intrinsic transcript cleavage in yeast RNA polymerase II elongation complexes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12692127"
      },
      {
        "pubmed_id": "8312968",
        "score": 0.6328635215759277,
        "title": "Transcription elongation by RNA polymerase II: mechanism of SII activation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8312968"
      },
      {
        "pubmed_id": "1379232",
        "score": 0.6304268836975098,
        "title": "The RNA polymerase II elongation complex. Factor-dependent transcription elongation involves nascent RNA cleavage.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1379232"
      },
      {
        "pubmed_id": "21454497",
        "score": 0.5677412748336792,
        "title": "Evolution of two modes of intrinsic RNA polymerase transcript cleavage.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21454497"
      },
      {
        "pubmed_id": "9869639",
        "score": 0.5663259029388428,
        "title": "The RNA cleavage activity of RNA polymerase III is mediated by an essential TFIIS-like subunit and is important for transcription termination.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9869639"
      },
      {
        "pubmed_id": "8798387",
        "score": 0.5545825958251953,
        "title": "Elongation factor SII contacts the 3'-end of RNA in the RNA polymerase II elongation complex.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8798387"
      },
      {
        "pubmed_id": "15383674",
        "score": 0.5479282140731812,
        "title": "Multiple links between transcription and splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15383674"
      }
    ],
    "query_time": 0.020941972732543945,
    "metrics": {
      "precision": 0.9,
      "recall": 0.75,
      "f1_score": 0.8181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 12
    }
  },
  "63f9cdcc33942b094c000013": {
    "query": "Does silencing of SRRM4 inhibit tumor growth across cancers?",
    "type": "yesno",
    "ideal_answer": [
      "No, silencing of SRRM4 promotes tumor growth across cancers."
    ],
    "ground_truth_ids": [
      "33621242"
    ],
    "retrieved_ids": [
      "33621242",
      "24183724",
      "32533590",
      "28251886",
      "19417021",
      "19604397",
      "22161747",
      "22279574",
      "30195756",
      "27614696"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "33621242",
        "score": 0.6048812866210938,
        "title": "Silencing of SRRM4 suppresses microexon inclusion and promotes tumor growth across cancers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33621242"
      },
      {
        "pubmed_id": "24183724",
        "score": 0.4783706068992615,
        "title": "Down-regulation of tripartite-motif containing 22 expression in breast cancer is associated with a lack of p53-mediated induction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24183724"
      },
      {
        "pubmed_id": "32533590",
        "score": 0.44062569737434387,
        "title": "Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32533590"
      },
      {
        "pubmed_id": "28251886",
        "score": 0.4292655289173126,
        "title": "Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the β-Catenin Pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28251886"
      },
      {
        "pubmed_id": "19417021",
        "score": 0.4268043041229248,
        "title": "Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of soft tissue sarcoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19417021"
      },
      {
        "pubmed_id": "19604397",
        "score": 0.4266641139984131,
        "title": "Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19604397"
      },
      {
        "pubmed_id": "22161747",
        "score": 0.42032110691070557,
        "title": "Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22161747"
      },
      {
        "pubmed_id": "22279574",
        "score": 0.41845792531967163,
        "title": "Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22279574"
      },
      {
        "pubmed_id": "30195756",
        "score": 0.4147701561450958,
        "title": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell Lung Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30195756"
      },
      {
        "pubmed_id": "27614696",
        "score": 0.41198796033859253,
        "title": "In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27614696"
      }
    ],
    "query_time": 0.01213216781616211,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "620155b6c9dfcb9c09000024": {
    "query": "Is covid-19 induced anosmia caused by disruption of nuclear architecture?",
    "type": "yesno",
    "ideal_answer": [
      "Yes. Disruption of nuclear architecture is a cause of COVID-19 induced anosmia."
    ],
    "ground_truth_ids": [
      "33594368"
    ],
    "retrieved_ids": [
      "34485577",
      "34368314",
      "33594368",
      "33748041",
      "32983172",
      "32661509",
      "33643779",
      "23146055",
      "33024342",
      "33998486"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "34485577",
        "score": 0.4751551151275635,
        "title": "An overview of 2019 novel coronavirus COVID-19 pandemic: A review study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34485577"
      },
      {
        "pubmed_id": "34368314",
        "score": 0.44514602422714233,
        "title": "COVID-19 patient with an incubation period of 27 d: A case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34368314"
      },
      {
        "pubmed_id": "33594368",
        "score": 0.4068569242954254,
        "title": "Disruption of nuclear architecture as a cause of COVID-19 induced anosmia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33594368"
      },
      {
        "pubmed_id": "33748041",
        "score": 0.38568904995918274,
        "title": "Distinct Characteristics of COVID-19 Infection in Children.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33748041"
      },
      {
        "pubmed_id": "32983172",
        "score": 0.38402703404426575,
        "title": "Cytokine Storm in COVID-19: \"When You Come Out of the Storm, You Won't Be the Same Person Who Walked in\".",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32983172"
      },
      {
        "pubmed_id": "32661509",
        "score": 0.3763599991798401,
        "title": "Longer incubation period of coronavirus disease 2019 (COVID-19) in older adults.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32661509"
      },
      {
        "pubmed_id": "33643779",
        "score": 0.3637963831424713,
        "title": "Incubation period for COVID-19: a systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33643779"
      },
      {
        "pubmed_id": "23146055",
        "score": 0.3583570122718811,
        "title": "Current clinical management of Fanconi anemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23146055"
      },
      {
        "pubmed_id": "33024342",
        "score": 0.3462759852409363,
        "title": "[Incubation period of COVID-19: A systematic review and meta-analysis].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33024342"
      },
      {
        "pubmed_id": "33998486",
        "score": 0.344559907913208,
        "title": "Incubation period of COVID-19: A systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33998486"
      }
    ],
    "query_time": 0.007133007049560547,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.3333333333333333,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "532bf6f2d6d3ac6a34000015": {
    "query": "Is there any research that relates the function of Notch Signaling with Alzheimer Disease?",
    "type": "yesno",
    "ideal_answer": [
      "Notch signaling is an evolutionarily conserved pathway, which is fundamental for neuronal development and specification. In the last decade, increasing evidence has pointed out an important role of this pathway beyond embryonic development, indicating that Notch also displays a critical function in the mature brain of vertebrates and invertebrates. This pathway appears to be involved in neural progenitor regulation, neuronal connectivity, synaptic plasticity and learning/memory. In addition, Notch appears to be aberrantly regulated in neurodegenerative diseases, including Alzheimer's disease and ischemic injury"
    ],
    "ground_truth_ids": [
      "22122056",
      "23570941",
      "23197721",
      "24099003",
      "21768095",
      "22792182",
      "21206757",
      "19881909"
    ],
    "retrieved_ids": [
      "23570941",
      "23197721",
      "21768095",
      "22122056",
      "24101600",
      "22842086",
      "22792182",
      "20935640",
      "21196490",
      "24099003"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23570941",
        "score": 0.7324070930480957,
        "title": "Notch signaling in the brain: in good and bad times.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23570941"
      },
      {
        "pubmed_id": "23197721",
        "score": 0.611372709274292,
        "title": "Alzheimer's disease: presenilin 2-sparing γ-secretase inhibition is a tolerable Aβ peptide-lowering strategy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23197721"
      },
      {
        "pubmed_id": "21768095",
        "score": 0.6056687235832214,
        "title": "Mutations in nicastrin protein differentially affect amyloid beta-peptide production and Notch protein processing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21768095"
      },
      {
        "pubmed_id": "22122056",
        "score": 0.5916010141372681,
        "title": "γ-Secretase inhibitors and modulators for Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22122056"
      },
      {
        "pubmed_id": "24101600",
        "score": 0.5815020799636841,
        "title": "Differential, dominant activation and inhibition of Notch signalling and APP cleavage by truncations of PSEN1 in human disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24101600"
      },
      {
        "pubmed_id": "22842086",
        "score": 0.5415509939193726,
        "title": "Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22842086"
      },
      {
        "pubmed_id": "22792182",
        "score": 0.5328965187072754,
        "title": "Alzheimer's-related peptide amyloid-β plays a conserved role in angiogenesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22792182"
      },
      {
        "pubmed_id": "20935640",
        "score": 0.5011911988258362,
        "title": "Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20935640"
      },
      {
        "pubmed_id": "21196490",
        "score": 0.4699251651763916,
        "title": "NOTCH, a new signaling pathway implicated in holoprosencephaly.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21196490"
      },
      {
        "pubmed_id": "24099003",
        "score": 0.4697840213775635,
        "title": "A fast growing spectrum of biological functions of γ-secretase in development and disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24099003"
      }
    ],
    "query_time": 0.008289098739624023,
    "metrics": {
      "precision": 0.6,
      "recall": 0.75,
      "f1_score": 0.6666666666666665,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "5c5607aa07647bbc4b00000e": {
    "query": "Is durvalumab used for lung cancer treatment?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, Durvalumab is an anti-PDL-1 antibody that is used for treatment of non-small-cell lung cancer."
    ],
    "ground_truth_ids": [
      "29069302",
      "29303787",
      "29593890",
      "29140105",
      "28664936",
      "30489337",
      "28705024",
      "29239189",
      "30116683",
      "29958099",
      "28585617",
      "29358503",
      "29760563",
      "30012210",
      "29545095",
      "28885881",
      "27196116",
      "28960263",
      "28512504",
      "30327351"
    ],
    "retrieved_ids": [
      "28885881",
      "30327351",
      "29760563",
      "28705024",
      "29140105",
      "29958099",
      "29545095",
      "30012210",
      "28585617",
      "29486607"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28885881",
        "score": 0.7409534454345703,
        "title": "Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28885881"
      },
      {
        "pubmed_id": "30327351",
        "score": 0.7390430569648743,
        "title": "Durvalumab Extends OS in NSCLC.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30327351"
      },
      {
        "pubmed_id": "29760563",
        "score": 0.7289501428604126,
        "title": "Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29760563"
      },
      {
        "pubmed_id": "28705024",
        "score": 0.7183148264884949,
        "title": "MEDI 4736 (durvalumab) in non-small cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28705024"
      },
      {
        "pubmed_id": "29140105",
        "score": 0.7067195177078247,
        "title": "Durvalumab in non-small-cell lung cancer patients: current developments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29140105"
      },
      {
        "pubmed_id": "29958099",
        "score": 0.6949575543403625,
        "title": "Durvalumab for the treatment of non-small cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29958099"
      },
      {
        "pubmed_id": "29545095",
        "score": 0.6831235289573669,
        "title": "Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29545095"
      },
      {
        "pubmed_id": "30012210",
        "score": 0.6524106860160828,
        "title": "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30012210"
      },
      {
        "pubmed_id": "28585617",
        "score": 0.6387960910797119,
        "title": "[Immunotherapy for lung cancer].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28585617"
      },
      {
        "pubmed_id": "29486607",
        "score": 0.6277477741241455,
        "title": "Durvalumab in urothelial cancers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29486607"
      }
    ],
    "query_time": 0.015876054763793945,
    "metrics": {
      "precision": 0.9,
      "recall": 0.45,
      "f1_score": 0.6,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 20
    }
  },
  "553fbe9fe00431e071000001": {
    "query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "type": "yesno",
    "ideal_answer": [
      "The regulation of Vsr endonuclease levels is growth phase dependent."
    ],
    "ground_truth_ids": [
      "10400606",
      "15184558",
      "12067333",
      "9537396"
    ],
    "retrieved_ids": [
      "9537396",
      "10400606",
      "12067333",
      "15184558",
      "23479439",
      "23386979",
      "3300731",
      "24323919",
      "34493791",
      "23770556"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "9537396",
        "score": 0.6856265068054199,
        "title": "Levels of the Vsr endonuclease do not regulate stationary-phase reversion of a Lac- frameshift allele in Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9537396"
      },
      {
        "pubmed_id": "10400606",
        "score": 0.6269646883010864,
        "title": "Growth phase-dependent regulation of Vsr endonuclease may contribute to 5-methylcytosine mutational hot spots in Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10400606"
      },
      {
        "pubmed_id": "12067333",
        "score": 0.5382459759712219,
        "title": "Cooperation and competition in mismatch repair: very short-patch repair and methyl-directed mismatch repair in Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12067333"
      },
      {
        "pubmed_id": "15184558",
        "score": 0.49540776014328003,
        "title": "DNA methyltransferases from Neisseria meningitidis and Neisseria gonorrhoeae FA1090 associated with mismatch nicking endonucleases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15184558"
      },
      {
        "pubmed_id": "23479439",
        "score": 0.48715752363204956,
        "title": "Proteolytic regulation of stress response pathways in Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23479439"
      },
      {
        "pubmed_id": "23386979",
        "score": 0.4071609377861023,
        "title": "Bacteria herald a new era of gene editing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23386979"
      },
      {
        "pubmed_id": "3300731",
        "score": 0.4036671817302704,
        "title": "Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3300731"
      },
      {
        "pubmed_id": "24323919",
        "score": 0.3895866870880127,
        "title": "Exploiting CRISPR/Cas systems for biotechnology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24323919"
      },
      {
        "pubmed_id": "34493791",
        "score": 0.3785281181335449,
        "title": "Burkholderia PglL enzymes are Serine preferring oligosaccharyltransferases which target conserved proteins across the Burkholderia genus.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34493791"
      },
      {
        "pubmed_id": "23770556",
        "score": 0.3732588589191437,
        "title": "High-level expression of Staphylococcal Protein A in Pichia pastoris and purification and characterization of the recombinant protein.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23770556"
      }
    ],
    "query_time": 0.015347957611083984,
    "metrics": {
      "precision": 0.4,
      "recall": 1.0,
      "f1_score": 0.5714285714285715,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "6081af3c4e6a4cf630000008": {
    "query": "Is colistin an antibiotic?",
    "type": "yesno",
    "ideal_answer": [
      "Yes,\ncolistin is an antibiotic."
    ],
    "ground_truth_ids": [
      "33057672",
      "30892111",
      "30088449"
    ],
    "retrieved_ids": [
      "30892111",
      "30088449",
      "36173175",
      "28467869",
      "21122555",
      "23006569",
      "1482192",
      "23627915",
      "32220667",
      "21659436"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30892111",
        "score": 0.49582138657569885,
        "title": "Development of a Standardized Scoring System to Assess a Murine Model of Clostridium difficile Colitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30892111"
      },
      {
        "pubmed_id": "30088449",
        "score": 0.48340293765068054,
        "title": "Identification and Ranking of Clinical Compounds with Activity Against Log-phase Growing Uropathogenic Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30088449"
      },
      {
        "pubmed_id": "36173175",
        "score": 0.45206785202026367,
        "title": "Repositioning small molecule drugs as allosteric inhibitors of the BFT-3 toxin from enterotoxigenic Bacteroides fragilis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36173175"
      },
      {
        "pubmed_id": "28467869",
        "score": 0.43578898906707764,
        "title": "Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28467869"
      },
      {
        "pubmed_id": "21122555",
        "score": 0.4291399121284485,
        "title": "Paneth's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21122555"
      },
      {
        "pubmed_id": "23006569",
        "score": 0.41900572180747986,
        "title": "Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23006569"
      },
      {
        "pubmed_id": "1482192",
        "score": 0.40413448214530945,
        "title": "Biosynthesis of the lantibiotic nisin: genomic organization and membrane localization of the NisB protein.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1482192"
      },
      {
        "pubmed_id": "23627915",
        "score": 0.3745359778404236,
        "title": "Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23627915"
      },
      {
        "pubmed_id": "32220667",
        "score": 0.3673039674758911,
        "title": "Oral Mutian®X stopped faecal feline coronavirus shedding by naturally infected cats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32220667"
      },
      {
        "pubmed_id": "21659436",
        "score": 0.354268342256546,
        "title": "Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE Organisms.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21659436"
      }
    ],
    "query_time": 0.013082027435302734,
    "metrics": {
      "precision": 0.2,
      "recall": 0.6666666666666666,
      "f1_score": 0.30769230769230765,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "5fd78702a43ad31278000005": {
    "query": "Does steroid 5A-Reductase deficiency lead to hermaphroditism?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, steroid 5A-reductase deficiency can lead to hermaphroditism.",
      "5α steroid reductase deficiency (5αSRD) is an autosomal recessive enzymatic deficiency and mutations in the 5α steroid reductase type 2 gene (SRD5A2) result in male pseudohermaphrodism caused by decreased dihydrotestosterone (DHT) synthesis. The diagnosis of steroid-5-alpha-reductase deficiency is rarely considered by the paediatrician.",
      "Yes, steroid 5A-reductase deficiency is a rare autosomal recessive disorder.",
      "Yes, steroid 5A-Reductase deficiency is associated with hermaphroditism.",
      "5α steroid reductase deficiency (5αSRD) is an autosomal recessive enzymatic deficiency and mutations in the 5α steroid reductase type 2 gene (SRD5A2) result in male pseudohermaphrodism caused by decreased dihydrotestosterone (DHT) synthesis.",
      "Male pseudo hermaphroditism caused by steroid 5 alpha reductase deficiency is a rare autosomal recessive disorder. This enzyme catalyses the conversion of testosterone to dihydrotestosterone (DHT) in genital tissue.",
      "Yes, steroid 5A-reductase deficiency is associated with hermaphroditism."
    ],
    "ground_truth_ids": [
      "11515490",
      "24383016",
      "23633205",
      "10458450",
      "20850730",
      "27693263",
      "8110760",
      "21147889",
      "10564874",
      "3489839",
      "8001864",
      "1944596",
      "17663907",
      "20511729",
      "8302780",
      "20132346",
      "8768837"
    ],
    "retrieved_ids": [
      "11515490",
      "8001864",
      "8110760",
      "8768837",
      "24383016",
      "3489839",
      "17663907",
      "1944596",
      "10564874",
      "8723114"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "11515490",
        "score": 0.6993057727813721,
        "title": "[Male pseudo-hermaphroditism due to partial 5 alpha-reductase deficiency, a case report].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11515490"
      },
      {
        "pubmed_id": "8001864",
        "score": 0.6708120107650757,
        "title": "[The importance of DNA analysis in the diagnosis of steroid 5-alpha-reductase deficiency].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8001864"
      },
      {
        "pubmed_id": "8110760",
        "score": 0.6500875353813171,
        "title": "Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8110760"
      },
      {
        "pubmed_id": "8768837",
        "score": 0.6466205716133118,
        "title": "Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8768837"
      },
      {
        "pubmed_id": "24383016",
        "score": 0.6428006291389465,
        "title": "5-alpha-reductase 2 deficiency in a woman with primary amenorrhea.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24383016"
      },
      {
        "pubmed_id": "3489839",
        "score": 0.6290977001190186,
        "title": "The prevalence of 5 alpha-reductase deficiency in children with ambiguous genitalia in the Dominican Republic.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3489839"
      },
      {
        "pubmed_id": "17663907",
        "score": 0.6282147169113159,
        "title": "[Male pseudohermaphroditism].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17663907"
      },
      {
        "pubmed_id": "1944596",
        "score": 0.6221883296966553,
        "title": "Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1944596"
      },
      {
        "pubmed_id": "10564874",
        "score": 0.614052414894104,
        "title": "New frameshift mutation in the 5alpha-reductase type 2 gene in a Brazilian patient with 5alpha-reductase deficiency.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10564874"
      },
      {
        "pubmed_id": "8723114",
        "score": 0.5958840847015381,
        "title": "Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8723114"
      }
    ],
    "query_time": 0.0072479248046875,
    "metrics": {
      "precision": 0.9,
      "recall": 0.5294117647058824,
      "f1_score": 0.6666666666666667,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "535d292a9a4572de6f000003": {
    "query": "Are long non coding RNAs spliced?",
    "type": "yesno",
    "ideal_answer": [
      "Long non coding RNAs appear to be spliced through the same pathway as the mRNAs"
    ],
    "ground_truth_ids": [
      "22955988",
      "22955974",
      "24285305",
      "22707570",
      "21622663",
      "24106460"
    ],
    "retrieved_ids": [
      "24106460",
      "22955974",
      "24285305",
      "18050426",
      "17189193",
      "22975042",
      "22156210",
      "22955988",
      "23097425",
      "24667321"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "24106460",
        "score": 0.6463155150413513,
        "title": "Identification and function of long non-coding RNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24106460"
      },
      {
        "pubmed_id": "22955974",
        "score": 0.6388400793075562,
        "title": "Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22955974"
      },
      {
        "pubmed_id": "24285305",
        "score": 0.61216139793396,
        "title": "NONCODEv4: exploring the world of long non-coding RNA genes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24285305"
      },
      {
        "pubmed_id": "18050426",
        "score": 0.5962427854537964,
        "title": "Trans-splicing and operons.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18050426"
      },
      {
        "pubmed_id": "17189193",
        "score": 0.5901306867599487,
        "title": "A genome-wide analysis indicates that yeast pre-mRNA splicing is predominantly posttranscriptional.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17189193"
      },
      {
        "pubmed_id": "22975042",
        "score": 0.5793617963790894,
        "title": "Transcriptional elongation and alternative splicing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22975042"
      },
      {
        "pubmed_id": "22156210",
        "score": 0.5791259407997131,
        "title": "Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in Drosophila.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22156210"
      },
      {
        "pubmed_id": "22955988",
        "score": 0.5747607946395874,
        "title": "The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22955988"
      },
      {
        "pubmed_id": "23097425",
        "score": 0.5624091625213623,
        "title": "Cotranscriptional splicing efficiency differs dramatically between Drosophila and mouse.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23097425"
      },
      {
        "pubmed_id": "24667321",
        "score": 0.5608327388763428,
        "title": "Genetic variation in the non-coding genome: Involvement of micro-RNAs and long non-coding RNAs in disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24667321"
      }
    ],
    "query_time": 0.014077901840209961,
    "metrics": {
      "precision": 0.4,
      "recall": 0.6666666666666666,
      "f1_score": 0.5,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "620c27e93a8413c653000006": {
    "query": "Is METTL1 overexpression associated with better patient survival?",
    "type": "yesno",
    "ideal_answer": [
      "No. METTL1 is frequently amplified and overexpressed in cancers and is associated with poor patient survival."
    ],
    "ground_truth_ids": [
      "34352207"
    ],
    "retrieved_ids": [
      "34352207",
      "34256819",
      "22160078",
      "22790201",
      "30327351",
      "26131212",
      "29958099",
      "17434631",
      "30466743",
      "29633730"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "34352207",
        "score": 0.47397077083587646,
        "title": "METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34352207"
      },
      {
        "pubmed_id": "34256819",
        "score": 0.4585316777229309,
        "title": "Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34256819"
      },
      {
        "pubmed_id": "22160078",
        "score": 0.3951758146286011,
        "title": "Dyskeratosis congenita.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22160078"
      },
      {
        "pubmed_id": "22790201",
        "score": 0.3927164375782013,
        "title": "Human Mut T Homolog 1 (MTH1): a roadblock for the tumor-suppressive effects of oncogenic RAS-induced ROS.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22790201"
      },
      {
        "pubmed_id": "30327351",
        "score": 0.39186155796051025,
        "title": "Durvalumab Extends OS in NSCLC.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30327351"
      },
      {
        "pubmed_id": "26131212",
        "score": 0.38755542039871216,
        "title": "Association of SLCO1B1 gene polymorphisms with toxicity response of high dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26131212"
      },
      {
        "pubmed_id": "29958099",
        "score": 0.37828224897384644,
        "title": "Durvalumab for the treatment of non-small cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29958099"
      },
      {
        "pubmed_id": "17434631",
        "score": 0.37637999653816223,
        "title": "Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17434631"
      },
      {
        "pubmed_id": "30466743",
        "score": 0.36982619762420654,
        "title": "Progress and predictions: AML in 2018.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30466743"
      },
      {
        "pubmed_id": "29633730",
        "score": 0.3607732653617859,
        "title": "An uncommon case of chronic myeloid leukemia with variant cytogenetic.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29633730"
      }
    ],
    "query_time": 0.007543087005615234,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5a6f77d7b750ff4455000051": {
    "query": "Is autosomal dominant inheritanced form of Osteogenesis imperfecta caused by mutations in the genes associated with collagen production?",
    "type": "yesno",
    "ideal_answer": [
      "Osteogenesis imperfecta (OI), also known as brittle bone disease, is a group of genetic disorders that mainly affect the bones. The autosomal dominant form of the disease is cause by a mutation in the COL1A1 or COL1A2 genes which produce type I collagen.",
      "steogenesis imperfecta (OI) is a heterogeneous bone disorder characterized by recurrent fractures. Although most cases of OI have heterozygous mutations inCOL1A1orCOL1A2and show autosomal dominant inheritance,"
    ],
    "ground_truth_ids": [
      "27312322",
      "2992938",
      "27677223",
      "21567925",
      "22863195",
      "28116328",
      "18566967",
      "27510842",
      "21341209",
      "28820180",
      "12362985",
      "2886666",
      "24928016",
      "29150909",
      "2037280",
      "27762305",
      "21667357",
      "19533842",
      "25402547",
      "20839288",
      "8456806"
    ],
    "retrieved_ids": [
      "28820180",
      "2886666",
      "19533842",
      "8456806",
      "2037280",
      "21667357",
      "21341209",
      "21567925",
      "12362985",
      "27677223"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28820180",
        "score": 0.788519024848938,
        "title": "Osteogenesis imperfecta.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28820180"
      },
      {
        "pubmed_id": "2886666",
        "score": 0.7881890535354614,
        "title": "Prenatal prediction of osteogenesis imperfecta (OI type IV): exclusion of inheritance using a collagen gene probe.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2886666"
      },
      {
        "pubmed_id": "19533842",
        "score": 0.777094841003418,
        "title": "Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19533842"
      },
      {
        "pubmed_id": "8456806",
        "score": 0.7662864327430725,
        "title": "Molecular heterogeneity in osteogenesis imperfecta type I.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8456806"
      },
      {
        "pubmed_id": "2037280",
        "score": 0.7643195986747742,
        "title": "Osteogenesis imperfecta due to recurrent point mutations at CpG dinucleotides in the COL1A1 gene of type I collagen.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2037280"
      },
      {
        "pubmed_id": "21667357",
        "score": 0.7582389116287231,
        "title": "The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21667357"
      },
      {
        "pubmed_id": "21341209",
        "score": 0.7501521110534668,
        "title": "Mutation characteristics in type I collagen genes in Chinese patients with osteogenesis imperfecta.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21341209"
      },
      {
        "pubmed_id": "21567925",
        "score": 0.7487339973449707,
        "title": "Type 1 collagenopathy presenting with a Russell-Silver phenotype.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21567925"
      },
      {
        "pubmed_id": "12362985",
        "score": 0.7282518148422241,
        "title": "Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12362985"
      },
      {
        "pubmed_id": "27677223",
        "score": 0.723293662071228,
        "title": "A novel homozygous variant in SERPINH1 associated with a severe, lethal presentation of osteogenesis imperfecta with hydranencephaly.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27677223"
      }
    ],
    "query_time": 0.014452934265136719,
    "metrics": {
      "precision": 1.0,
      "recall": 0.47619047619047616,
      "f1_score": 0.6451612903225806,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 21
    }
  },
  "5e2a04feaa19d74431000009": {
    "query": "Can LB-100 downregulate miR-33?",
    "type": "yesno",
    "ideal_answer": [
      "No, LB-100 has been reported to modulate (upregulate) only miR-181b-1."
    ],
    "ground_truth_ids": [
      "28588271"
    ],
    "retrieved_ids": [
      "23266889",
      "31752361",
      "22469780",
      "27895893",
      "23056006",
      "28259291",
      "28588271",
      "31546754",
      "26098216",
      "23187003"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23266889",
        "score": 0.4044508934020996,
        "title": "microRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23266889"
      },
      {
        "pubmed_id": "31752361",
        "score": 0.3941776752471924,
        "title": "The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31752361"
      },
      {
        "pubmed_id": "22469780",
        "score": 0.39400553703308105,
        "title": "B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22469780"
      },
      {
        "pubmed_id": "27895893",
        "score": 0.3820841312408447,
        "title": "Downregulation of long non-coding RNA H19 promotes P19CL6 cells proliferation and inhibits apoptosis during late-stage cardiac differentiation via miR-19b-modulated Sox6.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27895893"
      },
      {
        "pubmed_id": "23056006",
        "score": 0.3733963966369629,
        "title": "Role of CTCF in the regulation of microRNA expression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23056006"
      },
      {
        "pubmed_id": "28259291",
        "score": 0.36457788944244385,
        "title": "Epigenetic control of gene expression: Potential implications for cancer treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28259291"
      },
      {
        "pubmed_id": "28588271",
        "score": 0.3546900451183319,
        "title": "PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28588271"
      },
      {
        "pubmed_id": "31546754",
        "score": 0.3454072177410126,
        "title": "miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31546754"
      },
      {
        "pubmed_id": "26098216",
        "score": 0.3427204191684723,
        "title": "Mature T cell responses are controlled by microRNA-142.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26098216"
      },
      {
        "pubmed_id": "23187003",
        "score": 0.34056609869003296,
        "title": "microRNA-214-mediated UBC9 expression in glioma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23187003"
      }
    ],
    "query_time": 0.016889095306396484,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 1.0,
      "mrr": 0.14285714285714285,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "53386282d6d3ac6a3400005a": {
    "query": "Has the protein TIEG1 been associated with apoptosis?",
    "type": "yesno",
    "ideal_answer": [
      "Yes, TIEG1 (also known as KLF10) seems to play a role in regulating apoptosis."
    ],
    "ground_truth_ids": [
      "20691807",
      "23815903",
      "12065093",
      "12788480",
      "21524276",
      "21423731",
      "14743447",
      "22563190",
      "17659279",
      "10471833",
      "10573529",
      "17308981",
      "22349513",
      "18930345",
      "17951258",
      "22025675",
      "12771931",
      "20201061",
      "20945337",
      "18798273",
      "23244828",
      "17729309"
    ],
    "retrieved_ids": [
      "17659279",
      "17308981",
      "10573529",
      "14743447",
      "17729309",
      "10471833",
      "15302871",
      "22025675",
      "20945337",
      "18930345"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "17659279",
        "score": 0.6639262437820435,
        "title": "TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17659279"
      },
      {
        "pubmed_id": "17308981",
        "score": 0.6327710151672363,
        "title": "Human TIEG2/KLF11 induces oligodendroglial cell death by downregulation of Bcl-XL expression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17308981"
      },
      {
        "pubmed_id": "10573529",
        "score": 0.6005582809448242,
        "title": "The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10573529"
      },
      {
        "pubmed_id": "14743447",
        "score": 0.5878655910491943,
        "title": "TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14743447"
      },
      {
        "pubmed_id": "17729309",
        "score": 0.5845909118652344,
        "title": "Role of TIEG1 in biological processes and disease states.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17729309"
      },
      {
        "pubmed_id": "10471833",
        "score": 0.5739654302597046,
        "title": "A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10471833"
      },
      {
        "pubmed_id": "15302871",
        "score": 0.5520118474960327,
        "title": "Functional role of death-associated protein 3 (DAP3) in anoikis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15302871"
      },
      {
        "pubmed_id": "22025675",
        "score": 0.5296090841293335,
        "title": "TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22025675"
      },
      {
        "pubmed_id": "20945337",
        "score": 0.527427077293396,
        "title": "TIEG1 negatively controls the myoblast pool indispensable for fusion during myogenic differentiation of C2C12 cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20945337"
      },
      {
        "pubmed_id": "18930345",
        "score": 0.5164190530776978,
        "title": "Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18930345"
      }
    ],
    "query_time": 0.020496845245361328,
    "metrics": {
      "precision": 0.9,
      "recall": 0.4090909090909091,
      "f1_score": 0.5625000000000001,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 22
    }
  },
  "54f704b630767eb92e000001": {
    "query": "Is muscle lim protein (MLP) involved in cardiomyopathies?",
    "type": "yesno",
    "ideal_answer": [
      "The skeletal muscle LIM protein 1 (SLIM1) is highly expressed in skeletal and cardiac muscle, and its expression is downregulated significantly in dilated human cardiomyopathy. Loss of murine MLP results in dilated cardiomyopathy, and mutations in human MLP lead to cardiac hypertrophy, indicating a critical role for MLP in maintaining normal cardiac function.",
      "Yes, Muscle LIM protein is involved in cardiomyopathies. In specific, the skeletal muscle LIM protein 1 (SLIM1) is highly expressed in skeletal and cardiac muscle, and its expression is downregulated significantly in dilated human cardiomyopathy. Mutations in the human MLP gene are associated with hypertrophic and dilated cardiomyopathy. MLP became an important model for experimental cardiology when it was first demonstrated that MLP deficiency leads to myocardial hypertrophy followed by a dilated cardiomyopathy and heart failure phenotype."
    ],
    "ground_truth_ids": [
      "16228909",
      "22421737",
      "15978612",
      "15639480",
      "11788418",
      "21562304",
      "21484537",
      "15205937",
      "18083727",
      "22371524",
      "14567970",
      "16352453",
      "12642359",
      "18505755",
      "12397030",
      "17535853",
      "24860983"
    ],
    "retrieved_ids": [
      "21484537",
      "15205937",
      "24860983",
      "12642359",
      "11788418",
      "15978612",
      "18505755",
      "17535853",
      "18083727",
      "22421737"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "21484537",
        "score": 0.8325995802879333,
        "title": "MLP (muscle LIM protein) as a stress sensor in the heart.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21484537"
      },
      {
        "pubmed_id": "15205937",
        "score": 0.6959742903709412,
        "title": "Decreased interactions of mutant muscle LIM protein (MLP) with N-RAP and alpha-actinin and their implication for hypertrophic cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15205937"
      },
      {
        "pubmed_id": "24860983",
        "score": 0.6854287385940552,
        "title": "Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24860983"
      },
      {
        "pubmed_id": "12642359",
        "score": 0.6826440095901489,
        "title": "Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12642359"
      },
      {
        "pubmed_id": "11788418",
        "score": 0.6811385750770569,
        "title": "Muscle LIM protein deficiency leads to alterations in passive ventricular mechanics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11788418"
      },
      {
        "pubmed_id": "15978612",
        "score": 0.6767355799674988,
        "title": "Young MLP deficient mice show diastolic dysfunction before the onset of dilated cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15978612"
      },
      {
        "pubmed_id": "18505755",
        "score": 0.6588378548622131,
        "title": "Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18505755"
      },
      {
        "pubmed_id": "17535853",
        "score": 0.6564943790435791,
        "title": "The Drosophila muscle LIM protein, Mlp84B, cooperates with D-titin to maintain muscle structural integrity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17535853"
      },
      {
        "pubmed_id": "18083727",
        "score": 0.642808198928833,
        "title": "The Drosophila muscle LIM protein, Mlp84B, is essential for cardiac function.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18083727"
      },
      {
        "pubmed_id": "22421737",
        "score": 0.6365437507629395,
        "title": "Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22421737"
      }
    ],
    "query_time": 0.007817983627319336,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5882352941176471,
      "f1_score": 0.7407407407407407,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "5abcf010fcf4565872000023": {
    "query": "What nerve is involved in carpal tunnel syndrome?",
    "type": "factoid",
    "ideal_answer": [
      "Carpal tunnel syndrome (CTS) is a focal compressive neuropathy of the median nerve at the level of the wrist.",
      "Carpal tunnel syndrome (CTS) is a medical condition due to compression of the median nerve as it travels through the wrist at the carpal tunnel.",
      "Carpal tunnel syndrome (CTS) is a focal compressive neuropathy of the median nerve at the level of the wrist. "
    ],
    "ground_truth_ids": [
      "28718333",
      "18683528",
      "28582584",
      "1888865",
      "7594983",
      "28447963",
      "22215765",
      "26330845",
      "28594494",
      "28091439",
      "25630774"
    ],
    "retrieved_ids": [
      "1888865",
      "25630774",
      "7594983",
      "28594494",
      "28447963",
      "18683528",
      "26330845",
      "22215765",
      "28718333",
      "28582584"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "1888865",
        "score": 0.7150429487228394,
        "title": "[Carpal tunnel syndrome: report of 3 cases].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1888865"
      },
      {
        "pubmed_id": "25630774",
        "score": 0.705237865447998,
        "title": "Pathophysiology of carpal tunnel syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25630774"
      },
      {
        "pubmed_id": "7594983",
        "score": 0.7009027004241943,
        "title": "Restricted motion of the median nerve in carpal tunnel syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7594983"
      },
      {
        "pubmed_id": "28594494",
        "score": 0.6534181833267212,
        "title": "Carpal Tunnel Syndrome: Initial Management and the Treatment of Recalcitrant Patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28594494"
      },
      {
        "pubmed_id": "28447963",
        "score": 0.6533452272415161,
        "title": "Bifid median nerve and carpal tunnel syndrome: an uncommon anatomical variation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28447963"
      },
      {
        "pubmed_id": "18683528",
        "score": 0.6198440194129944,
        "title": "[Regional sympathetic disturbances in carpal tunnel syndrome--a review].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18683528"
      },
      {
        "pubmed_id": "26330845",
        "score": 0.6165275573730469,
        "title": "Does the ratio of the carpal tunnel inlet and outlet cross-sectional areas in the median nerve reflect carpal tunnel syndrome severity?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26330845"
      },
      {
        "pubmed_id": "22215765",
        "score": 0.6132568120956421,
        "title": "The nerve/tunnel index: a new diagnostic standard for carpal tunnel syndrome using sonography: a pilot study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22215765"
      },
      {
        "pubmed_id": "28718333",
        "score": 0.6007775068283081,
        "title": "Anomalous Radial Artery as an Incidental Finding During a Routine Carpal Tunnel Release.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28718333"
      },
      {
        "pubmed_id": "28582584",
        "score": 0.5832485556602478,
        "title": "Systematic review: hand activity and ultrasound of the median nerve.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28582584"
      }
    ],
    "query_time": 0.014420270919799805,
    "metrics": {
      "precision": 1.0,
      "recall": 0.9090909090909091,
      "f1_score": 0.9523809523809523,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 11
    }
  },
  "5a3e8683966455904c000007": {
    "query": "Which test is used to diagnose colour synesthesia?",
    "type": "factoid",
    "ideal_answer": [
      "A standardized test battery for the study of synesthesia. We used synesthetic versions of the Stroop test with colored letters and numbers presented either in the right or the left visual field of thirty-four synesthetes. Assessment of the hemispheric lateralization of grapheme-color synesthesia with Stroop-type tests. ",
      "Stroop-type testsWe",
      "We used synesthetic versions of the Stroop test with colored letters and numbers presented either in the right or the left visual field of thirty-four synesthetes"
    ],
    "ground_truth_ids": [
      "16919755",
      "22512712",
      "23458658",
      "25793307"
    ],
    "retrieved_ids": [
      "22512712",
      "16919755",
      "23458658",
      "25793307",
      "28594494",
      "28582584",
      "22564885",
      "28091439",
      "7629529",
      "25238668"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "22512712",
        "score": 0.679247260093689,
        "title": "A case of color-taste synesthesia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22512712"
      },
      {
        "pubmed_id": "16919755",
        "score": 0.6741940975189209,
        "title": "A standardized test battery for the study of synesthesia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16919755"
      },
      {
        "pubmed_id": "23458658",
        "score": 0.6510968208312988,
        "title": "Diagnosing synaesthesia with online colour pickers: maximising sensitivity and specificity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23458658"
      },
      {
        "pubmed_id": "25793307",
        "score": 0.6286845803260803,
        "title": "Assessment of the hemispheric lateralization of grapheme-color synesthesia with Stroop-type tests.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25793307"
      },
      {
        "pubmed_id": "28594494",
        "score": 0.3948499858379364,
        "title": "Carpal Tunnel Syndrome: Initial Management and the Treatment of Recalcitrant Patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28594494"
      },
      {
        "pubmed_id": "28582584",
        "score": 0.3697209656238556,
        "title": "Systematic review: hand activity and ultrasound of the median nerve.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28582584"
      },
      {
        "pubmed_id": "22564885",
        "score": 0.36946260929107666,
        "title": "Neurological findings in incontinentia pigmenti; a review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22564885"
      },
      {
        "pubmed_id": "28091439",
        "score": 0.3640364706516266,
        "title": "Is epineurectomy necessary in the surgical management of carpal tunnel syndrome?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28091439"
      },
      {
        "pubmed_id": "7629529",
        "score": 0.36331093311309814,
        "title": "Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7629529"
      },
      {
        "pubmed_id": "25238668",
        "score": 0.3545222282409668,
        "title": "Cerebrospinal fluid oxidative stress marker levels and cytokine concentrations in a neonate with incontinentia pigmenti.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25238668"
      }
    ],
    "query_time": 0.016962051391601562,
    "metrics": {
      "precision": 0.4,
      "recall": 1.0,
      "f1_score": 0.5714285714285715,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "58a9bbe81978bbde22000007": {
    "query": "Where are Paneth cells located?",
    "type": "factoid",
    "ideal_answer": [
      "Paneth cells are located in the intestinal crypt base columnar cells (CBCCs)."
    ],
    "ground_truth_ids": [
      "21122555",
      "19397593",
      "23006982",
      "24439803",
      "23232853",
      "19788585"
    ],
    "retrieved_ids": [
      "23232853",
      "21122555",
      "24439803",
      "19788585",
      "22507538",
      "28099525",
      "23024658",
      "11900484",
      "21606361",
      "15136145"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23232853",
        "score": 0.5061841011047363,
        "title": "Paneth cells in colonic adenomas: association with male sex and adenoma burden.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23232853"
      },
      {
        "pubmed_id": "21122555",
        "score": 0.40706390142440796,
        "title": "Paneth's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21122555"
      },
      {
        "pubmed_id": "24439803",
        "score": 0.4027060270309448,
        "title": "Intestinal stem cells and their defining niche.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24439803"
      },
      {
        "pubmed_id": "19788585",
        "score": 0.3620564639568329,
        "title": "The stem cells of small intestinal crypts: where are they?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19788585"
      },
      {
        "pubmed_id": "22507538",
        "score": 0.3450031280517578,
        "title": "The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22507538"
      },
      {
        "pubmed_id": "28099525",
        "score": 0.32976359128952026,
        "title": "Polyethylene Glycol Camouflaged Earthworm Hemoglobin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28099525"
      },
      {
        "pubmed_id": "23024658",
        "score": 0.32087773084640503,
        "title": "The Flatworm Macrostomum lignano Is a Powerful Model Organism for Ion Channel and Stem Cell Research.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23024658"
      },
      {
        "pubmed_id": "11900484",
        "score": 0.31053626537323,
        "title": "Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11900484"
      },
      {
        "pubmed_id": "21606361",
        "score": 0.30774182081222534,
        "title": "CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21606361"
      },
      {
        "pubmed_id": "15136145",
        "score": 0.3049169182777405,
        "title": "The ladybird homeobox genes are essential for the specification of a subpopulation of neural cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15136145"
      }
    ],
    "query_time": 0.018689870834350586,
    "metrics": {
      "precision": 0.4,
      "recall": 0.6666666666666666,
      "f1_score": 0.5,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "56c341acfedd0b786b000001": {
    "query": "What is the molecular function of psoralen photobinding on DNA?",
    "type": "factoid",
    "ideal_answer": [
      "The interaction of two water-soluble furocoumarins, 8-(omega-diethyl aminopropyloxy)psoralen hydrochloride (I) and its 5-isomer (II), with DNA has been investigated by spectroscopic, equilibrium dialysis, hydrodynamic and chiroptical techniques. Both compounds intercalate into the polynucleotide double helix."
    ],
    "ground_truth_ids": [
      "1432387",
      "23416947",
      "10075890",
      "1821628",
      "20685815",
      "3273186",
      "1445915",
      "6504703",
      "367436"
    ],
    "retrieved_ids": [
      "1445915",
      "1432387",
      "367436",
      "10075890",
      "3273186",
      "1821628",
      "6504703",
      "20685815",
      "19381941",
      "28255969"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "1445915",
        "score": 0.7106779217720032,
        "title": "Sequence specificity of psoralen photobinding to DNA: a quantitative approach.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1445915"
      },
      {
        "pubmed_id": "1432387",
        "score": 0.6302893161773682,
        "title": "Synthesis and photobiological activity of new methylpsoralen derivatives.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1432387"
      },
      {
        "pubmed_id": "367436",
        "score": 0.6112080812454224,
        "title": "Cross-linking and relaxation of supercoiled DNA by psoralen and light.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/367436"
      },
      {
        "pubmed_id": "10075890",
        "score": 0.6087112426757812,
        "title": "Psoralen cross-linking as probe of torsional tension and topological domain size in vivo.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10075890"
      },
      {
        "pubmed_id": "3273186",
        "score": 0.5953116416931152,
        "title": "Analysis of trimethylpsoralen photoreactivity to Z-DNA provides a general in vivo assay for Z-DNA: analysis of the hypersensitivity of (GT)n B-Z junctions.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3273186"
      },
      {
        "pubmed_id": "1821628",
        "score": 0.5566320419311523,
        "title": "Azapsoralens: new potential photochemotherapeutic agents for psoriasis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1821628"
      },
      {
        "pubmed_id": "6504703",
        "score": 0.5437292456626892,
        "title": "DNA-binding of water-soluble furocoumarins: a thermodynamic and conformational approach to understanding different biological effects.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6504703"
      },
      {
        "pubmed_id": "20685815",
        "score": 0.5304512977600098,
        "title": "A method for genome-wide analysis of DNA helical tension by means of psoralen-DNA photobinding.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20685815"
      },
      {
        "pubmed_id": "19381941",
        "score": 0.4213588237762451,
        "title": "Methods to study transcription-coupled repair in chromatin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19381941"
      },
      {
        "pubmed_id": "28255969",
        "score": 0.40941935777664185,
        "title": "[Optogenetics: A Therapeutic Option for Advanced Retinal Dystrophies].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28255969"
      }
    ],
    "query_time": 0.011606931686401367,
    "metrics": {
      "precision": 0.8,
      "recall": 0.8888888888888888,
      "f1_score": 0.8421052631578948,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 9
    }
  },
  "58a5b1fe60087bc10a000024": {
    "query": "What is the role of the UBC9 enzyme in the protein sumoylation pathway?",
    "type": "factoid",
    "ideal_answer": [
      "The small ubiquitin-like modifier (SUMO) pathway in eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis. SUMO-conjugating enzyme (Ubc9) is the sole conjunction enzyme in the SUMO pathway."
    ],
    "ground_truth_ids": [
      "24991007",
      "23078246",
      "25311713",
      "23628505",
      "16862185",
      "20800867",
      "23708104",
      "18617892",
      "19323834",
      "21518767",
      "21390240",
      "25097219",
      "20865051",
      "21510985",
      "25637535",
      "26582473",
      "26889037",
      "23097446",
      "17698038",
      "26826302",
      "23381475",
      "19826484",
      "23187003",
      "22525038",
      "21444718",
      "15546615",
      "11867732",
      "27142163",
      "20561671",
      "25191977",
      "15087395",
      "21278366",
      "22904261",
      "27425617"
    ],
    "retrieved_ids": [
      "25637535",
      "20865051",
      "21518767",
      "17698038",
      "23708104",
      "15546615",
      "23381475",
      "21444718",
      "25097219",
      "21510985"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25637535",
        "score": 0.7635509371757507,
        "title": "Characterization of amino acid residues within the N-terminal region of Ubc9 that play a role in Ubc9 nuclear localization.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25637535"
      },
      {
        "pubmed_id": "20865051",
        "score": 0.7278479337692261,
        "title": "A mechanistic view of the role of E3 in sumoylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20865051"
      },
      {
        "pubmed_id": "21518767",
        "score": 0.7143939733505249,
        "title": "UBC9 autosumoylation negatively regulates sumoylation of septins in Saccharomyces cerevisiae.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21518767"
      },
      {
        "pubmed_id": "17698038",
        "score": 0.6937445402145386,
        "title": "RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17698038"
      },
      {
        "pubmed_id": "23708104",
        "score": 0.6776944398880005,
        "title": "Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23708104"
      },
      {
        "pubmed_id": "15546615",
        "score": 0.6713414192199707,
        "title": "A mechanism for inhibiting the SUMO pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15546615"
      },
      {
        "pubmed_id": "23381475",
        "score": 0.6707797646522522,
        "title": "Ubc9 promotes invasion and metastasis of lung cancer cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23381475"
      },
      {
        "pubmed_id": "21444718",
        "score": 0.6690863370895386,
        "title": "DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21444718"
      },
      {
        "pubmed_id": "25097219",
        "score": 0.6419994831085205,
        "title": "Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25097219"
      },
      {
        "pubmed_id": "21510985",
        "score": 0.6416214108467102,
        "title": "HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21510985"
      }
    ],
    "query_time": 0.013509035110473633,
    "metrics": {
      "precision": 1.0,
      "recall": 0.29411764705882354,
      "f1_score": 0.45454545454545453,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 34
    }
  },
  "5fe3131ba43ad31278000047": {
    "query": "Which RNA polymerase transcribes enhancer RNAs?",
    "type": "factoid",
    "ideal_answer": [
      "Analogously to mRNAs, the non-protein-encoding enhancer RNAs are synthesized by RNA Pol II and post-transcriptionally modified by addition of a 5'-cap and a 3'-poly (A) tail.",
      "Enhancers are bound by sequence-specific transcription factors, which in turn facilitate the cooperative binding of chromatin remodeling enzymes, histone modifying enzymes, other co-factors, and ultimately the RNA polymerase II complex (RNA pol II). Both the target genes and the enhancers are transcribed by RNA pol II.",
      "Analogously to mRNAs, the non-protein-encoding enhancer RNAs are synthesized by RNA Pol II and post-transcriptionally modified by addition of a 5'-cap and a 3'-poly (A) tail. Recent evidence indicates that miRNA genes are transcribed by RNA polymerase II (Pol II)",
      "Enhancer RNAs (eRNAs) are a group of lncRNAs transcribed from enhancers by RNA Polymerase II.",
      "Analogously to mRNAs, the non-protein-encoding enhancers are synthesized by RNA polymerase II and post-transcriptionally modified by addition of a 5'-cap and a 3'-poly (A) tail. Recent evidence indicates that miRNA genes are transcribed by RNA Pol II (Pol II)",
      "Because the transcripts of most enhancer genes are the products of type-II RNA polymerase, enhancer RNA Pol II (Pol II) has a poly(A) tail and appears in expressed sequence tags (EST). Analogously to mRNAs, the non-protein-encoding enhancer RNAs (ncRNAs) are synthesized by RNAPol II and post-transcriptionally modified by addition of a 5'-cap and a 3'-poly (A) tails.",
      "Because the transcripts of most enhancers are the products of type-II RNA polymerase, enhancer RNA Pol II (Pol II) has a poly(A) tail and appears in expressed sequence tags (EST). Analogously to mRNAs, the non-protein-encoding enhancer RNAs are synthesized by RNAPol II and post-transcriptionally modified by addition of a 5'-cap and a 3'-poly ( A) tail.",
      "The enhancer produced an eRNA, termed AS1eRNA, that enhanced DHRS4-AS1 transcription by mediating the spatial interactions of the enhancer and DHRS4-AS1 promoter in cooperation with RNA polymerase II and p300/CBP."
    ],
    "ground_truth_ids": [
      "27662874",
      "30448228",
      "28533025",
      "27662872",
      "32060325",
      "26319018",
      "3299107",
      "25578728",
      "29378668",
      "26864944",
      "2218723",
      "3031599",
      "26219400",
      "20393465",
      "31824865",
      "3462718",
      "24599251",
      "2986013"
    ],
    "retrieved_ids": [
      "28533025",
      "2218723",
      "1371280",
      "3462718",
      "2986013",
      "27662874",
      "7503982",
      "37266452",
      "7513257",
      "27662872"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28533025",
        "score": 0.6773163080215454,
        "title": "Enhancer-derived RNA: A Primer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28533025"
      },
      {
        "pubmed_id": "2218723",
        "score": 0.6072491407394409,
        "title": "A transcriptional terminator between enhancer and promoter does not affect remote transcriptional control.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2218723"
      },
      {
        "pubmed_id": "1371280",
        "score": 0.6047073006629944,
        "title": "Elongation factor-dependent transcript shortening by template-engaged RNA polymerase II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1371280"
      },
      {
        "pubmed_id": "3462718",
        "score": 0.6044678092002869,
        "title": "RNA polymerase specificity of mRNA production and enhancer action.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3462718"
      },
      {
        "pubmed_id": "2986013",
        "score": 0.5982321500778198,
        "title": "Simian virus 40 enhancer increases number of RNA polymerase II molecules on linked DNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2986013"
      },
      {
        "pubmed_id": "27662874",
        "score": 0.5900492668151855,
        "title": "Computational Approaches for Mining GRO-Seq Data to Identify and Characterize Active Enhancers.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27662874"
      },
      {
        "pubmed_id": "7503982",
        "score": 0.5805241465568542,
        "title": "Nascent RNA cleavage by arrested RNA polymerase II does not require upstream translocation of the elongation complex on DNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7503982"
      },
      {
        "pubmed_id": "37266452",
        "score": 0.5777384638786316,
        "title": "Enhancer RNAs in transcriptional regulation: recent insights.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37266452"
      },
      {
        "pubmed_id": "7513257",
        "score": 0.5746038556098938,
        "title": "Complexes of yeast RNA polymerase II and RNA are substrates for TFIIS-induced RNA cleavage.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7513257"
      },
      {
        "pubmed_id": "27662872",
        "score": 0.5729864835739136,
        "title": "Identification of Transcribed Enhancers by Genome-Wide Chromatin Immunoprecipitation Sequencing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27662872"
      }
    ],
    "query_time": 0.014892101287841797,
    "metrics": {
      "precision": 0.6,
      "recall": 0.3333333333333333,
      "f1_score": 0.42857142857142855,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 18
    }
  },
  "52e92c6e98d0239505000024": {
    "query": "Which gene is associated with the Mitchell-Riley syndrome?",
    "type": "factoid",
    "ideal_answer": [
      "Mutations in the gene coding for the transcription factor RFX6 (regulatory factor X,6) have been described as the cause of the Mitchell-Riley syndrome."
    ],
    "ground_truth_ids": [
      "21215266",
      "23914949"
    ],
    "retrieved_ids": [
      "25419155",
      "16617304",
      "8357522",
      "19046652",
      "25606403",
      "18230842",
      "1968707",
      "20137753",
      "18975529",
      "2992938"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25419155",
        "score": 0.49737733602523804,
        "title": "The genetics of Leigh syndrome and its implications for clinical practice and risk management.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25419155"
      },
      {
        "pubmed_id": "16617304",
        "score": 0.4959218204021454,
        "title": "Parental and chromosomal origins of microdeletion and duplication syndromes involving 7q11.23, 15q11-q13 and 22q11.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16617304"
      },
      {
        "pubmed_id": "8357522",
        "score": 0.49358540773391724,
        "title": "[Alport's syndrome: new findings].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8357522"
      },
      {
        "pubmed_id": "19046652",
        "score": 0.4913552403450012,
        "title": "Unusual findings in Leigh syndrome caused by T8993C mutation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19046652"
      },
      {
        "pubmed_id": "25606403",
        "score": 0.487509548664093,
        "title": "The first family with Tay-Sachs disease in Cyprus: Genetic analysis reveals a nonsense (c.78G>A) and a silent (c.1305C>T) mutation and allows preimplantation genetic diagnosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25606403"
      },
      {
        "pubmed_id": "18230842",
        "score": 0.48115304112434387,
        "title": "Mowat-Wilson syndrome affecting 3 siblings.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18230842"
      },
      {
        "pubmed_id": "1968707",
        "score": 0.4713330566883087,
        "title": "Identification of the functional profilin gene, its localization to chromosome subband 17p13.3, and demonstration of its deletion in some patients with Miller-Dieker syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1968707"
      },
      {
        "pubmed_id": "20137753",
        "score": 0.4709053039550781,
        "title": "Piebaldism and neurofibromatosis type 1: family report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20137753"
      },
      {
        "pubmed_id": "18975529",
        "score": 0.4703742265701294,
        "title": "[Charcot-Marie-Tooth disease].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18975529"
      },
      {
        "pubmed_id": "2992938",
        "score": 0.46943187713623047,
        "title": "Detection of a high frequency RsaI polymorphism in the human pro alpha 2(I) collagen gene which is linked to an autosomal dominant form of osteogenesis imperfecta.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2992938"
      }
    ],
    "query_time": 0.022623062133789062,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "54fc99f36ad7dcbc12000004": {
    "query": "Neurostimulation of which nucleus is used for treatment of dystonia?",
    "type": "factoid",
    "ideal_answer": [
      "Neurostimulation of globus pallidus internus is effective for treatment of dystonia. Ventral intermediate thalamic nucleus has also been tested for neurostimulation in dystonia patients."
    ],
    "ground_truth_ids": [
      "17093249",
      "11254790",
      "11481711",
      "21549607",
      "12151848",
      "24268100",
      "16410002",
      "19576854",
      "15689584",
      "17277672",
      "16717218",
      "24292857",
      "25127231",
      "17973330",
      "23123071",
      "20482602",
      "23037556"
    ],
    "retrieved_ids": [
      "11481711",
      "11254790",
      "23037556",
      "12151848",
      "15689584",
      "17093249",
      "17973330",
      "25127231",
      "24268100",
      "16717218"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "11481711",
        "score": 0.687068521976471,
        "title": "Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11481711"
      },
      {
        "pubmed_id": "11254790",
        "score": 0.6689140200614929,
        "title": "Pallidal and thalamic neurostimulation in severe tardive dystonia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11254790"
      },
      {
        "pubmed_id": "23037556",
        "score": 0.6071321368217468,
        "title": "Surgical treatment for secondary dystonia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23037556"
      },
      {
        "pubmed_id": "12151848",
        "score": 0.5847418308258057,
        "title": "Dystonia: clinical features, genetics, and treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12151848"
      },
      {
        "pubmed_id": "15689584",
        "score": 0.5698795318603516,
        "title": "Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15689584"
      },
      {
        "pubmed_id": "17093249",
        "score": 0.5680444836616516,
        "title": "Pallidal deep-brain stimulation in primary generalized or segmental dystonia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17093249"
      },
      {
        "pubmed_id": "17973330",
        "score": 0.5416536927223206,
        "title": "Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17973330"
      },
      {
        "pubmed_id": "25127231",
        "score": 0.5389508008956909,
        "title": "Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25127231"
      },
      {
        "pubmed_id": "24268100",
        "score": 0.5341655015945435,
        "title": "Motor outcome of dystonic camptocormia treated with pallidal neurostimulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24268100"
      },
      {
        "pubmed_id": "16717218",
        "score": 0.524799108505249,
        "title": "Preservation of cognitive function in dystonia treated by pallidal stimulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16717218"
      }
    ],
    "query_time": 0.013711214065551758,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5882352941176471,
      "f1_score": 0.7407407407407407,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "6415c53e690f196b51000012": {
    "query": "When was Keytruda approved by the FDA for the treatment of metastatic non-small cell lung cancer?",
    "type": "factoid",
    "ideal_answer": [
      "On October 24, 2016, the U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) for treatment of metastatic non-small cell lung cancer."
    ],
    "ground_truth_ids": [
      "28835513"
    ],
    "retrieved_ids": [
      "37861218",
      "28835513",
      "30327351",
      "21109448",
      "28705024",
      "26045340",
      "29239189",
      "29760563",
      "29593890",
      "25701171"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "37861218",
        "score": 0.4886931777000427,
        "title": "Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37861218"
      },
      {
        "pubmed_id": "28835513",
        "score": 0.4881618022918701,
        "title": "FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28835513"
      },
      {
        "pubmed_id": "30327351",
        "score": 0.4832523465156555,
        "title": "Durvalumab Extends OS in NSCLC.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30327351"
      },
      {
        "pubmed_id": "21109448",
        "score": 0.4821777045726776,
        "title": "Monoclonal antibodies against EGFR in non-small cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21109448"
      },
      {
        "pubmed_id": "28705024",
        "score": 0.4744776487350464,
        "title": "MEDI 4736 (durvalumab) in non-small cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28705024"
      },
      {
        "pubmed_id": "26045340",
        "score": 0.47421738505363464,
        "title": "Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26045340"
      },
      {
        "pubmed_id": "29239189",
        "score": 0.4701356291770935,
        "title": "[Immunotherapy in the Treatment of Lung Cancer].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29239189"
      },
      {
        "pubmed_id": "29760563",
        "score": 0.4684945344924927,
        "title": "Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29760563"
      },
      {
        "pubmed_id": "29593890",
        "score": 0.467718243598938,
        "title": "Neoadjuvant and consolidation immuno-oncology therapy in stage III non-small cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29593890"
      },
      {
        "pubmed_id": "25701171",
        "score": 0.4664565324783325,
        "title": "Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25701171"
      }
    ],
    "query_time": 0.01483607292175293,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5e7745ea835f4e4777000006": {
    "query": "What is the active ingredient of Eligard?",
    "type": "factoid",
    "ideal_answer": [
      "The active ingredient of Eligard is leuprorelin acetate."
    ],
    "ground_truth_ids": [
      "29197875"
    ],
    "retrieved_ids": [
      "10037452",
      "26416477",
      "29290671",
      "30475090",
      "10627503",
      "27653758",
      "15982234",
      "27743318",
      "22454066",
      "30995909"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "10037452",
        "score": 0.3664625287055969,
        "title": "Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10037452"
      },
      {
        "pubmed_id": "26416477",
        "score": 0.35932785272598267,
        "title": "Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26416477"
      },
      {
        "pubmed_id": "29290671",
        "score": 0.3513065576553345,
        "title": "Pharmaceutical Approval Update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29290671"
      },
      {
        "pubmed_id": "30475090",
        "score": 0.34206774830818176,
        "title": "Advances in orally administered pharmacotherapy for the treatment of migraine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30475090"
      },
      {
        "pubmed_id": "10627503",
        "score": 0.3317309617996216,
        "title": "Conversion of epoxyeicosatrienoic acids (EETs) to chain-shortened epoxy fatty acids by human skin fibroblasts.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10627503"
      },
      {
        "pubmed_id": "27653758",
        "score": 0.3310726284980774,
        "title": "Apixaban: A Review in Venous Thromboembolism.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27653758"
      },
      {
        "pubmed_id": "15982234",
        "score": 0.3255038559436798,
        "title": "Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15982234"
      },
      {
        "pubmed_id": "27743318",
        "score": 0.3236815333366394,
        "title": "Novel Levodopa Formulations for Parkinson's Disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27743318"
      },
      {
        "pubmed_id": "22454066",
        "score": 0.3105575144290924,
        "title": "U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22454066"
      },
      {
        "pubmed_id": "30995909",
        "score": 0.3082648515701294,
        "title": "Therapeutic novelties in migraine: new drugs, new hope?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30995909"
      }
    ],
    "query_time": 0.018925189971923828,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "53357193d6d3ac6a34000047": {
    "query": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?",
    "type": "factoid",
    "ideal_answer": [
      "Tofacitinib (or CP690.550) is an oral JAK (Janus kinase) inhibitor that is approved for treatment of rheumatoid arthritis. Tofacitinib inhibits JAK family kinase members, in particular JAK1 and JAK3, achieving a broad limitation of inflammation by interfering with several cytokine receptors. Tofacitinib has also a proven efficacy as an immunosuppressive regimen after renal transplantation.  \nGLPG-0634 and INCB18424 are other JAK kinase inhibitors that are being studied for treatment of rheumatoid arthritis."
    ],
    "ground_truth_ids": [
      "19587388",
      "20732649",
      "22374445",
      "22899318",
      "22121136",
      "22777068",
      "23599436",
      "23212593",
      "23961674",
      "24285764",
      "19404006",
      "19565475",
      "20701804",
      "22006202",
      "24193189",
      "22209716",
      "22147632",
      "23523202",
      "22252297",
      "20233177",
      "23384668",
      "22971156",
      "24218541",
      "23642011",
      "21884580",
      "21105711",
      "22460142",
      "23627915",
      "24013646",
      "21548952",
      "21952978"
    ],
    "retrieved_ids": [
      "23961674",
      "23523202",
      "20732649",
      "24285764",
      "19404006",
      "24193189",
      "22971156",
      "22209716",
      "22777068",
      "23212593"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "23961674",
        "score": 0.8487332463264465,
        "title": "[JAK inhibitor].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23961674"
      },
      {
        "pubmed_id": "23523202",
        "score": 0.8467382192611694,
        "title": "Targeting kinases: a new approach to treating inflammatory rheumatic diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23523202"
      },
      {
        "pubmed_id": "20732649",
        "score": 0.8281307816505432,
        "title": "Inhibition of JAK kinases in patients with rheumatoid arthritis: scientific rationale and clinical outcomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20732649"
      },
      {
        "pubmed_id": "24285764",
        "score": 0.8217657804489136,
        "title": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24285764"
      },
      {
        "pubmed_id": "19404006",
        "score": 0.8181219696998596,
        "title": "Jak inhibitor ; possibility and mechanism as a new disease modifying anti-rheumatic drug.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19404006"
      },
      {
        "pubmed_id": "24193189",
        "score": 0.814543604850769,
        "title": "[Intracellular targets : current data on effectiveness and safety profile].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24193189"
      },
      {
        "pubmed_id": "22971156",
        "score": 0.8008725643157959,
        "title": "Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22971156"
      },
      {
        "pubmed_id": "22209716",
        "score": 0.7901833057403564,
        "title": "The many faces of Janus kinase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22209716"
      },
      {
        "pubmed_id": "22777068",
        "score": 0.7840718030929565,
        "title": "[New kinase inhibitors].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22777068"
      },
      {
        "pubmed_id": "23212593",
        "score": 0.7671475410461426,
        "title": "JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23212593"
      }
    ],
    "query_time": 0.012484073638916016,
    "metrics": {
      "precision": 1.0,
      "recall": 0.3225806451612903,
      "f1_score": 0.4878048780487805,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 31
    }
  },
  "65f7798dc4010b4d78000038": {
    "query": "What is the optimal antiemetic treatment for FOLFIRINOX chemotherapy?",
    "type": "factoid",
    "ideal_answer": [
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy includes a three-drug regimen with aprepitant, dexamethasone, and 5-HT3 receptor antagonists. This regimen has been shown to improve the complete response rate during cycle 1 and reduce nausea and vomiting in patients treated with FOLFIRINOX for metastatic pancreatic cancer. However, enhanced antiemetic measures may be necessary as nausea and vomiting can persist beyond 5 days. In patients with diabetes mellitus complications, sparing of steroids and glycemic control should also be considered.",
      "The optimal antiemetic treatment for managing side effects from FOLFIRINOX chemotherapy includes a combination of 5-hydroxytryptamine-3 receptor antagonists (5HT3RA), dexamethasone (DEX), and neurokinin 1 receptor antagonists (NK1RA).",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy includes 5HT3RA, DEX, and NK1RA.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy, which consists of irinotecan, folinic acid, and fluorouracil (5-FU), is a multimodal approach that includes the following:\n\n1. Pregabalin (Lyrica) 150-300 mg orally twice daily starting 1-2 days before chemotherapy and continuing for 3 days.\n\n2. Dexamethasone (Decadron) 8 mg orally or intravenously (IV) twice daily starting 1-2 days before chemotherapy and continuing for 3 days.\n\n3. Palonosetron (Aloxi) 0.25 mg IV or subcutaneously (SC) before chemotherapy.\n\n4. O",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy has not been definitively established. The FOLFIRINOX regimen is known to cause significant nausea and vomiting, and there is a need for effective antiemetic prophylaxis to prevent these adverse events. A study published in the Journal of Clinical Oncology found that a three-drug combination of 5-hydroxytryptamine-3 receptor antagonists (5HT3RA), dexamethasone (DEX), and neurokinin 1 receptor antagonists (NK1RA) was effective in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving FOLFIRINOX. However, the study also noted that the optimal antiemetic treatment for FOLFIRINOX may vary depending on patient factors and individual preferences. Other studies have suggested that",
      "A three-drug combination of 5-hydroxytryptamine-3 receptor antagonists (5HT3RA), dexamethasone (DEX), and neurokinin 1 receptor antagonists (NK1RA) for the prevention of chemotherapy-induced nausea and vomit during FOLFORINOX therapy",
      "5-hydroxytryptamine 3 (5-HT3) receptor antagonists are the optimal antiemetic treatments for FOLFIRINOX chemotherapy",
      "Based on the given context, the optimal antiemetic treatment for FOLFIRINOX chemotherapy, a standard chemotherapy regimen for advanced pancreatic cancer, should include a combination of 5-hydroxytryptamine-3 receptor antagonists (5HT3RA), dexamethasone (DEX), and neurokinin 1 receptor antagonists (NK1RA) for the prevention of chemotherapy-induced nausea and vomiting (CINV). However, it is important to note that CINV induced by FOLFIRINOX was poorly controlled even with this prophylactic antiemetic therapy, suggesting the need for enhanced antiemetic measures. Additionally, in patients with diabetes mellitus complications, sparing of steroids and glycemic control should be considered due to the risk of hyperglycemia.",
      "5-HT3RA is a standard antiemetic therapy for FOLFIRINOX chemotherapy. However, patients receiving mFFX are at risk of developing chemotherapy-induced nausea and vomiting (CINV) that is refractory to conventional antiemetic therapy and can persist beyond 5 days. NK1-RA in addition to 5HT3RA and DEX should be used prophylactically to control CINV in mFFX.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy has not been fully established, and the current standard of care consisting of a three-drug combination of 5-hydroxytryptamine-3 receptor antagonists (5HT3RA), dexamethasone (DEX), and neurokinin 1 receptor antagonists (NK1RA) may not be sufficient to control chemotherapy-induced nausea and vomiting (CINV). Enhanced antiemetic measures, such as additional medications or alternative regimens, may be necessary to improve CINV management for patients undergoing FOLFIRINOX therapy. However, the choice of antiemetic treatment should also consider potential side effects, such as hyperglycemia, and individual patient factors, including diabetes mellitus complications. Further research is needed to determine the most effective and safe antiemetic strategy for FOL",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is a single oral dose of NEPA (Akynzeo®) plus 12 mg of dexamethasone. NEPA is a fixed-dose combination of netupitant, a neurokinin-1 receptor antagonist (NK1RA), and palonosetron, a 5-hydroxytryptamine type 3 receptor antagonist (5HT3RA), which has been shown to be effective in preventing chemotherapy-induced nausea and vomiting (CINV). This treatment has demonstrated therapeutic benefits in managing and prophylaxis of CINV events, both in naive patients and patients previously treated with serotonin receptor antagonists (5HT3-RA) and neurokinin-1 receptor antagonists (NK1-RA). Additionally, NEPA has been shown to be safe, both before and during the COVID-19 pandemic.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is a combination of 5HT3RA, DEX, and NK1RA, with prophylactic therapy starting before the chemotherapy and continuing for at least 5 days after the treatment.",
      "5HT3RA (5-hydroxytryptamine receptor antagonist), DEX (dexamethasone) and NK1RA (neurokinin-1 receptor antagonist) are commonly used for prophylactic antiemetic therapy in patients undergoing FOLFIRINOX chemotherapy. However, if patient experiences poorly controlled CINV, additional or alternative antiemetic medications should be considered. Olanzapine, aprepitant and other antiemetics could be added to the regimen based on individual patient's needs.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is not specified in the provided context, but it mentions that CINV induced by mFFX was poorly controlled even with prophylactic antiemetic therapy using 5HT3RA, DEX, and NK1RA.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy includes a combination of multiple drugs. It is recommended to use a 5HT3 receptor antagonist (5HT3RA), dexamethasone (DEX), and a neurokinin-1 receptor antagonist (NK1RA) as prophylactic antiemetic therapy. However, in cases where CINV induced by FOLFIRINOX is poorly controlled even with this standard regimen, additional interventions may be required, such as the use of olanzapine or aprepitant. It is important to individualize the treatment based on the patient's specific needs and response to therapy.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy includes prophylactic antiemetic therapy using 5HT3RA, DEX.",
      "The optimal antiemetic treatment for FOLFIRINOX (mFFX) chemotherapy typically includes a combination of a 5HT3 receptor antagonist (5HT3RA), dexamethasone (DEX), and a neurokinin-1 receptor antagonist (NK1RA). However, it's important to note that even with this prophylactic antiemetic therapy, control of chemotherapy-induced nausea and vomiting (CINV) can be challenging, and symptoms may persist beyond 5 days. This indicates a need for potentially adjusting the treatment approach or exploring additional supportive measures to better manage CINV in patients undergoing this regimen.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is 5-hydroxytryptamine-3 receptor antagonists (5HT3RA), dexamethasone (DEX), and neurokinin 1 receptor antagonists (NK1RA).",
      " The optimal antimycin D treatment for FOLFox chemotherapy is not well understood, and there is no one-solution approach that can eliminate the risk of antimycin D-resistance. Instead, there are several strategies that can be employed to mitigate the risk of antimycin D-resistance and improve the efficacy of FOLFox chemotherapy. These strategies include:",
      "\nAnswer: Aprepitant, dexamethasone, and a 5-HT3 receptor antagonist (granisetron or palonosetron) before and after chemotherapy.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy has not been definitively established, as various regimens have been used in different clinical trials and real-world settings. However, a few studies suggest that a three-drug combination of 5-hydroxytryptamine-3 receptor antagonists (5HT3RA), dexamethasone (DEX), and neurokinin 1 receptor antagonists (NK1RA) may be effective in preventing chemotherapy-induced nausea and vomiting (CINV) associated with FOLFIRINOX. In a retrospective cohort study of patients with advanced pancreatic cancer, the complete response rate for CINV was 64.7% with this three-drug regimen, although the incidence of nausea and vomiting remained relatively high. Another study found that the addition of aprepitant to",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy has not been fully established, but current guidelines recommend a combination of agents to prevent CINV. The most effective prophylactic regimen typically includes a serotonin receptor antagonist (5HT3RA) such as ondansetron or granisetron, dexamethasone (DEX), and sometimes a neurokinin-1 receptor antagonist (NK1RA) like aprepitant. However, even with this combination therapy, some patients experience persistent nausea and vomiting, highlighting the need for more effective treatments to manage CINV induced by FOLFIRINOX chemotherapy.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy typically includes a combination of a 5HT3 receptor antagonist (5HT3RA), dexamethasone (DEX), and a neurokinin-1 receptor antagonist (NK1RA). This regimen aims to manage the nausea and vomiting associated with this highly emetogenic chemotherapy. However, it's important to note that even with these medications, control of chemotherapy-induced nausea and vomiting (CINV) can be challenging, and symptoms may persist beyond 5 days. Always consult with a healthcare provider for the most appropriate and individualized treatment plan",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is prochlorperazine (PC), a commonly used antiemetic agent. Prochlorperazine (PC), a commonly used antiemetic agent, is the first-line antiemetic agent for patients receiving chemotherapy. Food and liquid restrictions are also",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy includes prophylactic antiemetic therapy using 5HT3 receptor antagonists (5HT3RA), dexamethasone (DEX), and neurokinin-1 receptor antagonists (NK1RA).",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is a combination of 5HT3RA and DEX.",
      "CINV induced by mFFX was poorly controlled even with prophylactic antiemetic therapy using 5HT3RA, DEX, and NK1RA, and was found to persist beyond 5 days",
      "The recommended antiemetic treatment for FOLFIRINOX chemotherapy is a combination of 5HT3RA and DEX.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is NEPA (netupitant/palonosetron). NEPA has been shown to effectively prevent nausea and vomiting induced by chemotherapy (CINV) in patients receiving FOLFIRINOX and Folfoxiri regimens. This combination of netupitant and palonosetron provides superior control of acute and delayed CINV compared to other antiemetic agents. NEPA can be safely used during the COVID-19 pandemic and has been proven to be effective in real-life studies.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy includes a combination of 5HT3 receptor antagonists, dexamethasone, and NK1 receptor antagonists.",
      "Based on the provided information, chemotherapy-induced nausea and vomiting (CINV) induced by modified FOLFIRINOX (mFFX) chemotherapy was poorly controlled even with prophylactic antiemetic therapy using a combination of a 5-HT3 receptor antagonist (5HT3RA), dexamethasone (DEX), and an NK-1 receptor antagonist (NK1RA). The CINV persisted beyond 5 days.\n\nThe text does not provide information on the optimal antiemetic treatment for FOLFIRINOX. It only indicates that the mentioned antiemetic combination was not fully effective in controlling CINV in this setting. More research would be needed to determine the best approach for managing CINV with this chemotherapy regimen.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is a combination of netupitant/palonosetron (NEPA; Akynzeo(®)) with >85% antiemetic efficacy.",
      "5HT3RA, DEX, and NK1RA",
      "The recommended antiemetic treatment for FOLFIRINOX chemotherapy is either 5HT3RA or a combination of 5HT3RA and DEX.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is prochlorperazine (PC), ondansetron (OD), and dexamethasone (Dex) or a combination of these agents.",
      "In this study, the researchers found that a three-drug regimen with aprepitant can significantly reduce the incidence of nausea and vomiting in patients with metastatic pancreatic cancer who received FOLFIRINOX chemotherapy.",
      "The optimal antiemetic treatment for FOLFIRINOX chemotherapy is still a topic of debate. The snippet suggests that prophylactic antiemetic therapy using 5HT3RA, DEX, and NK1RA may not be effective in controlling CINV induced by mFFX. Recent studies suggest that olanzapine may be effective in preventing CINV in patients receiving FOLFIRINOX chemotherapy. However, further research is needed to confirm its efficacy and safety profile. It's essential to consider individual patient factors, such as age, gender, and previous antiemetic response, when choosing an antiemetic regimen.",
      "CINV induced by mFFX was poorly controlled even with prophylactic antiemetic therapy using 5HT3RA, DEX, and NK1RA, and was found to persist beyond 5 days.",
      "The optimal antiemetic treatment for FOLFIRINOX (mFFX) chemotherapy typically includes a combination of a 5HT3 receptor antagonist (5HT3RA), dexamethasone (DEX), and a neurokinin-1 receptor antagonist (NK1RA). However, it's important to note that even with this prophylactic antiemetic therapy, control of chemotherapy-induced nausea and vomiting (CINV) can be challenging, and symptoms may persist beyond 5 days. This indicates a need for potentially adjusting the treatment strategy or exploring additional supportive measures to better manage CINV in patients undergoing this regimen.",
      "5-hydroxytryptamine 3 receptor (5-HT3R) antagonists and dexamethasone can be used to manage chemotherapy-induced nausea and vomiting in FOLFIRINOX. Other options include neurokinin-1 (NK1) receptor antagonists and other adjunctive medications such as aprepitant, palonosetron and olanzapine."
    ],
    "ground_truth_ids": [
      "37884842",
      "33023657",
      "20413062",
      "34131576",
      "30019968",
      "30333194",
      "22316362",
      "3967569",
      "36033477",
      "34486707",
      "28191518"
    ],
    "retrieved_ids": [
      "37429749",
      "12482332",
      "3967569",
      "22316362",
      "18824706",
      "14665611",
      "25349295",
      "29246011",
      "30333194",
      "17901952"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "37429749",
        "score": 0.5916072130203247,
        "title": "ShorTrip Trial: A Prospective, Multicentric Phase II Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37429749"
      },
      {
        "pubmed_id": "12482332",
        "score": 0.5866142511367798,
        "title": "Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12482332"
      },
      {
        "pubmed_id": "3967569",
        "score": 0.5664607286453247,
        "title": "Combination antiemetic therapy in the control of chemotherapy-induced emesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3967569"
      },
      {
        "pubmed_id": "22316362",
        "score": 0.5421693921089172,
        "title": "Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22316362"
      },
      {
        "pubmed_id": "18824706",
        "score": 0.5252686142921448,
        "title": "Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18824706"
      },
      {
        "pubmed_id": "14665611",
        "score": 0.5166404843330383,
        "title": "A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14665611"
      },
      {
        "pubmed_id": "25349295",
        "score": 0.5138450860977173,
        "title": "Resampling the N9741 trial to compare tumor dynamic versus conventional end points in randomized phase II trials.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25349295"
      },
      {
        "pubmed_id": "29246011",
        "score": 0.5109081864356995,
        "title": "Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29246011"
      },
      {
        "pubmed_id": "30333194",
        "score": 0.5088779926300049,
        "title": "Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30333194"
      },
      {
        "pubmed_id": "17901952",
        "score": 0.5088621377944946,
        "title": "Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17901952"
      }
    ],
    "query_time": 0.011182069778442383,
    "metrics": {
      "precision": 0.3,
      "recall": 0.2727272727272727,
      "f1_score": 0.28571428571428564,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.3333333333333333,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 11
    }
  },
  "5e6d1c6f1af46fc130000021": {
    "query": "Han Wistar and Sprague Dawley are breeds of what laboratory animal?",
    "type": "factoid",
    "ideal_answer": [
      "Han-Wistar and Sprague-Dawley rats",
      "Han Wistar and Sprague Dawley are breeds of Rats"
    ],
    "ground_truth_ids": [
      "2756796",
      "15546683",
      "30476622",
      "24749500",
      "29097845",
      "22610983",
      "25537841",
      "23349040",
      "28068893",
      "32764845",
      "10321989",
      "22664268",
      "15764299",
      "32713280",
      "15533676",
      "24213005",
      "24213004",
      "11850967"
    ],
    "retrieved_ids": [
      "28068893",
      "32764845",
      "22174915",
      "24749500",
      "25537841",
      "24213005",
      "5444269",
      "32713280",
      "21982513",
      "24213004"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "28068893",
        "score": 0.43737804889678955,
        "title": "Differences in Types and Incidence of Neoplasms in Wistar Han and Sprague-Dawley Rats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28068893"
      },
      {
        "pubmed_id": "32764845",
        "score": 0.3916100561618805,
        "title": "Comparison of longevity and common tumor profiles between Sprague-Dawley and Han Wistar rats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32764845"
      },
      {
        "pubmed_id": "22174915",
        "score": 0.36461755633354187,
        "title": "A MITF mutation associated with a dominant white phenotype and bilateral deafness in German Fleckvieh cattle.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22174915"
      },
      {
        "pubmed_id": "24749500",
        "score": 0.36154478788375854,
        "title": "Domestication and diversification: a comparative analysis of the play fighting of the Brown Norway, Sprague-Dawley, and Wistar laboratory strains of (Rattus norvegicus).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24749500"
      },
      {
        "pubmed_id": "25537841",
        "score": 0.35391056537628174,
        "title": "Comparison of spatial learning in the partially baited radial-arm maze task between commonly used rat strains: Wistar, Spargue-Dawley, Long-Evans, and outcrossed Wistar/Sprague-Dawley.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25537841"
      },
      {
        "pubmed_id": "24213005",
        "score": 0.3517913818359375,
        "title": "Study for collecting background data on Wistar Hannover [Crl:WI(Han)] rats in general toxicity studies--comparative data to Sprague Dawley rats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24213005"
      },
      {
        "pubmed_id": "5444269",
        "score": 0.34695965051651,
        "title": "Indian muntjac, Muntiacus muntjak: a deer with a low diploid chromosome number.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/5444269"
      },
      {
        "pubmed_id": "32713280",
        "score": 0.3214854896068573,
        "title": "Comparative assessment for rat strain differences in metabolic profiles of 14 drugs in Wistar Han and Sprague Dawley hepatocytes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32713280"
      },
      {
        "pubmed_id": "21982513",
        "score": 0.31995925307273865,
        "title": "Snat: a SNP annotation tool for bovine by integrating various sources of genomic information.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21982513"
      },
      {
        "pubmed_id": "24213004",
        "score": 0.31044912338256836,
        "title": "Study for collecting background data on Wistar Hannover [Crl:WI(Han)] rats in embryo-fetal development studies--comparative data to Sprague Dawley rats.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24213004"
      }
    ],
    "query_time": 0.007217884063720703,
    "metrics": {
      "precision": 0.7,
      "recall": 0.3888888888888889,
      "f1_score": 0.5,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 7,
      "total_retrieved": 10,
      "total_relevant": 18
    }
  },
  "65cfd02e1930410b1300001c": {
    "query": "What channel is targeted by VX-548?",
    "type": "factoid",
    "ideal_answer": [
      "VX-548 is an oral, highly selective inhibitor of NaV1.8 that is studied for control of acute pain."
    ],
    "ground_truth_ids": [
      "37530822"
    ],
    "retrieved_ids": [
      "37530822",
      "16977285",
      "24333430",
      "25701212",
      "12063277",
      "25218469",
      "24475291",
      "24154981",
      "26363003",
      "26537679"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "37530822",
        "score": 0.2704468369483948,
        "title": "Selective Inhibition of NaV1.8 with VX-548 for Acute Pain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37530822"
      },
      {
        "pubmed_id": "16977285",
        "score": 0.23781633377075195,
        "title": "Herpes zoster vaccine (Zostavax).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16977285"
      },
      {
        "pubmed_id": "24333430",
        "score": 0.22489286959171295,
        "title": "Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24333430"
      },
      {
        "pubmed_id": "25701212",
        "score": 0.21861499547958374,
        "title": "Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25701212"
      },
      {
        "pubmed_id": "12063277",
        "score": 0.20914378762245178,
        "title": "Role of glycosylation in cell surface expression and stability of HERG potassium channels.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12063277"
      },
      {
        "pubmed_id": "25218469",
        "score": 0.20877353847026825,
        "title": "Down-regulation of ether-a-go-go-related gene potassium channel protein through sustained stimulation of AT1 receptor by angiotensin II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25218469"
      },
      {
        "pubmed_id": "24475291",
        "score": 0.2084399163722992,
        "title": "Up-regulation of hERG K⁺ channels by B-RAF.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24475291"
      },
      {
        "pubmed_id": "24154981",
        "score": 0.20274195075035095,
        "title": "Screening for cardiac HERG potassium channel interacting proteins using the yeast two-hybrid technique.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24154981"
      },
      {
        "pubmed_id": "26363003",
        "score": 0.20246532559394836,
        "title": "Regulation of the human ether-a-go-go-related gene (hERG) potassium channel by Nedd4 family interacting proteins (Ndfips).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26363003"
      },
      {
        "pubmed_id": "26537679",
        "score": 0.20243002474308014,
        "title": "Functional Characterization of the Serine-Rich Tract of Varicella-Zoster Virus IE62.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26537679"
      }
    ],
    "query_time": 0.015722990036010742,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "56c83f365795f9a73e000011": {
    "query": "Which domain allowing self-association do exist in TDP-43 and FUS proteins?",
    "type": "factoid",
    "ideal_answer": [
      "PRION PROTEINS",
      "Mutations in related RNA-binding proteins TDP-43, FUS/TLS and TAF15 have been connected to ALS. These three proteins share several features, including the presence of a bioinformatics-predicted prion domain, aggregation-prone nature in vitro and in vivo and toxic effects when expressed in multiple model systems. TDP-43, FUS and TAF15 share similar properties, including aggregation-prone behavior in vitro and ability to confer neurodegeneration in Drosophila. For TDP-43, both the RRM1 and the C-terminal glycine-rich domain are required for SG localization. Moreover, two RNA-binding proteins, FUS and TDP-43, which form cytoplasmic aggregates in amyotrophic lateral sclerosis, harbor a 'prion domain' similar to those found in several yeast prion protein",
      "Scouring the human genome with this algorithm enriches a select group of RNA-binding proteins harboring a canonical RNA recognition motif (RRM) and a putative prion domain. Moreover, two RNA-binding proteins, FUS and TDP-43, which form cytoplasmic aggregates in amyotrophic lateral sclerosis, harbor a 'prion domain' similar to those found in several yeast prion proteins. PrLDs are over-represented in human RNA-binding proteins and mediate phase transitions underpinning RNP granule assembly. For example, TDP-43 and FUS form cytoplasmic inclusions in amyotrophic lateral sclerosis (ALS) and mutations in TDP-43 and FUS can cause ALS.",
      "Two RNA-binding proteins, FUS and TDP-43, which form cytoplasmic aggregates in amyotrophic lateral sclerosis, harbor a 'prion domain' similar to those found in several yeast prion proteins."
    ],
    "ground_truth_ids": [
      "24842888",
      "20356930",
      "10521526",
      "22454397",
      "22065782",
      "23629963",
      "24920338",
      "21327870",
      "25002999",
      "22445064",
      "24262168",
      "21844169",
      "22563080",
      "20720006"
    ],
    "retrieved_ids": [
      "20720006",
      "24262168",
      "23629963",
      "21327870",
      "22065782",
      "15744326",
      "26582473",
      "20356930",
      "22454397",
      "22563080"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "20720006",
        "score": 0.5693262815475464,
        "title": "Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20720006"
      },
      {
        "pubmed_id": "24262168",
        "score": 0.5510239601135254,
        "title": "Investigating FUS variation in Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24262168"
      },
      {
        "pubmed_id": "23629963",
        "score": 0.519493818283081,
        "title": "Stress granules as crucibles of ALS pathogenesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23629963"
      },
      {
        "pubmed_id": "21327870",
        "score": 0.47943925857543945,
        "title": "Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21327870"
      },
      {
        "pubmed_id": "22065782",
        "score": 0.46770453453063965,
        "title": "A yeast functional screen predicts new candidate ALS disease genes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22065782"
      },
      {
        "pubmed_id": "15744326",
        "score": 0.46692177653312683,
        "title": "Multisite protein modification and intramolecular signaling.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15744326"
      },
      {
        "pubmed_id": "26582473",
        "score": 0.4662694036960602,
        "title": "Divergent signaling via SUMO modification: potential for CFTR modulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26582473"
      },
      {
        "pubmed_id": "20356930",
        "score": 0.45345422625541687,
        "title": "Prion-like disorders: blurring the divide between transmissibility and infectivity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20356930"
      },
      {
        "pubmed_id": "22454397",
        "score": 0.4480506181716919,
        "title": "Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22454397"
      },
      {
        "pubmed_id": "22563080",
        "score": 0.44453614950180054,
        "title": "Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22563080"
      }
    ],
    "query_time": 0.008565902709960938,
    "metrics": {
      "precision": 0.8,
      "recall": 0.5714285714285714,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 14
    }
  },
  "52bf217003868f1b0600001b": {
    "query": "What can Nothobranchius furzeri be used as a model system for?",
    "type": "factoid",
    "ideal_answer": [
      "N. furzeri an interesting model system to investigate the effects of experimental manipulations on longevity and age-related pathologies.\nN. furzeri could represent a model system for studying the genetic control of life-history traits in natural populations.\nN. furzeri could be a very useful model for comparative genomics of aging.\nIt can be employed to test the effects of experimental manipulation on aging and apharmacological research."
    ],
    "ground_truth_ids": [
      "19302373",
      "19052641",
      "17049789",
      "16687936",
      "16164422"
    ],
    "retrieved_ids": [
      "16164422",
      "17049789",
      "19302373",
      "8779182",
      "3781972",
      "19052641",
      "11254790",
      "21265828",
      "35118122",
      "33543619"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "16164422",
        "score": 0.38608109951019287,
        "title": "Annual fishes of the genus Nothobranchius as a model system for aging research.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16164422"
      },
      {
        "pubmed_id": "17049789",
        "score": 0.3690030574798584,
        "title": "The short-lived fish Nothobranchius furzeri as a new model system for aging studies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17049789"
      },
      {
        "pubmed_id": "19302373",
        "score": 0.24979226291179657,
        "title": "Effects of dietary restriction on mortality and age-related phenotypes in the short-lived fish Nothobranchius furzeri.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19302373"
      },
      {
        "pubmed_id": "8779182",
        "score": 0.23536503314971924,
        "title": "[The treatment of neurogenic bladder dysfunction with enuresis in children using the SKENAR apparatus. (self-controlled energy-neuroadaptive regulator)].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8779182"
      },
      {
        "pubmed_id": "3781972",
        "score": 0.23386387526988983,
        "title": "An integrated model for the interaction of muscle relaxants with their antagonists.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3781972"
      },
      {
        "pubmed_id": "19052641",
        "score": 0.2334294319152832,
        "title": "Large differences in aging phenotype between strains of the short-lived annual fish Nothobranchius furzeri.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19052641"
      },
      {
        "pubmed_id": "11254790",
        "score": 0.2263535112142563,
        "title": "Pallidal and thalamic neurostimulation in severe tardive dystonia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11254790"
      },
      {
        "pubmed_id": "21265828",
        "score": 0.22317394614219666,
        "title": "The utility of animal models to evaluate novel anti-obesity agents.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21265828"
      },
      {
        "pubmed_id": "35118122",
        "score": 0.22236454486846924,
        "title": "Trichotillomania: What Do We Know So Far?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35118122"
      },
      {
        "pubmed_id": "33543619",
        "score": 0.2216574102640152,
        "title": "Real-Time Optogenetics System for Controlling Gene Expression Using a Model-Based Design.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33543619"
      }
    ],
    "query_time": 0.007347822189331055,
    "metrics": {
      "precision": 0.4,
      "recall": 0.8,
      "f1_score": 0.5333333333333333,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "6277e52256bf9aee6f000009": {
    "query": "What is the incubation period for COVID-19?",
    "type": "factoid",
    "ideal_answer": [
      "For COVID-19, the mean incubation period was 6.0 days globally but near 7.0 days in the mainland of China, which will help identify the time of infection and make disease control decisions. The Delta VOC yielded a significantly shorter incubation period (4.0 vs. 6.0 days), higher viral load (20.6 vs. 34.0, cycle threshold of the ORF1a/b gene), and a longer duration of viral shedding in pharyngeal swab samples (14.0 vs. 8.0 days) compared with the wild-type strain.",
      "The incubation period for COVID-19 is thought to be within 14 days following exposure, with most cases occurring approximately five to seven days after exposure. The incubation period also varies by viral variant. For example, the incubation period for the Delta variant (B.1.617.2) appears to be slightly shorter, with symptoms first appearing around four days after exposure."
    ],
    "ground_truth_ids": [
      "34579681",
      "34131198",
      "33998486",
      "34368314",
      "33915459",
      "34485577",
      "34117868",
      "33548553",
      "33035373",
      "32627172",
      "34886835",
      "33643779",
      "33748041",
      "33024342",
      "34541481",
      "33706702",
      "32848488",
      "34535192",
      "33818217",
      "32594928",
      "34423821",
      "33832511",
      "33362233",
      "33773195",
      "32801208",
      "32661509"
    ],
    "retrieved_ids": [
      "33915459",
      "34131198",
      "34368314",
      "33818217",
      "33998486",
      "33643779",
      "33024342",
      "34117868",
      "32594928",
      "32661509"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "33915459",
        "score": 0.7622441053390503,
        "title": "In pursuit of the right tail for the COVID-19 incubation period.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33915459"
      },
      {
        "pubmed_id": "34131198",
        "score": 0.7284778356552124,
        "title": "Distribution of incubation periods of COVID-19 in the Canadian context.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34131198"
      },
      {
        "pubmed_id": "34368314",
        "score": 0.7241535186767578,
        "title": "COVID-19 patient with an incubation period of 27 d: A case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34368314"
      },
      {
        "pubmed_id": "33818217",
        "score": 0.722277820110321,
        "title": "Incubation period of coronavirus disease 2019: new implications for intervention and control.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33818217"
      },
      {
        "pubmed_id": "33998486",
        "score": 0.7192555665969849,
        "title": "Incubation period of COVID-19: A systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33998486"
      },
      {
        "pubmed_id": "33643779",
        "score": 0.7189692258834839,
        "title": "Incubation period for COVID-19: a systematic review and meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33643779"
      },
      {
        "pubmed_id": "33024342",
        "score": 0.715222954750061,
        "title": "[Incubation period of COVID-19: A systematic review and meta-analysis].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33024342"
      },
      {
        "pubmed_id": "34117868",
        "score": 0.7013447284698486,
        "title": "The Incubation Period Distribution of Coronavirus Disease 2019: A Systematic Review and Meta-analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34117868"
      },
      {
        "pubmed_id": "32594928",
        "score": 0.6915930509567261,
        "title": "Estimation of incubation period and serial interval of COVID-19: analysis of 178 cases and 131 transmission chains in Hubei province, China.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32594928"
      },
      {
        "pubmed_id": "32661509",
        "score": 0.6892569661140442,
        "title": "Longer incubation period of coronavirus disease 2019 (COVID-19) in older adults.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32661509"
      }
    ],
    "query_time": 0.018615007400512695,
    "metrics": {
      "precision": 1.0,
      "recall": 0.38461538461538464,
      "f1_score": 0.5555555555555556,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 26
    }
  },
  "5e822615835f4e4777000034": {
    "query": "Which protein is mutated in Erythropoietic Protoporphyria?",
    "type": "factoid",
    "ideal_answer": [
      "Erythropoietic protoporphyria (EPP) is a rare inherited disorder of the heme biosynthesis pathway resulting in the accumulation of protoporphyrins in the blood, erythrocytes, and other tissues. Because of a gene mutation in the FECH gene, ferrochelatase, the enzyme involved in the final step of heme synthesis, is deficient in these patients."
    ],
    "ground_truth_ids": [
      "29610169",
      "30175727",
      "29116687"
    ],
    "retrieved_ids": [
      "29116687",
      "30175727",
      "20603160",
      "28099525",
      "20616380",
      "29610169",
      "16621625",
      "8574597",
      "16310364",
      "12556518"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29116687",
        "score": 0.5884964466094971,
        "title": "Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: A case report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29116687"
      },
      {
        "pubmed_id": "30175727",
        "score": 0.5140941739082336,
        "title": "Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30175727"
      },
      {
        "pubmed_id": "20603160",
        "score": 0.46974265575408936,
        "title": "Protoporphyrinogen IX oxidase from Plasmodium falciparum is anaerobic and is localized to the mitochondrion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20603160"
      },
      {
        "pubmed_id": "28099525",
        "score": 0.44510313868522644,
        "title": "Polyethylene Glycol Camouflaged Earthworm Hemoglobin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28099525"
      },
      {
        "pubmed_id": "20616380",
        "score": 0.419938862323761,
        "title": "Putative mutation mechanism and light responses of a protochlorophyllide oxidoreductase-less barley mutant NYB.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20616380"
      },
      {
        "pubmed_id": "29610169",
        "score": 0.41333818435668945,
        "title": "Erythropoietic Protoporphyria: Initial Diagnosis With Cholestatic Liver Disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29610169"
      },
      {
        "pubmed_id": "16621625",
        "score": 0.41314899921417236,
        "title": "Mitochondrial targeting of human protoporphyrinogen oxidase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16621625"
      },
      {
        "pubmed_id": "8574597",
        "score": 0.40871673822402954,
        "title": "The immune system in uremia and during its treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8574597"
      },
      {
        "pubmed_id": "16310364",
        "score": 0.4011845886707306,
        "title": "The Arabidopsis inositol 1,3,4-trisphosphate 5/6 kinase, AtItpk-1, is involved in plant photomorphogenesis under red light conditions, possibly via interaction with COP9 signalosome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16310364"
      },
      {
        "pubmed_id": "12556518",
        "score": 0.40037816762924194,
        "title": "Mitochondrial targeting of normal and mutant protoporphyrinogen oxidase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12556518"
      }
    ],
    "query_time": 0.008279085159301758,
    "metrics": {
      "precision": 0.3,
      "recall": 1.0,
      "f1_score": 0.4615384615384615,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 3
    }
  },
  "601eab7d1cb411341a000053": {
    "query": "What class of drugs have been given a black box warning for suicide?",
    "type": "factoid",
    "ideal_answer": [
      "In 2004, the European and American authorities released a black-box warning on antidepressants indicating an association with an increased risk of suicidality (suicidal ideation and behavior) in young people",
      "In 2004, the US Food and Drug Administration (FDA) controversially issued a black box warning that antidepressants were associated with an increased risk of suicidal thoughts and behaviours in people aged under 18 years.",
      "The U.S Food and Drug Administration issued a Black box warning in October 2004 after placebo-controlled trials of antidepressant medications found an increased risk of suicidal thoughts and behaviors among children and adolescents taking antidepressant medications relative to placebo."
    ],
    "ground_truth_ids": [
      "31130881",
      "19488000",
      "26149466",
      "24696870",
      "20222492",
      "23109125",
      "25345238",
      "20011576",
      "31136275",
      "17074941",
      "32116839",
      "19996040",
      "32587531",
      "21903028",
      "17914327"
    ],
    "retrieved_ids": [
      "31130881",
      "32116839",
      "17914327",
      "26149466",
      "32587531",
      "19488000",
      "21274361",
      "19996040",
      "20011576",
      "24696870"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "31130881",
        "score": 0.7058942914009094,
        "title": "The FDA \"Black Box\" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31130881"
      },
      {
        "pubmed_id": "32116839",
        "score": 0.6540940999984741,
        "title": "Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32116839"
      },
      {
        "pubmed_id": "17914327",
        "score": 0.6387114524841309,
        "title": "Antidepressants and suicidality: the basis of controversies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17914327"
      },
      {
        "pubmed_id": "26149466",
        "score": 0.6130275130271912,
        "title": "Suicide in pediatrics: epidemiology, risk factors, warning signs and the role of the pediatrician in detecting them.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26149466"
      },
      {
        "pubmed_id": "32587531",
        "score": 0.5785869359970093,
        "title": "Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32587531"
      },
      {
        "pubmed_id": "19488000",
        "score": 0.5722507834434509,
        "title": "Antidepressant-induced suicidality: implications for clinical practice.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19488000"
      },
      {
        "pubmed_id": "21274361",
        "score": 0.5574678182601929,
        "title": "Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21274361"
      },
      {
        "pubmed_id": "19996040",
        "score": 0.5550701022148132,
        "title": "Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19996040"
      },
      {
        "pubmed_id": "20011576",
        "score": 0.5377089381217957,
        "title": "Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20011576"
      },
      {
        "pubmed_id": "24696870",
        "score": 0.537689745426178,
        "title": "Spotlight on depression: a Pharma Matters report.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24696870"
      }
    ],
    "query_time": 0.014673233032226562,
    "metrics": {
      "precision": 0.9,
      "recall": 0.6,
      "f1_score": 0.7200000000000001,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 15
    }
  },
  "53175e9fb166e2b80600000a": {
    "query": "What is the physiological role of LKB1 involved in Peutz-Jeghers syndrome?",
    "type": "factoid",
    "ideal_answer": [
      "LKB1 plays a physiological role in controlling the Wnt-signaling."
    ],
    "ground_truth_ids": [
      "20020146"
    ],
    "retrieved_ids": [
      "20020146",
      "29744576",
      "15589118",
      "26209625",
      "10613047",
      "19842203",
      "30871534",
      "18230842",
      "30656450",
      "10964697"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "20020146",
        "score": 0.5947270393371582,
        "title": "Immunohistological evidence for Wnt-signaling activation in Peutz-Jeghers polyposis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20020146"
      },
      {
        "pubmed_id": "29744576",
        "score": 0.4752766191959381,
        "title": "The lysosomal function of progranulin, a guardian against neurodegeneration.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29744576"
      },
      {
        "pubmed_id": "15589118",
        "score": 0.465674489736557,
        "title": "Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15589118"
      },
      {
        "pubmed_id": "26209625",
        "score": 0.46115803718566895,
        "title": "Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26209625"
      },
      {
        "pubmed_id": "10613047",
        "score": 0.4546498656272888,
        "title": "[Molecular genetics of the long QT syndrome: clinical aspects].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10613047"
      },
      {
        "pubmed_id": "19842203",
        "score": 0.4537065029144287,
        "title": "Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19842203"
      },
      {
        "pubmed_id": "30871534",
        "score": 0.4502696394920349,
        "title": "Genotype-phenotype correlations in FSHD.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30871534"
      },
      {
        "pubmed_id": "18230842",
        "score": 0.4450633227825165,
        "title": "Mowat-Wilson syndrome affecting 3 siblings.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18230842"
      },
      {
        "pubmed_id": "30656450",
        "score": 0.44450515508651733,
        "title": "Mutations in ACTL6B, coding for a subunit of the neuron-specific chromatin remodeling complex nBAF, cause early onset severe developmental and epileptic encephalopathy with brain hypomyelination and cerebellar atrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30656450"
      },
      {
        "pubmed_id": "10964697",
        "score": 0.4429870843887329,
        "title": "Functional analysis of five endothelin-B receptor mutations found in human Hirschsprung disease patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10964697"
      }
    ],
    "query_time": 0.011805057525634766,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "588f9950ed9bbee70d000002": {
    "query": "Which gene is mutated in the Karak syndrome?",
    "type": "factoid",
    "ideal_answer": [
      "PLA2G6 gene is mutated in the Karak syndrome."
    ],
    "ground_truth_ids": [
      "16783378",
      "26001724",
      "20938027",
      "27884548",
      "18443314",
      "24130795"
    ],
    "retrieved_ids": [
      "21520335",
      "25606403",
      "23840513",
      "10465109",
      "25438602",
      "17044971",
      "10613047",
      "26612766",
      "27884548",
      "10215406"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "21520335",
        "score": 0.5493878126144409,
        "title": "U1 snRNA-mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21520335"
      },
      {
        "pubmed_id": "25606403",
        "score": 0.539785623550415,
        "title": "The first family with Tay-Sachs disease in Cyprus: Genetic analysis reveals a nonsense (c.78G>A) and a silent (c.1305C>T) mutation and allows preimplantation genetic diagnosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25606403"
      },
      {
        "pubmed_id": "23840513",
        "score": 0.5349032878875732,
        "title": "Genetic Analyses of a Three Generation Family Segregating Hirschsprung Disease and Iris Heterochromia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23840513"
      },
      {
        "pubmed_id": "10465109",
        "score": 0.5242879390716553,
        "title": "Hydrometrocolpos and polydactyly: a common neonatal presentation of Bardet-Biedl and McKusick-Kaufman syndromes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10465109"
      },
      {
        "pubmed_id": "25438602",
        "score": 0.5222450494766235,
        "title": "[Frequency and causes of prevalence of p.Arg894* mutation in CLCN1 gene responsible for development of Thomsen's and Becker's myotonias in Russian population].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25438602"
      },
      {
        "pubmed_id": "17044971",
        "score": 0.5165880918502808,
        "title": "[A novel mutation in KCNQ2 gene causes benign familial infantile convulsions (BFIC) in a Chinese family].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17044971"
      },
      {
        "pubmed_id": "10613047",
        "score": 0.5098050832748413,
        "title": "[Molecular genetics of the long QT syndrome: clinical aspects].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10613047"
      },
      {
        "pubmed_id": "26612766",
        "score": 0.5074244737625122,
        "title": "Exome sequencing revealed a novel biallelic deletion in the DCAF17 gene underlying Woodhouse Sakati syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26612766"
      },
      {
        "pubmed_id": "27884548",
        "score": 0.5061075687408447,
        "title": "Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: An update for the diagnosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27884548"
      },
      {
        "pubmed_id": "10215406",
        "score": 0.5054640173912048,
        "title": "Identification of five new mutations and three novel polymorphisms in the muscle chloride channel gene (CLCN1) in 20 Italian patients with dominant and recessive myotonia congenita. Mutations in brief no. 118. Online.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10215406"
      }
    ],
    "query_time": 0.02149224281311035,
    "metrics": {
      "precision": 0.1,
      "recall": 0.16666666666666666,
      "f1_score": 0.125,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 1.0,
      "mrr": 0.1111111111111111,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 6
    }
  },
  "5e5d24811af46fc130000006": {
    "query": "What is romiplostim targeting?",
    "type": "factoid",
    "ideal_answer": [
      "Romiplostim (ROM) is a thrombopoietin (TPO)-receptor-agonist approved for treatment of adults with chronic immune thrombocytopenia (ITP)."
    ],
    "ground_truth_ids": [
      "29191945",
      "28548028"
    ],
    "retrieved_ids": [
      "16972673",
      "27641143",
      "28548028",
      "31085175",
      "32266704",
      "21985171",
      "29191945",
      "30681821",
      "26288713",
      "24291598"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "16972673",
        "score": 0.3808056116104126,
        "title": "[SERM].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16972673"
      },
      {
        "pubmed_id": "27641143",
        "score": 0.36445391178131104,
        "title": "Romosozumab Treatment in Postmenopausal Women with Osteoporosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27641143"
      },
      {
        "pubmed_id": "28548028",
        "score": 0.3492400050163269,
        "title": "Developmental differences between newborn and adult mice in response to romiplostim.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28548028"
      },
      {
        "pubmed_id": "31085175",
        "score": 0.32402968406677246,
        "title": "Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31085175"
      },
      {
        "pubmed_id": "32266704",
        "score": 0.31656455993652344,
        "title": "Eptinezumab: First Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32266704"
      },
      {
        "pubmed_id": "21985171",
        "score": 0.30803167819976807,
        "title": "Apixaban: first global approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21985171"
      },
      {
        "pubmed_id": "29191945",
        "score": 0.3053356409072876,
        "title": "Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29191945"
      },
      {
        "pubmed_id": "30681821",
        "score": 0.3051866888999939,
        "title": "Migraine overview and summary of current and emerging treatment options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30681821"
      },
      {
        "pubmed_id": "26288713",
        "score": 0.304241418838501,
        "title": "Clinical potential of pacritinib in the treatment of myelofibrosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26288713"
      },
      {
        "pubmed_id": "24291598",
        "score": 0.29616421461105347,
        "title": "TALE: a tale of genome editing.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24291598"
      }
    ],
    "query_time": 0.012530326843261719,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.3333333333333333,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "5fe3131ca43ad31278000048": {
    "query": "What is the major sequence determinant for nucleosome positioning?",
    "type": "factoid",
    "ideal_answer": [
      "G+C content is the primary determinant of MNase-derived nucleosome occupancy."
    ],
    "ground_truth_ids": [
      "20232936",
      "19620965",
      "21551148",
      "22435808",
      "26305225",
      "17038564",
      "21206756",
      "30113318"
    ],
    "retrieved_ids": [
      "21206756",
      "30113318",
      "20232936",
      "21551148",
      "19620965",
      "17038564",
      "26305225",
      "22435808",
      "27992255",
      "19246569"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "21206756",
        "score": 0.6636499762535095,
        "title": "The effect of micrococcal nuclease digestion on nucleosome positioning data.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21206756"
      },
      {
        "pubmed_id": "30113318",
        "score": 0.6601623296737671,
        "title": "A unified computational framework for modeling genome-wide nucleosome landscape.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30113318"
      },
      {
        "pubmed_id": "20232936",
        "score": 0.6562752723693848,
        "title": "Structure-based analysis of DNA sequence patterns guiding nucleosome positioning in vitro.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20232936"
      },
      {
        "pubmed_id": "21551148",
        "score": 0.6319375038146973,
        "title": "Genome-wide DNA sequence polymorphisms facilitate nucleosome positioning in yeast.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21551148"
      },
      {
        "pubmed_id": "19620965",
        "score": 0.619883120059967,
        "title": "Intrinsic histone-DNA interactions are not the major determinant of nucleosome positions in vivo.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19620965"
      },
      {
        "pubmed_id": "17038564",
        "score": 0.6179637908935547,
        "title": "Flexibility and constraint in the nucleosome core landscape of Caenorhabditis elegans chromatin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17038564"
      },
      {
        "pubmed_id": "26305225",
        "score": 0.6129189133644104,
        "title": "Nucleosome Organization in Human Embryonic Stem Cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26305225"
      },
      {
        "pubmed_id": "22435808",
        "score": 0.5944355130195618,
        "title": "DNA structure, nucleosome placement and chromatin remodelling: a perspective.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22435808"
      },
      {
        "pubmed_id": "27992255",
        "score": 0.5803046226501465,
        "title": "Drosophila H2A and H2A.Z Nucleosome Sequences Reveal Different Nucleosome Positioning Sequence Patterns.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27992255"
      },
      {
        "pubmed_id": "19246569",
        "score": 0.5693630576133728,
        "title": "Comparative analysis of H2A.Z nucleosome organization in the human and yeast genomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19246569"
      }
    ],
    "query_time": 0.011749982833862305,
    "metrics": {
      "precision": 0.8,
      "recall": 1.0,
      "f1_score": 0.888888888888889,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 8
    }
  },
  "5c53191a7e3cb0e231000016": {
    "query": "What periodontal disease associated bacteria is also associated with Alzheimer's disease?",
    "type": "factoid",
    "ideal_answer": [
      "Porphyromonas gingivalis, a keystone pathogen in chronic periodontitis, has been found to associate with remote body organ inflammatory pathologies, including atherosclerosis and Alzheimer's disease (AD).",
      "Among bacteria special attention is focused on spirochetes family and on periodontal pathogens such as Porphyromonas gingivalis or Treponema denticola that could cause chronic periodontitis and possibly contribute to the clinical onset of AD."
    ],
    "ground_truth_ids": [
      "22546352",
      "29046054",
      "28294067",
      "29249963"
    ],
    "retrieved_ids": [
      "29249963",
      "22546352",
      "35892582",
      "29046054",
      "28294067",
      "26600627",
      "31753458",
      "32093040",
      "29298722",
      "26614753"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29249963",
        "score": 0.7432867288589478,
        "title": "Exploring the Association between Alzheimer's Disease, Oral Health, Microbial Endocrinology and Nutrition.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29249963"
      },
      {
        "pubmed_id": "22546352",
        "score": 0.711443305015564,
        "title": "Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22546352"
      },
      {
        "pubmed_id": "35892582",
        "score": 0.577416718006134,
        "title": "Human Palatine Tonsils Are Linked to Alzheimer's Disease through Function of Reservoir of Amyloid Beta Protein Associated with Bacterial Infection.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35892582"
      },
      {
        "pubmed_id": "29046054",
        "score": 0.5473294258117676,
        "title": "Porphyromonas gingivalis lipopolysaccharide stimulation in human periodontal ligament stem cells: role of epigenetic modifications to the inflammation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29046054"
      },
      {
        "pubmed_id": "28294067",
        "score": 0.544535219669342,
        "title": "The Infectious Etiology of Alzheimer's Disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28294067"
      },
      {
        "pubmed_id": "26600627",
        "score": 0.4903452396392822,
        "title": "Porphyromonas gingivalis Fim-A genotype distribution among Colombians.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26600627"
      },
      {
        "pubmed_id": "31753458",
        "score": 0.4641723036766052,
        "title": "Association of oral health-related quality of life and Alzheimer disease: A systematic review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31753458"
      },
      {
        "pubmed_id": "32093040",
        "score": 0.4176282286643982,
        "title": "Amyloidogenic Peptides in Human Neuro-Degenerative Diseases and in Microorganisms: A Sorrow Shared Is a Sorrow Halved?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32093040"
      },
      {
        "pubmed_id": "29298722",
        "score": 0.41701140999794006,
        "title": "Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29298722"
      },
      {
        "pubmed_id": "26614753",
        "score": 0.4152001142501831,
        "title": "Is amyloid-β harmful to the brain? Insights from human imaging studies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26614753"
      }
    ],
    "query_time": 0.00851583480834961,
    "metrics": {
      "precision": 0.4,
      "recall": 1.0,
      "f1_score": 0.5714285714285715,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "55242d512c8b63434a000006": {
    "query": "Which receptors can be evaluated with the [18F]altanserin?",
    "type": "factoid",
    "ideal_answer": [
      "5-HT2A (5-hydroxytryptamine type 2a) receptor can be evaluated with the [18F]altanserin."
    ],
    "ground_truth_ids": [
      "22940693",
      "12902843",
      "16206185",
      "23824248",
      "20641567",
      "12642173",
      "17195073",
      "21098981",
      "7995287",
      "24120220",
      "21996132",
      "9027929",
      "21359565",
      "21722741",
      "21473029",
      "18828013",
      "17241616",
      "10587097",
      "19007894",
      "17541696",
      "23137806",
      "19162492",
      "20956470",
      "10688105",
      "19959344",
      "9826230",
      "12224404",
      "15356424",
      "7673371",
      "23456885",
      "17185512",
      "19015089",
      "19353726",
      "21473027",
      "10588399",
      "23390031",
      "23303045",
      "21750562",
      "9257335",
      "1428914",
      "9824691"
    ],
    "retrieved_ids": [
      "9257335",
      "7995287",
      "10587097",
      "23390031",
      "9826230",
      "9027929",
      "16206185",
      "21750562",
      "15356424",
      "7673371"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "9257335",
        "score": 0.647908627986908,
        "title": "In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9257335"
      },
      {
        "pubmed_id": "7995287",
        "score": 0.6334931254386902,
        "title": "Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7995287"
      },
      {
        "pubmed_id": "10587097",
        "score": 0.6322153806686401,
        "title": "Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10587097"
      },
      {
        "pubmed_id": "23390031",
        "score": 0.6228681802749634,
        "title": "Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23390031"
      },
      {
        "pubmed_id": "9826230",
        "score": 0.6204452514648438,
        "title": "Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9826230"
      },
      {
        "pubmed_id": "9027929",
        "score": 0.617301344871521,
        "title": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9027929"
      },
      {
        "pubmed_id": "16206185",
        "score": 0.6020137071609497,
        "title": "Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16206185"
      },
      {
        "pubmed_id": "21750562",
        "score": 0.5966907143592834,
        "title": "Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21750562"
      },
      {
        "pubmed_id": "15356424",
        "score": 0.5865131616592407,
        "title": "[18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15356424"
      },
      {
        "pubmed_id": "7673371",
        "score": 0.5841500759124756,
        "title": "Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7673371"
      }
    ],
    "query_time": 0.007586002349853516,
    "metrics": {
      "precision": 1.0,
      "recall": 0.24390243902439024,
      "f1_score": 0.39215686274509803,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 41
    }
  },
  "5e920fe42d3121100d00000f": {
    "query": "What is the microgenderome?",
    "type": "factoid",
    "ideal_answer": [
      "The sexually dimorphic microbiome has been termed the 'microgenderome'."
    ],
    "ground_truth_ids": [
      "26757840",
      "27808584",
      "24627581",
      "30298433"
    ],
    "retrieved_ids": [
      "30298433",
      "27808584",
      "22294878",
      "23438854",
      "26757840",
      "11261244",
      "9150929",
      "3776472",
      "1337883",
      "21931505"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30298433",
        "score": 0.4100973904132843,
        "title": "The microgenderome revealed: sex differences in bidirectional interactions between the microbiota, hormones, immunity and disease susceptibility.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30298433"
      },
      {
        "pubmed_id": "27808584",
        "score": 0.39406949281692505,
        "title": "Support for the microgenderome invites enquiry into sex differences.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27808584"
      },
      {
        "pubmed_id": "22294878",
        "score": 0.3774877190589905,
        "title": "Stemming epigenetics in marine stramenopiles.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22294878"
      },
      {
        "pubmed_id": "23438854",
        "score": 0.3692484498023987,
        "title": "The coming age of complete, accurate, and ubiquitous proteomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23438854"
      },
      {
        "pubmed_id": "26757840",
        "score": 0.3591945767402649,
        "title": "Support for the Microgenderome: Associations in a Human Clinical Population.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26757840"
      },
      {
        "pubmed_id": "11261244",
        "score": 0.35458436608314514,
        "title": "[The human genome project in the year 2000].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11261244"
      },
      {
        "pubmed_id": "9150929",
        "score": 0.34848785400390625,
        "title": "The Dictyostelium discoideum proteome--the SWISS-2DPAGE database of the multicellular aggregate (slug).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/9150929"
      },
      {
        "pubmed_id": "3776472",
        "score": 0.34238386154174805,
        "title": "The origin of psammoma bodies in the human arachnoid villi.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3776472"
      },
      {
        "pubmed_id": "1337883",
        "score": 0.3390316665172577,
        "title": "Replication of SV40 minichromosomes in vitro.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1337883"
      },
      {
        "pubmed_id": "21931505",
        "score": 0.32258832454681396,
        "title": "Mechanisms and role of microRNA deregulation in cancer onset and progression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21931505"
      }
    ],
    "query_time": 0.016453981399536133,
    "metrics": {
      "precision": 0.3,
      "recall": 0.75,
      "f1_score": 0.4285714285714285,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 3,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "66151045fdcbea915f000048": {
    "query": "What is the approximate prevalence of autoimmune diseases?",
    "type": "factoid",
    "ideal_answer": [
      "Autoimmune diseases affect approximately 10% of the population, with a higher prevalence in females (about 64% of diagnosed individuals are female). Some of the most common autoimmune diseases, such as Sjögren's syndrome, systemic lupus erythematosus, and systemic sclerosis, are often associated with each other.",
      "There is an approximate incidence of 10% autoimmune diseases affecting the general population."
    ],
    "ground_truth_ids": [
      "37156255"
    ],
    "retrieved_ids": [
      "37156255",
      "34605948",
      "32802495",
      "34904748",
      "22985493",
      "10619926",
      "33261023",
      "33407048",
      "23217568",
      "30924130"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "37156255",
        "score": 0.7387831211090088,
        "title": "Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37156255"
      },
      {
        "pubmed_id": "34605948",
        "score": 0.5364082455635071,
        "title": "Beyond GWAS: from simple associations to functional insights.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34605948"
      },
      {
        "pubmed_id": "32802495",
        "score": 0.46158838272094727,
        "title": "Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32802495"
      },
      {
        "pubmed_id": "34904748",
        "score": 0.44843459129333496,
        "title": "Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34904748"
      },
      {
        "pubmed_id": "22985493",
        "score": 0.44831451773643494,
        "title": "Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22985493"
      },
      {
        "pubmed_id": "10619926",
        "score": 0.43000608682632446,
        "title": "Plasmapheresis with a substitution solution of human serum protein (5%) versus plasmapheresis with a substitution solution of human albumin (5%) in patients suffering from autoimmune diseases.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10619926"
      },
      {
        "pubmed_id": "33261023",
        "score": 0.42696213722229004,
        "title": "New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33261023"
      },
      {
        "pubmed_id": "33407048",
        "score": 0.42395615577697754,
        "title": "Predictive models of infection in patients with systemic lupus erythematosus: A systematic literature review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33407048"
      },
      {
        "pubmed_id": "23217568",
        "score": 0.4211463928222656,
        "title": "Gender differences in Latin-American patients with rheumatoid arthritis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23217568"
      },
      {
        "pubmed_id": "30924130",
        "score": 0.41754773259162903,
        "title": "The role of plasma exchange in the management of autoimmune disorders.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30924130"
      }
    ],
    "query_time": 0.02009892463684082,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "6442933f57b1c7a315000060": {
    "query": "What is the cause of Facioscapulohumeral Muscular Dystrophy type 1 (FSHD1)?",
    "type": "factoid",
    "ideal_answer": [
      "Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is caused by contraction of the D4Z4 repeat array.",
      "Facioscapulohumeral Muscular Dystrophy type 1 (FSHD1) is caused by the loss of DNA repetitive elements (D4Z4 repeats) in the subtelomeric region of chromosome 4q, leading to decreased methylation and epigenetic derepression of the toxic protein DUX4.",
      "FSHD1 is an autosomal dominant disease that is caused by partial deletion of the D4Z4 repeats on the 4th chromosome, affecting the expression of DUX4.",
      "Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogenesis is ectopic expression of the transcription factor DUX4 in skeletal muscle.",
      "FSHD1 is caused by partial deletion of the D4Z4 repeats on the 4th chromosome.",
      "The cause of FSHD1 is a partial deletion of the D4Z4 repeats on the 4th chromosome, which affects the expression of DUX4.",
      "The cause of Facioscapulohumeral Muscular Dystrophy type 1 (FSHD1) is a partial deletion of the D4Z4 repeats on the 4th chromosome, which affects the expression of DUX4.",
      "FSHD1 is caused by a partial deletion of the D4Z4 repeats on chromosome 4.",
      "FSHD1 is caused by a partial deletion of D4Z4 repeats on chromosome 4, which affects the expression of the transcription factor DUX4 in skeletal muscle."
    ],
    "ground_truth_ids": [
      "31518905",
      "14634647",
      "24882751",
      "30871534",
      "27822859",
      "32576599",
      "29436205",
      "30122154",
      "32703466",
      "24075187",
      "24755953",
      "24128691",
      "23593020"
    ],
    "retrieved_ids": [
      "29436205",
      "24128691",
      "24882751",
      "32703466",
      "24755953",
      "30871534",
      "14634647",
      "24075187",
      "7557061",
      "27822859"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29436205",
        "score": 0.7275441884994507,
        "title": "FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29436205"
      },
      {
        "pubmed_id": "24128691",
        "score": 0.6729987263679504,
        "title": "Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24128691"
      },
      {
        "pubmed_id": "24882751",
        "score": 0.6612193584442139,
        "title": "Facioscapulohumeral muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24882751"
      },
      {
        "pubmed_id": "32703466",
        "score": 0.655375599861145,
        "title": "Case Studies on the Genetic and Clinical Diagnosis of Facioscapulohumeral Muscular Dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32703466"
      },
      {
        "pubmed_id": "24755953",
        "score": 0.6412684321403503,
        "title": "Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24755953"
      },
      {
        "pubmed_id": "30871534",
        "score": 0.6294031739234924,
        "title": "Genotype-phenotype correlations in FSHD.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30871534"
      },
      {
        "pubmed_id": "14634647",
        "score": 0.626394510269165,
        "title": "Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14634647"
      },
      {
        "pubmed_id": "24075187",
        "score": 0.6092715859413147,
        "title": "The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24075187"
      },
      {
        "pubmed_id": "7557061",
        "score": 0.5934368371963501,
        "title": "[Relations between delayed diagnosis and forms of onset in Duchenne muscular dystrophy].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7557061"
      },
      {
        "pubmed_id": "27822859",
        "score": 0.5818139314651489,
        "title": "Analyzing Copy Number Variation Using Pulsed-Field Gel Electrophoresis: Providing a Genetic Diagnosis for FSHD1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27822859"
      }
    ],
    "query_time": 0.038535118103027344,
    "metrics": {
      "precision": 0.9,
      "recall": 0.6923076923076923,
      "f1_score": 0.7826086956521738,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 13
    }
  },
  "623345bf3a8413c6530000ab": {
    "query": "LINC00339 is a diagnostic, prognostic and treatment efficacy biomarker for what disease?",
    "type": "factoid",
    "ideal_answer": [
      "LINC00339 as a cancer diagnostic, prognostic and treatment efficacy biomarker."
    ],
    "ground_truth_ids": [
      "31239716",
      "31269584",
      "28171565",
      "34741346",
      "31188482",
      "31128030",
      "34105151",
      "30618083",
      "32991297",
      "31081143",
      "29499931",
      "30485513",
      "29906749",
      "32308105",
      "33235461",
      "31781497"
    ],
    "retrieved_ids": [
      "27087232",
      "31269584",
      "30466743",
      "32308105",
      "31128030",
      "31258549",
      "29906749",
      "31239716",
      "28185174",
      "30618083"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27087232",
        "score": 0.5342657566070557,
        "title": "[Precision medicine: new opportunities and challenges for molecular epidemiology].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27087232"
      },
      {
        "pubmed_id": "31269584",
        "score": 0.49201512336730957,
        "title": "[The expression and functional mechanism of long non-coding RNA LINC00339 in colorectal cancer].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31269584"
      },
      {
        "pubmed_id": "30466743",
        "score": 0.4882891774177551,
        "title": "Progress and predictions: AML in 2018.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30466743"
      },
      {
        "pubmed_id": "32308105",
        "score": 0.4832266569137573,
        "title": "Long noncoding RNA LINC00339 promotes the oncogenicity of gastric cancer by regulating SRY-box 9 expression via sponging of microRNA-539.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32308105"
      },
      {
        "pubmed_id": "31128030",
        "score": 0.4628763794898987,
        "title": "LINC00339 promotes cell proliferation and metastasis in pancreatic cancer via miR-497-5p/IGF1R axis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31128030"
      },
      {
        "pubmed_id": "31258549",
        "score": 0.45482558012008667,
        "title": "L1000 Viewer: A Search Engine and Web Interface for the LINCS Data Repository.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31258549"
      },
      {
        "pubmed_id": "29906749",
        "score": 0.45127612352371216,
        "title": "Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29906749"
      },
      {
        "pubmed_id": "31239716",
        "score": 0.446389377117157,
        "title": "LINC00339 promotes growth and invasiveness of hepatocellular carcinoma by the miR-1182/SKA1 pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31239716"
      },
      {
        "pubmed_id": "28185174",
        "score": 0.43847599625587463,
        "title": "Current Treatment of Chronic Lymphocytic Leukemia.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28185174"
      },
      {
        "pubmed_id": "30618083",
        "score": 0.43336206674575806,
        "title": "Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30618083"
      }
    ],
    "query_time": 0.011444330215454102,
    "metrics": {
      "precision": 0.6,
      "recall": 0.375,
      "f1_score": 0.4615384615384615,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 16
    }
  },
  "56c1f01cef6e394741000044": {
    "query": "What is targeted by Palbociclib?",
    "type": "factoid",
    "ideal_answer": [
      "Necitumumab is a fully human IgG(1) monoclonal antibody directed at the epidermal growth factor receptor (EGFR). It is used for treatment of nonsmall cell lung cancer."
    ],
    "ground_truth_ids": [
      "21815704",
      "21679088",
      "20197484",
      "25701171",
      "25636162",
      "21806477",
      "21109448",
      "24216225",
      "26045340",
      "23300028"
    ],
    "retrieved_ids": [
      "30681821",
      "30475090",
      "21274361",
      "31800988",
      "21985171",
      "37877814",
      "12043548",
      "26137782",
      "24906121",
      "32266704"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "30681821",
        "score": 0.38669344782829285,
        "title": "Migraine overview and summary of current and emerging treatment options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30681821"
      },
      {
        "pubmed_id": "30475090",
        "score": 0.38438811898231506,
        "title": "Advances in orally administered pharmacotherapy for the treatment of migraine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30475090"
      },
      {
        "pubmed_id": "21274361",
        "score": 0.37026482820510864,
        "title": "Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21274361"
      },
      {
        "pubmed_id": "31800988",
        "score": 0.361579954624176,
        "title": "Ubrogepant for the Treatment of Migraine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31800988"
      },
      {
        "pubmed_id": "21985171",
        "score": 0.3594996929168701,
        "title": "Apixaban: first global approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21985171"
      },
      {
        "pubmed_id": "37877814",
        "score": 0.3583090901374817,
        "title": "Tarlatamab Shows Promise in SCLC.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37877814"
      },
      {
        "pubmed_id": "12043548",
        "score": 0.35592201352119446,
        "title": "Bupropion sustained release. A therapeutic review of Zyban.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12043548"
      },
      {
        "pubmed_id": "26137782",
        "score": 0.3525897264480591,
        "title": "[The pharmacotherapy of obesity].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26137782"
      },
      {
        "pubmed_id": "24906121",
        "score": 0.35090988874435425,
        "title": "A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24906121"
      },
      {
        "pubmed_id": "32266704",
        "score": 0.35019156336784363,
        "title": "Eptinezumab: First Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32266704"
      }
    ],
    "query_time": 0.016203880310058594,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "6415c8f1690f196b51000017": {
    "query": "Which form of cancer have paclitaxel, docetaxel, doxorubicin, and epirubicin been approved for?",
    "type": "factoid",
    "ideal_answer": [
      "Paclitaxel, docetaxel, doxorubicin, and epirubicin have been longstanding, Food and Drug Administration (FDA)-approved therapies against \nTriple negative breast cancer."
    ],
    "ground_truth_ids": [
      "35976445"
    ],
    "retrieved_ids": [
      "35976445",
      "27891147",
      "28585617",
      "30012210",
      "33264544",
      "27487107",
      "37861218",
      "14665611",
      "23810788",
      "29760563"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "35976445",
        "score": 0.5616166591644287,
        "title": "Triple negative breast cancer: approved treatment options and their mechanisms of action.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35976445"
      },
      {
        "pubmed_id": "27891147",
        "score": 0.4961162805557251,
        "title": "Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27891147"
      },
      {
        "pubmed_id": "28585617",
        "score": 0.4749121367931366,
        "title": "[Immunotherapy for lung cancer].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28585617"
      },
      {
        "pubmed_id": "30012210",
        "score": 0.468677282333374,
        "title": "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30012210"
      },
      {
        "pubmed_id": "33264544",
        "score": 0.46696799993515015,
        "title": "Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33264544"
      },
      {
        "pubmed_id": "27487107",
        "score": 0.4657212793827057,
        "title": "Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27487107"
      },
      {
        "pubmed_id": "37861218",
        "score": 0.4583393335342407,
        "title": "Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37861218"
      },
      {
        "pubmed_id": "14665611",
        "score": 0.45746129751205444,
        "title": "A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14665611"
      },
      {
        "pubmed_id": "23810788",
        "score": 0.4549211263656616,
        "title": "The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23810788"
      },
      {
        "pubmed_id": "29760563",
        "score": 0.4514596462249756,
        "title": "Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29760563"
      }
    ],
    "query_time": 0.04279685020446777,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5a4e50b242878bf97d000001": {
    "query": "Which topoisomerase is essential in yeast?",
    "type": "factoid",
    "ideal_answer": [
      "Eukaryotic DNA topoisomerase II is an abundant nuclear enzyme that is essential for cell proliferation. Yeast DNA topoisomerase II is encoded by a single-copy, essential gene.",
      "Yeast DNA topoisomerase II is encoded by a single-copy, essential gene. Disruption of one copy of the gene in a diploid yeast creates a recessive lethal mutation, indicating that the single DNA topoisomerase II gene of yeast has an essential function.",
      "Yeast DNA topoisomerase II is encoded by a single-copy, essential gene."
    ],
    "ground_truth_ids": [
      "16651657",
      "23935120",
      "7932731",
      "2840207",
      "1332607",
      "18570880",
      "6090122",
      "2842762",
      "21767457",
      "6323017",
      "12888496",
      "1316274"
    ],
    "retrieved_ids": [
      "6323017",
      "7932731",
      "2840207",
      "1332607",
      "2842762",
      "1316274",
      "23935120",
      "12888496",
      "6090122",
      "18570880"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "6323017",
        "score": 0.6854909062385559,
        "title": "Yeast DNA topoisomerase II is encoded by a single-copy, essential gene.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6323017"
      },
      {
        "pubmed_id": "7932731",
        "score": 0.664254903793335,
        "title": "Phosphorylation of the C-terminal domain of yeast topoisomerase II by casein kinase II affects DNA-protein interaction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/7932731"
      },
      {
        "pubmed_id": "2840207",
        "score": 0.6500412225723267,
        "title": "Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutants.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2840207"
      },
      {
        "pubmed_id": "1332607",
        "score": 0.6345082521438599,
        "title": "Topoisomerase II: its functions and phosphorylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1332607"
      },
      {
        "pubmed_id": "2842762",
        "score": 0.6254115104675293,
        "title": "Functional expression of a Drosophila gene in yeast: genetic complementation of DNA topoisomerase II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2842762"
      },
      {
        "pubmed_id": "1316274",
        "score": 0.6055325269699097,
        "title": "Casein kinase II phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1316274"
      },
      {
        "pubmed_id": "23935120",
        "score": 0.5938593745231628,
        "title": "Topoisomerase II regulates yeast genes with singular chromatin architectures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23935120"
      },
      {
        "pubmed_id": "12888496",
        "score": 0.5805438756942749,
        "title": "Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12888496"
      },
      {
        "pubmed_id": "6090122",
        "score": 0.5667200684547424,
        "title": "Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6090122"
      },
      {
        "pubmed_id": "18570880",
        "score": 0.5569441318511963,
        "title": "Topoisomerase II inactivation prevents the completion of DNA replication in budding yeast.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18570880"
      }
    ],
    "query_time": 0.017302989959716797,
    "metrics": {
      "precision": 1.0,
      "recall": 0.8333333333333334,
      "f1_score": 0.9090909090909091,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 12
    }
  },
  "5c6be8f07c78d69471000032": {
    "query": "Which database has been developed that contains experimentally-confirmed carbonylated proteins?",
    "type": "factoid",
    "ideal_answer": [
      "Protein carbonylation, a chemically diverse oxidative post-translational modification, is widely considered as the biomarker for oxidative stress and protein damage. CarbonylDB has been developed as a manually curated data-resource of experimentally-confirmed carbonylated proteins/sites. The CarbonylDB currently contains 1495 carbonylated proteins and 3781 sites from 21 species, with human, rat and yeast as the top three species."
    ],
    "ground_truth_ids": [
      "29509874"
    ],
    "retrieved_ids": [
      "29509874",
      "31251384",
      "31258549",
      "15941473",
      "32390640",
      "27899579",
      "24304894",
      "24903420",
      "23262288",
      "22013161"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29509874",
        "score": 0.7318694591522217,
        "title": "CarbonylDB: a curated data-resource of protein carbonylation sites.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29509874"
      },
      {
        "pubmed_id": "31251384",
        "score": 0.5443106889724731,
        "title": "The PSIPRED Protein Analysis Workbench: 20 years on.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31251384"
      },
      {
        "pubmed_id": "31258549",
        "score": 0.43820837140083313,
        "title": "L1000 Viewer: A Search Engine and Web Interface for the LINCS Data Repository.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31258549"
      },
      {
        "pubmed_id": "15941473",
        "score": 0.4334927797317505,
        "title": "Discovery of protein-protein interactions using a combination of linguistic, statistical and graphical information.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15941473"
      },
      {
        "pubmed_id": "32390640",
        "score": 0.42555779218673706,
        "title": "Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32390640"
      },
      {
        "pubmed_id": "27899579",
        "score": 0.41503387689590454,
        "title": "SNP2TFBS - a database of regulatory SNPs affecting predicted transcription factor binding site affinity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27899579"
      },
      {
        "pubmed_id": "24304894",
        "score": 0.41219562292099,
        "title": "canSAR: updated cancer research and drug discovery knowledgebase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24304894"
      },
      {
        "pubmed_id": "24903420",
        "score": 0.4088452458381653,
        "title": "Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24903420"
      },
      {
        "pubmed_id": "23262288",
        "score": 0.40593335032463074,
        "title": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23262288"
      },
      {
        "pubmed_id": "22013161",
        "score": 0.3967103362083435,
        "title": "canSAR: an integrated cancer public translational research and drug discovery resource.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22013161"
      }
    ],
    "query_time": 0.01304173469543457,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "6217da133a8413c653000026": {
    "query": "Where is the the protein perforin localized?",
    "type": "factoid",
    "ideal_answer": [
      "Perforin are stored inside the leukocytes in secretory granules."
    ],
    "ground_truth_ids": [
      "33710487",
      "33884612",
      "33410220",
      "33467515"
    ],
    "retrieved_ids": [
      "10673358",
      "17760832",
      "11159198",
      "22445064",
      "17905609",
      "21742803",
      "12397030",
      "24322426",
      "16923831",
      "12123827"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "10673358",
        "score": 0.47391873598098755,
        "title": "Internalization and processing of human angiogenin by cultured aortic smooth muscle cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10673358"
      },
      {
        "pubmed_id": "17760832",
        "score": 0.41415274143218994,
        "title": "Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17760832"
      },
      {
        "pubmed_id": "11159198",
        "score": 0.39784061908721924,
        "title": "A compound heterozygous one amino-acid insertion/nonsense mutation in the plectin gene causes epidermolysis bullosa simplex with plectin deficiency.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11159198"
      },
      {
        "pubmed_id": "22445064",
        "score": 0.39337924122810364,
        "title": "The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22445064"
      },
      {
        "pubmed_id": "17905609",
        "score": 0.38903477787971497,
        "title": "Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17905609"
      },
      {
        "pubmed_id": "21742803",
        "score": 0.38883307576179504,
        "title": "The human proteome project: current state and future direction.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21742803"
      },
      {
        "pubmed_id": "12397030",
        "score": 0.38822048902511597,
        "title": "Skeletal muscle LIM protein 1 regulates integrin-mediated myoblast adhesion, spreading, and migration.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12397030"
      },
      {
        "pubmed_id": "24322426",
        "score": 0.3862488567829132,
        "title": "Review series: From uncertain beginnings: initiation mechanisms of clathrin-mediated endocytosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24322426"
      },
      {
        "pubmed_id": "16923831",
        "score": 0.379873663187027,
        "title": "Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16923831"
      },
      {
        "pubmed_id": "12123827",
        "score": 0.3767656981945038,
        "title": "The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12123827"
      }
    ],
    "query_time": 0.013818025588989258,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "626aeab6e764a5320400003e": {
    "query": "When was Volanesorsen approved in the EU?",
    "type": "factoid",
    "ideal_answer": [
      "In May 2019, volanesorsen was approved in the EU for the treatment of adult patients with familial chylomicronemia syndrome."
    ],
    "ground_truth_ids": [
      "31301033"
    ],
    "retrieved_ids": [
      "31301033",
      "36480476",
      "29290671",
      "26949713",
      "29288370",
      "28191518",
      "14769010",
      "30681821",
      "18619194",
      "30053275"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "31301033",
        "score": 0.36585691571235657,
        "title": "Volanesorsen: First Global Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/31301033"
      },
      {
        "pubmed_id": "36480476",
        "score": 0.31416723132133484,
        "title": "Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36480476"
      },
      {
        "pubmed_id": "29290671",
        "score": 0.29705262184143066,
        "title": "Pharmaceutical Approval Update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29290671"
      },
      {
        "pubmed_id": "26949713",
        "score": 0.2852226793766022,
        "title": "Erratum: Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26949713"
      },
      {
        "pubmed_id": "29288370",
        "score": 0.2814180552959442,
        "title": "Letermovir: First Global Approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29288370"
      },
      {
        "pubmed_id": "28191518",
        "score": 0.28045982122421265,
        "title": "Corticosteroids, the oldest agent in the prevention of chemotherapy-induced nausea and vomiting: What about the guidelines?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28191518"
      },
      {
        "pubmed_id": "14769010",
        "score": 0.276987224817276,
        "title": "Problematic notions in Dutch health care package decisions.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/14769010"
      },
      {
        "pubmed_id": "30681821",
        "score": 0.26683351397514343,
        "title": "Migraine overview and summary of current and emerging treatment options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30681821"
      },
      {
        "pubmed_id": "18619194",
        "score": 0.25527656078338623,
        "title": "Which drug to be used in smoking cessation?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18619194"
      },
      {
        "pubmed_id": "30053275",
        "score": 0.2457188069820404,
        "title": "SHOULD PERSONNEL OF NUCLEAR MEDICINE DEPARTMENTS USE PERSONAL DOSIMETERS FOR EYE LENS DOSE MONITORING?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30053275"
      }
    ],
    "query_time": 0.02234196662902832,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5abbe429fcf456587200001c": {
    "query": "What is the drug target for Eliquis (Apixaban)?",
    "type": "factoid",
    "ideal_answer": [
      "The new oral anticoagulants (NOAC) Apixaban (Eliquis) is a direct anti-Xa inhibitors"
    ],
    "ground_truth_ids": [
      "27653758",
      "26095540",
      "24624626",
      "26369819",
      "25322783",
      "28439702",
      "23649961",
      "23677804",
      "24711240",
      "23535530",
      "21985171"
    ],
    "retrieved_ids": [
      "27653758",
      "21985171",
      "25322783",
      "26095540",
      "24711240",
      "28439702",
      "23649961",
      "23677804",
      "23535530",
      "22008738"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27653758",
        "score": 0.6330642700195312,
        "title": "Apixaban: A Review in Venous Thromboembolism.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27653758"
      },
      {
        "pubmed_id": "21985171",
        "score": 0.5911810994148254,
        "title": "Apixaban: first global approval.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21985171"
      },
      {
        "pubmed_id": "25322783",
        "score": 0.5258826017379761,
        "title": "LC-MS/MS determination of apixaban (BMS-562247) and its major metabolite in human plasma: an application of polarity switching and monolithic HPLC column.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25322783"
      },
      {
        "pubmed_id": "26095540",
        "score": 0.525239884853363,
        "title": "Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26095540"
      },
      {
        "pubmed_id": "24711240",
        "score": 0.5107857584953308,
        "title": "[Perioperative management and therapy of bleeding complications].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24711240"
      },
      {
        "pubmed_id": "28439702",
        "score": 0.5020970702171326,
        "title": "A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28439702"
      },
      {
        "pubmed_id": "23649961",
        "score": 0.49422648549079895,
        "title": "Use of new oral anticoagulants in antiphospholipid syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23649961"
      },
      {
        "pubmed_id": "23677804",
        "score": 0.49134013056755066,
        "title": "Apixaban: a review of its use for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23677804"
      },
      {
        "pubmed_id": "23535530",
        "score": 0.4744134247303009,
        "title": "Apixaban: a new factor Xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23535530"
      },
      {
        "pubmed_id": "22008738",
        "score": 0.4525763988494873,
        "title": "[New anticoagulants. Characteristics, monitoring and management of bleeding].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22008738"
      }
    ],
    "query_time": 0.01239323616027832,
    "metrics": {
      "precision": 0.9,
      "recall": 0.8181818181818182,
      "f1_score": 0.8571428571428572,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 9,
      "total_retrieved": 10,
      "total_relevant": 11
    }
  },
  "5c72f5247c78d6947100007e": {
    "query": "Which gene mutation is associated with Woodhouse Sakati syndrome?",
    "type": "factoid",
    "ideal_answer": [
      "DCAF17 mutations are associated with Woodhouse-Sakati syndrome, a rare disorder characterized by alopecia, hypogonadotropic hypogonadism, sensorineural hearing loss, diabetes mellitus, and extrapyramidal movements."
    ],
    "ground_truth_ids": [
      "30409855",
      "26664771",
      "26612766",
      "29574468",
      "24464444"
    ],
    "retrieved_ids": [
      "29574468",
      "24464444",
      "26612766",
      "26664771",
      "30409855",
      "22781092",
      "2992938",
      "18230842",
      "20839288",
      "8357522"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29574468",
        "score": 0.770392119884491,
        "title": "Phenotypic Variability of c.436delC DCAF17 Gene Mutation in Woodhouse-Sakati Syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29574468"
      },
      {
        "pubmed_id": "24464444",
        "score": 0.7198200225830078,
        "title": "Endocrine disorders in Woodhouse-Sakati syndrome: a systematic review of the literature.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24464444"
      },
      {
        "pubmed_id": "26612766",
        "score": 0.7173192501068115,
        "title": "Exome sequencing revealed a novel biallelic deletion in the DCAF17 gene underlying Woodhouse Sakati syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26612766"
      },
      {
        "pubmed_id": "26664771",
        "score": 0.6459870338439941,
        "title": "The Use of High-Density SNP Array to Map Homozygosity in Consanguineous Families to Efficiently Identify Candidate Genes: Application to Woodhouse-Sakati Syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26664771"
      },
      {
        "pubmed_id": "30409855",
        "score": 0.623487651348114,
        "title": "Brain MR Imaging Findings in Woodhouse-Sakati Syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30409855"
      },
      {
        "pubmed_id": "22781092",
        "score": 0.5413423776626587,
        "title": "A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22781092"
      },
      {
        "pubmed_id": "2992938",
        "score": 0.5412314534187317,
        "title": "Detection of a high frequency RsaI polymorphism in the human pro alpha 2(I) collagen gene which is linked to an autosomal dominant form of osteogenesis imperfecta.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2992938"
      },
      {
        "pubmed_id": "18230842",
        "score": 0.5174152851104736,
        "title": "Mowat-Wilson syndrome affecting 3 siblings.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18230842"
      },
      {
        "pubmed_id": "20839288",
        "score": 0.5173723697662354,
        "title": "Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20839288"
      },
      {
        "pubmed_id": "8357522",
        "score": 0.5104680061340332,
        "title": "[Alport's syndrome: new findings].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8357522"
      }
    ],
    "query_time": 0.020521163940429688,
    "metrics": {
      "precision": 0.5,
      "recall": 1.0,
      "f1_score": 0.6666666666666666,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "5c74305d7c78d694710000a4": {
    "query": "Which mRNAs are sequestered in stress granules?",
    "type": "factoid",
    "ideal_answer": [
      "Stress granules are higher order assemblies of nontranslating mRNAs and proteins that form when translation initiation is inhibited. \nThis subset of mRNAs is characterized by extended length and adenylate-uridylate (AU)-rich motifs, is highly enriched with genes critical for cell survival and proliferation. mRNA accumulation in stress granules correlates with longer coding and UTR regions and poor translatability"
    ],
    "ground_truth_ids": [
      "29576526",
      "24013423",
      "29129640",
      "21118122",
      "29483269"
    ],
    "retrieved_ids": [
      "29129640",
      "29576526",
      "29483269",
      "22976942",
      "23629963",
      "25957348",
      "25845599",
      "23479439",
      "24842888",
      "24013423"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29129640",
        "score": 0.7440491914749146,
        "title": "The Stress Granule Transcriptome Reveals Principles of mRNA Accumulation in Stress Granules.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29129640"
      },
      {
        "pubmed_id": "29576526",
        "score": 0.6732979416847229,
        "title": "Systematic Characterization of Stress-Induced RNA Granulation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29576526"
      },
      {
        "pubmed_id": "29483269",
        "score": 0.6689860224723816,
        "title": "RNA self-assembly contributes to stress granule formation and defining the stress granule transcriptome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29483269"
      },
      {
        "pubmed_id": "22976942",
        "score": 0.5836694240570068,
        "title": "Long non-coding RNAs coordinate cellular responses to stress.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22976942"
      },
      {
        "pubmed_id": "23629963",
        "score": 0.5502887964248657,
        "title": "Stress granules as crucibles of ALS pathogenesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23629963"
      },
      {
        "pubmed_id": "25957348",
        "score": 0.500121533870697,
        "title": "INSPEcT: a computational tool to infer mRNA synthesis, processing and degradation dynamics from RNA- and 4sU-seq time course experiments.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25957348"
      },
      {
        "pubmed_id": "25845599",
        "score": 0.4895150065422058,
        "title": "Nuclear pore components affect distinct stages of intron-containing gene expression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25845599"
      },
      {
        "pubmed_id": "23479439",
        "score": 0.4743725061416626,
        "title": "Proteolytic regulation of stress response pathways in Escherichia coli.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23479439"
      },
      {
        "pubmed_id": "24842888",
        "score": 0.469648540019989,
        "title": "Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24842888"
      },
      {
        "pubmed_id": "24013423",
        "score": 0.46305370330810547,
        "title": "Recruitment into stress granules prevents irreversible aggregation of FUS protein mislocalized to the cytoplasm.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24013423"
      }
    ],
    "query_time": 0.023528099060058594,
    "metrics": {
      "precision": 0.4,
      "recall": 0.8,
      "f1_score": 0.5333333333333333,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 5
    }
  },
  "5c897167d558e5f232000005": {
    "query": "What does the strimvelis treatment consist of?",
    "type": "factoid",
    "ideal_answer": [
      "Strimvelis consists of autologous CD34+ cells transduced to express adenosine deaminase [ADA]."
    ],
    "ground_truth_ids": [
      "29625577"
    ],
    "retrieved_ids": [
      "29625577",
      "3614758",
      "27779083",
      "29290671",
      "20107296",
      "17644699",
      "27225853",
      "20510766",
      "22136872",
      "21992150"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "29625577",
        "score": 0.3996123671531677,
        "title": "Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29625577"
      },
      {
        "pubmed_id": "3614758",
        "score": 0.3964988589286804,
        "title": "[Saint's triad. Statistico-epidemiologic research and case contribution].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/3614758"
      },
      {
        "pubmed_id": "27779083",
        "score": 0.3893754184246063,
        "title": "Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27779083"
      },
      {
        "pubmed_id": "29290671",
        "score": 0.3657070994377136,
        "title": "Pharmaceutical Approval Update.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29290671"
      },
      {
        "pubmed_id": "20107296",
        "score": 0.36559492349624634,
        "title": "Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20107296"
      },
      {
        "pubmed_id": "17644699",
        "score": 0.36239904165267944,
        "title": "Old world meets modern: a case report of scurvy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17644699"
      },
      {
        "pubmed_id": "27225853",
        "score": 0.3583361804485321,
        "title": "Safety and Tolerability of Stribild in the Southeast United States.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27225853"
      },
      {
        "pubmed_id": "20510766",
        "score": 0.3569130003452301,
        "title": "Innovative uses of thalidomide.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20510766"
      },
      {
        "pubmed_id": "22136872",
        "score": 0.338489294052124,
        "title": "Letter: Docetaxel-induced supravenous serpentine dermatitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22136872"
      },
      {
        "pubmed_id": "21992150",
        "score": 0.3349486291408539,
        "title": "Dupuytren's contracture: a retrospective database analysis to determine hospitalizations in the Netherlands.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21992150"
      }
    ],
    "query_time": 0.016305923461914062,
    "metrics": {
      "precision": 0.1,
      "recall": 1.0,
      "f1_score": 0.18181818181818182,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 1,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "56bb68f9ac7ad1001900000b": {
    "query": "What is the cause of Phthiriasis Palpebrarum?",
    "type": "factoid",
    "ideal_answer": [
      "Phthiriasis palpebrarum is a rare eyelid infestation caused by phthirus pubis."
    ],
    "ground_truth_ids": [
      "26451147",
      "24909484",
      "16903509",
      "12523816",
      "20339456",
      "19728949",
      "24556565",
      "22707338",
      "23993722",
      "12898406",
      "24157356"
    ],
    "retrieved_ids": [
      "12898406",
      "19728949",
      "24157356",
      "24556565",
      "22707338",
      "16903509",
      "24909484",
      "20339456",
      "26451147",
      "23993722"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "12898406",
        "score": 0.638194739818573,
        "title": "[Phthiriasis palpebrarum: diagnosis and treatment].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12898406"
      },
      {
        "pubmed_id": "19728949",
        "score": 0.6105096936225891,
        "title": "Phthiriasis palpebrarum.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19728949"
      },
      {
        "pubmed_id": "24157356",
        "score": 0.6079752445220947,
        "title": "Phthiriasis palpebrarum: diagnosis and treatment.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24157356"
      },
      {
        "pubmed_id": "24556565",
        "score": 0.5869919061660767,
        "title": "Phthiriasis palpebrarum infection: a concern for child abuse.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24556565"
      },
      {
        "pubmed_id": "22707338",
        "score": 0.5433694124221802,
        "title": "Chronic conjunctivitis related to phthiriasis palpebrarum.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22707338"
      },
      {
        "pubmed_id": "16903509",
        "score": 0.5426667332649231,
        "title": "Phthiriasis palpebrarum: 2 case reports.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16903509"
      },
      {
        "pubmed_id": "24909484",
        "score": 0.5067340135574341,
        "title": "Phthiriasis palpebrarum misdiagnosed as allergic blepharoconjunctivitis in a 6-year-old girl.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24909484"
      },
      {
        "pubmed_id": "20339456",
        "score": 0.48549002408981323,
        "title": "Phthriasis palpebrarum mimicking lid eczema and blepharitis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20339456"
      },
      {
        "pubmed_id": "26451147",
        "score": 0.45281901955604553,
        "title": "Treatment of Phthiriasis Palpebrarum and Crab Louse: Petrolatum Jelly and 1% Permethrin Shampoo.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26451147"
      },
      {
        "pubmed_id": "23993722",
        "score": 0.44702479243278503,
        "title": "Phthriasis palpebrarum can resemble tick larva infestation in an eyelid.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23993722"
      }
    ],
    "query_time": 0.011110782623291016,
    "metrics": {
      "precision": 1.0,
      "recall": 0.9090909090909091,
      "f1_score": 0.9523809523809523,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 11
    }
  },
  "5891b125621ea6ff7e00000e": {
    "query": "Which disease is treated with taliglucerase alfa?",
    "type": "factoid",
    "ideal_answer": [
      "Taliglucerase alfa, the first available plant cell-expressed recombinant therapeutic protein, is an enzyme replacement therapy approved for Gaucher disease."
    ],
    "ground_truth_ids": [
      "27102949",
      "23980545",
      "27174694",
      "21235447",
      "24630271",
      "27559188",
      "21900191",
      "27499018",
      "26053270",
      "22654679",
      "23199589",
      "24950666",
      "25453586",
      "23046562",
      "27839981",
      "25812601",
      "22916340"
    ],
    "retrieved_ids": [
      "27174694",
      "27839981",
      "24950666",
      "27499018",
      "27102949",
      "25453586",
      "22654679",
      "22916340",
      "24630271",
      "26053270"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27174694",
        "score": 0.6236936450004578,
        "title": "Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27174694"
      },
      {
        "pubmed_id": "27839981",
        "score": 0.601823627948761,
        "title": "Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imiglucerase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27839981"
      },
      {
        "pubmed_id": "24950666",
        "score": 0.5950398445129395,
        "title": "A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24950666"
      },
      {
        "pubmed_id": "27499018",
        "score": 0.5918371677398682,
        "title": "Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27499018"
      },
      {
        "pubmed_id": "27102949",
        "score": 0.5841627717018127,
        "title": "Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27102949"
      },
      {
        "pubmed_id": "25453586",
        "score": 0.5723413228988647,
        "title": "Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25453586"
      },
      {
        "pubmed_id": "22654679",
        "score": 0.5659909248352051,
        "title": "An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22654679"
      },
      {
        "pubmed_id": "22916340",
        "score": 0.5598461627960205,
        "title": "Taliglucerase alfa for the treatment of Gaucher's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22916340"
      },
      {
        "pubmed_id": "24630271",
        "score": 0.557999849319458,
        "title": "Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24630271"
      },
      {
        "pubmed_id": "26053270",
        "score": 0.5461922883987427,
        "title": "Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26053270"
      }
    ],
    "query_time": 0.016942977905273438,
    "metrics": {
      "precision": 1.0,
      "recall": 0.5882352941176471,
      "f1_score": 0.7407407407407407,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 10,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "56c5c7915795f9a73e000004": {
    "query": "Where does CTCF colocalize with cohesin?",
    "type": "factoid",
    "ideal_answer": [
      "Cohesin subunits associate with viral and cellular CTCF sites involved in complex gene regulation and chromatin organization. Cohesin cobinds across the genome with transcription factors independently of CTCF, plays a functional role in estrogen-regulated transcription, and may help to mediate tissue-specific transcriptional responses via long-range chromosomal interactions.\nNumerous CTCF/cohesin sites potentially form the bases of the multiloop rosette structures at the Igh locus that compact during Ig heavy chain rearrangement. Cohesins colocalize with CTCF at two additional imprinted loci, the Dlk1-Dio3 and the Kcnq1/Kcnq1ot1 loci."
    ],
    "ground_truth_ids": [
      "23150255",
      "22780989",
      "20219941",
      "21628529",
      "19369356",
      "18219272",
      "21606361",
      "20159591",
      "19109133",
      "21550623"
    ],
    "retrieved_ids": [
      "22780989",
      "19109133",
      "23334284",
      "20219941",
      "21628529",
      "21550623",
      "15226378",
      "16962805",
      "19369356",
      "29447171"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "22780989",
        "score": 0.49067986011505127,
        "title": "Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22780989"
      },
      {
        "pubmed_id": "19109133",
        "score": 0.48543012142181396,
        "title": "Cutting edge: developmental stage-specific recruitment of cohesin to CTCF sites throughout immunoglobulin loci during B lymphocyte development.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19109133"
      },
      {
        "pubmed_id": "23334284",
        "score": 0.4770258963108063,
        "title": "An Eco1-independent sister chromatid cohesion establishment pathway in S. cerevisiae.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23334284"
      },
      {
        "pubmed_id": "20219941",
        "score": 0.4664421081542969,
        "title": "A CTCF-independent role for cohesin in tissue-specific transcription.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20219941"
      },
      {
        "pubmed_id": "21628529",
        "score": 0.45566266775131226,
        "title": "Nonallelic transcriptional roles of CTCF and cohesins at imprinted loci.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21628529"
      },
      {
        "pubmed_id": "21550623",
        "score": 0.4385128319263458,
        "title": "Occupancy of chromatin organizers in the Epstein-Barr virus genome.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21550623"
      },
      {
        "pubmed_id": "15226378",
        "score": 0.4325483441352844,
        "title": "Sister-chromatid cohesion mediated by the alternative RF-CCtf18/Dcc1/Ctf8, the helicase Chl1 and the polymerase-alpha-associated protein Ctf4 is essential for chromatid disjunction during meiosis II.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15226378"
      },
      {
        "pubmed_id": "16962805",
        "score": 0.42669951915740967,
        "title": "Establishment of sister chromatid cohesion at the S. cerevisiae replication fork.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16962805"
      },
      {
        "pubmed_id": "19369356",
        "score": 0.4108473062515259,
        "title": "Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19369356"
      },
      {
        "pubmed_id": "29447171",
        "score": 0.40622037649154663,
        "title": "Brca2, Pds5 and Wapl differentially control cohesin chromosome association and function.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29447171"
      }
    ],
    "query_time": 0.007044792175292969,
    "metrics": {
      "precision": 0.6,
      "recall": 0.6,
      "f1_score": 0.6,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 10
    }
  },
  "54d7ae1fe19bba8909000001": {
    "query": "Which is the molecular weight of the protein angiogenin?",
    "type": "factoid",
    "ideal_answer": [
      "The molecular weight of angiogenin is 14,120 Da. The bovine angiogenin is 14,595 Da"
    ],
    "ground_truth_ids": [
      "7585697",
      "1723310",
      "18055286",
      "2775757",
      "10486275",
      "8574597",
      "10673358",
      "10441122",
      "4074709"
    ],
    "retrieved_ids": [
      "2775757",
      "10673358",
      "4074709",
      "10486275",
      "1723310",
      "18055286",
      "21507890",
      "32514935",
      "21484537",
      "25309450"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "2775757",
        "score": 0.6150460839271545,
        "title": "Amino acid sequence of bovine angiogenin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/2775757"
      },
      {
        "pubmed_id": "10673358",
        "score": 0.568374514579773,
        "title": "Internalization and processing of human angiogenin by cultured aortic smooth muscle cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10673358"
      },
      {
        "pubmed_id": "4074709",
        "score": 0.5365538001060486,
        "title": "Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/4074709"
      },
      {
        "pubmed_id": "10486275",
        "score": 0.5265559554100037,
        "title": "Isolation and characterization of angiogenin-1 and a novel protein designated lactogenin from bovine milk.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/10486275"
      },
      {
        "pubmed_id": "1723310",
        "score": 0.5232688784599304,
        "title": "In vivo and in vitro studies of angiogenin--a potent angiogenic factor.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/1723310"
      },
      {
        "pubmed_id": "18055286",
        "score": 0.44535550475120544,
        "title": "Identification of angiogenin as the osteoclastic bone resorption-inhibitory factor in bovine milk.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18055286"
      },
      {
        "pubmed_id": "21507890",
        "score": 0.436979740858078,
        "title": "Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21507890"
      },
      {
        "pubmed_id": "32514935",
        "score": 0.39380407333374023,
        "title": "Renin-angiotensin system inhibition in COVID-19 patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32514935"
      },
      {
        "pubmed_id": "21484537",
        "score": 0.3853260278701782,
        "title": "MLP (muscle LIM protein) as a stress sensor in the heart.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21484537"
      },
      {
        "pubmed_id": "25309450",
        "score": 0.3810596764087677,
        "title": "Hypothesis and theory: mechanical instabilities and non-uniformities in hereditary sarcomere myopathies.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25309450"
      }
    ],
    "query_time": 0.014480829238891602,
    "metrics": {
      "precision": 0.6,
      "recall": 0.6666666666666666,
      "f1_score": 0.631578947368421,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 6,
      "total_retrieved": 10,
      "total_relevant": 9
    }
  },
  "5a87145861bb38fb24000004": {
    "query": "What causes Black Lung?",
    "type": "factoid",
    "ideal_answer": [
      "Black lung, also known as pneumoconiosis, is caused by chronic exposure to coal dust."
    ],
    "ground_truth_ids": [
      "6453959",
      "8803434",
      "8199664",
      "8456342"
    ],
    "retrieved_ids": [
      "8199664",
      "6453959",
      "36381061",
      "8456342",
      "33088545",
      "33853812",
      "8803434",
      "29121645",
      "17644699",
      "22836745"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "8199664",
        "score": 0.524439811706543,
        "title": "Airways obstruction, coal mining, and disability.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8199664"
      },
      {
        "pubmed_id": "6453959",
        "score": 0.4511960446834564,
        "title": "Coal workers' pneumoconiosis and the compensation dilemma.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/6453959"
      },
      {
        "pubmed_id": "36381061",
        "score": 0.40702229738235474,
        "title": "Black liver in a patient with Wilson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/36381061"
      },
      {
        "pubmed_id": "8456342",
        "score": 0.40442195534706116,
        "title": "From explosions to black lung: a history of efforts to control coal mine dust.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8456342"
      },
      {
        "pubmed_id": "33088545",
        "score": 0.4011344909667969,
        "title": "A rare case of nitrofurantoin-induced acute lung injury.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33088545"
      },
      {
        "pubmed_id": "33853812",
        "score": 0.3712819218635559,
        "title": "Acute lung toxicity by nitrofurantoin.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33853812"
      },
      {
        "pubmed_id": "8803434",
        "score": 0.3526812195777893,
        "title": "Pulmonary disability in former Appalachian coal miners.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8803434"
      },
      {
        "pubmed_id": "29121645",
        "score": 0.34991246461868286,
        "title": "Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29121645"
      },
      {
        "pubmed_id": "17644699",
        "score": 0.3463608920574188,
        "title": "Old world meets modern: a case report of scurvy.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17644699"
      },
      {
        "pubmed_id": "22836745",
        "score": 0.343182772397995,
        "title": "Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22836745"
      }
    ],
    "query_time": 0.017120838165283203,
    "metrics": {
      "precision": 0.4,
      "recall": 1.0,
      "f1_score": 0.5714285714285715,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 4,
      "total_retrieved": 10,
      "total_relevant": 4
    }
  },
  "56c073fcef6e394741000020": {
    "query": "What is the association of spermidine with α-synuclein neurotoxicity?",
    "type": "factoid",
    "ideal_answer": [
      "Spermidine protects against α-synuclein neurotoxicity. In the fruit fly, simple feeding with spermidine inhibited loss of climbing activity and early organismal death upon heterologous expression of human α-synuclein, which is thought to be the principal toxic trigger of Parkinson's Disease (PD). In this line, administration of spermidine rescued α-synuclein-induced loss of dopaminergic neurons, a hallmark of PD, in nematodes. Alleviation of PD-related neurodegeneration by spermidine was accompanied by induction of autophagy, suggesting that this cytoprotective process may be responsible for the beneficial effects of spermidine administration."
    ],
    "ground_truth_ids": [
      "25483063",
      "22662273"
    ],
    "retrieved_ids": [
      "25483063",
      "22662273",
      "24465140",
      "21844169",
      "38075821",
      "37556728",
      "20678581",
      "23629963",
      "20182024",
      "29154879"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25483063",
        "score": 0.6884803175926208,
        "title": "Spermidine protects against α-synuclein neurotoxicity.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25483063"
      },
      {
        "pubmed_id": "22662273",
        "score": 0.6103146076202393,
        "title": "Effect of spermidine on misfolding and interactions of alpha-synuclein.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22662273"
      },
      {
        "pubmed_id": "24465140",
        "score": 0.5417425632476807,
        "title": "LRRK2 as a Potential Genetic Modifier of Synucleinopathies: Interlacing the Two Major Genetic Factors of Parkinson's Disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24465140"
      },
      {
        "pubmed_id": "21844169",
        "score": 0.4826488494873047,
        "title": "Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21844169"
      },
      {
        "pubmed_id": "38075821",
        "score": 0.4701736569404602,
        "title": "Amyloid β,α-Synuclein and Amyloid β-α-Synuclein Combination Exert Significant but Different Alterations in Inflammatory Response Profile in Differentiated Human SH-SY5Y Cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/38075821"
      },
      {
        "pubmed_id": "37556728",
        "score": 0.441321462392807,
        "title": "α-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-β 42 via Heterogeneous Primary Nucleation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/37556728"
      },
      {
        "pubmed_id": "20678581",
        "score": 0.43112412095069885,
        "title": "Tau protein: relevance to Parkinson's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20678581"
      },
      {
        "pubmed_id": "23629963",
        "score": 0.3995451331138611,
        "title": "Stress granules as crucibles of ALS pathogenesis.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23629963"
      },
      {
        "pubmed_id": "20182024",
        "score": 0.39206820726394653,
        "title": "Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20182024"
      },
      {
        "pubmed_id": "29154879",
        "score": 0.39066970348358154,
        "title": "Perillyl alcohol alleviates amyloid-β peptides-induced mitochondrial dysfunction and cytotoxicity in SH-SY5Y cells.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29154879"
      }
    ],
    "query_time": 0.014076948165893555,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "603404f41cb411341a00014f": {
    "query": "When is DELE1 exiting the mitochondrion?",
    "type": "factoid",
    "ideal_answer": [
      "Mitochondrial stress stimulates OMA1-dependent cleavage of DELE1 and leads to the accumulation of DELE1 in the cytosol."
    ],
    "ground_truth_ids": [
      "32132707",
      "32132706"
    ],
    "retrieved_ids": [
      "21913110",
      "32132706",
      "32132707",
      "18539900",
      "12556518",
      "24615518",
      "34688664",
      "25784211",
      "20603160",
      "24080278"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "21913110",
        "score": 0.4881836175918579,
        "title": "Monitoring mitophagy in neuronal cell cultures.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/21913110"
      },
      {
        "pubmed_id": "32132706",
        "score": 0.47267240285873413,
        "title": "A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32132706"
      },
      {
        "pubmed_id": "32132707",
        "score": 0.45031410455703735,
        "title": "Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/32132707"
      },
      {
        "pubmed_id": "18539900",
        "score": 0.43879520893096924,
        "title": "Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18539900"
      },
      {
        "pubmed_id": "12556518",
        "score": 0.43807879090309143,
        "title": "Mitochondrial targeting of normal and mutant protoporphyrinogen oxidase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/12556518"
      },
      {
        "pubmed_id": "24615518",
        "score": 0.43651503324508667,
        "title": "P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24615518"
      },
      {
        "pubmed_id": "34688664",
        "score": 0.43347451090812683,
        "title": "Regulation of mitochondrial cargo-selective autophagy by posttranslational modifications.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34688664"
      },
      {
        "pubmed_id": "25784211",
        "score": 0.42735323309898376,
        "title": "Mitochondrial Genome Maintenance 1 (Mgm1) Protein Alters Membrane Topology and Promotes Local Membrane Bending.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25784211"
      },
      {
        "pubmed_id": "20603160",
        "score": 0.42599058151245117,
        "title": "Protoporphyrinogen IX oxidase from Plasmodium falciparum is anaerobic and is localized to the mitochondrion.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20603160"
      },
      {
        "pubmed_id": "24080278",
        "score": 0.42073386907577515,
        "title": "Cytoplasmic irradiation results in mitochondrial dysfunction and DRP1-dependent mitochondrial fission.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24080278"
      }
    ],
    "query_time": 0.017084121704101562,
    "metrics": {
      "precision": 0.2,
      "recall": 1.0,
      "f1_score": 0.33333333333333337,
      "hit@1": 0.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 0.5,
      "relevant_retrieved": 2,
      "total_retrieved": 10,
      "total_relevant": 2
    }
  },
  "602c19e71cb411341a00011a": {
    "query": "What is the mode of administration of AZD8601?",
    "type": "factoid",
    "ideal_answer": [
      "AZD8601 is administered intradermally."
    ],
    "ground_truth_ids": [
      "32438492"
    ],
    "retrieved_ids": [
      "25874001",
      "34408543",
      "22039473",
      "22218274",
      "29155416",
      "30053275",
      "35268299",
      "28990968",
      "24338165",
      "33748156"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "25874001",
        "score": 0.2241072952747345,
        "title": "A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25874001"
      },
      {
        "pubmed_id": "34408543",
        "score": 0.2143314778804779,
        "title": "Cabenuva®: Differentiated service delivery and the community Pharmacists' roles in achieving UNAIDS 2030 target in Nigeria.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/34408543"
      },
      {
        "pubmed_id": "22039473",
        "score": 0.19400613009929657,
        "title": "Deactivation of the default mode network as a marker of impaired consciousness: an fMRI study.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22039473"
      },
      {
        "pubmed_id": "22218274",
        "score": 0.1898793876171112,
        "title": "Disruptions of functional connectivity in the default mode network of comatose patients.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22218274"
      },
      {
        "pubmed_id": "29155416",
        "score": 0.18658608198165894,
        "title": "Eye lens dose monitoring in the UK nuclear industry using active personal dosemeters.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/29155416"
      },
      {
        "pubmed_id": "30053275",
        "score": 0.1844259649515152,
        "title": "SHOULD PERSONNEL OF NUCLEAR MEDICINE DEPARTMENTS USE PERSONAL DOSIMETERS FOR EYE LENS DOSE MONITORING?",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/30053275"
      },
      {
        "pubmed_id": "35268299",
        "score": 0.18422910571098328,
        "title": "Advance Directives in Oncology and Haematology: A Long Way to Go-A Narrative Review.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/35268299"
      },
      {
        "pubmed_id": "28990968",
        "score": 0.1785561442375183,
        "title": "Improvements in Radiation Monitoring Trending.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/28990968"
      },
      {
        "pubmed_id": "24338165",
        "score": 0.17138221859931946,
        "title": "Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): a review of its use in the management of HIV-1 infection in adults.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24338165"
      },
      {
        "pubmed_id": "33748156",
        "score": 0.17072850465774536,
        "title": "Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/33748156"
      }
    ],
    "query_time": 0.016621112823486328,
    "metrics": {
      "precision": 0.0,
      "recall": 0.0,
      "f1_score": 0,
      "hit@1": 0.0,
      "hit@3": 0.0,
      "hit@5": 0.0,
      "hit@10": 0.0,
      "mrr": 0.0,
      "relevant_retrieved": 0,
      "total_retrieved": 10,
      "total_relevant": 1
    }
  },
  "5880be1dc872c95565000007": {
    "query": "Which enzyme is inhibited by niraparib?",
    "type": "factoid",
    "ideal_answer": [
      "Niraparib is a Poly(ADP-ribose) Polymerase (PARP) Inhibitor. It is used for ovarian cancer treatment."
    ],
    "ground_truth_ids": [
      "27898364",
      "26217019",
      "23810788",
      "23934192",
      "27141070",
      "27716873",
      "27717299",
      "26351319",
      "26281686",
      "25685067",
      "25758918",
      "27141062",
      "26513298",
      "24970803",
      "25761096",
      "26518726",
      "23118055",
      "27614696",
      "24356813",
      "27810860"
    ],
    "retrieved_ids": [
      "27898364",
      "25761096",
      "26518726",
      "27810860",
      "8914439",
      "23810788",
      "24356813",
      "23118055",
      "27717299",
      "19323834"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "27898364",
        "score": 0.5686595439910889,
        "title": "Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27898364"
      },
      {
        "pubmed_id": "25761096",
        "score": 0.4933502674102783,
        "title": "Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/25761096"
      },
      {
        "pubmed_id": "26518726",
        "score": 0.4798182249069214,
        "title": "Sirtuins are Unaffected by PARP Inhibitors Containing Planar Nicotinamide Bioisosteres.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/26518726"
      },
      {
        "pubmed_id": "27810860",
        "score": 0.452004075050354,
        "title": "Niraparib Slows Ovarian Cancer Progression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27810860"
      },
      {
        "pubmed_id": "8914439",
        "score": 0.450507789850235,
        "title": "[Drug therapy in subjects with impaired glucose tolerance].",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/8914439"
      },
      {
        "pubmed_id": "23810788",
        "score": 0.4489363133907318,
        "title": "The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23810788"
      },
      {
        "pubmed_id": "24356813",
        "score": 0.4452109932899475,
        "title": "Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/24356813"
      },
      {
        "pubmed_id": "23118055",
        "score": 0.4381243586540222,
        "title": "Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/23118055"
      },
      {
        "pubmed_id": "27717299",
        "score": 0.43787288665771484,
        "title": "Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/27717299"
      },
      {
        "pubmed_id": "19323834",
        "score": 0.4375438988208771,
        "title": "Modulation of inducible nitric oxide synthase expression by sumoylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19323834"
      }
    ],
    "query_time": 0.015449047088623047,
    "metrics": {
      "precision": 0.8,
      "recall": 0.4,
      "f1_score": 0.5333333333333333,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 20
    }
  },
  "5ebac76b0d431b5f7300000d": {
    "query": "Which histone mark is recognized by HP1?",
    "type": "factoid",
    "ideal_answer": [
      "h3k9me3 is the major histone mark that is recognized by hp1.",
      "Here, we present structural, energetic, and mutational analyses of the complex between the Drosophila HP1 chromodomain and the histone H3 tail with a methyllysine at residue 9, a modification associated with epigenetic silencing Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.",
      "Histone H3 at lysine 9 trimethylation (H3K9me3)",
      "Methylation of lysine 9 in histone H3 is recognized by heterochromatin protein 1 (HP1), which directs the binding of other proteins to control chromatin structure and gene expression.",
      "Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. We show that methylated lysine 9 of histone H3 (Me9H3) is a marker of heterochromatin in divergent animal species.",
      "HP1 can bind with high affinity to histone H3 methylated at lysine 9 but not at lysine 4. Methylation of lysine 9 in histone H3 is recognized by heterochromatin protein 1 (HP1), which directs the binding of other proteins to control chromatin structure and gene expression.",
      "Histone H3 at lysine 9 (H3K9me3)",
      "Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.  Here we show that mammalian methyltransferases that selectively methylate histone H3 on lysine 9 (Suv39h HMTases) generate a binding site for HP1 proteins--a family of heterochromatic adaptor molecules implicated in both gene silencing and supra-nucleosomal chromatin structure."
    ],
    "ground_truth_ids": [
      "11242054",
      "27733730",
      "16222246",
      "19788305",
      "17406994",
      "11859155",
      "12897054",
      "17172865",
      "17542647",
      "19880879",
      "23166515",
      "11242053",
      "22514736",
      "18926834",
      "11882902",
      "22815475",
      "12068920"
    ],
    "retrieved_ids": [
      "18926834",
      "17172865",
      "19788305",
      "15970672",
      "11242053",
      "11242054",
      "11882902",
      "16222246",
      "22514736",
      "17168535"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "18926834",
        "score": 0.5431011915206909,
        "title": "Linking Heterochromatin Protein 1 (HP1) to cancer progression.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18926834"
      },
      {
        "pubmed_id": "17172865",
        "score": 0.53640216588974,
        "title": "Dynamic regulation of effector protein binding to histone modifications: the biology of HP1 switching.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17172865"
      },
      {
        "pubmed_id": "19788305",
        "score": 0.5345064401626587,
        "title": "Importance of charge independent effects in readout of the trimethyllysine mark by HP1 chromodomain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19788305"
      },
      {
        "pubmed_id": "15970672",
        "score": 0.5239088535308838,
        "title": "Effector proteins for methylated histones: an expanding family.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15970672"
      },
      {
        "pubmed_id": "11242053",
        "score": 0.5200486779212952,
        "title": "Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11242053"
      },
      {
        "pubmed_id": "11242054",
        "score": 0.5012632012367249,
        "title": "Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11242054"
      },
      {
        "pubmed_id": "11882902",
        "score": 0.5000535845756531,
        "title": "Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11882902"
      },
      {
        "pubmed_id": "16222246",
        "score": 0.49161607027053833,
        "title": "Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/16222246"
      },
      {
        "pubmed_id": "22514736",
        "score": 0.47714585065841675,
        "title": "Structural basis of the chromodomain of Cbx3 bound to methylated peptides from histone h1 and G9a.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/22514736"
      },
      {
        "pubmed_id": "17168535",
        "score": 0.472732812166214,
        "title": "MLL core components give the green light to histone methylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17168535"
      }
    ],
    "query_time": 0.039649009704589844,
    "metrics": {
      "precision": 0.8,
      "recall": 0.47058823529411764,
      "f1_score": 0.5925925925925927,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 8,
      "total_retrieved": 10,
      "total_relevant": 17
    }
  },
  "533be71dfd9a95ea0d000009": {
    "query": "Which is the histone residue methylated by MLL1?",
    "type": "factoid",
    "ideal_answer": [
      "Histone H3 at lysine 4 (H3K4)"
    ],
    "ground_truth_ids": [
      "18562676",
      "16651450",
      "19855399",
      "17942719",
      "15960975",
      "21875999",
      "22666422",
      "21124902",
      "19187761",
      "18838538",
      "15941828",
      "17168535",
      "21113167",
      "22488473",
      "19818711",
      "19219072",
      "23399917",
      "20861184",
      "22046413",
      "19481096",
      "23038103"
    ],
    "retrieved_ids": [
      "17168535",
      "15970672",
      "15941828",
      "18838538",
      "11859155",
      "11242054",
      "19788305",
      "19187761",
      "20861184",
      "11242053"
    ],
    "retrieved_docs": [
      {
        "pubmed_id": "17168535",
        "score": 0.6766814589500427,
        "title": "MLL core components give the green light to histone methylation.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/17168535"
      },
      {
        "pubmed_id": "15970672",
        "score": 0.6402753591537476,
        "title": "Effector proteins for methylated histones: an expanding family.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15970672"
      },
      {
        "pubmed_id": "15941828",
        "score": 0.5846495628356934,
        "title": "Global and Hox-specific roles for the MLL1 methyltransferase.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/15941828"
      },
      {
        "pubmed_id": "18838538",
        "score": 0.5783007740974426,
        "title": "Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/18838538"
      },
      {
        "pubmed_id": "11859155",
        "score": 0.5625674724578857,
        "title": "Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11859155"
      },
      {
        "pubmed_id": "11242054",
        "score": 0.5615067481994629,
        "title": "Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11242054"
      },
      {
        "pubmed_id": "19788305",
        "score": 0.555787205696106,
        "title": "Importance of charge independent effects in readout of the trimethyllysine mark by HP1 chromodomain.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19788305"
      },
      {
        "pubmed_id": "19187761",
        "score": 0.5520657300949097,
        "title": "Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/19187761"
      },
      {
        "pubmed_id": "20861184",
        "score": 0.5504144430160522,
        "title": "Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/20861184"
      },
      {
        "pubmed_id": "11242053",
        "score": 0.5449429750442505,
        "title": "Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.",
        "link": "http://www.ncbi.nlm.nih.gov/pubmed/11242053"
      }
    ],
    "query_time": 0.014361143112182617,
    "metrics": {
      "precision": 0.5,
      "recall": 0.23809523809523808,
      "f1_score": 0.3225806451612903,
      "hit@1": 1.0,
      "hit@3": 1.0,
      "hit@5": 1.0,
      "hit@10": 1.0,
      "mrr": 1.0,
      "relevant_retrieved": 5,
      "total_retrieved": 10,
      "total_relevant": 21
    }
  }
}